1 00:00:05,604 --> 00:00:07,039 GOOD AFTERNOON. 2 00:00:07,039 --> 00:00:11,177 MY NAME IS MARY GLENSHAW, 3 00:00:11,177 --> 00:00:15,214 DESIGNATED FEDERAL OFFICIAL OR 4 00:00:15,214 --> 00:00:18,718 EXECUTIVE SECRETARY OF THE 5 00:00:18,718 --> 00:00:19,352 ADVISORY COUNCIL. 6 00:00:19,352 --> 00:00:28,160 OUR COUNCIL IS GOVERNED BY FACA 7 00:00:28,160 --> 00:00:29,595 SETTING FORTH FORMATION AND USE 8 00:00:29,595 --> 00:00:30,529 OF ADVISORY COMMITTEES. 9 00:00:30,529 --> 00:00:33,933 IN THIS REGARD MY ROLE IS TO 10 00:00:33,933 --> 00:00:35,401 PREPARE MEETING AGENDAS, 11 00:00:35,401 --> 00:00:37,336 ORGANIZE MEETINGS, ATTEND AND 12 00:00:37,336 --> 00:00:39,005 APPROVE COUNCIL AND SUBCOMMITTEE 13 00:00:39,005 --> 00:00:39,872 MEETINGS, ADJOURN MEETING WHEN 14 00:00:39,872 --> 00:00:50,383 DETERMINED TO BE IN THE PUBLIC 15 00:00:53,052 --> 00:00:53,419 INTEREST. 16 00:00:53,419 --> 00:00:55,421 AS PREVIOUS MEETINGS, WE'LL GO 17 00:00:55,421 --> 00:00:58,457 OVER GENERAL GUIDELINES FOR 18 00:00:58,457 --> 00:00:59,191 TODAY. 19 00:00:59,191 --> 00:01:00,860 FIRST PLEASE STAY MUTED UNLESS 20 00:01:00,860 --> 00:01:01,227 YOU'RE SPEAKING. 21 00:01:01,227 --> 00:01:02,628 PLEASE KEEP YOUR CAMERA ON FOR 22 00:01:02,628 --> 00:01:03,929 MOST OF THE MEETING, YOU'RE 23 00:01:03,929 --> 00:01:05,364 WELCOME TO HIDE YOUR CAMERA IF 24 00:01:05,364 --> 00:01:07,967 YOU NEED TO LEAVE MOMENTARILY. 25 00:01:07,967 --> 00:01:08,934 WHEN YOU'D LIKE TO PARTICIPATE 26 00:01:08,934 --> 00:01:13,005 IN DISCUSSIONS WE ASK YOU TO USE 27 00:01:13,005 --> 00:01:14,673 THE "RAISE HAND" FEATURE, IF YOU 28 00:01:14,673 --> 00:01:15,574 ARE ABLE TO. 29 00:01:15,574 --> 00:01:17,410 DR. TURNBULL AND I WILL NOTE 30 00:01:17,410 --> 00:01:18,844 THOSE WHO WANT TO SPEAK AND CALL 31 00:01:18,844 --> 00:01:21,814 ON YOU IN TURN TO AVOID SPEAKING 32 00:01:21,814 --> 00:01:23,149 OVER EACH OTHER. 33 00:01:23,149 --> 00:01:24,784 PLEASE BE AWARE YOU NEED TO 34 00:01:24,784 --> 00:01:27,486 LOWER YOUR HAND ONCE YOU'VE MADE 35 00:01:27,486 --> 00:01:28,621 YOUR REMARKS. 36 00:01:28,621 --> 00:01:31,223 FOR THIS MEETING THE ZOOM CHAT 37 00:01:31,223 --> 00:01:34,293 MEET HAS BEEN DISABLED EXCEPT 38 00:01:34,293 --> 00:01:35,428 FOR LOGISTICS MESSAGES TO THE 39 00:01:35,428 --> 00:01:36,262 HOST. 40 00:01:36,262 --> 00:01:46,105 IF YOU HAVE ISSUES OR CONCERNS 41 00:01:46,105 --> 00:01:47,440 E-MAIL OARAFINFO@NIH.GOV. 42 00:01:47,440 --> 00:01:49,942 OR YOU CAN TEXT ME ON MY CELL 43 00:01:49,942 --> 00:01:50,409 PHONE. 44 00:01:50,409 --> 00:01:52,244 FOR EVERYONE ON THE VIDEOCAST, 45 00:01:52,244 --> 00:01:54,013 IF YOU'D LIKE TO SEE CLOSED 46 00:01:54,013 --> 00:01:55,514 CAPTION FOR THE MEETINGS CLICK 47 00:01:55,514 --> 00:01:57,516 ON THE C.C. ICON AT THE BOTTOM 48 00:01:57,516 --> 00:02:00,252 RIGHT-HAND CORNER OF THE SCREEN. 49 00:02:00,252 --> 00:02:03,422 I'LL NOW REMIND MEMBERS OF 50 00:02:03,422 --> 00:02:06,158 POLICIES REGARDING CONFLICTS OF 51 00:02:06,158 --> 00:02:06,425 INTEREST. 52 00:02:06,425 --> 00:02:07,326 COUNCIL MEMBERS MAY NOT 53 00:02:07,326 --> 00:02:08,994 PARTICIPATE IN THE REVIEW OR 54 00:02:08,994 --> 00:02:11,163 DISCUSSION OF A SPECIFIC PROGRAM 55 00:02:11,163 --> 00:02:12,832 OR PROJECT FOR WHICH THEY HAVE A 56 00:02:12,832 --> 00:02:15,234 REAL OR APPARENT CONFLICT OF 57 00:02:15,234 --> 00:02:15,601 INTEREST. 58 00:02:15,601 --> 00:02:17,203 IF A PROGRAM OR PROJECT IS 59 00:02:17,203 --> 00:02:22,208 DISCUSSED THAT PRESENTS A 60 00:02:22,208 --> 00:02:23,342 CONFLICT YOU MUST EXCUSE 61 00:02:23,342 --> 00:02:25,311 YOURSELF FROM THE ZOOM CALL. 62 00:02:25,311 --> 00:02:26,912 SIGNAL ME AND WE'LL MOVE YOU 63 00:02:26,912 --> 00:02:28,247 INTO A SEPARATE CASE. 64 00:02:28,247 --> 00:02:29,715 AFTER THE MEETING SIGN THE 65 00:02:29,715 --> 00:02:31,450 CONFLICT OF INTEREST FORM THAT 66 00:02:31,450 --> 00:02:33,752 WE WILL BE SENDING YOU THIS 67 00:02:33,752 --> 00:02:35,187 AFTERNOON, AND PLEASE E-MAIL IT 68 00:02:35,187 --> 00:02:37,389 BACK TO VERIFY THAT NOTHING 69 00:02:37,389 --> 00:02:39,458 TODAY POSED A CONFLICT FOR YOU. 70 00:02:39,458 --> 00:02:41,327 BEFORE I MOVE FORWARD, I'M HAPPY 71 00:02:41,327 --> 00:02:44,630 TO ANSWER QUESTIONS ABOUT 72 00:02:44,630 --> 00:02:47,566 CONFLICTS OF INTEREST, IF THERE 73 00:02:47,566 --> 00:02:49,502 ARE ANY. 74 00:02:49,502 --> 00:02:49,702 OKAY. 75 00:02:49,702 --> 00:02:51,270 HEARING NONE, PLEASE REMEMBER 76 00:02:51,270 --> 00:02:52,671 TODAY'S MEETING IS OPEN TO THE 77 00:02:52,671 --> 00:02:55,374 GENERAL PUBLIC AND IS CURRENTLY 78 00:02:55,374 --> 00:02:56,642 RECORDED AND VIDEOCAST LIVE. 79 00:02:56,642 --> 00:02:58,511 I'LL NOW TURN THE MEETING OVER 80 00:02:58,511 --> 00:03:00,679 TO OUR CHAIR, DR. IVY TURNBULL, 81 00:03:00,679 --> 00:03:03,415 TO BRING THE MEETING TO ORDER. 82 00:03:03,415 --> 00:03:04,850 THANK YOU. 83 00:03:04,850 --> 00:03:06,752 >> THANK YOU, DR. GLENSHAW. 84 00:03:06,752 --> 00:03:09,421 GOOD AFTERNOON, EVERYONE. 85 00:03:09,421 --> 00:03:12,191 THE 66th MEETING OF OFFICE OF 86 00:03:12,191 --> 00:03:13,626 AIDS RESEARCH ADVISORY COUNCIL, 87 00:03:13,626 --> 00:03:17,563 OARAC, IS NOW IN SESSION. 88 00:03:17,563 --> 00:03:19,532 WELCOME, COUNCIL MEMBERS, 89 00:03:19,532 --> 00:03:21,433 INVITED SPEAKERS AND GUESTS. 90 00:03:21,433 --> 00:03:26,872 COLLEAGUES, WE'LL NOW CONDUCT 91 00:03:26,872 --> 00:03:30,809 THE ROLL CALL. 92 00:03:30,809 --> 00:03:32,011 STATE YOUR POSITION AND 93 00:03:32,011 --> 00:03:32,311 INSTITUTION. 94 00:03:32,311 --> 00:03:35,214 DR. GLENSHAW, PROCEED WITH THE 95 00:03:35,214 --> 00:03:36,081 ROLL CALL. 96 00:03:36,081 --> 00:03:37,183 >> THANK YOU VERY MUCH. 97 00:03:37,183 --> 00:03:42,421 WE'LL START WITH OUR VOTING 98 00:03:42,421 --> 00:03:44,390 MEMBERS, DR. OMAR GALARRAGA. 99 00:03:44,390 --> 00:03:47,560 >> OMAR GAL RAGA DIRECTOR OF 100 00:03:47,560 --> 00:03:48,093 HEALTH SERVICES DOCTORAL 101 00:03:48,093 --> 00:03:49,662 PROGRAM, BROWN UNIVERSITY SCHOOL 102 00:03:49,662 --> 00:03:50,896 OF PUBLIC HEALTH, PROVIDENCE, 103 00:03:50,896 --> 00:03:55,434 RHODE ISLAND. 104 00:03:55,434 --> 00:03:56,869 >> THANK YOU. 105 00:03:56,869 --> 00:04:00,239 DR. LUIS MONTANER. 106 00:04:00,239 --> 00:04:01,907 >> PROFESSOR OF IMMUNOLOGY AND 107 00:04:01,907 --> 00:04:05,611 HIV CURE RAB AER TO. 108 00:04:05,611 --> 00:04:06,145 >> THANK YOU. 109 00:04:06,145 --> 00:04:07,947 DR. SHRUTI MEHTA I DON'T BELIEVE 110 00:04:07,947 --> 00:04:10,883 HAS JOINED US, IS TRAVELING BUT 111 00:04:10,883 --> 00:04:15,054 TRYING TO JOIN LATER. 112 00:04:15,054 --> 00:04:17,756 DR. NAGHAVI? 113 00:04:17,756 --> 00:04:19,391 >> I'M MOJGAN NAGHAVI, PROFESSOR 114 00:04:19,391 --> 00:04:22,661 AT DEPARTMENT OF MICROBIOLOGY 115 00:04:22,661 --> 00:04:24,430 AND IMMUNOLOGY, NORTHWESTERN 116 00:04:24,430 --> 00:04:25,731 UNIVERSITY. 117 00:04:25,731 --> 00:04:26,198 >> WELCOME. 118 00:04:26,198 --> 00:04:29,568 DR. ANNE NEILAN. 119 00:04:29,568 --> 00:04:31,403 >> GOOD AFTERNOON, INFECTIOUS 120 00:04:31,403 --> 00:04:32,738 DISEASE PHYSICIAN AT 121 00:04:32,738 --> 00:04:34,707 MASSACHUSETTS GENERAL HOSPITAL, 122 00:04:34,707 --> 00:04:34,940 BOSTON. 123 00:04:34,940 --> 00:04:36,875 DIRECT THE RESEARCH PROGRAM IN 124 00:04:36,875 --> 00:04:38,544 ADOLESCENT HEALTH MEDICAL 125 00:04:38,544 --> 00:04:40,512 PRACTICE EVALUATION CENTER, 126 00:04:40,512 --> 00:04:41,981 ASSISTANT PROFESSOR OF 127 00:04:41,981 --> 00:04:46,051 PEDIATRICS AND MEDICINE HARVARD 128 00:04:46,051 --> 00:04:46,418 MEDICAL SCHOOL. 129 00:04:46,418 --> 00:04:50,923 >> WE HAVE A VERY, VERY RECENTLY 130 00:04:50,923 --> 00:04:52,858 JOINED NEW VOTING MEMBER, DR. 131 00:04:52,858 --> 00:04:55,060 COURTNEY FLETCHER, TRYING TO 132 00:04:55,060 --> 00:04:57,263 JOIN US LATER THIS MORNING, I'LL 133 00:04:57,263 --> 00:04:57,730 INTRODUCE BRIEFLY. 134 00:04:57,730 --> 00:05:08,007 DR. PHILADELPHIA - FLETCHER ISF 135 00:05:08,007 --> 00:05:09,475 ANTI-VIRAL PHARMACOLOGY LAB AT 136 00:05:09,475 --> 00:05:11,410 CENTER FOR DRUG DISCOVERY AT THE 137 00:05:11,410 --> 00:05:13,212 UNIVERSITY OF NEBRASKA MEDICAL 138 00:05:13,212 --> 00:05:15,848 CENTER, DR. FLETCHER HAS DEVOTED 139 00:05:15,848 --> 00:05:17,383 HIS RESEARCH AND PRACTICE 140 00:05:17,383 --> 00:05:19,418 INTERESTS TOWARDS CLINICAL 141 00:05:19,418 --> 00:05:20,119 PHARMACOLOGY OF ANTI-VIRAL 142 00:05:20,119 --> 00:05:20,552 AGENTS. 143 00:05:20,552 --> 00:05:23,222 AND HE RECEIVED HIS DOCTOR OF 144 00:05:23,222 --> 00:05:24,790 PHARMACY DEGREE FROM UNIVERSITY 145 00:05:24,790 --> 00:05:25,891 OF MINNESOTA IN MINNEAPOLIS. 146 00:05:25,891 --> 00:05:29,094 SO WE HOPE HE CAN JOIN US LATER 147 00:05:29,094 --> 00:05:29,662 THIS MORNING. 148 00:05:29,662 --> 00:05:30,929 OR THIS AFTERNOON. 149 00:05:30,929 --> 00:05:34,099 I'LL NOW MOVE TO OUR EX 150 00:05:34,099 --> 00:05:40,205 OFFICIOS, I DON'T BELIEVE SHE'S 151 00:05:40,205 --> 00:05:41,540 JOINED YET BUT COLONEL JULIE AKE 152 00:05:41,540 --> 00:05:44,043 WILL JOIN US LATER. 153 00:05:44,043 --> 00:05:46,478 DR. VICKIE DAVEEY. 154 00:05:46,478 --> 00:05:48,681 >> FROM THE V.A., DEPARTMENT OF 155 00:05:48,681 --> 00:05:50,616 VETERANS AFFAIRS, IN THE U.S. 156 00:05:50,616 --> 00:05:54,486 OFFICE OF RESEARCH AND 157 00:05:54,486 --> 00:05:55,854 DEVELOPMENT. 158 00:05:55,854 --> 00:05:56,188 >> WELCOME. 159 00:05:56,188 --> 00:05:57,956 DR. DIEFFENBACH? 160 00:05:57,956 --> 00:06:00,025 >> GOOD MORNING, DIRECTOR OF 161 00:06:00,025 --> 00:06:00,859 DIVISION OF AIDS, NATIONAL 162 00:06:00,859 --> 00:06:02,127 INSTITUTES OF ALLERGY, 163 00:06:02,127 --> 00:06:02,861 INFECTIOUS DISEASE, IT'S A 164 00:06:02,861 --> 00:06:04,997 PLEASURE TO BE HERE. 165 00:06:04,997 --> 00:06:08,834 >> THANK YOU, WELCOME. 166 00:06:08,834 --> 00:06:11,103 DR. JONATHAN MERMIN. 167 00:06:11,103 --> 00:06:13,339 >> DIRECTOR OF NATIONAL CENTER 168 00:06:13,339 --> 00:06:17,343 FOR HIV VIRAL HEPATITIS, STD AND 169 00:06:17,343 --> 00:06:18,243 PREVENTION, AT THE CDC. 170 00:06:18,243 --> 00:06:19,011 GREAT TO BE HERE. 171 00:06:19,011 --> 00:06:20,346 >> GREAT TO SEE YOU. 172 00:06:20,346 --> 00:06:22,081 I DON'T BELIEVE OUR ADVISORY 173 00:06:22,081 --> 00:06:24,350 COUNCIL REPRESENTATIVES ARE HERE 174 00:06:24,350 --> 00:06:30,089 WITH THE EXCEPTION OF DR. ELAINE 175 00:06:30,089 --> 00:06:30,989 ABRAMS. 176 00:06:30,989 --> 00:06:33,692 >> PROFESSOR OF PEDIATRICS AND 177 00:06:33,692 --> 00:06:34,159 EPIDEMIOLOGY, COLUMBIA 178 00:06:34,159 --> 00:06:34,693 UNIVERSITY. 179 00:06:34,693 --> 00:06:37,162 >> THANK YOU FOR JOINING US 180 00:06:37,162 --> 00:06:37,696 TODAY, DR. ABRAMS. 181 00:06:37,696 --> 00:06:45,838 I KNOW THIS IS YOUR FIRST OARAC 182 00:06:45,838 --> 00:06:46,805 MEETING. 183 00:06:46,805 --> 00:06:49,775 NOW LEADERS AND SPEAKERS. 184 00:06:49,775 --> 00:06:51,410 DR. FINZI. 185 00:06:51,410 --> 00:06:52,845 >> GOOD AFTERNOON, I AM ACTING 186 00:06:52,845 --> 00:06:55,981 DIRECTOR OF THE OFFICE OF AIDS 187 00:06:55,981 --> 00:06:58,183 RESEARCH AND I AM ALSO THE 188 00:06:58,183 --> 00:07:02,121 DIRECTOR OF THE BASIC SCIENCES 189 00:07:02,121 --> 00:07:06,091 PROGRAM AT NIAID. 190 00:07:06,091 --> 00:07:07,393 >> THANK YOU. 191 00:07:07,393 --> 00:07:07,860 MS. RACHEL ANDERSON. 192 00:07:07,860 --> 00:07:09,995 >> GOOD AFTERNOON, RACHEL 193 00:07:09,995 --> 00:07:13,532 ANDERSON, SENIOR POLICY ADVISER 194 00:07:13,532 --> 00:07:18,203 AT OAR. 195 00:07:18,203 --> 00:07:18,570 >> THANK YOU. 196 00:07:18,570 --> 00:07:21,006 AND BRETTA BIRD ABOUT JOIN US 197 00:07:21,006 --> 00:07:21,473 LATER. 198 00:07:21,473 --> 00:07:29,448 I'D LIKE TO WELCOME INVITED 199 00:07:29,448 --> 00:07:30,649 GUESTS, MR. FRANCISCO RUIZ. 200 00:07:30,649 --> 00:07:31,984 >> NICE TO MEET YOU. 201 00:07:31,984 --> 00:07:34,353 >> NICE TO MEET YOU, MR. RUIZ IS 202 00:07:34,353 --> 00:07:35,687 DIRECTOR OF THE WHITE HOUSE 203 00:07:35,687 --> 00:07:37,656 OFFICE OF NATIONAL AIDS POLICY. 204 00:07:37,656 --> 00:07:40,092 WE'RE VERY EXCITED FOR YOU TO 205 00:07:40,092 --> 00:07:44,329 JOIN US TODAY. 206 00:07:44,329 --> 00:07:46,298 DR. MARTINS? 207 00:07:46,298 --> 00:07:51,870 >> I'M ASSOCIATE PROFESSOR IN 208 00:07:51,870 --> 00:07:52,504 SCRIPPS INSTITUTE PART OF 209 00:07:52,504 --> 00:07:53,639 UNIVERSITY OF FLORIDA NOW. 210 00:07:53,639 --> 00:07:57,276 THANK YOU FOR THE INVITATION. 211 00:07:57,276 --> 00:08:06,118 >> THANK YOU. 212 00:08:06,118 --> 00:08:13,325 KIMBERLY CANADY-GRIFFITH WILL 213 00:08:13,325 --> 00:08:17,830 JOIN US LATER, AND AND DR. 214 00:08:17,830 --> 00:08:21,467 SHOKTUR WILL JOIN US LATER. 215 00:08:21,467 --> 00:08:28,106 DR. TURNBULL, BACK TO YOU. 216 00:08:28,106 --> 00:08:31,844 >> THANK YOU. 217 00:08:31,844 --> 00:08:39,985 >> THE OARAC ADVISES INCLUDING 218 00:08:39,985 --> 00:08:43,021 REVIEW OF NIH HIV/AIDS PROGRAMS, 219 00:08:43,021 --> 00:08:45,624 I WILL NOW PROVIDE A BRIEF 220 00:08:45,624 --> 00:08:47,626 OVERVIEW OF TODAY'S AGENDA, 221 00:08:47,626 --> 00:08:51,630 WHICH WILL INCLUDE A REPORT FROM 222 00:08:51,630 --> 00:08:53,832 THE ACTING OAR DIRECTOR, DR. 223 00:08:53,832 --> 00:08:56,768 DIANA FINZI, AN UPDATE FROM DR. 224 00:08:56,768 --> 00:08:59,438 RACHEL ANDERSON ON NIH STRATEGIC 225 00:08:59,438 --> 00:09:02,040 PLAN FOR HIV AND HIV-RELATED 226 00:09:02,040 --> 00:09:02,441 RESEARCH. 227 00:09:02,441 --> 00:09:04,643 A PRESENTATION FROM 228 00:09:04,643 --> 00:09:06,645 MR. FRANCISCO RUIZ, THE NEW 229 00:09:06,645 --> 00:09:08,180 DIRECTOR OF THE WHITE HOUSE 230 00:09:08,180 --> 00:09:11,550 OFFICE OF AIDS NATIONAL AIDS 231 00:09:11,550 --> 00:09:12,050 POLICY. 232 00:09:12,050 --> 00:09:14,720 A SPECIAL SEGMENT ON THE ISSUES 233 00:09:14,720 --> 00:09:18,156 OF PERINATAL HIV RESEARCH AND 234 00:09:18,156 --> 00:09:22,261 RESPONSES WHICH INCLUDES 235 00:09:22,261 --> 00:09:28,066 PRESENTATION FROM DR. MAURICIO 236 00:09:28,066 --> 00:09:30,402 MARTINS AND MS. KIMBERLY CANADY, 237 00:09:30,402 --> 00:09:32,371 FOLLOWING THAT AN UPDATE FROM 238 00:09:32,371 --> 00:09:36,408 THE RESEARCH COMMITTEE, WE'LL 239 00:09:36,408 --> 00:09:38,377 HAVE AN UPDATE FROM NIH ADVISORY 240 00:09:38,377 --> 00:09:39,912 COMMITTEE, FINALLY AN UPDATE 241 00:09:39,912 --> 00:09:44,650 FROM ONE OF THE OAR HIV CLINICAL 242 00:09:44,650 --> 00:09:46,785 GUIDELINES WORKING GROUPS. 243 00:09:46,785 --> 00:09:49,688 THE AGENDA ALSO INCLUDES TIME 244 00:09:49,688 --> 00:09:51,924 FOR REGISTERED PUBLIC COMMENT. 245 00:09:51,924 --> 00:09:53,625 ANYONE INTERESTED IN TODAY 246 00:09:53,625 --> 00:10:02,234 WISHING TO MAKE A PUBLIC COMMENT 247 00:10:02,234 --> 00:10:06,204 SHOULD E-MAIL OARACINFO@NIH.GOV. 248 00:10:06,204 --> 00:10:08,273 WITH YOUR NAME, AFFILIATION, AND 249 00:10:08,273 --> 00:10:10,042 QUESTION OR COMMENT. 250 00:10:10,042 --> 00:10:13,345 PLEASE VISIT THE NIH OAR WEBSITE 251 00:10:13,345 --> 00:10:17,549 OR THE FEDERAL REGISTRY NOTICE 252 00:10:17,549 --> 00:10:18,550 FOR MORE DETAIL. 253 00:10:18,550 --> 00:10:21,186 NOW I INTRODUCE DR. DIANA FINZI, 254 00:10:21,186 --> 00:10:24,990 ACTING NIH ASSOCIATE DIRECTOR OF 255 00:10:24,990 --> 00:10:26,191 AIDS RESEARCH, ACTING DIRECTOR 256 00:10:26,191 --> 00:10:27,426 OF OAR. 257 00:10:27,426 --> 00:10:29,962 DR. FINZI, I TURN IT OVER TO 258 00:10:29,962 --> 00:10:32,130 YOU. 259 00:10:32,130 --> 00:10:33,565 >> THANK YOU, DR. TURNBULL. 260 00:10:33,565 --> 00:10:38,470 SO, I WILL START BY LETTING YOU 261 00:10:38,470 --> 00:10:40,639 KNOW THAT PERMANENT OAR DIRECTOR 262 00:10:40,639 --> 00:10:43,008 SHOULD BE ANNOUNCED VERY SOON. 263 00:10:43,008 --> 00:10:45,210 IN THE MEANTIME I WOULD LIKE TO 264 00:10:45,210 --> 00:10:48,981 MENTION HOW GRATEFUL I HAVE BEEN 265 00:10:48,981 --> 00:10:51,350 FOR THIS EXPERIENCE AS ACTING 266 00:10:51,350 --> 00:10:54,586 DIRECTOR OF THE OFFICE OF AIDS 267 00:10:54,586 --> 00:10:55,120 RESEARCH. 268 00:10:55,120 --> 00:10:56,021 I'VE LEARNED SO MUCH ABOUT 269 00:10:56,021 --> 00:10:58,724 PEOPLE HERE AND ABOUT YOU WHO 270 00:10:58,724 --> 00:11:01,226 THE OAR FUNCTIONS AND THE 271 00:11:01,226 --> 00:11:05,731 AMAZING BREADTH OF RESEARCH ON 272 00:11:05,731 --> 00:11:08,200 HIV THAT IS COVERED BY THE OAR 273 00:11:08,200 --> 00:11:10,469 AND THE NIH AS A WHOLE. 274 00:11:10,469 --> 00:11:16,108 AND JUST A FEW HIGHLIGHTS WILL 275 00:11:16,108 --> 00:11:18,744 INCLUDE PUBLISHING A NOTICE OF 276 00:11:18,744 --> 00:11:20,379 INFORMATION AND SPECIAL NOSI 277 00:11:20,379 --> 00:11:23,348 WITH THE OFFICE OF RESEARCH ON 278 00:11:23,348 --> 00:11:24,983 WOMEN'S HEALTH, AND THAT 279 00:11:24,983 --> 00:11:26,618 REAFFIRMS OUR SHARED COMMITMENT 280 00:11:26,618 --> 00:11:29,388 TO ADVANCING SCIENCE ON HIV AND 281 00:11:29,388 --> 00:11:31,456 WOMEN'S HEALTH. 282 00:11:31,456 --> 00:11:38,563 WORKING ON VARIOUS DOCUMENTS, 283 00:11:38,563 --> 00:11:39,865 INCLUDING PROFESSIONAL JUDGMENT, 284 00:11:39,865 --> 00:11:42,534 THE STRATEGIC PLAN, THE OAR 285 00:11:42,534 --> 00:11:44,036 BUDGET DOCUMENTS, AND EVEN 286 00:11:44,036 --> 00:11:46,672 REALLY ON THE DAY-TO-DAY WORK 287 00:11:46,672 --> 00:11:51,043 THAT THE OAR DOES IN APPROVING 288 00:11:51,043 --> 00:11:51,910 FUNDING. 289 00:11:51,910 --> 00:11:54,112 AND WE'VE ALSO PARTICIPATED, AND 290 00:11:54,112 --> 00:11:55,847 I PERSONNEL HAVE PARTICIPATED, 291 00:11:55,847 --> 00:11:57,716 IN MANY DIFFERENT ENGAGEMENTS 292 00:11:57,716 --> 00:11:58,817 INCLUDING MEMBERS OF CONGRESS. 293 00:11:58,817 --> 00:12:02,954 SO NOW JUST TO GIVE AN OVERVIEW, 294 00:12:02,954 --> 00:12:06,024 FOR TODAY, TODAY WE WILL SHARE 295 00:12:06,024 --> 00:12:10,095 SOME UPDATES ON OARAC, ON NIH, 296 00:12:10,095 --> 00:12:12,364 AND OTHER LEADERSHIP 297 00:12:12,364 --> 00:12:14,332 TRANSITIONS, FY 2026 298 00:12:14,332 --> 00:12:15,767 PROFESSIONAL JUDGMENT, OAR 299 00:12:15,767 --> 00:12:16,968 ENGAGEMENTS, AND ON THE 300 00:12:16,968 --> 00:12:18,003 STRATEGIC PLAN. 301 00:12:18,003 --> 00:12:20,906 AND I WILL CLOSE BY KICKING OFF 302 00:12:20,906 --> 00:12:22,808 OUR DISCUSSION OF A VERY 303 00:12:22,808 --> 00:12:24,643 IMPORTANT POPULATION TO US, AND 304 00:12:24,643 --> 00:12:31,083 TO OUR WORK, THOSE WHO ACQUIRED 305 00:12:31,083 --> 00:12:31,983 HIV PERINATALLY. 306 00:12:31,983 --> 00:12:36,354 FIRST I WANTED TO SAY HAPPY 307 00:12:36,354 --> 00:12:36,588 PRIDE. 308 00:12:36,588 --> 00:12:38,890 NIH RECOGNIZES JUNE AS PRIDE 309 00:12:38,890 --> 00:12:40,692 MONTH AND REAFFIRMS OUR 310 00:12:40,692 --> 00:12:42,627 COMMITMENT TO UPLIFTING AND 311 00:12:42,627 --> 00:12:48,233 CELEBRATING THE LIVED 312 00:12:48,233 --> 00:12:50,535 EXPERIENCES OF OUR LGBTQIA+ 313 00:12:50,535 --> 00:12:51,503 PEOPLE, EMPLOYEES AND PEOPLE 314 00:12:51,503 --> 00:12:51,937 EVERYWHERE. 315 00:12:51,937 --> 00:12:54,005 YOU CAN LEARN MORE ABOUT ALL OF 316 00:12:54,005 --> 00:12:57,843 OUR ACTIVITIES BY SCANNING THE 317 00:12:57,843 --> 00:13:02,013 QR CODE HERE. 318 00:13:02,013 --> 00:13:04,616 AND THEN NEXT SLIDE, I'M NOT 319 00:13:04,616 --> 00:13:07,519 SURE IF WE HAVE COURTNEY HERE 320 00:13:07,519 --> 00:13:08,787 YET OR NOT. 321 00:13:08,787 --> 00:13:11,423 BUT I WANTED TO WELCOME 322 00:13:11,423 --> 00:13:16,261 COURTNEY, AND WE LOOK FORWARD TO 323 00:13:16,261 --> 00:13:19,498 HIS PARTICIPATION ON COUNCIL. 324 00:13:19,498 --> 00:13:22,267 THEN MOVING TO A FEW TRANSITIONS 325 00:13:22,267 --> 00:13:27,873 AT THE NIH LEADERSHIP LEVEL, NIH 326 00:13:27,873 --> 00:13:31,376 WELCOMES DR. KATHLEEN NEUZIL AS 327 00:13:31,376 --> 00:13:31,977 FOGARTY INTERNATIONAL NEWEST 328 00:13:31,977 --> 00:13:34,312 DIRECTOR, AND SHE WILL BE THE 329 00:13:34,312 --> 00:13:36,448 FIRST WOMAN TO HOLD THIS 330 00:13:36,448 --> 00:13:39,417 POSITION, AND SHE COMES TO US 331 00:13:39,417 --> 00:13:40,886 FROM THE UNIVERSITY OF MARYLAND, 332 00:13:40,886 --> 00:13:43,021 WHERE SHE SERVED AS THE DIRECTOR 333 00:13:43,021 --> 00:13:44,589 OF THE CENTER FOR VACCINE 334 00:13:44,589 --> 00:13:46,024 DEVELOPMENT AND GLOBAL HEALTH. 335 00:13:46,024 --> 00:13:49,928 AND WAS ALSO THE CHIEF OF THE 336 00:13:49,928 --> 00:13:51,496 DIVISION OF GEOGRAPHIC MEDICINE 337 00:13:51,496 --> 00:13:56,134 AT THE UNIVERSITY OF MARYLAND IN 338 00:13:56,134 --> 00:13:56,802 BALTIMORE. 339 00:13:56,802 --> 00:13:59,971 AND THEN LAST WEEK, DR. JOSHUA 340 00:13:59,971 --> 00:14:01,606 GORDON DEPARTED FROM HIS 341 00:14:01,606 --> 00:14:02,908 POSITION AT DIRECTOR OF THE 342 00:14:02,908 --> 00:14:05,644 NATIONAL INSTITUTE OF MENTAL 343 00:14:05,644 --> 00:14:07,412 HEALTH, TO RETURN TO COLUMBIA 344 00:14:07,412 --> 00:14:10,415 UNIVERSITY, AS CHAIR OF THE 345 00:14:10,415 --> 00:14:12,517 DEPARTMENT OF PSYCHIATRY AND 346 00:14:12,517 --> 00:14:15,153 PSYCHIATRIST IN CHIEF OF THE NEW 347 00:14:15,153 --> 00:14:16,054 YORK-PRESBYTERIAN HOSPITAL. 348 00:14:16,054 --> 00:14:19,691 DR. GORDON WILL ALSO SERVE AS 349 00:14:19,691 --> 00:14:22,194 THE DIRECTOR OF THE NEW YORK 350 00:14:22,194 --> 00:14:24,296 STATE PSYCHIATRIC INSTITUTE. 351 00:14:24,296 --> 00:14:26,698 AND FOLLOWING HIS DEPARTURE AND 352 00:14:26,698 --> 00:14:30,769 WHILE NIH CONDUCTING A NATIONAL 353 00:14:30,769 --> 00:14:33,738 SEARCH FOR A REPLACEMENT, THE 354 00:14:33,738 --> 00:14:37,375 CURRENT NIMH DEPUTY DIRECTOR, 355 00:14:37,375 --> 00:14:42,047 DR. SHELLY AVENEVOLI, WILL SERVE 356 00:14:42,047 --> 00:14:44,149 AS ACTING DIRECTOR. 357 00:14:44,149 --> 00:14:47,652 AND ONE TRANSITION TO NOTE FROM 358 00:14:47,652 --> 00:14:49,154 OUTSIDE THE NIH, FRANCISCO RUIZ 359 00:14:49,154 --> 00:14:50,455 HAS BEEN NAMED NEW DIRECTOR OF 360 00:14:50,455 --> 00:14:56,595 THE WHITE HOUSE OFFICE OF 361 00:14:56,595 --> 00:14:58,263 NATIONAL AIDS POLICY, ONAC, WE 362 00:14:58,263 --> 00:15:02,767 LOOK FORWARD TO HEARING HIM 363 00:15:02,767 --> 00:15:03,335 TALK. 364 00:15:03,335 --> 00:15:05,303 MR. RUIZ IS A SEASONED PUBLIC 365 00:15:05,303 --> 00:15:07,906 HEALTH EXPERT WELL KNOWN FOR 366 00:15:07,906 --> 00:15:10,208 EXTENSIVE COLLABORATION WITH 367 00:15:10,208 --> 00:15:11,042 COMMUNITY-BASED ORGANIZATIONS, 368 00:15:11,042 --> 00:15:12,844 NATIONAL COALITIONS, AND 369 00:15:12,844 --> 00:15:15,046 GOVERNMENT AGENCIES AT THE 370 00:15:15,046 --> 00:15:17,549 LOCAL, STATE, FEDERAL LEVELS. 371 00:15:17,549 --> 00:15:20,552 AS THE FIRST EVER LATINO SERVING 372 00:15:20,552 --> 00:15:23,355 AS THE ONAC DIRECTOR HE BRINGS A 373 00:15:23,355 --> 00:15:25,190 UNIQUE BLEND OF PROFESSIONAL 374 00:15:25,190 --> 00:15:26,224 EXPERTISE AND PERSONAL 375 00:15:26,224 --> 00:15:28,059 EXPERIENCE TO THIS VERY 376 00:15:28,059 --> 00:15:29,995 IMPORTANT ROLE. 377 00:15:29,995 --> 00:15:32,864 HE SUCCEEDS THE FORMER ONAC 378 00:15:32,864 --> 00:15:34,699 DIRECTOR, HAROLD PHILLIPS, WHO 379 00:15:34,699 --> 00:15:39,404 LED THE DEVELOPMENT OF THE 380 00:15:39,404 --> 00:15:40,739 BIDEN-HARRIS ADMINISTRATION'S 381 00:15:40,739 --> 00:15:42,941 NATIONAL HIV/AIDS STRATEGY AND 382 00:15:42,941 --> 00:15:45,010 WORKED TIRELESSLY TO ILLUSTRATE 383 00:15:45,010 --> 00:15:47,846 THE NEED FOR A NATIONAL PrEP 384 00:15:47,846 --> 00:15:48,079 PROGRAM. 385 00:15:48,079 --> 00:15:50,148 WE LOOK FORWARD TO WORKING WITH 386 00:15:50,148 --> 00:15:53,752 MR. PHILLIPS IN HIS NEW ROLE AS 387 00:15:53,752 --> 00:15:58,690 DEPUTY DIRECTOR OF PROGRAMS AT 388 00:15:58,690 --> 00:15:59,457 NMAC. 389 00:15:59,457 --> 00:16:03,728 NEXT I'LL PROVIDE AN UPDATE ON 390 00:16:03,728 --> 00:16:05,931 THE PROFESSIONAL JUDGMENT 391 00:16:05,931 --> 00:16:08,566 BUDGET, THE PJ. 392 00:16:08,566 --> 00:16:10,302 OAR PREPARES A PROFESSIONAL 393 00:16:10,302 --> 00:16:11,436 JUDGMENT BUDGET EVERY YEAR, 394 00:16:11,436 --> 00:16:15,040 WHICH ESTIMATES THE FUNDS NEEDED 395 00:16:15,040 --> 00:16:16,007 TO FULLY PURSUE SCIENTIFIC 396 00:16:16,007 --> 00:16:18,076 OPPORTUNITIES LEADING TO THE 397 00:16:18,076 --> 00:16:21,279 ENDS OF THE HIV PANDEMIC. 398 00:16:21,279 --> 00:16:25,617 IT IS BASED ON CURRENT RESEARCH 399 00:16:25,617 --> 00:16:28,820 OPPORTUNITIES, AND THE NIH 400 00:16:28,820 --> 00:16:30,055 HIV/AIDS RESEARCH PRIORITIES. 401 00:16:30,055 --> 00:16:33,224 IT IS REFERRED TO AS THE 402 00:16:33,224 --> 00:16:34,092 PROFESSIONAL JUDGMENT BUDGET 403 00:16:34,092 --> 00:16:35,727 BECAUSE IT REPRESENTS THE 404 00:16:35,727 --> 00:16:37,562 PROFESSIONAL JUDGMENT OF OAR AS 405 00:16:37,562 --> 00:16:40,098 TO THE HIV RESEARCH FUNDING 406 00:16:40,098 --> 00:16:42,167 NEEDS AND IT IS PRESENTED 407 00:16:42,167 --> 00:16:46,004 DIRECTLY TO THE PRESIDENT 408 00:16:46,004 --> 00:16:47,739 WITHOUT MODIFICATION THAT IS -- 409 00:16:47,739 --> 00:16:50,542 THAT THERE USUALLY IS WITH THE 410 00:16:50,542 --> 00:16:52,077 STANDARD FEDERAL BUDGET PROCESS. 411 00:16:52,077 --> 00:16:55,313 THE PJ IS ONE OF TWO REQUIRED 412 00:16:55,313 --> 00:16:57,382 DOCUMENTS THAT OAR PRODUCES 413 00:16:57,382 --> 00:16:57,816 ANNUALLY. 414 00:16:57,816 --> 00:17:01,653 THE OTHER BUDGET DOCUMENT IS THE 415 00:17:01,653 --> 00:17:03,088 CONGRESSIONAL BUDGET 416 00:17:03,088 --> 00:17:04,189 JUSTIFICATION, WHICH EXPLAINS 417 00:17:04,189 --> 00:17:10,295 THE NIH HIV BUDGET TO CONGRESS. 418 00:17:10,295 --> 00:17:13,531 WE EXPECT TO RELEASE THE NIH OAR 419 00:17:13,531 --> 00:17:16,668 FY 26 PJ IN THE NEXT FEW WEEKS. 420 00:17:16,668 --> 00:17:18,870 THE DOCUMENT WILL BE STRUCTURED 421 00:17:18,870 --> 00:17:20,038 TO ALIGN WITH THE STRATEGIC 422 00:17:20,038 --> 00:17:23,108 GOALS FEATURED IN THE NEXT 423 00:17:23,108 --> 00:17:24,976 PROPOSED ITERATION OF THE NIH 424 00:17:24,976 --> 00:17:30,548 STRATEGIC PLAN WHICH YOU'LL HEAR 425 00:17:30,548 --> 00:17:32,217 MORE ABOUT LATER TODAY. 426 00:17:32,217 --> 00:17:34,052 NOW TURNING NEXT TO THE 427 00:17:34,052 --> 00:17:39,357 HIGHLIGHTS OF SOME OF THE OAR 428 00:17:39,357 --> 00:17:40,158 ENGAGEMENT ACTIVITIES THAT TOOK 429 00:17:40,158 --> 00:17:45,897 PLACE SINCE LAST MEETING AND TO 430 00:17:45,897 --> 00:17:47,065 MENTION UPCOMING EVENTS, OAR HAS 431 00:17:47,065 --> 00:17:48,099 BEEN VERY PRODUCTIVE. 432 00:17:48,099 --> 00:17:49,501 THIS SLIDE HIGHLIGHTS FOUR 433 00:17:49,501 --> 00:17:53,204 EVENTS THAT WERE EITHER LED OR 434 00:17:53,204 --> 00:17:56,574 CO-SPONSORED BY THE OAR. 435 00:17:56,574 --> 00:17:59,778 OAR AND THE OFFICE OF RESEARCH 436 00:17:59,778 --> 00:18:01,713 ON WOMEN'S HEALTH CO-SPONSORED A 437 00:18:01,713 --> 00:18:03,148 TWO-DAY VIRTUAL WORKSHOP IN 438 00:18:03,148 --> 00:18:05,683 MARCH THAT REVIEWED THE STATE OF 439 00:18:05,683 --> 00:18:07,986 THE SCIENCE, HIV AND WOMEN, TO 440 00:18:07,986 --> 00:18:13,358 INFORM THE FUTURE RESEARCH 441 00:18:13,358 --> 00:18:13,591 AGENDA. 442 00:18:13,591 --> 00:18:19,297 IN EARLY APRIL OAR FEATURED A 443 00:18:19,297 --> 00:18:20,799 TALK BY DR. SARA WEIBEL ON THE 444 00:18:20,799 --> 00:18:23,635 LAST GIFT PROGRAM FOCUSING ON 445 00:18:23,635 --> 00:18:26,137 ALTRUISM OF PEOPLE WHO DONATE 446 00:18:26,137 --> 00:18:28,673 THEIR BODIES FOR SCIENTIFIC 447 00:18:28,673 --> 00:18:29,374 DISCOVERY. 448 00:18:29,374 --> 00:18:33,344 AND THIS WORK IS PARTICULARLY 449 00:18:33,344 --> 00:18:36,448 IMPORTANT TO CURE RESEARCH WHERE 450 00:18:36,448 --> 00:18:40,485 YOU CAN GET TISSUES AND SAMPLES 451 00:18:40,485 --> 00:18:41,719 THAT ARE OTHERWISE VERY HARD TO 452 00:18:41,719 --> 00:18:46,291 LOOK AT IN PEOPLE WHO HAVE BEEN 453 00:18:46,291 --> 00:18:48,326 ON TREATMENT AND THIS IS HELPFUL 454 00:18:48,326 --> 00:18:50,528 TO LOOK AT RESIDUAL VIRUS IN 455 00:18:50,528 --> 00:18:54,265 PEOPLE WHO HAVE PASSED AWAY. 456 00:18:54,265 --> 00:18:55,600 OAR ALSO SPONSORED A HYBRID 457 00:18:55,600 --> 00:18:59,070 WORKSHOP AS PART OF THE 15th 458 00:18:59,070 --> 00:19:02,474 INTERNATIONAL WORKSHOP ON HIV 459 00:19:02,474 --> 00:19:05,743 AND WOMEN, AND APRIL 24 OAR HELD 460 00:19:05,743 --> 00:19:08,847 ITS THIRD WORKSHOP FOR EARLY 461 00:19:08,847 --> 00:19:10,415 CAREER INVESTIGATORS IN HIV IN 462 00:19:10,415 --> 00:19:13,685 ITS EFFORTS TO PROVIDE RESOURCES 463 00:19:13,685 --> 00:19:15,820 AND MENTORING TO THE NEXT 464 00:19:15,820 --> 00:19:17,889 GENERATION OF HIV INVESTIGATORS, 465 00:19:17,889 --> 00:19:22,060 AND THIS PARTICULAR WORKSHOP WAS 466 00:19:22,060 --> 00:19:26,231 EXTREMELY WELL ATTENDED WITH 467 00:19:26,231 --> 00:19:29,300 HUNDREDS OF EARLY INVESTIGATORS. 468 00:19:29,300 --> 00:19:29,834 OKAY. 469 00:19:29,834 --> 00:19:31,703 SO, OAR HAS ALSO PARTICIPATED IN 470 00:19:31,703 --> 00:19:35,006 SEVERAL OTHER EVENTS IN THE PAST 471 00:19:35,006 --> 00:19:36,808 FEW MONTHS. 472 00:19:36,808 --> 00:19:39,577 CAPTAIN MARY GLENSHAW PRESENTED 473 00:19:39,577 --> 00:19:49,687 AT AN OPENING PLENARY AT NMAC'S 474 00:19:49,687 --> 00:19:55,927 SUMMIT. 475 00:19:55,927 --> 00:19:59,931 I SPOKE AT NASEM'S CONFERENCE 476 00:19:59,931 --> 00:20:00,899 AND HOW ADVOCACY INFLUENCED HIV 477 00:20:00,899 --> 00:20:03,568 RESEARCH AND FUNDING AT THE NIH. 478 00:20:03,568 --> 00:20:08,072 AND THEN DR. GLENSHAW ALSO SPOKE 479 00:20:08,072 --> 00:20:09,274 AT PATCH'S 81th FULL COUNCIL 480 00:20:09,274 --> 00:20:14,612 MEETING ON PROGRESS ON ENDING 481 00:20:14,612 --> 00:20:18,249 THE HIV EPIDEMIC, SPOKE ON 482 00:20:18,249 --> 00:20:21,119 VARIOUS AGENCY PERSPECTIVES. 483 00:20:21,119 --> 00:20:23,755 NOW I WANT TO MENTION OAR IS 484 00:20:23,755 --> 00:20:26,824 VERY GRATEFUL TO THE MANY HIV 485 00:20:26,824 --> 00:20:30,628 NETWORKS FOR THEIR EFFORTS AND 486 00:20:30,628 --> 00:20:32,463 RESEARCH, CARE, PREVENTION, AND 487 00:20:32,463 --> 00:20:36,000 MANY OF THE -- ALL OF THESE 488 00:20:36,000 --> 00:20:38,636 NETWORKS HAVE RECENTLY HELD 489 00:20:38,636 --> 00:20:42,674 MEETINGS TO TALK ABOUT THEIR 490 00:20:42,674 --> 00:20:43,274 WORK. 491 00:20:43,274 --> 00:20:46,511 AND I WANTED ALSO TO QUICKLY 492 00:20:46,511 --> 00:20:50,882 MENTION THAT THE NETWORK 493 00:20:50,882 --> 00:20:52,083 RECOMPETITION HAS BEGUN. 494 00:20:52,083 --> 00:20:55,053 THIS SLIDE YOU CAN SEE THE 495 00:20:55,053 --> 00:20:56,354 TIMELINE, AND YOU'LL HEAR MUCH 496 00:20:56,354 --> 00:20:59,524 MORE ABOUT THIS IN OUR NEXT 497 00:20:59,524 --> 00:21:00,258 MEETING. 498 00:21:00,258 --> 00:21:01,326 CARL DIEFFENBACH WILL GIVE AN 499 00:21:01,326 --> 00:21:08,099 UPDATE OF WHERE WE ARE WITH THE 500 00:21:08,099 --> 00:21:10,235 NETWORK RECOMPETITION IN 501 00:21:10,235 --> 00:21:12,103 OCTOBER. 502 00:21:12,103 --> 00:21:14,072 SO, MOVING ON, MOVING ALONG 503 00:21:14,072 --> 00:21:16,708 BEFORE OUR NEXT OARAC MEETING 504 00:21:16,708 --> 00:21:18,676 OAR IS LOOKING FORWARD TO MANY 505 00:21:18,676 --> 00:21:20,211 ENGAGEMENTS, SOME OF WHICH ARE 506 00:21:20,211 --> 00:21:21,779 SHOWN HERE. 507 00:21:21,779 --> 00:21:24,515 OAR IS ALSO INVOLVED IN SEVERAL 508 00:21:24,515 --> 00:21:25,783 COLLABORATIVE SESSIONS THAT WILL 509 00:21:25,783 --> 00:21:30,288 TAKE PLACE AT THE UPCOMING AIDS 510 00:21:30,288 --> 00:21:32,724 2012 IN MUNICH, INCLUDING WE 511 00:21:32,724 --> 00:21:35,793 HAVE SESSIONS ON AGING, ON 512 00:21:35,793 --> 00:21:41,566 CHILDREN AND ADOLESCENTS, WITH 513 00:21:41,566 --> 00:21:43,034 PERINATAL HIV EXPOSURE, AND ON 514 00:21:43,034 --> 00:21:49,774 RESERVOIRS AND FINDING A CURE 515 00:21:49,774 --> 00:21:51,676 FOR HIV. 516 00:21:51,676 --> 00:21:53,111 OAR CONTINUES TO WORK ON THE 517 00:21:53,111 --> 00:21:54,946 NEXT STRATEGIC PLAN, AND YOU'LL 518 00:21:54,946 --> 00:21:58,650 HEAR MORE ABOUT THIS VERY 519 00:21:58,650 --> 00:21:58,883 SHORTLY. 520 00:21:58,883 --> 00:22:05,590 BUT I WILL SAY THAT THIS 521 00:22:05,590 --> 00:22:07,759 STRATEGIC PLAN AND THE PLAN 522 00:22:07,759 --> 00:22:10,628 GUIDES THE LARGEST PUBLIC HEALTH 523 00:22:10,628 --> 00:22:12,930 INVESTMENT IN HIV RESEARCH, AND 524 00:22:12,930 --> 00:22:18,269 IS PART OF THE PROCESS OAR SEEKS 525 00:22:18,269 --> 00:22:21,673 INPUT FROM ALL POSSIBLE 526 00:22:21,673 --> 00:22:23,141 INTERESTED CONSTITUENTS, 527 00:22:23,141 --> 00:22:24,542 INCLUDING RESEARCHERS, 528 00:22:24,542 --> 00:22:25,677 HEALTHCARE PROFESSIONALS, 529 00:22:25,677 --> 00:22:28,980 ADVOCATES, AND ADVOCACY HEALTH 530 00:22:28,980 --> 00:22:29,647 ORGANIZATIONS, SCIENTIFIC AND 531 00:22:29,647 --> 00:22:31,082 PROFESSIONAL ORGANIZATIONS, 532 00:22:31,082 --> 00:22:33,651 PUBLIC HEALTH OFFICIALS, 533 00:22:33,651 --> 00:22:34,819 GOVERNMENT AGENCIES, AND 534 00:22:34,819 --> 00:22:35,787 COMMUNITY MEMBERS. 535 00:22:35,787 --> 00:22:37,989 ON THE RIGHT-HAND SIDE OF THE 536 00:22:37,989 --> 00:22:41,859 SLIDE YOU CAN SEE THERE'S SIX 537 00:22:41,859 --> 00:22:43,361 FUNDAMENTAL SOURCES OF INPUT IN 538 00:22:43,361 --> 00:22:44,662 THE DEVELOPMENT OF THIS 539 00:22:44,662 --> 00:22:45,897 STRATEGIC PLAN. 540 00:22:45,897 --> 00:22:46,964 AND, AGAIN, YOU'LL HEAR MUCH 541 00:22:46,964 --> 00:22:50,001 MORE ABOUT THIS IN JUST A FEW 542 00:22:50,001 --> 00:22:50,234 MINUTES. 543 00:22:50,234 --> 00:22:53,271 AND NOW BEFORE I WRAP UP, I'D 544 00:22:53,271 --> 00:22:55,840 LIKE TO PREVIEW OUR CONVERSATION 545 00:22:55,840 --> 00:23:00,044 ON ISSUES RELATED TO PERINATAL 546 00:23:00,044 --> 00:23:01,979 RESEARCH, AND THIS -- AND 547 00:23:01,979 --> 00:23:03,247 MENTION THIS POPULATION IS SO 548 00:23:03,247 --> 00:23:06,584 IMPORTANT TO OUR WORK AND GIVES 549 00:23:06,584 --> 00:23:08,319 US ANOTHER KEY TOWARDS UNLOCKING 550 00:23:08,319 --> 00:23:11,489 QUESTIONS ABOUT HIV LATENCY AND 551 00:23:11,489 --> 00:23:12,156 PERSISTENCE. 552 00:23:12,156 --> 00:23:16,294 LATER IN OUR PROGRAM, WE'LL HEAR 553 00:23:16,294 --> 00:23:20,131 A BASIC AND TRANSLATIONAL 554 00:23:20,131 --> 00:23:22,333 PERSPECTIVE FROM DR. MAURICEIO 555 00:23:22,333 --> 00:23:26,804 MARTINS AND COMMUNITY 556 00:23:26,804 --> 00:23:30,641 PERSPECTIVE FROM KIM CANADAY. 557 00:23:30,641 --> 00:23:33,344 SO, PERINATAL ACQUISITION IS OF 558 00:23:33,344 --> 00:23:35,046 COURSE LINKED TO LONG-TERM 559 00:23:35,046 --> 00:23:35,613 SURVIVORSHIP. 560 00:23:35,613 --> 00:23:37,782 THE PERCENTAGE OF OLDER ADULTS 561 00:23:37,782 --> 00:23:39,417 LIVING WITH HIV IS INCREASING IN 562 00:23:39,417 --> 00:23:41,953 ALL REGIONS OF THE WORLD. 563 00:23:41,953 --> 00:23:45,623 AND PEOPLE IN THEIR 20s AND 564 00:23:45,623 --> 00:23:53,231 30s WHO ARE DANDELIONS, A 565 00:23:53,231 --> 00:23:55,533 UNIQUE POPULATION THAT LIVED 566 00:23:55,533 --> 00:23:58,703 WITH HIV THEIR ENTIRE LIVES, 567 00:23:58,703 --> 00:24:04,008 THOSE WHO A ACQUIRED AT YOUNG AE 568 00:24:04,008 --> 00:24:06,778 ARE ALSO LONG TERM SURVIVORS, 569 00:24:06,778 --> 00:24:08,546 ESPECIALLY IN THEIR 20s AND 570 00:24:08,546 --> 00:24:08,713 30s. 571 00:24:08,713 --> 00:24:12,049 WE ALSO KNOW THAT RATES OF 572 00:24:12,049 --> 00:24:17,722 PERINATAL TRANSMISSION HAVE 573 00:24:17,722 --> 00:24:19,424 DROPPED SIGNIFICANTLY BUT THERE 574 00:24:19,424 --> 00:24:21,159 ARE MANY PEOPLE LIVING SINCE 575 00:24:21,159 --> 00:24:24,829 BIRTH WITH HIV. 576 00:24:24,829 --> 00:24:25,763 WITH SUCCESSIVE TREATMENT COME 577 00:24:25,763 --> 00:24:27,465 QUESTIONS HOW HIV INTERACTS WITH 578 00:24:27,465 --> 00:24:31,335 THE BODY AND WHILE ART CAN 579 00:24:31,335 --> 00:24:34,972 SUPPRESS VIRAL REPLICATIONS 580 00:24:34,972 --> 00:24:36,374 THERE'S STILL SIGNIFICANT 581 00:24:36,374 --> 00:24:38,810 DIFFERENCES IN COMORBIDITIES AND 582 00:24:38,810 --> 00:24:40,978 LIFE EXPECTANCY. 583 00:24:40,978 --> 00:24:42,113 SOME AGE-RELATED COMORBIDITIES 584 00:24:42,113 --> 00:24:46,717 OCCUR EARLIER IN PEOPLE WITH HIV 585 00:24:46,717 --> 00:24:48,186 INFECTION THAN AMONG 586 00:24:48,186 --> 00:24:49,120 HIV-INFECTED INDIVIDUALS -- 587 00:24:49,120 --> 00:24:51,289 UNINFECTED INDIVIDUALS. 588 00:24:51,289 --> 00:24:54,459 IT'S, WITH THE SUCCESS OF 589 00:24:54,459 --> 00:24:56,761 TREATMENT AND ART DESPITE GLOBAL 590 00:24:56,761 --> 00:24:58,496 INVESTMENT NEARLY ONE-THIRD OF 591 00:24:58,496 --> 00:25:01,999 THE 38 MILLION PEOPLE CURRENTLY 592 00:25:01,999 --> 00:25:04,302 LIVING WITH HIV REMAIN 593 00:25:04,302 --> 00:25:04,902 UNTREATED. 594 00:25:04,902 --> 00:25:07,839 SO, TO ME, THESE ISSUES REALLY 595 00:25:07,839 --> 00:25:10,875 HIGHLIGHT THE URGENT NEED FOR A 596 00:25:10,875 --> 00:25:11,075 CURE. 597 00:25:11,075 --> 00:25:13,845 SEVERAL DIFFERENT STRATEGIES ARE 598 00:25:13,845 --> 00:25:17,648 BEING STUDIED, AND INTERESTINGLY 599 00:25:17,648 --> 00:25:19,717 STUDIES ON PERINATALLY ACQUIRED 600 00:25:19,717 --> 00:25:22,687 HIV ARE YIELDING VERY IMPORTANT 601 00:25:22,687 --> 00:25:27,191 INFORMATION ON THE HIV 602 00:25:27,191 --> 00:25:35,166 RESERVOIR. 603 00:25:35,166 --> 00:25:37,902 I WANTED -- BEFORE MOVING ON, I 604 00:25:37,902 --> 00:25:46,477 JUST WANTED TO QUICKLY REMIND 605 00:25:46,477 --> 00:25:49,180 YOU ALL TO MARK YOUR CALENDAR 606 00:25:49,180 --> 00:25:52,383 FOR OCTOBER 24, NEXT MEETING, 607 00:25:52,383 --> 00:26:00,224 AND FOR MAKING THESE MEETINGS A 608 00:26:00,224 --> 00:26:01,859 PRIORITY. 609 00:26:01,859 --> 00:26:04,929 THIS AFTERNOON YOU'LL HEAR FROM 610 00:26:04,929 --> 00:26:08,132 CAPTAIN MARY GLENSHAW AND DR. 611 00:26:08,132 --> 00:26:09,467 NON-PROVIDING UPDATES OF THE 612 00:26:09,467 --> 00:26:17,408 NEXT STRATEGIC PLAN AND MR. RUIZ 613 00:26:17,408 --> 00:26:17,742 ABOUT ONAC. 614 00:26:17,742 --> 00:26:23,915 DR. MARTIN AND MS. CANADAY WILL 615 00:26:23,915 --> 00:26:30,054 PROVIDE INFORMATION ABOUT 616 00:26:30,054 --> 00:26:31,155 SURVIVORSHIP, THE COUNCIL 617 00:26:31,155 --> 00:26:34,959 MEETING, AND UPDATES FROM THE 618 00:26:34,959 --> 00:26:45,469 NIH AIDS EXECUTIVE COMMITTEE, 619 00:26:49,140 --> 00:26:51,409 AND DR. CORETTÉ BIRD, AND 620 00:26:51,409 --> 00:26:57,715 CLINICAL GUIDELINES WORKING 621 00:26:57,715 --> 00:26:58,082 GROUP OF OARAC. 622 00:26:58,082 --> 00:27:00,685 I'D LIKE TO TAKE A MOMENT TO 623 00:27:00,685 --> 00:27:04,455 REMEMBER DR. STEVE DOUGLAS WHO 624 00:27:04,455 --> 00:27:10,861 PASSED AWAY MARCH 13, A DEAR 625 00:27:10,861 --> 00:27:14,465 FRIEND OF MINE, ON EXPLORED THE 626 00:27:14,465 --> 00:27:15,833 NEUROIMMUNOLOGY OF HIV, SPENT 627 00:27:15,833 --> 00:27:19,403 MUCH OF HIS REMARKABLE CAREER AT 628 00:27:19,403 --> 00:27:22,473 CHOP, CHILDREN'S HOSPITAL AT 629 00:27:22,473 --> 00:27:24,208 PHILADELPHIA, AND AS PROFESSOR 630 00:27:24,208 --> 00:27:24,976 OF PEDIATRICS AT PERLEMAN SCHOOL 631 00:27:24,976 --> 00:27:28,879 OF MEDICINE AT UNIVERSITY OF 632 00:27:28,879 --> 00:27:29,213 PENNSYLVANIA. 633 00:27:29,213 --> 00:27:33,818 WE REALLY WILL MISS HIM. 634 00:27:33,818 --> 00:27:38,422 I WANT TO END AND THANK YOU 635 00:27:38,422 --> 00:27:40,157 AGAIN FOR YOUR ATTENTION, AND 636 00:27:40,157 --> 00:27:42,560 WANT TO CLOSE WITH A QUICK PLUG 637 00:27:42,560 --> 00:27:47,031 FOR NATIONAL HIV TESTING DAY, 638 00:27:47,031 --> 00:27:49,200 NEXT WEEK, ON JUNE 27. 639 00:27:49,200 --> 00:27:50,901 AN IMPORTANT DAY TO REMIND -- TO 640 00:27:50,901 --> 00:27:54,505 GET AS MANY PEOPLE TESTED AS 641 00:27:54,505 --> 00:27:56,540 POSSIBLE, AND OF COURSE 642 00:27:56,540 --> 00:27:58,843 TREATMENT AND PREVENTION WHICH 643 00:27:58,843 --> 00:28:02,580 ARE JUST VITAL TO OUR ENDING THE 644 00:28:02,580 --> 00:28:03,547 HIV EPIDEMIC EFFORTS. 645 00:28:03,547 --> 00:28:04,649 THANK YOU AGAIN. 646 00:28:04,649 --> 00:28:08,152 AND I LOOK FORWARD TO THE REST 647 00:28:08,152 --> 00:28:17,294 OF THIS MEETING. 648 00:28:17,294 --> 00:28:18,095 DR. TURNBULL? 649 00:28:18,095 --> 00:28:18,429 >> YES. 650 00:28:18,429 --> 00:28:20,765 >> I TURN IT BACK OVER TO YOU. 651 00:28:20,765 --> 00:28:21,799 >> THANK YOU, DR. FINZI. 652 00:28:21,799 --> 00:28:25,369 THANK YOU SO MUCH FOR THE GREAT 653 00:28:25,369 --> 00:28:25,703 UPDATE. 654 00:28:25,703 --> 00:28:28,873 WE'LL HOLD QUESTIONS UNTIL THE 655 00:28:28,873 --> 00:28:31,842 OPEN DISCUSSION PERIOD. 656 00:28:31,842 --> 00:28:34,245 WE WILL NOW HEAR FROM SENIOR 657 00:28:34,245 --> 00:28:38,549 POLICY ADVISER, DR. RACHEL 658 00:28:38,549 --> 00:28:38,816 ANDERSON. 659 00:28:38,816 --> 00:28:40,818 DR. ANDERSON, PLEASE BEGIN WHEN 660 00:28:40,818 --> 00:28:43,754 YOU'RE READY. 661 00:28:43,754 --> 00:28:44,755 >> THANKS, DR. TURNBULL. 662 00:28:44,755 --> 00:28:48,492 AND I'M HERE TODAY TO SPEAK ON 663 00:28:48,492 --> 00:28:50,227 BEHALF OF THE NIH OAR STRATEGIC 664 00:28:50,227 --> 00:28:51,862 PLAN AND HIV RESEARCH PRIORITIES 665 00:28:51,862 --> 00:28:54,331 WORKING GROUP TO GIVE AN UPDATE 666 00:28:54,331 --> 00:28:55,633 ON THE STRATEGIC PLAN PROCESS. 667 00:28:55,633 --> 00:29:00,571 LET'S GO TO THE NEXT SLIDE. 668 00:29:00,571 --> 00:29:02,206 I'LL REVIEW WHERE WE ARE WITH 669 00:29:02,206 --> 00:29:04,308 THE UPDATE PROCESS AND REMIND 670 00:29:04,308 --> 00:29:06,477 YOU OF PROPOSED FRAMEWORK. 671 00:29:06,477 --> 00:29:10,548 I WILL TALK ABOUT THE RFI 672 00:29:10,548 --> 00:29:12,516 RELEASED THIS YEAR TO SOLICIT 673 00:29:12,516 --> 00:29:13,984 PUBLIC FEED BACK, I WON'T BE 674 00:29:13,984 --> 00:29:15,820 GOING INTO A LOT OF DETAIL ABOUT 675 00:29:15,820 --> 00:29:17,788 THE RESPONSES THAT WE RECEIVED 676 00:29:17,788 --> 00:29:20,725 BUT RATHER TALKING ABOUT HOW 677 00:29:20,725 --> 00:29:22,493 THIS INFORMATION FROM THE RFI 678 00:29:22,493 --> 00:29:24,395 RESPONSES ALONG WITH THE OTHER 679 00:29:24,395 --> 00:29:25,763 SOURCES OF INFORMATION WILL 680 00:29:25,763 --> 00:29:27,498 INFORM THE FUNDING PRIORITIES 681 00:29:27,498 --> 00:29:28,733 OUTLINED IN THE NEW PLAN. 682 00:29:28,733 --> 00:29:31,235 SO TO DO THAT I'LL PROVIDE SOME 683 00:29:31,235 --> 00:29:32,737 ADDITIONAL INFORMATION ABOUT THE 684 00:29:32,737 --> 00:29:34,739 STRUCTURE OF THE NEW PLAN, 685 00:29:34,739 --> 00:29:36,173 INCLUDING GOALS AND OBJECTIVES, 686 00:29:36,173 --> 00:29:38,676 AND FINALLY I'LL SHARE AN UPDATE 687 00:29:38,676 --> 00:29:41,712 ON OAR TASK FORCES INCLUDING 688 00:29:41,712 --> 00:29:42,379 NEXT STEPS. 689 00:29:42,379 --> 00:29:47,551 LET'S GO TO THE NEXT SLIDE. 690 00:29:47,551 --> 00:29:47,985 OKAY. 691 00:29:47,985 --> 00:29:50,488 SO, AS WE DESCRIBED IN FEBRUARY 692 00:29:50,488 --> 00:29:52,423 OAR OPTED TO RECONSIDER THE 693 00:29:52,423 --> 00:29:53,891 STRUCTURE OF OUR STRATEGIC PLAN 694 00:29:53,891 --> 00:29:55,526 IN ORDER TO LEVERAGE INCREASING 695 00:29:55,526 --> 00:30:03,000 INTERSECTION OF SCIENTIFIC 696 00:30:03,000 --> 00:30:03,300 APPROACHES. 697 00:30:03,300 --> 00:30:05,603 SO WE'RE MOVING AWAY FROM THE 698 00:30:05,603 --> 00:30:07,838 FIVE OVERARCHING PRIORITIES THAT 699 00:30:07,838 --> 00:30:09,140 HAVE BEEN FEATURED IN THE 700 00:30:09,140 --> 00:30:11,008 STRATEGIC PLAN FOR MANY YEARS 701 00:30:11,008 --> 00:30:17,114 NOW. 702 00:30:17,114 --> 00:30:25,222 THIS IS NOT TO ELIMINATE BUT TO 703 00:30:25,222 --> 00:30:27,224 HIGHLIGHT, ALIGNING WITH NEW NIH 704 00:30:27,224 --> 00:30:28,826 TEMPLATE FOR STRATEGIC PLANS, 705 00:30:28,826 --> 00:30:30,928 AND WE LOOK TO THE STRUCTURE OF 706 00:30:30,928 --> 00:30:33,130 THE MOST RECENT PROFESSIONAL 707 00:30:33,130 --> 00:30:33,998 JUDGMENT BUDGET WHICH ALSO 708 00:30:33,998 --> 00:30:40,871 FOLLOWS STAGES OF THE RESEARCH 709 00:30:40,871 --> 00:30:41,505 CONTINUUM. 710 00:30:41,505 --> 00:30:44,909 GOAL ONE IS TO ENHANCE DISCOVERY 711 00:30:44,909 --> 00:30:47,778 AND ADVANCE HIV SCIENCE THROUGH 712 00:30:47,778 --> 00:30:48,979 FUNDAMENTAL RESEARCH. 713 00:30:48,979 --> 00:30:50,948 GOAL 2, TO ADVANCE THE 714 00:30:50,948 --> 00:30:52,783 DEVELOPMENT AND ASSESSMENT OF 715 00:30:52,783 --> 00:30:54,852 NOVEL INTERVENTIONS FOR HIV 716 00:30:54,852 --> 00:30:56,720 PREVENTION, TREATMENT, 717 00:30:56,720 --> 00:30:58,589 CO-MORBIDITIES, AND CURE. 718 00:30:58,589 --> 00:31:03,427 GOAL 3 TO OPTIMIZE PUBLIC HEALTH 719 00:31:03,427 --> 00:31:05,930 IMPACT OF HIV DISCOVERIES. 720 00:31:05,930 --> 00:31:08,866 AND FINALLY, CAPACITY GOAL IS TO 721 00:31:08,866 --> 00:31:10,501 BUILD RESEARCH WORKFORCE AND 722 00:31:10,501 --> 00:31:11,735 INFRASTRUCTURE CAPACITY TO 723 00:31:11,735 --> 00:31:22,246 ENHANCE THE SUSTAINABILITY OF 724 00:31:26,250 --> 00:31:27,918 HIV SCIENTIFIC DISCOVERY. 725 00:31:27,918 --> 00:31:29,386 WE'VE DRAFTED REVISED FRAMEWORK 726 00:31:29,386 --> 00:31:31,188 AND WE'VE RECEIVED A LOT OF 727 00:31:31,188 --> 00:31:32,990 DIFFERENT INPUT FROM INTERNAL 728 00:31:32,990 --> 00:31:33,924 AND EXTERNAL SOURCES, THAT I'LL 729 00:31:33,924 --> 00:31:37,995 TALK ABOUT IN JUST A MOMENT. 730 00:31:37,995 --> 00:31:39,330 WE'RE CURRENTLY HERE PROCESSING 731 00:31:39,330 --> 00:31:41,699 INPUT TO GENERATE COMBINED LIST 732 00:31:41,699 --> 00:31:42,566 OF PROPOSED FUNDING PRIORITIES. 733 00:31:42,566 --> 00:31:43,901 AND THESE ARE THE PRIORITIES 734 00:31:43,901 --> 00:31:46,303 THAT WILL BE SHARED WITH THE OAR 735 00:31:46,303 --> 00:31:48,606 TASK FORCES TO REVIEW AND USE AS 736 00:31:48,606 --> 00:31:51,041 A BASIS FOR DEVELOPING 737 00:31:51,041 --> 00:31:51,675 RECOMMENDATIONS. 738 00:31:51,675 --> 00:31:52,977 SO THE TASK FORCE 739 00:31:52,977 --> 00:31:54,945 RECOMMENDATIONS WILL INFORM THE 740 00:31:54,945 --> 00:31:56,714 FINAL FUNDING PRIORITIES, AND 741 00:31:56,714 --> 00:31:57,815 OAR'S STRATEGIC PLAN WORKING 742 00:31:57,815 --> 00:32:00,784 GROUP WILL THEN START WRITING 743 00:32:00,784 --> 00:32:03,420 THE PLAN. 744 00:32:03,420 --> 00:32:06,423 OAR -- EXCUSE ME, AFTER OARAC 745 00:32:06,423 --> 00:32:09,126 REVIEW AND NIH CLEARANCE THE 746 00:32:09,126 --> 00:32:11,395 PLAN WILL BE PUBLISHED IN 747 00:32:11,395 --> 00:32:14,098 ADVANCE OF FISCAL YEAR 26. 748 00:32:14,098 --> 00:32:15,132 NEXT SLIDE. 749 00:32:15,132 --> 00:32:17,635 THIS IS A SLIGHTLY MODIFIED 750 00:32:17,635 --> 00:32:24,008 VERSION OF THE SLIDE DR. FINZI 751 00:32:24,008 --> 00:32:27,611 SHOWED EARLIER, INFORMED BY 752 00:32:27,611 --> 00:32:29,446 MULTIPLE SOURCES OF INPUT, 753 00:32:29,446 --> 00:32:30,648 INCLUDING INTERNAL ANALYSIS AND 754 00:32:30,648 --> 00:32:33,017 OTHER FEEDBACK FROM NIH SOURCES, 755 00:32:33,017 --> 00:32:38,122 AS WELL AS EXTERNAL SOURCES SUCH 756 00:32:38,122 --> 00:32:39,890 AS OAR LISTENING SITUATIONS 757 00:32:39,890 --> 00:32:42,059 WORKSHOPS AND PUBLIC INPUT. 758 00:32:42,059 --> 00:32:45,796 OARAC REMAINS AN IMPORTANT 759 00:32:45,796 --> 00:32:52,169 SOURCE OF INPUT AS WELL. 760 00:32:52,169 --> 00:32:53,904 I SPOKE ABOUT THIS IN FEBRUARY 761 00:32:53,904 --> 00:32:55,773 AT OUR OARAC MEETING. 762 00:32:55,773 --> 00:32:57,942 WE POSTED A PUBLIC RFI, REQUEST 763 00:32:57,942 --> 00:33:00,077 FOR INFORMATION, THAT WAS OPEN 764 00:33:00,077 --> 00:33:02,546 FROM FEBRUARY 12 THROUGH MARCH 765 00:33:02,546 --> 00:33:02,913 28. 766 00:33:02,913 --> 00:33:06,216 THIS RFI DESCRIBES THE NEW 767 00:33:06,216 --> 00:33:07,117 FRAMEWORK AND INVITED 768 00:33:07,117 --> 00:33:08,585 RESPONDENTS TO PROPOSE RESEARCH 769 00:33:08,585 --> 00:33:10,554 PRIORITIES WITH POTENTIAL TO 770 00:33:10,554 --> 00:33:13,257 ADVANCE HIV SCIENCE AND IMPACT 771 00:33:13,257 --> 00:33:14,091 HIV-ASSOCIATED PUBLIC HEALTH 772 00:33:14,091 --> 00:33:15,426 ACROSS THE FOUR GOALS. 773 00:33:15,426 --> 00:33:17,027 WE ALSO INCLUDED AN OPTION TO 774 00:33:17,027 --> 00:33:21,832 PROVIDE FEEDBACK ON THE 775 00:33:21,832 --> 00:33:23,968 FRAMEWORK ITSELF. 776 00:33:23,968 --> 00:33:28,105 IN RESPONSE TO THE RFI, WE HEARD 777 00:33:28,105 --> 00:33:31,775 FROM 205 RESPONDENTS, AND THIS 778 00:33:31,775 --> 00:33:33,177 INCLUDES 52 RESPONSES SUBMITTED 779 00:33:33,177 --> 00:33:37,548 ON THE BEHALF OF ORGANIZATIONS. 780 00:33:37,548 --> 00:33:40,317 RESPONDENTS HAD THE OPTION TO 781 00:33:40,317 --> 00:33:41,685 SELF-IDENTIFY THEIR SECTOR, AND 782 00:33:41,685 --> 00:33:45,322 SO THIS FIGURE IS SHOWING HOW 783 00:33:45,322 --> 00:33:47,024 THE 205 RESPONDENTS IDENTIFIED. 784 00:33:47,024 --> 00:33:51,528 AS YOU CAN SEE, JUST OVER 40% OF 785 00:33:51,528 --> 00:33:52,963 OUR RESPONDENTS REPRESENTED 786 00:33:52,963 --> 00:33:55,733 ACADEMIC SECTOR BUT WE ALSO HAD 787 00:33:55,733 --> 00:33:58,202 GOOD REPRESENTATION FROM HEALTH 788 00:33:58,202 --> 00:34:03,240 CARE, ADVOCACY, GOVERNMENT, AND 789 00:34:03,240 --> 00:34:04,842 NON-GOVERNMENT ORGANIZATIONS. 790 00:34:04,842 --> 00:34:07,111 JUST FOR YOUR AWARENESS OF THE 791 00:34:07,111 --> 00:34:08,712 ORGANIZATIONS THAT SUBMITTED 792 00:34:08,712 --> 00:34:11,348 COORDINATED RESPONSES, ABOUT 793 00:34:11,348 --> 00:34:13,851 HALF IDENTIFIED AS NGOs, 794 00:34:13,851 --> 00:34:16,286 COMMUNITY-BASED ORGANIZATIONS, 795 00:34:16,286 --> 00:34:17,287 OR ADVOCACY ORGANIZATIONS. 796 00:34:17,287 --> 00:34:19,857 NEXT SLIDE. 797 00:34:19,857 --> 00:34:23,360 OUR RESPONDENTS HAD THE OPTION 798 00:34:23,360 --> 00:34:25,129 TO DISCLOSE GEOGRAPHIC LOCATION, 799 00:34:25,129 --> 00:34:27,464 SO 65% OF OUR RESPONDENTS WERE 800 00:34:27,464 --> 00:34:29,400 FROM THE UNITED STATES. 801 00:34:29,400 --> 00:34:31,402 10% FROM AFRICA. 802 00:34:31,402 --> 00:34:32,936 WE ALSO RECEIVED A FEW OTHER 803 00:34:32,936 --> 00:34:36,106 RESPONSES FROM OTHER COUNTRIES 804 00:34:36,106 --> 00:34:37,908 IN NORTH AMERICA, SOUTH AMERICA, 805 00:34:37,908 --> 00:34:38,842 EUROPE, ASIA. 806 00:34:38,842 --> 00:34:40,711 20% OF RESPONDENTS DID NOT 807 00:34:40,711 --> 00:34:41,745 DISCLOSE A LOCATION. 808 00:34:41,745 --> 00:34:45,149 I WANTED TO NOTE THAT AS WELL. 809 00:34:45,149 --> 00:34:45,449 NEXT SLIDE. 810 00:34:45,449 --> 00:34:47,718 WHEN WE LOOK AT THE BREAKDOWN OF 811 00:34:47,718 --> 00:34:51,722 REPRESENTATION ACROSS THE UNITED 812 00:34:51,722 --> 00:34:53,357 STATES, BACK ONE SLIDE PLEASE. 813 00:34:53,357 --> 00:34:54,024 THANK YOU. 814 00:34:54,024 --> 00:34:56,293 MOST OF THE RESPONSES CAME FROM 815 00:34:56,293 --> 00:34:57,461 THE SOUTH. 816 00:34:57,461 --> 00:34:59,563 WE RECEIVED OTHER RESPONSES 817 00:34:59,563 --> 00:35:01,899 ROUGHLY DIVIDED EQUALLY ACROSS 818 00:35:01,899 --> 00:35:03,667 THE WEST, MIDWEST, NORTHEAST. 819 00:35:03,667 --> 00:35:06,837 AGAIN, I'M NOT GOING TO TALK 820 00:35:06,837 --> 00:35:08,105 ABOUT SPECIFIC FEEDBACK TODAY 821 00:35:08,105 --> 00:35:09,706 BUT RATHER DESCRIBE HOW THAT 822 00:35:09,706 --> 00:35:11,375 INFORMATION WILL BE USED TO 823 00:35:11,375 --> 00:35:12,543 INFORM THE FUNDING PRIORITIES 824 00:35:12,543 --> 00:35:13,944 THAT THE NEW PLAN WILL 825 00:35:13,944 --> 00:35:14,511 HIGHLIGHT. 826 00:35:14,511 --> 00:35:17,681 NOW WE CAN GO TO THE NEXT SLIDE. 827 00:35:17,681 --> 00:35:17,981 GREAT. 828 00:35:17,981 --> 00:35:20,317 SO IN FEBRUARY, WE DESCRIBED THE 829 00:35:20,317 --> 00:35:21,085 STRATEGIC PLAN STRUCTURE, EACH 830 00:35:21,085 --> 00:35:23,720 OF THE FOUR GOALS WILL INCLUDE 831 00:35:23,720 --> 00:35:26,256 FOUR OBJECTIVES THAT BROADLY 832 00:35:26,256 --> 00:35:28,292 REFLECT DIFFERENT RESEARCH 833 00:35:28,292 --> 00:35:28,492 AREAS. 834 00:35:28,492 --> 00:35:29,293 WITHIN THESE OBJECTIVES, 835 00:35:29,293 --> 00:35:31,395 SPECIFIC FUNDING PRIORITIES WILL 836 00:35:31,395 --> 00:35:32,463 BE DESIGNATED. 837 00:35:32,463 --> 00:35:35,799 CLICK THROUGH ONE TIME PLEASE. 838 00:35:35,799 --> 00:35:38,268 SO THIS APPROACH WILL ENSURE OUR 839 00:35:38,268 --> 00:35:39,937 STRATEGIC PLAN REFLECTS THE 840 00:35:39,937 --> 00:35:42,106 BREADTH OF HIV RESEARCH WHILE 841 00:35:42,106 --> 00:35:43,740 ALSO SPECIFYING TOPICS THAT WILL 842 00:35:43,740 --> 00:35:45,375 BE PRIORITIZED FOR FUNDING. 843 00:35:45,375 --> 00:35:48,445 SO TODAY I'LL SHARE WITH YOU THE 844 00:35:48,445 --> 00:35:49,446 BROAD OBJECTIVES THAT COMPRISE 845 00:35:49,446 --> 00:35:51,048 EACH GOAL. 846 00:35:51,048 --> 00:35:52,783 AND THESE OBJECTIVES REFLECT 847 00:35:52,783 --> 00:35:55,419 INPUT FROM OAR STAFF AND FROM 848 00:35:55,419 --> 00:35:57,688 THE NIH REPRESENTATIVES ON THE 849 00:35:57,688 --> 00:35:59,356 NIH AIDS EXECUTIVE COMMITTEE, 850 00:35:59,356 --> 00:36:00,991 WHILE ALSO GENERALLY ALIGNING 851 00:36:00,991 --> 00:36:03,527 WITH OUR PREVIOUS STRATEGIC 852 00:36:03,527 --> 00:36:03,727 PLANS. 853 00:36:03,727 --> 00:36:05,596 AND I WANTED TO TAKE A MOMENT TO 854 00:36:05,596 --> 00:36:07,464 NOTE HERE THAT WE DID RECEIVE 855 00:36:07,464 --> 00:36:10,234 SOME COMMENTS IN RESPONSE TO THE 856 00:36:10,234 --> 00:36:11,735 RFI THAT EMPHASIZED SEVERAL 857 00:36:11,735 --> 00:36:12,736 UNDERLYING PRINCIPLES THAT WE 858 00:36:12,736 --> 00:36:14,271 SHOULD BE MINDFUL OF WHEN 859 00:36:14,271 --> 00:36:15,939 UPDATING THE PLAN. 860 00:36:15,939 --> 00:36:18,342 SO I WANTED TO AFFIRM HERE THAT 861 00:36:18,342 --> 00:36:20,277 THE GOALS, OBJECTIVES, FUNDING 862 00:36:20,277 --> 00:36:22,813 PRIORITIES WILL REFLECT 863 00:36:22,813 --> 00:36:24,448 PRINCIPLES SUCH AS 864 00:36:24,448 --> 00:36:26,650 INCLUSIVENESS, AND THAT'S 865 00:36:26,650 --> 00:36:28,285 INCLUSIVENESS OF SCIENTIFIC 866 00:36:28,285 --> 00:36:30,053 DISCIPLINES, INCLUSIVENESS OF 867 00:36:30,053 --> 00:36:31,488 DIFFERENT RESEARCH TOPICS, AND 868 00:36:31,488 --> 00:36:33,891 INCLUSIVENESS OF DIFFERENT 869 00:36:33,891 --> 00:36:36,560 POPULATIONS AND SETTINGS. 870 00:36:36,560 --> 00:36:39,530 THE PLAN WILL ALSO ADDRESS 871 00:36:39,530 --> 00:36:40,964 HEALTH DISPARITIES AND PROMOTE 872 00:36:40,964 --> 00:36:43,200 ENGAGEMENT IN ETHICAL RESEARCH 873 00:36:43,200 --> 00:36:44,935 PRACTICES, AND THE PLAN WILL 874 00:36:44,935 --> 00:36:46,303 ALSO BE MINDFUL OF THE 875 00:36:46,303 --> 00:36:49,673 IMPORTANCE OF CHOICE AND VALUE 876 00:36:49,673 --> 00:36:53,043 OF COMMUNITY VOICES. 877 00:36:53,043 --> 00:36:53,710 NEXT SLIDE. 878 00:36:53,710 --> 00:36:55,546 FOR OUR OARAC MEMBERS, I'LL 879 00:36:55,546 --> 00:36:57,414 REMIND YOU, YOU DID RECEIVE A 880 00:36:57,414 --> 00:36:58,882 MORE DETAILED DESCRIPTION OF 881 00:36:58,882 --> 00:37:01,385 EACH OBJECTIVE WITH YOUR MEETING 882 00:37:01,385 --> 00:37:03,587 BRIEFING MATERIALS, SO IN THIS 883 00:37:03,587 --> 00:37:04,888 PRESENTATION I'LL MOVE PRETTY 884 00:37:04,888 --> 00:37:06,657 QUICKLY THROUGH THIS LIST JUST 885 00:37:06,657 --> 00:37:07,991 TO PROVIDE A SENSE OF THE BROAD 886 00:37:07,991 --> 00:37:09,760 RESEARCH THAT WILL BE REFLECTED 887 00:37:09,760 --> 00:37:11,261 IN THE PLAN. 888 00:37:11,261 --> 00:37:16,033 SO STARTING WITH GOAL NUMBER 1, 889 00:37:16,033 --> 00:37:20,137 THE OBJECTIVES INCLUDE HIV 890 00:37:20,137 --> 00:37:21,071 BIOLOGY, VIROLOGY, IMMUNOLOGY 891 00:37:21,071 --> 00:37:24,942 AND PATHOGENESIS OF HIV 892 00:37:24,942 --> 00:37:27,110 ASSOCIATED COMORBIDITIES, 893 00:37:27,110 --> 00:37:27,711 CO-INFECTIONS, COMPLICATIONS. 894 00:37:27,711 --> 00:37:30,847 EPIDEMIOLOGIC ASPECTS OF HIV 895 00:37:30,847 --> 00:37:32,082 INFECTION, CO-INFECTIONS, AND 896 00:37:32,082 --> 00:37:32,449 COMORBIDITIES. 897 00:37:32,449 --> 00:37:37,087 AND BEHAVIORAL AND SOCIAL 898 00:37:37,087 --> 00:37:39,423 FACTORS AND PROCESSES. 899 00:37:39,423 --> 00:37:42,893 FOR GOAL 2, OBJECTIVES INCLUDE 900 00:37:42,893 --> 00:37:43,660 PRE-CLINICAL AND TRANSLATIONAL 901 00:37:43,660 --> 00:37:45,162 RESEARCH, CLINICAL TRIALS AND 902 00:37:45,162 --> 00:37:49,666 OTHER INTERVENTION STUDIES OF 903 00:37:49,666 --> 00:37:50,634 PROMISING HIV PREVENTION 904 00:37:50,634 --> 00:37:52,169 TREATMENT COMORBIDITY AND CURE 905 00:37:52,169 --> 00:37:52,603 STRATEGIES. 906 00:37:52,603 --> 00:37:55,472 AS WELL AS NEW AND INTEGRATED 907 00:37:55,472 --> 00:37:57,774 MODELS OF HIV PREVENTION, 908 00:37:57,774 --> 00:37:59,209 TREATMENT, CARE, COMORBIDITIES, 909 00:37:59,209 --> 00:38:04,147 AND CURE RESEARCH AND SERVICES. 910 00:38:04,147 --> 00:38:07,084 GOAL 3 INCLUDES FOCUSING ON 911 00:38:07,084 --> 00:38:08,552 IMPLEMENTATION SCIENCE AND 912 00:38:08,552 --> 00:38:11,421 TRANSLATIONAL RESEARCH, 913 00:38:11,421 --> 00:38:14,625 COMMUNITY ENGAGED AND COMMUNITY 914 00:38:14,625 --> 00:38:15,859 LED RESEARCH, DISSEMINATION AND 915 00:38:15,859 --> 00:38:18,962 COMMUNICATION OF HIV SCIENCE. 916 00:38:18,962 --> 00:38:22,432 FINALLY, GOAL 4 OBJECTIVES 917 00:38:22,432 --> 00:38:23,500 INCLUDE WORKFORCE CAPACITY 918 00:38:23,500 --> 00:38:26,169 STRENGTHENING, RESEARCH 919 00:38:26,169 --> 00:38:27,604 INFRASTRUCTURE AND CAPACITY, AND 920 00:38:27,604 --> 00:38:33,777 METHODS AND TECHNOLOGIES FOR HIV 921 00:38:33,777 --> 00:38:34,177 RESEARCH. 922 00:38:34,177 --> 00:38:36,480 SO, AS OAR HAS GATHERED INPUT 923 00:38:36,480 --> 00:38:38,615 FROM DIFFERENT SOURCES OUR TEAM 924 00:38:38,615 --> 00:38:41,018 HAS BEEN BUSY EXTRACTING IDEAS 925 00:38:41,018 --> 00:38:44,187 TO GENERATE ROBUST LIST OF 926 00:38:44,187 --> 00:38:47,024 PROPOSED FUNDING PRIORITIES. 927 00:38:47,024 --> 00:38:47,858 NEXT SLIDE. 928 00:38:47,858 --> 00:38:51,061 THAT'S WHERE THE OAR TASK FORCES 929 00:38:51,061 --> 00:38:52,396 COME IN. 930 00:38:52,396 --> 00:38:54,698 AS EARLY AS NEXT WEEK OAR WILL 931 00:38:54,698 --> 00:38:55,666 SECOND OUT INVITATIONS FOR 932 00:38:55,666 --> 00:38:58,302 MEMBERSHIP IN THREE TASK FORCES 933 00:38:58,302 --> 00:38:59,736 CHARGED WITH REFINING THIS 934 00:38:59,736 --> 00:39:02,172 INITIAL LIST OF FUNDING 935 00:39:02,172 --> 00:39:02,472 PRIORITIES. 936 00:39:02,472 --> 00:39:05,542 SO EACH TASK FORCE WILL INCLUDE 937 00:39:05,542 --> 00:39:07,944 OARAC MEMBERS IN ADDITION TO 938 00:39:07,944 --> 00:39:09,079 EXTERNAL SUBJECT MATTER EXPERTS, 939 00:39:09,079 --> 00:39:10,881 THOSE EXPERTS WILL INCLUDE 940 00:39:10,881 --> 00:39:11,682 RESEARCHERS, PRACTITIONERS, AS 941 00:39:11,682 --> 00:39:15,719 WELL AS OTHER MEMBERS OF THE HIV 942 00:39:15,719 --> 00:39:17,688 COMMUNITY WITH LIVED EXPERIENCE. 943 00:39:17,688 --> 00:39:19,856 SO BETWEEN NOW AND OCTOBER, THE 944 00:39:19,856 --> 00:39:23,126 TASK FORCES WILL REVIEW THE 945 00:39:23,126 --> 00:39:23,927 FRAMEWORK WITH GOALS, 946 00:39:23,927 --> 00:39:25,896 OBJECTIVES, LIST OF PROPOSED 947 00:39:25,896 --> 00:39:26,763 FUNDING PRIORITIES GENERATED 948 00:39:26,763 --> 00:39:29,499 FROM THESE MULTIPLE SOURCES OF 949 00:39:29,499 --> 00:39:31,802 INPUT, AND AT THE OCTOBER OARAC 950 00:39:31,802 --> 00:39:34,137 MEETING EACH TASK FORCE WILL 951 00:39:34,137 --> 00:39:38,642 REPORT OUT THEIR RECOMMENDATIONS 952 00:39:38,642 --> 00:39:39,376 FOR FUNDING PRIORITIES. 953 00:39:39,376 --> 00:39:42,379 I'LL CLOSE TODAY WITH A RECAP OF 954 00:39:42,379 --> 00:39:44,281 THE PROCESS AND ANTICIPATED 955 00:39:44,281 --> 00:39:46,850 TIMELINE SO WE'RE STILL IN THE 956 00:39:46,850 --> 00:39:51,288 PHASE OF CONVENING AND ENGAGING, 957 00:39:51,288 --> 00:39:53,523 LATER THIS YEAR AFTER RECEIVING 958 00:39:53,523 --> 00:39:56,560 THE TASK FORCE RECOMMENDATIONS 959 00:39:56,560 --> 00:39:57,260 OAR WILL FINALIZE FUNDING 960 00:39:57,260 --> 00:39:58,995 PRIORITIES AND START WRITING THE 961 00:39:58,995 --> 00:39:59,296 PLAN. 962 00:39:59,296 --> 00:40:00,130 AND PLAN DEVELOPMENT WILL 963 00:40:00,130 --> 00:40:03,400 CONTINUE THROUGH THE MIDDLE OF 964 00:40:03,400 --> 00:40:05,469 NEXT YEAR, AND THAT TIMELINE 965 00:40:05,469 --> 00:40:07,404 WILL INCLUDE OARAC REVIEW AND 966 00:40:07,404 --> 00:40:11,108 NIH CLEARANCE OF THE PLAN. 967 00:40:11,108 --> 00:40:12,376 FINALLY, WE'RE AIMING TO LAUNCH 968 00:40:12,376 --> 00:40:17,381 AND PROMOTE THE PLAN BEFORE THE 969 00:40:17,381 --> 00:40:18,915 START OF FISCAL YEAR 2026. 970 00:40:18,915 --> 00:40:21,017 AND WITH THAT I WANT TO TAKE A 971 00:40:21,017 --> 00:40:23,053 BRIEF MOMENT TO ACKNOWLEDGE 972 00:40:23,053 --> 00:40:24,621 EFFORTS OF MY COLLEAGUES, NAMED 973 00:40:24,621 --> 00:40:28,425 ON THE NEXT SLIDE, WHO SUPPORTED 974 00:40:28,425 --> 00:40:29,426 THIS EFFORT. 975 00:40:29,426 --> 00:40:32,496 SO WITH THAT, WE HAVE TIME FOR 976 00:40:32,496 --> 00:40:32,896 DISCUSSION. 977 00:40:32,896 --> 00:40:43,106 THANK YOU. 978 00:40:49,780 --> 00:40:51,114 >> DR. TURNBULL, I THINK YOU'RE 979 00:40:51,114 --> 00:40:54,818 ON MUTE. 980 00:40:54,818 --> 00:40:55,752 >> OKAY. 981 00:40:55,752 --> 00:40:57,220 I ALWAYS FORGET THAT. 982 00:40:57,220 --> 00:41:00,624 AS DR. ANDERSON JUST MENTIONED, 983 00:41:00,624 --> 00:41:03,927 WE NOW HAVE TIME FOR DISCUSSION. 984 00:41:03,927 --> 00:41:05,729 OARAC MEMBERS, PLEASE USE YOUR 985 00:41:05,729 --> 00:41:09,032 RAISE HAND FUNCTION, IF YOU HAVE 986 00:41:09,032 --> 00:41:17,808 A QUESTION OR COMMENT. 987 00:41:17,808 --> 00:41:19,676 988 00:41:19,676 --> 00:41:20,310 DR. MONTANER. 989 00:41:20,310 --> 00:41:26,082 >> YES, THANK YOU FOR THAT 990 00:41:26,082 --> 00:41:28,785 OVERVIEW OF THE STRATEGIC PLAN 991 00:41:28,785 --> 00:41:29,419 TIMELINE. 992 00:41:29,419 --> 00:41:30,754 EXPAND ON THE TASK FORCE 993 00:41:30,754 --> 00:41:32,122 MEMBERSHIP, HOW MANY INDIVIDUALS 994 00:41:32,122 --> 00:41:33,957 DOES THAT USUALLY ENTAIL AND 995 00:41:33,957 --> 00:41:37,694 WHAT IS THE STRIKING BALANCE 996 00:41:37,694 --> 00:41:40,664 OBJECTIVE BETWEEN INTRAMURAL AND 997 00:41:40,664 --> 00:41:42,666 EXTRAMURAL AND COMMUNITY AND/OR 998 00:41:42,666 --> 00:41:46,102 INDUSTRY, IS THERE ANY KIND OF 999 00:41:46,102 --> 00:41:48,972 FRAMEWORK THAT IS IN PLACE FOR 1000 00:41:48,972 --> 00:41:49,272 MEMBERSHIP? 1001 00:41:49,272 --> 00:41:49,739 >> SURE. 1002 00:41:49,739 --> 00:41:51,942 I CAN PROVIDE A LITTLE BIT OF 1003 00:41:51,942 --> 00:41:54,945 DETAIL THERE. 1004 00:41:54,945 --> 00:41:57,380 AGAIN, AS THE FINAL LISTS ARE 1005 00:41:57,380 --> 00:41:58,348 BEING REVIEWED FOR INVITATIONS 1006 00:41:58,348 --> 00:42:02,052 TO GO OUT NEXT WEEK, I CAN SAY 1007 00:42:02,052 --> 00:42:03,286 THAT THREE TASK FORCES ARE 1008 00:42:03,286 --> 00:42:06,456 ENVISIONED WITH A LITTLE BIT OF 1009 00:42:06,456 --> 00:42:07,491 SPECIALIZATION OF AREAS OF 1010 00:42:07,491 --> 00:42:09,993 EXPERTISE IN ORDER TO OFFER A 1011 00:42:09,993 --> 00:42:11,394 DISTINCT LENS ON HIV RESEARCH, 1012 00:42:11,394 --> 00:42:15,332 SO WE WILL HAVE A BASIC 1013 00:42:15,332 --> 00:42:17,400 BIOMEDICAL FOCUSED TASK FORCE, A 1014 00:42:17,400 --> 00:42:19,202 SEPARATE TASK FORCE FOCUSING ON 1015 00:42:19,202 --> 00:42:21,171 BEHAVIORAL AND SOCIAL SCIENCES 1016 00:42:21,171 --> 00:42:24,741 RESEARCH, AND THE THIRD TASK 1017 00:42:24,741 --> 00:42:28,078 FORCE WILL CONCENTRATE CLINICAL 1018 00:42:28,078 --> 00:42:30,213 AND INTERVENTION RESEARCH AS AN 1019 00:42:30,213 --> 00:42:31,581 AREA OF EXPERTISE. 1020 00:42:31,581 --> 00:42:32,983 MEMBERS OF THE COMMUNITY WILL BE 1021 00:42:32,983 --> 00:42:36,686 INCLUDED IN ALL OF THE TASK 1022 00:42:36,686 --> 00:42:38,989 FORCES, ALL OF THE TASK FORCES 1023 00:42:38,989 --> 00:42:44,227 WILL ADDRESS THE WORKFORCE AND 1024 00:42:44,227 --> 00:42:45,862 CAPACITY ISSUES, SO THE 1025 00:42:45,862 --> 00:42:49,633 INVITATION PROCESS IS SORT OF 1026 00:42:49,633 --> 00:42:52,569 WORKING TO BALANCE DIFFERENT 1027 00:42:52,569 --> 00:42:55,939 SECTORS WITHIN THESE ROUGHLY 1028 00:42:55,939 --> 00:42:56,740 SPECIALIZED TASK FORCES, AND 1029 00:42:56,740 --> 00:42:58,942 THERE WAS ANOTHER PART OF YOUR 1030 00:42:58,942 --> 00:42:59,209 QUESTION. 1031 00:42:59,209 --> 00:43:00,343 OH, THE NUMBER, THE NUMBER. 1032 00:43:00,343 --> 00:43:03,413 I THINK WE'RE AIMING TO HAVE 1033 00:43:03,413 --> 00:43:07,017 ABOUT TEN MEMBERS ON EACH TASK 1034 00:43:07,017 --> 00:43:07,250 FORCE. 1035 00:43:07,250 --> 00:43:09,886 >> I WOULD JUST ENCOURAGE THAT 1036 00:43:09,886 --> 00:43:11,721 YOU KIND OF TASK THE TASK FORCE 1037 00:43:11,721 --> 00:43:14,157 TO NOT BE INSULAR. 1038 00:43:14,157 --> 00:43:17,093 FOR EXAMPLE, SOCIAL SCIENCE WORK 1039 00:43:17,093 --> 00:43:19,195 INTERFACE WAS CLINICAL AND 1040 00:43:19,195 --> 00:43:21,431 PRE-CLINICAL WORK, SO TO THE 1041 00:43:21,431 --> 00:43:24,668 EXTENT THAT YOU COULD FOSTER 1042 00:43:24,668 --> 00:43:25,869 SORT OF HAVING INSIGHT ACROSS 1043 00:43:25,869 --> 00:43:27,604 ALL THREE OBJECTIVES FOR THE 1044 00:43:27,604 --> 00:43:29,573 TASK FORCE, NOT NECESSARILY 1045 00:43:29,573 --> 00:43:31,308 FOCUS ON ONE SPECIFIC AREA, 1046 00:43:31,308 --> 00:43:33,610 BECAUSE AS WE MOVE FORWARD A LOT 1047 00:43:33,610 --> 00:43:39,416 OF THESE AREAS, YOU KNOW, ARE 1048 00:43:39,416 --> 00:43:43,386 EMPOWERED BY SYNERGY AS OPPOSED 1049 00:43:43,386 --> 00:43:44,688 TO SILOING INTO SPECIFIC 1050 00:43:44,688 --> 00:43:45,889 BUCKETS. 1051 00:43:45,889 --> 00:43:46,990 >> SURE, I APPRECIATE THAT 1052 00:43:46,990 --> 00:43:48,058 COMMENT AND WE COULD HAVE 1053 00:43:48,058 --> 00:43:52,195 EXPLORE OPPORTUNITIES TO HAVE 1054 00:43:52,195 --> 00:43:52,462 AS 1055 00:43:52,462 --> 00:43:53,697 IT TASK FORCES WORK TOGETHER. 1056 00:43:53,697 --> 00:44:02,105 SO THANK YOU. 1057 00:44:02,105 --> 00:44:03,506 >> DR. NEILAN? 1058 00:44:03,506 --> 00:44:04,708 >> THANKS FOR THAT OVERVIEW. 1059 00:44:04,708 --> 00:44:06,943 I KNOW YOU ARE NOT PLANNING TO 1060 00:44:06,943 --> 00:44:10,213 GO INTO DETAILS OF THE FEEDBACK 1061 00:44:10,213 --> 00:44:11,681 YOU RECEIVED ON RFA TODAY. 1062 00:44:11,681 --> 00:44:13,783 WONDERING IF YOU COULD SPEAK TO 1063 00:44:13,783 --> 00:44:16,386 HOW THE DISTRIBUTION OF THE 1064 00:44:16,386 --> 00:44:18,221 FEEDBACK DIFFERED OR WAS SIMILAR 1065 00:44:18,221 --> 00:44:20,790 TO PRIOR SOLICITATIONS FOR PRIOR 1066 00:44:20,790 --> 00:44:21,625 STRATEGIC PLANS. 1067 00:44:21,625 --> 00:44:24,794 >> I ACTUALLY CAN SPEAK TO THAT. 1068 00:44:24,794 --> 00:44:27,330 SO, THIS YEAR, OUR PROMOTIONAL 1069 00:44:27,330 --> 00:44:34,638 EFFORTS DR. -- DID RESULT IN 1070 00:44:34,638 --> 00:44:35,872 BROADER REPRESENTATION OF 1071 00:44:35,872 --> 00:44:36,406 RESPONDENTS. 1072 00:44:36,406 --> 00:44:38,174 FOR THE LAST STRATEGIC PLAN RFI 1073 00:44:38,174 --> 00:44:42,412 ABOUT 80% OF THE RESPONSES WERE 1074 00:44:42,412 --> 00:44:45,248 FROM ACADEMIC -- FROM PEOPLE 1075 00:44:45,248 --> 00:44:46,783 REPRESENTING ACADEMIC 1076 00:44:46,783 --> 00:44:47,384 INSTITUTIONS. 1077 00:44:47,384 --> 00:44:50,854 OR INDIVIDUALS FROM THE ACADEMIC 1078 00:44:50,854 --> 00:44:51,087 SECTOR. 1079 00:44:51,087 --> 00:44:53,690 AND WE DID RECEIVE RESPONSES 1080 00:44:53,690 --> 00:44:55,692 FROM MANY OTHER SECTORS THIS 1081 00:44:55,692 --> 00:44:55,892 TIME. 1082 00:44:55,892 --> 00:44:59,629 SO THERE WAS I THINK MORE 1083 00:44:59,629 --> 00:45:07,937 DIVERSITY IN THE RESPONDENTS 1084 00:45:07,937 --> 00:45:08,838 THIS TIME. 1085 00:45:08,838 --> 00:45:12,609 >> CAN I MAKE A COMMENT? 1086 00:45:12,609 --> 00:45:14,377 I FOUND THIS IMPRESSIVE AND 1087 00:45:14,377 --> 00:45:14,711 FOUGHTFUL. 1088 00:45:14,711 --> 00:45:18,314 MY QUESTION IS A BIT ON THE META 1089 00:45:18,314 --> 00:45:20,183 SIDE, WHICH IS THESE ALL MAKE 1090 00:45:20,183 --> 00:45:25,755 SENSE BUT WE HAVE A RAPIDLY 1091 00:45:25,755 --> 00:45:28,291 CHANGING SCIENTIFIC ENVIRONMENT, 1092 00:45:28,291 --> 00:45:29,592 INCLUDING, YOU KNOW, POTENTIAL 1093 00:45:29,592 --> 00:45:31,695 SIX MONTHS INJECTION FOR PrEP, 1094 00:45:31,695 --> 00:45:34,631 AND LONG ACTING AGENTS THAT 1095 00:45:34,631 --> 00:45:35,832 ALMOST CERTAINLILY WILL BE 1096 00:45:35,832 --> 00:45:38,334 SEVERAL MONTHS, EITHER ORAL OR 1097 00:45:38,334 --> 00:45:40,003 INJECTABLE, FOR TREATMENT. 1098 00:45:40,003 --> 00:45:43,606 I'M WONDERING IF THAT INFLUENCES 1099 00:45:43,606 --> 00:45:46,342 THE DISTRIBUTION OF RESOURCES 1100 00:45:46,342 --> 00:45:47,877 AMONG THESE TOPICS THAT HAVE 1101 00:45:47,877 --> 00:45:52,015 PICKED, IN OTHER WORDS, WE MAY 1102 00:45:52,015 --> 00:45:55,952 BE HEARING LESS ABOUT 1103 00:45:55,952 --> 00:46:00,690 OPPORTUNISTIC INFECTION AND MORE 1104 00:46:00,690 --> 00:46:02,826 ABOUT ACCESS TO TREATMENT, 1105 00:46:02,826 --> 00:46:03,393 TREATMENT ADHERENCE, OTHER 1106 00:46:03,393 --> 00:46:07,464 THINGS WE MAY HAVE HAD IN THE 1107 00:46:07,464 --> 00:46:09,399 MIXTURE BUT HOW IS OAR DEALING 1108 00:46:09,399 --> 00:46:10,867 WITH DISTRIBUTION OF RESOURCES 1109 00:46:10,867 --> 00:46:14,938 THAT ARE PROVIDED TO NIH TO DO 1110 00:46:14,938 --> 00:46:15,572 RESEARCH? 1111 00:46:15,572 --> 00:46:17,307 >> MAYBE I CAN PROVIDE 1112 00:46:17,307 --> 00:46:20,043 CONCEPTUAL COMMENTS AND THEN SEE 1113 00:46:20,043 --> 00:46:21,711 IF ANY MY COLLEAGUES WOULD LIKE 1114 00:46:21,711 --> 00:46:23,012 TO WEIGH IN SPECIFICALLY ON THE 1115 00:46:23,012 --> 00:46:27,951 TOPICAL ISSUES THAT YOU RAISE. 1116 00:46:27,951 --> 00:46:30,253 YOU KNOW, AS FAR AS IDENTIFYING 1117 00:46:30,253 --> 00:46:31,888 NEW PRIORITIES AND TRYING TO 1118 00:46:31,888 --> 00:46:33,990 STEER THE SHIP OF THE RESEARCH 1119 00:46:33,990 --> 00:46:35,692 THAT IS PROPOSED IN THE 1120 00:46:35,692 --> 00:46:38,461 APPLICATIONS THAT COME IN, YOU 1121 00:46:38,461 --> 00:46:41,631 KNOW, IT'S SLOW TO CHANGE SOURCE 1122 00:46:41,631 --> 00:46:44,167 A LITTLE BIT. 1123 00:46:44,167 --> 00:46:46,102 AND ANY GIVEN YEAR WE'RE STILL 1124 00:46:46,102 --> 00:46:49,205 FUNDING A LOT OF RESEARCH THAT 1125 00:46:49,205 --> 00:46:49,973 INITIATED IN PREVIOUS YEARS, SO, 1126 00:46:49,973 --> 00:46:54,210 YOU KNOW, THE HOPE IS THAT WE 1127 00:46:54,210 --> 00:46:55,779 ARE STIMULATING INVESTIGATORS TO 1128 00:46:55,779 --> 00:46:57,781 SUBMIT APPLICATIONS FOR THESE 1129 00:46:57,781 --> 00:46:59,582 TOPICS THAT ARE HIGHLIGHTED IN 1130 00:46:59,582 --> 00:47:00,950 THE PLAN, RECOGNIZING IT WILL 1131 00:47:00,950 --> 00:47:04,988 TAKE SOME TIME TO CHANGE THE 1132 00:47:04,988 --> 00:47:07,090 RESEARCH LANDSCAPE. 1133 00:47:07,090 --> 00:47:09,392 AND I ALSO THINK THAT, WELL, ONE 1134 00:47:09,392 --> 00:47:12,495 THING I DIDN'T SPEAK TO 1135 00:47:12,495 --> 00:47:15,431 SPECIFICALLY IN MY PRESENTATION 1136 00:47:15,431 --> 00:47:17,767 TODAY IS THAT WE DO INTEND FOR 1137 00:47:17,767 --> 00:47:21,037 THE PLAN TO BE REVIEWED 1138 00:47:21,037 --> 00:47:21,404 ANNUALLY. 1139 00:47:21,404 --> 00:47:24,340 SO AS NEW OPPORTUNITIES COME UP, 1140 00:47:24,340 --> 00:47:31,014 WE WILL HAVE THE OPPORTUNITY TO 1141 00:47:31,014 --> 00:47:31,748 ADJUST, AND HIGHLIGHT NEW 1142 00:47:31,748 --> 00:47:33,950 FUNDING OPPORTUNITIES IN ORDER 1143 00:47:33,950 --> 00:47:36,719 TO BE RESPONSIVE TO EMERGENT 1144 00:47:36,719 --> 00:47:38,521 AREAS OF RESEARCH. 1145 00:47:38,521 --> 00:47:43,526 DID ANYONE ELSE FROM OAR WANT TO 1146 00:47:43,526 --> 00:47:46,362 ADD TO MY COMMENTS? 1147 00:47:46,362 --> 00:47:52,368 1148 00:47:52,368 --> 00:47:59,843 1149 00:47:59,843 --> 00:48:01,044 >> I LOST CONNECTION FOR A 1150 00:48:01,044 --> 00:48:02,312 MOMENT BUT WILL BE HAPPY TO 1151 00:48:02,312 --> 00:48:03,713 RESPOND BUT I'M JUST CATCHING 1152 00:48:03,713 --> 00:48:04,280 UP. 1153 00:48:04,280 --> 00:48:12,155 I WILL RESPOND OFFLINE. 1154 00:48:12,155 --> 00:48:13,223 THANK YOU. 1155 00:48:13,223 --> 00:48:14,991 >> THANK YOU. 1156 00:48:14,991 --> 00:48:16,526 >> THAT WAS A GREAT OVERVIEW OF 1157 00:48:16,526 --> 00:48:17,594 THE STRATEGIC PLAN. 1158 00:48:17,594 --> 00:48:20,363 I WAS PLEASED TO SEE THERE'S 1159 00:48:20,363 --> 00:48:24,601 MORE EMPHASIS ON IMPLEMENTATION 1160 00:48:24,601 --> 00:48:25,401 SCIENCE AND DISSEMINATION 1161 00:48:25,401 --> 00:48:29,138 EFFORTS, SEEMS TO ME THAT THE 1162 00:48:29,138 --> 00:48:31,274 PLAN IS VERY HIGH LEVEL. 1163 00:48:31,274 --> 00:48:33,176 IS THE ROLE OF THE TASK FORCE 1164 00:48:33,176 --> 00:48:36,546 THEN TO BECOME A BIT MORE 1165 00:48:36,546 --> 00:48:39,616 SPECIFIC, IS THIS GREATER 1166 00:48:39,616 --> 00:48:40,416 EMPHASIS IN IMPLEMENTATION 1167 00:48:40,416 --> 00:48:41,885 SCIENCE GOING TO TRANSLATE IN 1168 00:48:41,885 --> 00:48:44,554 MORE REQUESTS FOR PROPOSALS IN 1169 00:48:44,554 --> 00:48:47,223 THAT AREA OR SOME OTHER 1170 00:48:47,223 --> 00:48:50,126 STRATEGIC NUDGING SO AS YOU WERE 1171 00:48:50,126 --> 00:48:51,027 SAYING RACHEL THAT THERE'S GOING 1172 00:48:51,027 --> 00:48:54,731 TO HAVE TO BE NEW SCIENCE THAT 1173 00:48:54,731 --> 00:48:56,599 MOVES INTO THIS NEW AREA, HOW 1174 00:48:56,599 --> 00:48:57,901 SPECIFICALLY ARE WE GOING TO GET 1175 00:48:57,901 --> 00:48:59,469 THERE, IS THAT THE ROLE OF THE 1176 00:48:59,469 --> 00:49:01,537 TASK FORCE OR HOW ARE YOU GOING 1177 00:49:01,537 --> 00:49:02,505 TO GET THERE? 1178 00:49:02,505 --> 00:49:02,772 >> SURE. 1179 00:49:02,772 --> 00:49:04,641 I APPRECIATE THE QUESTION. 1180 00:49:04,641 --> 00:49:06,676 AND YOU'RE RIGHT, THAT AS OF 1181 00:49:06,676 --> 00:49:07,977 RIGHT NOW THE PLAN AND WHAT 1182 00:49:07,977 --> 00:49:09,412 YOU'VE SEEN, IT IS VERY HIGH 1183 00:49:09,412 --> 00:49:12,348 LEVEL AND DOESN'T GET INTO THE 1184 00:49:12,348 --> 00:49:12,749 DETAILS. 1185 00:49:12,749 --> 00:49:14,784 THAT IS EXACTLY THE ROLE OF THE 1186 00:49:14,784 --> 00:49:15,818 TASK FORCES. 1187 00:49:15,818 --> 00:49:18,388 SO, WHAT WE'VE BEEN GOING IS 1188 00:49:18,388 --> 00:49:20,390 COMPILING ALL OF THE DIFFERENT 1189 00:49:20,390 --> 00:49:21,557 SOURCES OF INPUT WE'VE RECEIVED, 1190 00:49:21,557 --> 00:49:23,192 NOT ONLY FROM THE RFI BUT WHAT 1191 00:49:23,192 --> 00:49:26,162 WE'VE BEEN HEARING AT WORKSHOPS, 1192 00:49:26,162 --> 00:49:28,431 LISTENING SESSIONS, AND 1193 00:49:28,431 --> 00:49:29,265 INTEGRATING THAT INTO 1194 00:49:29,265 --> 00:49:32,001 ESSENTIALLY A LIST OF THINGS 1195 00:49:32,001 --> 00:49:34,837 THAT COULD BE PRIORITIES. 1196 00:49:34,837 --> 00:49:36,472 SO IT'S A REALLY ROBUST LIST 1197 00:49:36,472 --> 00:49:39,409 THAT COVERS A LOT OF TOPICS. 1198 00:49:39,409 --> 00:49:41,577 IT'S PROBABLY TOO MANY TOPICS TO 1199 00:49:41,577 --> 00:49:44,547 TRULY CALL PRIORITIES RIGHT NOW. 1200 00:49:44,547 --> 00:49:48,618 AND SO HANDING OVER THESE MORE 1201 00:49:48,618 --> 00:49:50,553 SPECIFIC THREE RESEARCH AREAS TO 1202 00:49:50,553 --> 00:49:52,689 THE TASK FORCES TO DELIBERATE 1203 00:49:52,689 --> 00:49:55,425 AND REALLY LOOK AT THEM AND SEE 1204 00:49:55,425 --> 00:49:57,060 WHICH ONES SHOULD BE INCLUDED 1205 00:49:57,060 --> 00:50:00,863 AND HELP US REFINE THE LIST 1206 00:50:00,863 --> 00:50:03,967 USING YOUR SUBJECT MATTER 1207 00:50:03,967 --> 00:50:05,401 EXPERTISE AND EXAMINING THE 1208 00:50:05,401 --> 00:50:08,671 OPPORTUNITIES FOR THE RESEARCH 1209 00:50:08,671 --> 00:50:08,871 FIELD. 1210 00:50:08,871 --> 00:50:10,606 SO, THERE ARE PARTS OF THIS THAT 1211 00:50:10,606 --> 00:50:12,575 HAVEN'T BEEN WORKED OUT YET BUT 1212 00:50:12,575 --> 00:50:14,811 THE TASK FORCES WILL RECOMMEND 1213 00:50:14,811 --> 00:50:17,413 MORE SPECIFIC FUNDING 1214 00:50:17,413 --> 00:50:18,081 PRIORITIES. 1215 00:50:18,081 --> 00:50:20,717 AND AS ALWAYS WITH HOW THE PLAN 1216 00:50:20,717 --> 00:50:22,352 IS IMPLEMENTED, YOU KNOW, A LOT 1217 00:50:22,352 --> 00:50:24,320 OF THIS WILL DEPEND ON THE 1218 00:50:24,320 --> 00:50:25,955 APPLICATIONS THAT ARE RECEIVED 1219 00:50:25,955 --> 00:50:29,826 AND THE INITIATIVES THAT THE 1220 00:50:29,826 --> 00:50:33,096 I.C.s SUPPORT FOR HIV 1221 00:50:33,096 --> 00:50:34,364 APPLICATIONS. 1222 00:50:34,364 --> 00:50:36,599 SO, YOU KNOW, WE CERTAINLY -- WE 1223 00:50:36,599 --> 00:50:42,739 HOPE TO STIR UP NEW INTEREST 1224 00:50:42,739 --> 00:50:43,940 IN -- OR ENHANCED INTEREST IN 1225 00:50:43,940 --> 00:50:45,675 THESE AREAS TO EXPAND. 1226 00:50:45,675 --> 00:50:48,911 THANK YOU. 1227 00:50:48,911 --> 00:50:54,350 >> GREAT. 1228 00:50:54,350 --> 00:50:55,418 DR. NAGHAVI? 1229 00:50:55,418 --> 00:51:00,123 >> FOLLOWING UP ON ALL THE 1230 00:51:00,123 --> 00:51:01,324 INDIVIDUAL COMMENTS BE INCLUDED 1231 00:51:01,324 --> 00:51:02,759 IN THE TASK FORCE FOR 1232 00:51:02,759 --> 00:51:05,228 CONSIDERATION OR ARE THERE ONLY 1233 00:51:05,228 --> 00:51:09,332 LIKE THE ONES THAT HAVE OVERLAP? 1234 00:51:09,332 --> 00:51:12,835 I MEAN, IF SOMEONE, ONE SINGLE 1235 00:51:12,835 --> 00:51:14,037 INDIVIDUAL, AS AN OUT-OF-BOX 1236 00:51:14,037 --> 00:51:16,973 IDEA WOULD THAT BE INCLUDED FOR 1237 00:51:16,973 --> 00:51:17,473 CONSIDERATION? 1238 00:51:17,473 --> 00:51:19,742 >> WE ARE PLANNING TO BE VERY 1239 00:51:19,742 --> 00:51:20,510 INCLUSIVE WITH THE MATERIALS 1240 00:51:20,510 --> 00:51:22,779 THAT WE SHARE WITH THE TASK 1241 00:51:22,779 --> 00:51:25,648 FORCES TO CONSIDER. 1242 00:51:25,648 --> 00:51:28,918 SO, EACH TASK FORCE WILL RECEIVE 1243 00:51:28,918 --> 00:51:30,853 OUR KIND OF HIGH LEVEL LIST OF 1244 00:51:30,853 --> 00:51:32,955 WHAT WE'VE PULLED OUT OF ALL OF 1245 00:51:32,955 --> 00:51:35,024 THESE SOURCES BUT THE TASK 1246 00:51:35,024 --> 00:51:40,063 FORCES WILL ALSO RECEIVE THE 1247 00:51:40,063 --> 00:51:41,297 SOURCE MATERIAL ITSELF, SO 1248 00:51:41,297 --> 00:51:42,031 EVERYTHING. 1249 00:51:42,031 --> 00:51:43,566 EVERYTHING YOU COULD POSSIBLY 1250 00:51:43,566 --> 00:51:44,133 WANT, I THINK. 1251 00:51:44,133 --> 00:51:48,771 >> THANK YOU. 1252 00:51:48,771 --> 00:51:50,673 >> DR. GALARRAGA, DID YOU HAVE 1253 00:51:50,673 --> 00:51:51,908 ADDITIONAL COMMENT OR QUESTION 1254 00:51:51,908 --> 00:51:53,543 FOR DR. ANDERSON? 1255 00:51:53,543 --> 00:51:55,078 >> NO, I DIDN'T. 1256 00:51:55,078 --> 00:51:57,013 I RAISED -- I LOWERED MY HAND 1257 00:51:57,013 --> 00:51:58,047 ALREADY. 1258 00:51:58,047 --> 00:51:59,348 THANK YOU. 1259 00:51:59,348 --> 00:51:59,682 >> OKAY. 1260 00:51:59,682 --> 00:52:01,951 ALL RIGHT. 1261 00:52:01,951 --> 00:52:04,454 ARE THERE ANY MORE COMMENTS OR 1262 00:52:04,454 --> 00:52:09,759 QUESTIONS? 1263 00:52:09,759 --> 00:52:09,959 OKAY. 1264 00:52:09,959 --> 00:52:13,162 SEEING NONE, I'D LIKE TO THANK 1265 00:52:13,162 --> 00:52:16,666 OUR PRESENTERS AND OARAC MEMBERS 1266 00:52:16,666 --> 00:52:17,733 FOR THEIR DISCUSSION. 1267 00:52:17,733 --> 00:52:20,470 AND I'M GOING TO MOVE FORWARD 1268 00:52:20,470 --> 00:52:22,772 WITH THE NEXT PRESENTER. 1269 00:52:22,772 --> 00:52:25,174 I'M PLEASED TO INTRODUCE OUR 1270 00:52:25,174 --> 00:52:33,816 NEXT PRESENTER, DR. FRANCISCO 1271 00:52:33,816 --> 00:52:35,985 RUIZ, IN THIS ROLE FRANCISCO 1272 00:52:35,985 --> 00:52:39,288 LEADS EFFORTS TO IMPLEMENT THE 1273 00:52:39,288 --> 00:52:41,023 NATION'S STRATEGY TO ADDRESSING 1274 00:52:41,023 --> 00:52:42,358 HIV, WORKING CLOSELY WITH 1275 00:52:42,358 --> 00:52:45,761 GOVERNMENT AGENCIES AT ALL 1276 00:52:45,761 --> 00:52:46,863 LEVELS, COMMUNITY-BASED 1277 00:52:46,863 --> 00:52:48,097 ORGANIZATIONS, HEALTHCARE 1278 00:52:48,097 --> 00:52:49,832 PROVIDERS, AND MANY OTHER 1279 00:52:49,832 --> 00:52:52,201 ENTITIES TO COORDINATE A 1280 00:52:52,201 --> 00:52:55,438 COMPREHENSIVE RESPONSE TO THE 1281 00:52:55,438 --> 00:52:56,472 HIV EPIDEMIC. 1282 00:52:56,472 --> 00:52:59,442 MR. RUIZ, I WILL TURN IT OVER TO 1283 00:52:59,442 --> 00:52:59,675 YOU. 1284 00:52:59,675 --> 00:53:04,046 >> THANK YOU SO MUCH, EVERYONE. 1285 00:53:04,046 --> 00:53:06,649 MY SLIDES WILL APPEAR MAGICALLY 1286 00:53:06,649 --> 00:53:06,949 SOMEHOW. 1287 00:53:06,949 --> 00:53:08,084 BUT I'LL GET STARTED. 1288 00:53:08,084 --> 00:53:10,920 I WANT TO THANK EVERYONE, OAR IN 1289 00:53:10,920 --> 00:53:13,890 PARTICULAR FOR THE INVITATION TO 1290 00:53:13,890 --> 00:53:16,392 JOIN YOU. 1291 00:53:16,392 --> 00:53:18,194 AND THESE PAST TWO MONTHS IN THE 1292 00:53:18,194 --> 00:53:20,530 NEW ROLE I'VE HAD THE PRIVILEGE 1293 00:53:20,530 --> 00:53:22,532 OF ENGAGING IN INSIGHTFUL AND 1294 00:53:22,532 --> 00:53:24,367 MEANINGFUL CONVERSATION WAS 1295 00:53:24,367 --> 00:53:24,967 FEDERAL COLLEAGUES, NATIONAL, 1296 00:53:24,967 --> 00:53:26,502 LOCAL PARTNERS, MOST IMPORTANTLY 1297 00:53:26,502 --> 00:53:27,803 PEOPLE WITH HIV. 1298 00:53:27,803 --> 00:53:35,978 ARE MY SLIDES SHOWING? 1299 00:53:35,978 --> 00:53:37,613 I WANT TO MAKE SURE THAT -- 1300 00:53:37,613 --> 00:53:41,651 HAPPY TO SHARE MY DESKTOP. 1301 00:53:41,651 --> 00:53:42,051 PERFECT, OKAY. 1302 00:53:42,051 --> 00:53:46,989 KEEP GOING. 1303 00:53:46,989 --> 00:53:49,192 SO CONVERSATIONS I HAVE HEARD 1304 00:53:49,192 --> 00:53:51,260 FROM COMMUNITY PEOPLE WITH HIV 1305 00:53:51,260 --> 00:53:53,563 ABOUT THE WORK THAT YOU WANT TO 1306 00:53:53,563 --> 00:53:55,431 DO, SHARE KEY AREAS I'VE 1307 00:53:55,431 --> 00:53:57,700 IDENTIFIED IN COLLABORATION AS I 1308 00:53:57,700 --> 00:54:01,571 SAID IN CONVERSATION WITH FOLKS 1309 00:54:01,571 --> 00:54:03,639 CENTERING SCIENCE, ACCELERATING 1310 00:54:03,639 --> 00:54:05,975 PROGRESS, ADVANCING HEALTH 1311 00:54:05,975 --> 00:54:07,143 EQUITY. 1312 00:54:07,143 --> 00:54:08,244 >> EXCUSE ME, MR. RUIZ. 1313 00:54:08,244 --> 00:54:10,346 THOSE WERE THE WRONG SLIDES. 1314 00:54:10,346 --> 00:54:13,382 DID WE GET THE RIGHT SLIDES UP 1315 00:54:13,382 --> 00:54:14,817 FOR FRANCISCO'S PRESENTATION? 1316 00:54:14,817 --> 00:54:17,019 THOSE ARE DR. MARTIN'S SLIDES WE 1317 00:54:17,019 --> 00:54:19,655 WERE LOOKING AT. 1318 00:54:19,655 --> 00:54:20,923 >> YEAH, YOU CAN PROCEED AND WE 1319 00:54:20,923 --> 00:54:23,426 WILL PULL THEM UP AS YOU GO. 1320 00:54:23,426 --> 00:54:23,759 >> PERFECT. 1321 00:54:23,759 --> 00:54:25,861 I COULD ALSO SHARE MY SCREEN IF 1322 00:54:25,861 --> 00:54:27,430 IT'S EASIER. 1323 00:54:27,430 --> 00:54:33,336 WHATEVER WORKS ON YOUR END. 1324 00:54:33,336 --> 00:54:34,837 SO THERE WE GO. 1325 00:54:34,837 --> 00:54:35,771 >> THERE WE GO. 1326 00:54:35,771 --> 00:54:36,606 THANK YOU. 1327 00:54:36,606 --> 00:54:36,973 >> ALL RIGHT. 1328 00:54:36,973 --> 00:54:47,450 SO IF YOU GO TO THE NEXT SLIDE. 1329 00:54:47,450 --> 00:54:49,952 AWESOME. 1330 00:54:49,952 --> 00:54:53,522 WE'LL DISP THE CURRENT STATE AND 1331 00:54:53,522 --> 00:54:55,825 WORK THAT LIES AHEAD, LAY 1332 00:54:55,825 --> 00:54:57,159 FOUNDATION FOR APPROACH AN 1333 00:54:57,159 --> 00:54:57,493 COMMITMENT. 1334 00:54:57,493 --> 00:54:59,328 WE'LL THEN EXPLORE THE FOCUS 1335 00:54:59,328 --> 00:55:02,632 AREAS FOR ONAP INCLUDING CALL TO 1336 00:55:02,632 --> 00:55:03,633 ACTION. 1337 00:55:03,633 --> 00:55:05,167 NEXT SLIDE. 1338 00:55:05,167 --> 00:55:07,436 SO LAST MONTH CDC RELEASED 1339 00:55:07,436 --> 00:55:08,504 THROUGH NEW HIV SURVEILLANCE 1340 00:55:08,504 --> 00:55:10,373 REPORTS, GLAD TO SEE DR. MERMIN 1341 00:55:10,373 --> 00:55:13,909 ON THE CALL. 1342 00:55:13,909 --> 00:55:15,311 I'M CONFIDENT YOU ALREADY 1343 00:55:15,311 --> 00:55:16,412 REVIEWED THE REPORT. 1344 00:55:16,412 --> 00:55:17,647 LET'S DELVE INTO FINDINGS TO 1345 00:55:17,647 --> 00:55:18,814 GROUND OUR PROGRESS AND GUIDE 1346 00:55:18,814 --> 00:55:21,884 OUR FUTURE EFFORTS. 1347 00:55:21,884 --> 00:55:22,585 NEXT SLIDE. 1348 00:55:22,585 --> 00:55:25,521 THE OVERALL NUMBER OF NEW 1349 00:55:25,521 --> 00:55:28,224 INFECTIONS INCREASED 12% IN 2022 1350 00:55:28,224 --> 00:55:29,759 COMPARED TO 2018 WHICH MEANS 1351 00:55:29,759 --> 00:55:33,029 WE'RE GOING IN THE RIGHT 1352 00:55:33,029 --> 00:55:34,130 DIRECTION, REDUCTION 1353 00:55:34,130 --> 00:55:34,830 DEMONSTRATES EFFECTIVENESS OF 1354 00:55:34,830 --> 00:55:37,433 CURRENT STRATEGIES AND POTENTIAL 1355 00:55:37,433 --> 00:55:40,269 FOR FUTURE PROGRESS. 1356 00:55:40,269 --> 00:55:43,572 IN 2020 THERE WERE 31,800 NEW 1357 00:55:43,572 --> 00:55:47,510 INFECTIONS, AT YEAR END, 22, 1358 00:55:47,510 --> 00:55:50,246 1.2 MILLION PERSONS LIVING WITH 1359 00:55:50,246 --> 00:55:54,950 HIV OF WHICH 87 HAD RECEIVED A 1360 00:55:54,950 --> 00:55:55,518 DIAGNOSIS. 1361 00:55:55,518 --> 00:55:56,786 HIGHLIGHT POPULATIONS WITH 1362 00:55:56,786 --> 00:55:58,187 NOTABLE CHANGES IN 2022 COMPARED 1363 00:55:58,187 --> 00:56:02,625 TO 2018. 1364 00:56:02,625 --> 00:56:07,897 NEXT SLIDE. 1365 00:56:07,897 --> 00:56:10,533 2022 NEW INFECTION DECREASED 18% 1366 00:56:10,533 --> 00:56:18,641 AMONG BLACK PERSONS. 1367 00:56:18,641 --> 00:56:22,345 YOU SEE BY AGE, FINISH INCIDENCE 1368 00:56:22,345 --> 00:56:25,381 DECREASED 30% IN 2022 AMONG 1369 00:56:25,381 --> 00:56:27,149 PERSONS AGED 13 TO 24, THE 1370 00:56:27,149 --> 00:56:31,420 LARGEST NUMBER OF INFECTIONS 1371 00:56:31,420 --> 00:56:34,824 AMONG PERSONS 25-34, EACH YEAR. 1372 00:56:34,824 --> 00:56:38,094 40% OF INFECTIONS IN 2022. 1373 00:56:38,094 --> 00:56:38,694 NEXT SLIDE. 1374 00:56:38,694 --> 00:56:48,337 IN 2022 NEW INFECTIONED DECREAE 1375 00:56:48,337 --> 00:56:50,806 THE 16%, EACH YEAR LATINO MALES 1376 00:56:50,806 --> 00:56:52,775 HAD HIGHER ESTIMATED NUMBER OF 1377 00:56:52,775 --> 00:56:57,913 NEW INFECTIONS, NO CHANGE AMONG 1378 00:56:57,913 --> 00:56:59,782 FEMALE OR ETHNIC POPULATIONS, 1379 00:56:59,782 --> 00:57:02,418 47% OF NEW INFECTION AMONGST 1380 00:57:02,418 --> 00:57:04,053 FEMALES WERE AMONG BLACK 1381 00:57:04,053 --> 00:57:06,889 FEMALES. 1382 00:57:06,889 --> 00:57:07,189 NEXT SLIDE. 1383 00:57:07,189 --> 00:57:10,292 NEW INFECTION DECREASED 20% 1384 00:57:10,292 --> 00:57:17,099 AMONG WHITE, MSM, 16% AMONG 1385 00:57:17,099 --> 00:57:22,838 BLACK MSM. 1386 00:57:22,838 --> 00:57:26,342 IN 2022, 39%, WE MUST ENSURE 1387 00:57:26,342 --> 00:57:28,644 PROGRESS AMONG ALL COMMUNITIES. 1388 00:57:28,644 --> 00:57:30,179 BY REGION NEW INFECTION 1389 00:57:30,179 --> 00:57:33,783 INCREASED 16% IN THE SOUTH, 49% 1390 00:57:33,783 --> 00:57:38,254 OF INFECTIONS IN 2022. 1391 00:57:38,254 --> 00:57:38,921 NEXT SLIDE. 1392 00:57:38,921 --> 00:57:45,294 THE STATE OF HIV IN THE UNITED 1393 00:57:45,294 --> 00:57:48,164 STATES, I WILL DIVE INTO SOME 1394 00:57:48,164 --> 00:57:48,631 ONAP PRIORITIES. 1395 00:57:48,631 --> 00:57:57,139 I WANT TO SHARE BEFORE THAT SOME 1396 00:57:57,139 --> 00:57:57,706 VALUES ENVISIONED, ENSURING 1397 00:57:57,706 --> 00:57:59,375 EFFORTS ARE ROOTED IN NEEDS OF 1398 00:57:59,375 --> 00:58:02,011 PEOPLE WITH AND 1399 00:58:02,011 --> 00:58:04,914 DISPROPORTIONATELY IMPACTED BY 1400 00:58:04,914 --> 00:58:05,948 HIV. 1401 00:58:05,948 --> 00:58:07,583 THIS DECISION-MAKING PROCESS AND 1402 00:58:07,583 --> 00:58:09,385 POLICY DEVELOPMENT, WE CAN 1403 00:58:09,385 --> 00:58:10,252 FOSTER ENVIRONMENT THAT 1404 00:58:10,252 --> 00:58:11,554 PRIORITIZEs WELL-BEING OF ALL 1405 00:58:11,554 --> 00:58:12,121 INDIVIDUALS REGARDLESS OF 1406 00:58:12,121 --> 00:58:14,824 BACKGROUND OR CIRCUMSTANCES. 1407 00:58:14,824 --> 00:58:17,793 AS YOU SEE THE EQUITY, BY 1408 00:58:17,793 --> 00:58:19,895 FOCUSING ON EQUITY WORK TO 1409 00:58:19,895 --> 00:58:20,629 ELIMINATE DISPARITIES. 1410 00:58:20,629 --> 00:58:22,164 THIS COMMITMENT IS ABOUT 1411 00:58:22,164 --> 00:58:23,365 FAIRNESS, ABOUT HELPING TO 1412 00:58:23,365 --> 00:58:25,668 ELIMINATE THE GAP IN HEALTH 1413 00:58:25,668 --> 00:58:28,070 OUTCOMES ACROSS DIFFERENT 1414 00:58:28,070 --> 00:58:28,838 COMMUNITIES. 1415 00:58:28,838 --> 00:58:30,806 NUMBER 2, ACCOUNTABILITY. 1416 00:58:30,806 --> 00:58:31,407 WE'LL TRACK PROGRESS WITH 1417 00:58:31,407 --> 00:58:32,641 TRANSPARENCY ENSURING THAT OUR 1418 00:58:32,641 --> 00:58:34,677 EFFORTS ARE MEASURABLE AND OPEN 1419 00:58:34,677 --> 00:58:35,511 TO PUBLIC REVIEW. 1420 00:58:35,511 --> 00:58:38,013 THIS WILL HELP BUILD TRUST AND 1421 00:58:38,013 --> 00:58:40,416 DEMONSTRATE COMMITMENT TO 1422 00:58:40,416 --> 00:58:41,884 ACHIEVING OUR GOALS. 1423 00:58:41,884 --> 00:58:44,153 AND THIRD IS INNOVATION, TO 1424 00:58:44,153 --> 00:58:48,858 DRIVE US TO ADOPT CUTTING EDGE 1425 00:58:48,858 --> 00:58:50,626 SOLUTIONS TO BE EFFECTIVE AND 1426 00:58:50,626 --> 00:58:53,863 FORWARD THINKING. 1427 00:58:53,863 --> 00:58:56,632 INCLUSIVITY IS THE NEXT VALUE, 1428 00:58:56,632 --> 00:59:00,903 SHAKING OUR STRATEGIES. 1429 00:59:00,903 --> 00:59:02,104 AS A CONGRESSWOMAN SAID THE 1430 00:59:02,104 --> 00:59:04,039 PEOPLE CLOSEES TO THE PAIN 1431 00:59:04,039 --> 00:59:06,542 SHOULD BE CLOSEST TO THE POWER, 1432 00:59:06,542 --> 00:59:11,013 THIS HELPS CREATE MORE 1433 00:59:11,013 --> 00:59:12,414 EMPATHETIC POLICIES, THIS VALUE 1434 00:59:12,414 --> 00:59:14,483 RECENTERS COMMITMENT MADE IN 1435 00:59:14,483 --> 00:59:16,552 1983 AT DENVER PRINCIPLES, THE 1436 00:59:16,552 --> 00:59:17,319 IMPORTANCE OF MEANFUL 1437 00:59:17,319 --> 00:59:21,156 INVOLVEMENT OF PEOPLE WITH HIV. 1438 00:59:21,156 --> 00:59:22,258 ACCESSIBILITY WILL GUARANTEE 1439 00:59:22,258 --> 00:59:23,425 EVERYONE HAS RESOURCES BREAKING 1440 00:59:23,425 --> 00:59:28,998 DOWN BARRIERS TO CARE AND 1441 00:59:28,998 --> 00:59:29,965 SUPPORT. 1442 00:59:29,965 --> 00:59:30,633 ADAPTABILITY, RESPONDING SWIFTLY 1443 00:59:30,633 --> 00:59:32,201 TO EMERGING CHALLENGES AS 1444 00:59:32,201 --> 00:59:35,004 SCIENCE EMERGE, WE MUST BE 1445 00:59:35,004 --> 00:59:37,540 ADAPTABLE, FLEXIBLE TO CHANGE, 1446 00:59:37,540 --> 00:59:38,374 ADDRESS DEVELOPMENTS. 1447 00:59:38,374 --> 00:59:42,678 AND LAST BUT NOT LEAST 1448 00:59:42,678 --> 00:59:43,012 COLLABORATION. 1449 00:59:43,012 --> 00:59:43,646 COLLABORATION WILL AMPLIFY 1450 00:59:43,646 --> 00:59:46,181 IMPACT, BRING TOGETHER A BROAD 1451 00:59:46,181 --> 00:59:47,716 COLLECTION OF PARTNERS, MUST 1452 00:59:47,716 --> 00:59:53,322 ELIMINATE US VERSUS THEM 1453 00:59:53,322 --> 00:59:55,958 MENTALITY, WE MUST WORK AS ONE 1454 00:59:55,958 --> 00:59:57,893 UNIFIED FORCE TOWARDS OUR COMMON 1455 00:59:57,893 --> 00:59:58,227 GOALS. 1456 00:59:58,227 --> 01:00:00,729 THE INTENT IN DEVELOPING THESE 1457 01:00:00,729 --> 01:00:02,665 VALUES TO INTEGRATE SCIENCE WITH 1458 01:00:02,665 --> 01:00:04,533 HUMANITY. 1459 01:00:04,533 --> 01:00:05,935 SO IT'S CRUCIAL TO REMEMBER THAT 1460 01:00:05,935 --> 01:00:07,770 WHAT DRIVES US IS THE LIVES AND 1461 01:00:07,770 --> 01:00:09,605 HOPES AND DREAMS OF EVERY 1462 01:00:09,605 --> 01:00:11,140 INDIVIDUAL WE SERVE. 1463 01:00:11,140 --> 01:00:14,643 LET'S DISCUSS ONAP PRIORITIES, 1464 01:00:14,643 --> 01:00:15,010 STRAIGHTFORWARD. 1465 01:00:15,010 --> 01:00:17,079 THEY FOCUS ON THREE KEY AREAS, 1466 01:00:17,079 --> 01:00:21,450 UPDATING POLICY, BASED ON LATEST 1467 01:00:21,450 --> 01:00:22,685 SCIENTIFIC EVIDENCE. 1468 01:00:22,685 --> 01:00:23,419 ACCELERATING PROGRESS, PROMOTING 1469 01:00:23,419 --> 01:00:26,155 HEALTH EQUITY FOR ALL AMERICANS. 1470 01:00:26,155 --> 01:00:28,190 AS YOU SEE HERE ON THE STRATEGY, 1471 01:00:28,190 --> 01:00:30,292 I WANT TO REGROUND US. 1472 01:00:30,292 --> 01:00:32,361 IT'S HARD TO PUT ALL THESE 1473 01:00:32,361 --> 01:00:33,996 ELEMENTS ON ONE SLIDE BUT I DID 1474 01:00:33,996 --> 01:00:35,331 MY BEST. 1475 01:00:35,331 --> 01:00:37,399 AS YOU KNOW, THESE DOCUMENTS 1476 01:00:37,399 --> 01:00:42,771 WERE RELEASED IN THE FIRST YEAR 1477 01:00:42,771 --> 01:00:45,641 OF THE BIDEN-HARRISS 1478 01:00:45,641 --> 01:00:47,376 ADMINISTRATION BY MY 1479 01:00:47,376 --> 01:00:49,011 PREDECESSORS, TO STRENGTHEN THE 1480 01:00:49,011 --> 01:00:53,415 WHOLE-OF-GOVERNMENT APPROACH. 1481 01:00:53,415 --> 01:00:55,150 THE DOCUMENTS HAVE OUR -- ONE 1482 01:00:55,150 --> 01:00:56,685 VISION, FOUR GOALS. 1483 01:00:56,685 --> 01:01:00,623 THE GOALS ARE SUPPORTED BY 21 1484 01:01:00,623 --> 01:01:01,523 OBJECTIVES, FURTHER ENRICHED BY 1485 01:01:01,523 --> 01:01:02,524 78 STRATEGIES. 1486 01:01:02,524 --> 01:01:04,727 STRATEGY LAYS OUT EIGHT 1487 01:01:04,727 --> 01:01:06,895 INDICATORS, TO TRACK PROGRESS 1488 01:01:06,895 --> 01:01:11,834 TOWARDS NATIONAL HIV GOALS, 1489 01:01:11,834 --> 01:01:12,935 FEDERAL IMPLEMENTATION PLAN 1490 01:01:12,935 --> 01:01:16,972 CENTERS HHS AND NINE FEDERAL 1491 01:01:16,972 --> 01:01:20,142 DEPARTMENTS, 38 0 ACTION ITEMS, 1492 01:01:20,142 --> 01:01:21,577 INTRODUCING FIVE NEW STRATEGY 1493 01:01:21,577 --> 01:01:23,212 INDICATORS FOCUSED ON QUALITY OF 1494 01:01:23,212 --> 01:01:26,415 LIFE AMONG PEOPLE WITH HIV, AND 1495 01:01:26,415 --> 01:01:28,183 THOSE ARE SELF-RATED HEALTH 1496 01:01:28,183 --> 01:01:30,586 STATUS, MENTAL HEALTH, HUNGER, 1497 01:01:30,586 --> 01:01:34,490 UM EMPLOYMENT, UNSTABLE HOUSING. 1498 01:01:34,490 --> 01:01:37,559 NEXT SLIDE YOU SEE BUILT ON THE 1499 01:01:37,559 --> 01:01:38,994 SHOULDERS OF MANY, THE 1500 01:01:38,994 --> 01:01:41,864 PRIORITIES AND FOCUS AREAS, SO 1501 01:01:41,864 --> 01:01:43,799 THE FIRST BEING MODERNIZING 1502 01:01:43,799 --> 01:01:47,102 POLICIES BASED ON SCIENCE. 1503 01:01:47,102 --> 01:01:51,040 FIRST SHRINE SORT OF LEARNS INTO 1504 01:01:51,040 --> 01:01:54,943 SCIENCE, MANY POLICIES ARE 1505 01:01:54,943 --> 01:01:57,046 OUTDATE AND CONTRIBUTE TO 1506 01:01:57,046 --> 01:01:57,746 STIGMATIZATION, SO MODERNIZING 1507 01:01:57,746 --> 01:01:59,848 ARE REALLY IMPORTANT. 1508 01:01:59,848 --> 01:02:01,950 WE'VE SEEN PROGRESS, LAST YEAR 1509 01:02:01,950 --> 01:02:04,386 THE FDA UPDATED INDIVIDUAL RISK 1510 01:02:04,386 --> 01:02:06,588 ASSESSMENT FOR BLOOD DONATION, 1511 01:02:06,588 --> 01:02:07,990 ELIMINATED BLANKET EXCLUSION OF 1512 01:02:07,990 --> 01:02:12,928 GENDER -- BASED ON GENDER AND 1513 01:02:12,928 --> 01:02:14,530 SEXUAL ORIENTATION. 1514 01:02:14,530 --> 01:02:17,399 WE SUE THE UPDATE OF THE 1515 01:02:17,399 --> 01:02:19,468 POLICIES BASED, CHANGING MEDICAL 1516 01:02:19,468 --> 01:02:23,205 STANDARDS TO ACCEPT APPLICANTS 1517 01:02:23,205 --> 01:02:25,040 LIVING WITH CHRONIC HEPATITIS B 1518 01:02:25,040 --> 01:02:26,742 AND HIV. 1519 01:02:26,742 --> 01:02:29,845 YOU SEE REVIEWING EXISTING OTHER 1520 01:02:29,845 --> 01:02:30,879 EXISTING EMPLOYMENT POLICIES, 1521 01:02:30,879 --> 01:02:33,315 ENSURING EQUITABLE ACCESS FOR 1522 01:02:33,315 --> 01:02:35,417 PEOPLE AROUND ORGAN TRANSPLANT 1523 01:02:35,417 --> 01:02:37,119 AND CLINICAL TRIALS, UPDATING 1524 01:02:37,119 --> 01:02:39,955 CURRICULA, MAKING SURE THEY ARE 1525 01:02:39,955 --> 01:02:41,590 ACCURATE AND INCLUSIVE, 1526 01:02:41,590 --> 01:02:42,791 MODERNIZING LAWS TO REFLECT 1527 01:02:42,791 --> 01:02:45,060 CURRENT SCIENCE AND REDUCE 1528 01:02:45,060 --> 01:02:45,294 STIGMA. 1529 01:02:45,294 --> 01:02:50,599 NEXT IS ACCELERATING PROGRESS IN 1530 01:02:50,599 --> 01:02:52,868 OUR HIV RESPONSE. 1531 01:02:52,868 --> 01:03:03,378 WE'VE MADE INCREDIBLE STRIDES, 1532 01:03:04,213 --> 01:03:07,783 REGARDLESS OF RACE MUST HAVE 1533 01:03:07,783 --> 01:03:09,551 INDIVIDUAL CHOICES. 1534 01:03:09,551 --> 01:03:10,285 LARGER SOCIETAL FACTORS NEED TO 1535 01:03:10,285 --> 01:03:11,286 BE ADDRESSED. 1536 01:03:11,286 --> 01:03:13,021 NEXT SLIDE YOU SEE SOME OF THOSE 1537 01:03:13,021 --> 01:03:16,959 PRIORITY AREAS UNDER THIS SORT 1538 01:03:16,959 --> 01:03:20,028 OF BUCKET, LOOKING AT BUILDING 1539 01:03:20,028 --> 01:03:23,632 INTO MOMENTUM WE HAVE, IGNITING 1540 01:03:23,632 --> 01:03:25,534 NEW ONES, STRENGTHENING 1541 01:03:25,534 --> 01:03:27,903 COLLABORATION, BY SOUGHING DATA 1542 01:03:27,903 --> 01:03:29,204 CONNECTION OR CROSS-AGENCY 1543 01:03:29,204 --> 01:03:32,074 LOOKING AT CO-HOSTING COMMUNITY 1544 01:03:32,074 --> 01:03:33,175 ENGAGEMENT ACTIVITIES. 1545 01:03:33,175 --> 01:03:34,343 CROSS-POLLINATING T.A. RESOURCES 1546 01:03:34,343 --> 01:03:35,410 AND TRAINING. 1547 01:03:35,410 --> 01:03:36,979 SO A LOT OF THESE OPPORTUNITIES 1548 01:03:36,979 --> 01:03:39,214 ARE THINGS THAT ARE ALREADY IN 1549 01:03:39,214 --> 01:03:40,382 MOTION, WORKING ACROSS AGENCIES 1550 01:03:40,382 --> 01:03:42,217 TO DO THAT MORE. 1551 01:03:42,217 --> 01:03:43,652 LOOKING AT VIRAL SUPPRESSION 1552 01:03:43,652 --> 01:03:44,953 ENHANCING EFFORTS TO INCREASE 1553 01:03:44,953 --> 01:03:47,489 VIRAL SUPPRESSION RATES THROUGH 1554 01:03:47,489 --> 01:03:48,657 TAILORED INTERVENTIONS. 1555 01:03:48,657 --> 01:03:53,262 ACCESS TO ARTs. 1556 01:03:53,262 --> 01:03:55,697 LOOKING AT INTERCONNECTED 1557 01:03:55,697 --> 01:03:57,032 EPIDEMICS, ADAPTING HOLISTIC 1558 01:03:57,032 --> 01:03:58,066 RESPONSES, STREAMLINE 1559 01:03:58,066 --> 01:04:00,435 TRANSLATION OF HIV RESEARCH INTO 1560 01:04:00,435 --> 01:04:01,637 EFFECTIVE PROGRAMS AND POLICIES. 1561 01:04:01,637 --> 01:04:04,807 LASTLY CONTINUE TO LAY THE 1562 01:04:04,807 --> 01:04:05,674 GROUND WORK FOR CONGRESSIONAL 1563 01:04:05,674 --> 01:04:08,844 CHAMPIONS ON HIV. 1564 01:04:08,844 --> 01:04:09,945 NEXT SLIDE. 1565 01:04:09,945 --> 01:04:12,247 NEXT IS FOCUSING ON AS I 1566 01:04:12,247 --> 01:04:13,782 MENTIONED EQUITY, ONE OF THE 1567 01:04:13,782 --> 01:04:15,217 CORNERSTONES IN OUR VALUES, 1568 01:04:15,217 --> 01:04:17,119 MAKING SURE WE ADDRESS THE 1569 01:04:17,119 --> 01:04:18,754 NUMBER OF OLDER ADULTS LIVING 1570 01:04:18,754 --> 01:04:21,023 WITH HIV, SO THE NEXT SLIDE YOU 1571 01:04:21,023 --> 01:04:23,225 SEE SOME PRIORITIES UNDER 1572 01:04:23,225 --> 01:04:23,926 EQUITY, CONTINUING EFFORTS 1573 01:04:23,926 --> 01:04:26,295 ACROSS FEDERAL GOVERNMENT TO 1574 01:04:26,295 --> 01:04:29,064 STRENGTHEN EXISTING PROGRAMS AND 1575 01:04:29,064 --> 01:04:31,433 ASSESSING GAPS AND SERVICES. 1576 01:04:31,433 --> 01:04:32,201 NEXT SLIDE. 1577 01:04:32,201 --> 01:04:33,368 PrEP ACCESS EXPANSION TO 1578 01:04:33,368 --> 01:04:34,503 COLLABORATE ACROSS FEDERAL 1579 01:04:34,503 --> 01:04:36,905 AGENCIES TO INCREASE PrEP 1580 01:04:36,905 --> 01:04:39,741 ACCESSIBILITY AND AFFORDABILITY. 1581 01:04:39,741 --> 01:04:40,976 EXPANDING POLICIES AND 1582 01:04:40,976 --> 01:04:41,577 PARTNERSHIPS. 1583 01:04:41,577 --> 01:04:45,214 SUPPORT AND RETAIN CURRENT 1584 01:04:45,214 --> 01:04:47,182 WORKFORCE, DEVELOPING INCENTIVE 1585 01:04:47,182 --> 01:04:48,350 TO ATTRACT TALENT, FOSTERING 1586 01:04:48,350 --> 01:04:52,187 DIVERSITY AND INCLUSION IN THE 1587 01:04:52,187 --> 01:04:52,855 WORKFORCE. 1588 01:04:52,855 --> 01:04:55,891 ELEVATING INVOLVEMENT OF 1589 01:04:55,891 --> 01:04:56,558 BUSINESSES, FAITH-BASED 1590 01:04:56,558 --> 01:04:57,459 INSTITUTIONS, SOCIAL 1591 01:04:57,459 --> 01:04:58,427 ORGANIZATIONS TO LEVERAGE 1592 01:04:58,427 --> 01:04:59,294 INFLUENCE, EXPERTISE AND 1593 01:04:59,294 --> 01:05:02,598 PLATFORMS FOR THE WORK THAT WE 1594 01:05:02,598 --> 01:05:02,931 DO. 1595 01:05:02,931 --> 01:05:05,434 NEXT SLIDE, YOU SEE SORT OF THE 1596 01:05:05,434 --> 01:05:07,603 ADMINISTRATION CALL TO ACTION IS 1597 01:05:07,603 --> 01:05:08,136 SIMPLE. 1598 01:05:08,136 --> 01:05:09,371 AND THE CALL TO ACTION IS TO 1599 01:05:09,371 --> 01:05:10,572 JOIN US IN THIS. 1600 01:05:10,572 --> 01:05:12,441 MANY OF YOU HAVE BEEN DOING THIS 1601 01:05:12,441 --> 01:05:14,176 WORK FOR MANY YEARS SO WE WANT 1602 01:05:14,176 --> 01:05:16,745 TO HAVE YOU RECOMMIT TO THIS 1603 01:05:16,745 --> 01:05:18,247 WORK, AND CONTINUE TO MOVE 1604 01:05:18,247 --> 01:05:20,215 FORWARD IN SOME OF THE ACTIONS 1605 01:05:20,215 --> 01:05:21,516 THAT WE'VE SEEN SOME PROGRESS 1606 01:05:21,516 --> 01:05:22,050 IN. 1607 01:05:22,050 --> 01:05:24,019 SO THE NEXT SLIDE YOU'LL SEE 1608 01:05:24,019 --> 01:05:25,354 THESE PAST TWO MONTHS HAVE BEEN 1609 01:05:25,354 --> 01:05:26,088 BUSY AND BEAUTIFUL. 1610 01:05:26,088 --> 01:05:28,557 I'VE HAD THE OPPORTUNITY TO 1611 01:05:28,557 --> 01:05:32,127 SPEAK WITH MANY DOING THE WORK, 1612 01:05:32,127 --> 01:05:34,129 AND THOSE RECEIVING SERVICES. 1613 01:05:34,129 --> 01:05:37,766 PAST TWO MONTHS REMINDED ME IT'S 1614 01:05:37,766 --> 01:05:39,368 ABOUT THE SCIENCE THAT DRIVES US 1615 01:05:39,368 --> 01:05:41,169 AND HUMANITY THAT INSPIRES US. 1616 01:05:41,169 --> 01:05:43,872 LET'S MAKE SURE EVERY PERSON IS 1617 01:05:43,872 --> 01:05:47,276 SEEN, HEARD, SUPPORTED, IN OUR 1618 01:05:47,276 --> 01:05:47,709 COLLECTIVE RESPONSE. 1619 01:05:47,709 --> 01:05:50,112 THANK YOU FOR YOUR DEDICATION 1620 01:05:50,112 --> 01:05:54,082 AND PARTNERSHIP. 1621 01:05:54,082 --> 01:05:55,550 AND LET'S MOVE FORWARD WITH A 1622 01:05:55,550 --> 01:05:55,951 PURPOSE. 1623 01:05:55,951 --> 01:05:58,020 I WENT FAST BUT WE'LL MAKE SURE 1624 01:05:58,020 --> 01:05:59,488 THE SLIDES ARE AVAILABLE TO 1625 01:05:59,488 --> 01:05:59,688 FOLKS. 1626 01:05:59,688 --> 01:06:01,456 AND THEN I'LL STOP THERE AND SEE 1627 01:06:01,456 --> 01:06:09,831 IF THERE'S ANY QUESTIONS. 1628 01:06:09,831 --> 01:06:11,500 >> THANK YOU FOR YOUR 1629 01:06:11,500 --> 01:06:12,768 PRESENTATION, MR. RUIZ. 1630 01:06:12,768 --> 01:06:15,971 I WOULD LIKE TO JUST REMIND 1631 01:06:15,971 --> 01:06:18,140 OARAC MEMBERS TO RAISE YOUR 1632 01:06:18,140 --> 01:06:19,007 HANDS, WITH THE RAISE-HAND 1633 01:06:19,007 --> 01:06:20,342 FUNCTION, IF YOU HAVE ANY 1634 01:06:20,342 --> 01:06:24,646 QUESTIONS OR COMMENTS. 1635 01:06:24,646 --> 01:06:31,420 1636 01:06:31,420 --> 01:06:31,553 1637 01:06:31,553 --> 01:06:32,854 >> THANK YOU FOR YOUR 1638 01:06:32,854 --> 01:06:34,056 PRESENTATIONS, EXCITING TO HAVE 1639 01:06:34,056 --> 01:06:36,325 YOU LEADING THIS OFFICE AND 1640 01:06:36,325 --> 01:06:36,558 EFFORT. 1641 01:06:36,558 --> 01:06:38,827 ONE COMMENT AND TWO QUESTIONS. 1642 01:06:38,827 --> 01:06:40,529 IS IT YOUR INTERPRETATION THAT 1643 01:06:40,529 --> 01:06:42,798 THE DECREASES IN INFECTION ARE 1644 01:06:42,798 --> 01:06:43,665 NOT REALLY POLARIZED TO ANY 1645 01:06:43,665 --> 01:06:45,867 PARTICULAR AGE GROUP, IT'S A 1646 01:06:45,867 --> 01:06:48,036 UNIFORM DECREASE ACROSS ALL AGE 1647 01:06:48,036 --> 01:06:52,007 GROUPS BASED ON THE DATA YOU THE 1648 01:06:52,007 --> 01:06:54,710 SHOWED, IS THAT A CORRECT 1649 01:06:54,710 --> 01:06:56,912 INTERPRETATION OF THE 1650 01:06:56,912 --> 01:06:57,379 INFORMATION? 1651 01:06:57,379 --> 01:07:01,616 >> OVERALL I THINK, AS I SAY 1652 01:07:01,616 --> 01:07:03,585 THERE'S BEEN A 12% DECREASE 1653 01:07:03,585 --> 01:07:04,286 SINCE 2022. 1654 01:07:04,286 --> 01:07:05,520 SOME COMMUNITIES AS MENTIONED 1655 01:07:05,520 --> 01:07:10,292 HAVE SEEN MORE OF A DRASTIC 1656 01:07:10,292 --> 01:07:11,827 INCREASE BUT NOT CONSISTENT 1657 01:07:11,827 --> 01:07:12,627 ACROSS COMMUNITIES. 1658 01:07:12,627 --> 01:07:14,997 >> AGE-WISE, SEEMS TO BE STABLE, 1659 01:07:14,997 --> 01:07:20,035 THE AGE, FROM THE AGE GROUPINGS. 1660 01:07:20,035 --> 01:07:22,471 THAT'S RELATED TO MY FIRST 1661 01:07:22,471 --> 01:07:23,805 QUESTION, HISPANIC INCREASE, IS 1662 01:07:23,805 --> 01:07:26,308 THAT MORE DIAGNOSIS OR MORE 1663 01:07:26,308 --> 01:07:26,641 INFECTIONS? 1664 01:07:26,641 --> 01:07:29,378 BECAUSE THAT'S THE ONLY GROUP 1665 01:07:29,378 --> 01:07:30,479 THAT CONSISTENTLY WENT OPPOSITE 1666 01:07:30,479 --> 01:07:34,783 THAN THE OTHER GROUPS, SO WHAT'S 1667 01:07:34,783 --> 01:07:35,283 HAPPENING THERE? 1668 01:07:35,283 --> 01:07:43,058 >> I THINK I DON'T KNOW IF 1669 01:07:43,058 --> 01:07:45,160 MR. MERMIN WANTS TO JUMP IN. 1670 01:07:45,160 --> 01:07:46,228 >> THE FIRST QUESTION, MAJOR 1671 01:07:46,228 --> 01:07:47,863 DECREASES OVER THE PAST FEW 1672 01:07:47,863 --> 01:07:50,599 YEARS IN HIV INCIDENCE HAS BEEN 1673 01:07:50,599 --> 01:07:54,569 IN YOUNGER AND YOUNG-ISH PEOPLE. 1674 01:07:54,569 --> 01:07:55,637 SO PARTICULARLY THE YOUNGISH 1675 01:07:55,637 --> 01:07:57,839 POPULATION, OVER A LONGER PERIOD 1676 01:07:57,839 --> 01:07:59,975 OF TIME WE'VE SEEN DECREASES IN 1677 01:07:59,975 --> 01:08:00,809 YOUNG AFRICAN AMERICAN GAY MEN 1678 01:08:00,809 --> 01:08:03,211 WHO USED TO HAVE THE HIGHEST 1679 01:08:03,211 --> 01:08:04,546 INCIDENCE RATE, THIS IS 1680 01:08:04,546 --> 01:08:06,915 INCIDENCE RATE, LIKE NUMBER OF 1681 01:08:06,915 --> 01:08:11,486 NEW INFECTION PER POPULATION OF 1682 01:08:11,486 --> 01:08:12,854 ANY POPULATION, ALMOST 50 1683 01:08:12,854 --> 01:08:19,428 PASADENA - 50% DECREASE IN THE 1684 01:08:19,428 --> 01:08:21,696 PAST TEN YEARS, DECREASE IN 1685 01:08:21,696 --> 01:08:22,631 YOUNGISH PEOPLE, INCREASE 1686 01:08:22,631 --> 01:08:25,967 BETWEEN 20 AND 35 TO 40 AND 45 A 1687 01:08:25,967 --> 01:08:27,402 LITTLE BIT, THAT'S DECREASING, 1688 01:08:27,402 --> 01:08:30,906 SO WHAT'S HAPPENED IS ALMOST ALL 1689 01:08:30,906 --> 01:08:31,773 POPULATIONS MOST OF THE EFFECT 1690 01:08:31,773 --> 01:08:37,479 HAS BEEN SEEN IN YOUNGER 1691 01:08:37,479 --> 01:08:38,980 POPULATIONS. 1692 01:08:38,980 --> 01:08:43,151 THERE'S BEEN A STARTING IN SOME 1693 01:08:43,151 --> 01:08:47,756 POPULATIONS IN MID-RANGES, AND 1694 01:08:47,756 --> 01:08:50,292 WHAT'S -- BUT HISPANIC/LATINO 1695 01:08:50,292 --> 01:08:52,627 POPULATIONS HAVE NOT FOLLOWED 1696 01:08:52,627 --> 01:08:53,428 THIS, AS FRANCISCO HIGHLIGHTED 1697 01:08:53,428 --> 01:08:54,429 THAT TREND. 1698 01:08:54,429 --> 01:08:56,865 THE SECOND QUESTION, WE DON'T 1699 01:08:56,865 --> 01:08:58,733 REALLY KNOW, OUR CASE 1700 01:08:58,733 --> 01:09:00,102 SURVEILLANCE FORM DOES NOT 1701 01:09:00,102 --> 01:09:01,136 COLLECT INFORMATION ABOUT HOW 1702 01:09:01,136 --> 01:09:02,237 LONG PEOPLE HAVE BEEN IN THE 1703 01:09:02,237 --> 01:09:07,075 UNITED STATES AND OTHER FACTORS, 1704 01:09:07,075 --> 01:09:10,445 AND SO WE ARE -- IT'S AN 1705 01:09:10,445 --> 01:09:11,546 OUTSTANDING QUESTION OF GREAT 1706 01:09:11,546 --> 01:09:12,080 INTEREST. 1707 01:09:12,080 --> 01:09:15,083 STILL WE HAVE THE NEED AND 1708 01:09:15,083 --> 01:09:15,884 OPPORTUNITY IN THE FEDERAL 1709 01:09:15,884 --> 01:09:18,753 GOVERNMENT TO BE ABLE TO DO A 1710 01:09:18,753 --> 01:09:22,557 BETTER JOB WITH OUR PARTNERS, TO 1711 01:09:22,557 --> 01:09:24,960 PROVIDE PREVENTION AND CARE 1712 01:09:24,960 --> 01:09:26,428 SERVICES TO HISPANIC AND LATINOS 1713 01:09:26,428 --> 01:09:28,063 IN THE UNITED STATES AND SHOULD 1714 01:09:28,063 --> 01:09:31,233 TAKE THAT ON WITH RELISH. 1715 01:09:31,233 --> 01:09:32,300 THE QUESTION DETERMINING HOW 1716 01:09:32,300 --> 01:09:37,772 MUCH OF NEW DIAGNOSES ARE NEW 1717 01:09:37,772 --> 01:09:39,107 INFECTIONS, ESTIMATED NEW 1718 01:09:39,107 --> 01:09:40,609 INFECTIONS ARE INCIDENTS IS 1719 01:09:40,609 --> 01:09:41,943 SOMETHING WE'RE INTERESTED IN 1720 01:09:41,943 --> 01:09:44,346 LOOKING IN MORE DEPTH WITH 1721 01:09:44,346 --> 01:09:45,113 FRANCISCO'S GUIDANCE. 1722 01:09:45,113 --> 01:09:47,349 >> THANK YOU. 1723 01:09:47,349 --> 01:09:51,686 ONE MORE QUESTION, MR. RUIZ. 1724 01:09:51,686 --> 01:09:53,455 REGARDING THE FEDERAL OVERSIGHT 1725 01:09:53,455 --> 01:09:54,589 AS YOU MENTIONED, INCLUSIVITY 1726 01:09:54,589 --> 01:09:57,192 AND ACCESS, WHAT ARE YOUR VIEWS 1727 01:09:57,192 --> 01:09:59,161 ON THE STATE LEGISLATIONS 1728 01:09:59,161 --> 01:10:01,663 AGAINST DIVERSITY AND EQUITY 1729 01:10:01,663 --> 01:10:04,299 COLLECTION OF DATA RELATIVE TO 1730 01:10:04,299 --> 01:10:09,337 HAVING LESS TOOLS TO KIND OF 1731 01:10:09,337 --> 01:10:10,639 MONITOR DIVERSITY WITHIN SOME 1732 01:10:10,639 --> 01:10:11,573 ACADEMIC ENVIRONMENTS, AND I 1733 01:10:11,573 --> 01:10:15,911 KNOW SOME STATES HAVE 1734 01:10:15,911 --> 01:10:17,779 LEGISLATION, SOME DON'T, BUT 1735 01:10:17,779 --> 01:10:19,181 IT'S AN EMERGING KIND OF TREND. 1736 01:10:19,181 --> 01:10:20,749 MY QUESTION IS MORE GENERAL. 1737 01:10:20,749 --> 01:10:24,319 DO YOU THINK THAT THESE WILL 1738 01:10:24,319 --> 01:10:26,855 HAVE AN IMPACT ON FEDERAL 1739 01:10:26,855 --> 01:10:29,891 EFFORTS FOR COLLECTION OF DATA? 1740 01:10:29,891 --> 01:10:32,093 OR IN RELATION TO ACCESS? 1741 01:10:32,093 --> 01:10:35,430 OR HOW -- WHAT ARE YOUR THOUGHTS 1742 01:10:35,430 --> 01:10:36,798 REGARDING THIS EMERGING AREA? 1743 01:10:36,798 --> 01:10:40,135 >> YEAH, I THINK WE'VE SEEN A 1744 01:10:40,135 --> 01:10:41,836 LOT OF ANTI--- A LOT OF THINGS 1745 01:10:41,836 --> 01:10:42,971 HAPPENING IN DIFFERENT PARTS OF 1746 01:10:42,971 --> 01:10:43,638 THE COUNTRY. 1747 01:10:43,638 --> 01:10:45,006 I THINK THAT'S SOMETHING THAT'S 1748 01:10:45,006 --> 01:10:46,875 ALARMING TO THE ADMINISTRATION. 1749 01:10:46,875 --> 01:10:48,710 SO THERE'S A LOT OF TEAMS 1750 01:10:48,710 --> 01:10:50,045 THINKING ABOUT THAT. 1751 01:10:50,045 --> 01:10:52,547 NOT OBVIOUSLY WITHIN HIV BUT 1752 01:10:52,547 --> 01:10:54,282 LARGER IN TERMS OF EDUCATION AND 1753 01:10:54,282 --> 01:10:55,283 EMPLOYMENT, SOMETHING WE NEED TO 1754 01:10:55,283 --> 01:10:57,986 KEEP AND EYE ON. 1755 01:10:57,986 --> 01:10:59,754 THERE'S BEEN SOME CONVERSATIONS 1756 01:10:59,754 --> 01:11:00,889 AT PACHA, THE PRESIDENTIAL 1757 01:11:00,889 --> 01:11:02,324 ADVISORY COUNCIL ON HIV AND 1758 01:11:02,324 --> 01:11:03,725 AIDS, THINKING ABOUT WHAT THEY 1759 01:11:03,725 --> 01:11:07,629 CAN DO AS THAT BODY OF FOLKS 1760 01:11:07,629 --> 01:11:09,531 AROUND THE COUNTRY, AS RELATES 1761 01:11:09,531 --> 01:11:12,834 TO THE WORK THAT WE DO IN HIV, I 1762 01:11:12,834 --> 01:11:16,538 KNOW THERE'S A LOT OF INTEREST, 1763 01:11:16,538 --> 01:11:19,507 MAKE SURE -- THAT'S MORE THE 1764 01:11:19,507 --> 01:11:21,543 INCLUSIVITY PART MAKING SURE 1765 01:11:21,543 --> 01:11:24,279 PEOPLE DO WHAT WE CAN DO FROM 1766 01:11:24,279 --> 01:11:26,615 THE ADMINISTRATION, PEOPLE WITH 1767 01:11:26,615 --> 01:11:27,782 LIVING WITH HIV AND/OR 1768 01:11:27,782 --> 01:11:29,584 DISPROPORTIONATELY IMPACTED BY 1769 01:11:29,584 --> 01:11:30,518 HIV ARE GIVEN OPPORTUNITIES TO 1770 01:11:30,518 --> 01:11:31,953 HAVE A CONVERSATION AT THE 1771 01:11:31,953 --> 01:11:33,688 TABLE, ONE THING I'M PASSIONATE 1772 01:11:33,688 --> 01:11:34,289 ABOUT. 1773 01:11:34,289 --> 01:11:36,291 I THINK AT THE LOCAL LEVEL, 1774 01:11:36,291 --> 01:11:37,659 OBVIOUSLY THERE'S A LOT OF OTHER 1775 01:11:37,659 --> 01:11:37,926 THINGS. 1776 01:11:37,926 --> 01:11:40,495 THAT'S A LOT OF WHERE THE 1777 01:11:40,495 --> 01:11:42,364 LEGISLATION HAPPENS, AND SOME 1778 01:11:42,364 --> 01:11:42,831 OTHER RESTRICTIONS AND 1779 01:11:42,831 --> 01:11:45,100 CHALLENGES, AND SO I KNOW WE'RE 1780 01:11:45,100 --> 01:11:47,535 MONITORING THAT AND WORKING WITH 1781 01:11:47,535 --> 01:11:50,171 THE OFFICE OF INTERAGENCY 1782 01:11:50,171 --> 01:11:52,107 AFFAIRS DOES A LOT OF THAT WORK. 1783 01:11:52,107 --> 01:11:55,844 IN THE TWO MONTHS I'VE BEEN IN 1784 01:11:55,844 --> 01:11:57,712 THIS ROLE, IDENTIFYING WHO ARE 1785 01:11:57,712 --> 01:12:00,649 THE PLAYERS ACROSS THE AGENCY, 1786 01:12:00,649 --> 01:12:02,284 AND SO IT'S ONE OF THOSE THINGS 1787 01:12:02,284 --> 01:12:04,653 I'M LEARNING THE PROCESS IN THE 1788 01:12:04,653 --> 01:12:06,254 NEXT -- IN THE PAST TWO MONTHS, 1789 01:12:06,254 --> 01:12:08,523 BUT THAT'S SOMETHING THAT I'M 1790 01:12:08,523 --> 01:12:10,525 DEFINITELY LOOKING AT, AGAIN, 1791 01:12:10,525 --> 01:12:12,494 NOT JUST FROM THE ACCESS TO 1792 01:12:12,494 --> 01:12:16,097 SERVICES BUT ALSO WHAT ARE THE 1793 01:12:16,097 --> 01:12:20,135 OTHER THINGS THAT NEGATE ONE'S 1794 01:12:20,135 --> 01:12:22,003 IDENTITY, WHAT DOES THAT DO FOR 1795 01:12:22,003 --> 01:12:23,571 ENABLING THEM TO SEEK OUT 1796 01:12:23,571 --> 01:12:24,506 TESTING BEHAVIORS, SEEK OUT 1797 01:12:24,506 --> 01:12:28,877 TESTING OR CARE IF THEY TEST 1798 01:12:28,877 --> 01:12:29,511 POSITIVE. 1799 01:12:29,511 --> 01:12:31,413 THEY DEFINITELY HAVE DIRECT AND 1800 01:12:31,413 --> 01:12:35,650 INDIRECT IMPLICATIONS. 1801 01:12:35,650 --> 01:12:37,085 >> THANK YOU. 1802 01:12:37,085 --> 01:12:37,952 >> DR. GALARRAGA? 1803 01:12:37,952 --> 01:12:42,691 THANK YOU, THAT WAS A GREAT 1804 01:12:42,691 --> 01:12:43,024 PRESENTATION. 1805 01:12:43,024 --> 01:12:47,195 I WANT TO FOLLOW UP ON THE ISSUE 1806 01:12:47,195 --> 01:12:48,496 OF HISPANIC LATIN X INCIDENCE 1807 01:12:48,496 --> 01:12:52,200 RATE WHICH SEEMS SO HIGH, VERY 1808 01:12:52,200 --> 01:12:55,036 PRICING. 1809 01:12:55,036 --> 01:13:00,275 39%, THAT'S ALMOST DOUBLE THE 1810 01:13:00,275 --> 01:13:03,745 EXPECTED, I SUPPOSE, ONE-TO-ONE 1811 01:13:03,745 --> 01:13:05,313 LATIN X, HISPANIC POPULATION IN 1812 01:13:05,313 --> 01:13:08,516 THE UNITED STATES, AROUND 18%, 1813 01:13:08,516 --> 01:13:09,818 STUDENTS, MORE THAN DOUBLES, THE 1814 01:13:09,818 --> 01:13:11,753 ONLY ONE THAT HAS NOT COME DOWN, 1815 01:13:11,753 --> 01:13:13,788 THE ONE THAT IS HAVE INCREASED. 1816 01:13:13,788 --> 01:13:15,757 THE POINT WE MADE, THE ISSUE OF 1817 01:13:15,757 --> 01:13:17,392 AGE AND MAYBE COUNTRY OF ORIGIN 1818 01:13:17,392 --> 01:13:20,695 WHICH MAY BE RELATED TO TIME IN 1819 01:13:20,695 --> 01:13:23,865 THE U.S., BUT I THINK FROM AN 1820 01:13:23,865 --> 01:13:24,833 IMPLEMENTATION SCIENCE AND 1821 01:13:24,833 --> 01:13:26,034 HEALTH SERVICES RESEARCH POINT 1822 01:13:26,034 --> 01:13:31,106 OF VIEW WE NEED A LOT MORE 1823 01:13:31,106 --> 01:13:31,806 INFORMATION, RIGHT? 1824 01:13:31,806 --> 01:13:34,075 WE NEED THROUGH THE BASIC 1825 01:13:34,075 --> 01:13:38,480 THINGS, YOU KNOW, INSURANCE, 1826 01:13:38,480 --> 01:13:38,880 RIGHT? 1827 01:13:38,880 --> 01:13:41,483 HEALTH INSURANCE, NO ACCESS TO 1828 01:13:41,483 --> 01:13:43,084 PRIMARY CARE PROVIDER AND 1829 01:13:43,084 --> 01:13:45,820 CONTINUITY OF PRIMARY CARE 1830 01:13:45,820 --> 01:13:47,389 PROVIDER, IN TERMS OF REFERRALS 1831 01:13:47,389 --> 01:13:51,626 TO PrEP AND OF COURSE ACCESS 1832 01:13:51,626 --> 01:13:52,394 TO PrEP. 1833 01:13:52,394 --> 01:13:58,500 IT JUST SEEMS VERY WORRISOME, 1834 01:13:58,500 --> 01:13:59,634 SOMETHING THAT WE NEED TO KNOW A 1835 01:13:59,634 --> 01:14:01,803 LOT MORE IN ORDER TO REVERSE 1836 01:14:01,803 --> 01:14:02,537 THAT TREND. 1837 01:14:02,537 --> 01:14:06,474 >> YEAH, AND I THINK JUST TO 1838 01:14:06,474 --> 01:14:08,009 CLARIFY, I THINK THAT PERCENTAGE 1839 01:14:08,009 --> 01:14:10,779 OF LATINOS IN THE U.S. IS 1840 01:14:10,779 --> 01:14:17,819 COMPRISE - COMPREHENSIVE. 1841 01:14:17,819 --> 01:14:19,120 19% IS MALE AND FEMALE. 1842 01:14:19,120 --> 01:14:24,192 ONE THING I POINTED OUT IN, 1843 01:14:24,192 --> 01:14:27,529 WE'VE SEEN A DECREASE IN BLACK 1844 01:14:27,529 --> 01:14:31,366 AFRICAN AMERICAN MSM, A LOT OF 1845 01:14:31,366 --> 01:14:34,335 EMPHASIS RIGHTFULLY SO BY THE 1846 01:14:34,335 --> 01:14:36,304 GOVERNMENT, PRIVATE SECTOR, 1847 01:14:36,304 --> 01:14:37,405 PROVEN TO BE EFFECTIVE. 1848 01:14:37,405 --> 01:14:40,041 WHEN YOU INVEST MONEY IN A 1849 01:14:40,041 --> 01:14:40,942 COMMUNITY AND DEVELOP TAILORED 1850 01:14:40,942 --> 01:14:41,910 INTERVENTIONS YOU SEE THIS 1851 01:14:41,910 --> 01:14:42,710 DECREASE THAT WE'VE BEEN SEEING 1852 01:14:42,710 --> 01:14:44,446 IN SOME OF THE COMMUNITIES AND I 1853 01:14:44,446 --> 01:14:45,947 THINK THAT HAS SOMETHING THAT I 1854 01:14:45,947 --> 01:14:47,949 THINK WE NEED TO REVISIT HOW WE 1855 01:14:47,949 --> 01:14:51,586 CAN DO SIMILAR FOR THIS 1856 01:14:51,586 --> 01:14:53,621 POPULATION, I THINK THAT WE TEND 1857 01:14:53,621 --> 01:14:55,690 TO RECEIVE -- YOU PUT MONEY 1858 01:14:55,690 --> 01:14:58,326 WHERE THERE'S A NEED, AND YOU 1859 01:14:58,326 --> 01:14:59,561 GET THE OUTCOME, MAYBE NOT AS 1860 01:14:59,561 --> 01:15:02,263 FAST AS YOU WANT BUT WE SEE 1861 01:15:02,263 --> 01:15:03,264 OUTCOMES SO THAT'S SOMETHING 1862 01:15:03,264 --> 01:15:06,201 THAT I'M PLANNING TO PUT 1863 01:15:06,201 --> 01:15:07,202 TOGETHER A CONVENING TO TALK 1864 01:15:07,202 --> 01:15:08,837 ABOUT WHAT THAT LOOKS LIKE. 1865 01:15:08,837 --> 01:15:11,606 HOW CAN WE LEARN? 1866 01:15:11,606 --> 01:15:13,374 IT'S NOT ABOUT FORGETTING THE 1867 01:15:13,374 --> 01:15:14,309 COMMUNITY, BECAUSE OBJECTSLY 1868 01:15:14,309 --> 01:15:15,076 WE'RE NOT FORGETTING WHAT WE 1869 01:15:15,076 --> 01:15:17,645 NEAT TO GET FOR AFRICAN 1870 01:15:17,645 --> 01:15:18,379 AMERICANS, BLACK MSM OR AFRICAN 1871 01:15:18,379 --> 01:15:20,782 AMERICAN WOMEN BUT MAKING SURE 1872 01:15:20,782 --> 01:15:23,451 WE LEARN FROM OUR -- FROM THE 1873 01:15:23,451 --> 01:15:24,352 WORK IN THESE COMMUNITIES TO 1874 01:15:24,352 --> 01:15:26,354 HELP INFORM THE WORK THAT NEEDS 1875 01:15:26,354 --> 01:15:31,159 TO HAPPEN IN HISPANIC LATINO, SO 1876 01:15:31,159 --> 01:15:32,927 100%, IT'S MORE THAN JUST AN 1877 01:15:32,927 --> 01:15:34,462 ORAL SWAB OR PILL. 1878 01:15:34,462 --> 01:15:36,297 IT'S HOW DO WE PROVIDE SPACE FOR 1879 01:15:36,297 --> 01:15:38,500 FOLKS TO HAVE ACCESS TO THESE 1880 01:15:38,500 --> 01:15:38,900 SERVICES. 1881 01:15:38,900 --> 01:15:42,303 HOW DO WE MAKE SURE THAT THEY 1882 01:15:42,303 --> 01:15:44,606 FEEL ENABLED TO SORT OF GO INTO 1883 01:15:44,606 --> 01:15:46,708 AND GET THAT TEST, SO THERE'S A 1884 01:15:46,708 --> 01:15:52,280 LOT OF OTHER THINGS, YOU KNOW, 1885 01:15:52,280 --> 01:15:53,681 AND THE NEEDS IN NEW YORK 1886 01:15:53,681 --> 01:15:54,916 DIFFERENT THAN THE SOUTH, RIGHT? 1887 01:15:54,916 --> 01:15:57,519 THERE'S A LOT OF AS I MENTIONED 1888 01:15:57,519 --> 01:15:59,921 A LOT OF IMMIGRATION, 1889 01:15:59,921 --> 01:16:00,455 ANTI-IMMIGRATION SENTIMENT 1890 01:16:00,455 --> 01:16:02,223 HAPPENING SO WE NEED TO ALSO 1891 01:16:02,223 --> 01:16:04,759 ADDRESS THAT AND WHAT 1892 01:16:04,759 --> 01:16:07,795 IMPLICATIONS THOSE POLICIES HAVE 1893 01:16:07,795 --> 01:16:08,563 ON HEALTH-SEEKING BEHAVIORS. 1894 01:16:08,563 --> 01:16:11,399 >> IT WOULD BE GREAT TO SEE SOME 1895 01:16:11,399 --> 01:16:14,736 SORT OF REPORT WITH BEST 1896 01:16:14,736 --> 01:16:17,872 PRACTICES AND THERE'S SOME YOU 1897 01:16:17,872 --> 01:16:18,873 KNOW GOOD NEWS FROM SOME 1898 01:16:18,873 --> 01:16:20,942 COMMUNITIES THAT HAVE BEEN ABLE 1899 01:16:20,942 --> 01:16:23,444 TO NOT BE PART OF THE 1900 01:16:23,444 --> 01:16:24,779 UNFORTUNATE TREND AND TURN 1901 01:16:24,779 --> 01:16:25,980 THINGS AROUND. 1902 01:16:25,980 --> 01:16:30,018 YEAH, THANK YOU. 1903 01:16:30,018 --> 01:16:30,752 >> PROFESSOR GALARRAGA, TO 1904 01:16:30,752 --> 01:16:33,855 CLARIFY, STILL AFRICAN AMERICANS 1905 01:16:33,855 --> 01:16:37,659 HAVE THE HIGHEST RATE OF NEW HIV 1906 01:16:37,659 --> 01:16:38,893 INFECTIONS PER POPULATION, UP BY 1907 01:16:38,893 --> 01:16:41,629 RACE AND ETHNICITY IN THE UNITED 1908 01:16:41,629 --> 01:16:41,996 STATES. 1909 01:16:41,996 --> 01:16:43,598 BUT BECAUSE THERE ARE MORE 1910 01:16:43,598 --> 01:16:45,233 HISPANIC AND LATINOS IN AMERICA, 1911 01:16:45,233 --> 01:16:47,035 EVEN THOUGH AT LOWER RATE, THE 1912 01:16:47,035 --> 01:16:50,505 ABSOLUTE NUMBER OF NEW 1913 01:16:50,505 --> 01:16:51,272 INFECTIONS THEREFORE PROPORTION 1914 01:16:51,272 --> 01:16:55,176 OF NEW CASES ARE ACTUALLY HIGHER 1915 01:16:55,176 --> 01:16:55,476 IN LATINOS. 1916 01:16:55,476 --> 01:16:59,781 SO IT'S OUR KIND OF EQUITY 1917 01:16:59,781 --> 01:17:01,282 NUMBERS ISSUE WE DEAL WITH IN 1918 01:17:01,282 --> 01:17:05,053 PUBLIC HEALTH ALL THE TIME. 1919 01:17:05,053 --> 01:17:06,588 >> YEAH, BUT I THINK IT'S 1920 01:17:06,588 --> 01:17:07,355 TERRIBLE, RIGHT? 1921 01:17:07,355 --> 01:17:08,790 EACH NEW INFECTION IS ONE TOO 1922 01:17:08,790 --> 01:17:10,091 MANY IN MY OPINION, RIGHT? 1923 01:17:10,091 --> 01:17:14,095 SO IF YOU JUST DO ONE-TO-ONE TO 1924 01:17:14,095 --> 01:17:20,935 THE PROPORTION OF POPULATION AND 1925 01:17:20,935 --> 01:17:22,937 SAY 50-50 MALE FEMALE WHICH I 1926 01:17:22,937 --> 01:17:23,838 UNDERSTAND, MAJORITY ARE MEN 1927 01:17:23,838 --> 01:17:26,007 THAT HAVE SEX WITH MEN IS WHAT I 1928 01:17:26,007 --> 01:17:31,412 ASSUME BUT IN MY HEAD 1929 01:17:31,412 --> 01:17:32,313 SIMPLE-MINDED ECONOMIST HERE 1930 01:17:32,313 --> 01:17:35,450 DOING 18, 19% OF HISPANIC AND 1931 01:17:35,450 --> 01:17:37,118 LATINX POPULATION, AS A 1932 01:17:37,118 --> 01:17:39,854 PROPORTION OF NEW INFECTIONS, IF 1933 01:17:39,854 --> 01:17:42,490 IT WAS ONE-TO-ONE YOU SHOULD 1934 01:17:42,490 --> 01:17:44,359 EXPECT NO MORE THAN THAT AND 1935 01:17:44,359 --> 01:17:46,794 WE'RE SEEING DOUBLE, IN MY HEAD. 1936 01:17:46,794 --> 01:17:50,598 SEEMS LIKE A LOT. 1937 01:17:50,598 --> 01:17:52,000 DISPROPORTIONATELY AFFECTING THE 1938 01:17:52,000 --> 01:17:53,301 LATIN X HISPANIC POPULATION. 1939 01:17:53,301 --> 01:17:54,636 ONE INFECTION IS ONE TOO MANY. 1940 01:17:54,636 --> 01:17:56,638 I DON'T WISH NEW INFECTIONS ON 1941 01:17:56,638 --> 01:17:59,574 ANYBODY, ON ANY GROUP. 1942 01:17:59,574 --> 01:18:02,443 BUT IT SEEMS LIKE SOMETHING IS 1943 01:18:02,443 --> 01:18:07,782 NOT RIGHT WITH THE 1944 01:18:07,782 --> 01:18:08,616 HISPANIC/LATINX POPULATIONS, AS 1945 01:18:08,616 --> 01:18:09,317 FRANCISCO POINTS OUT SOME 1946 01:18:09,317 --> 01:18:10,418 COMMUNITIES ARE DOING THE RIGHT 1947 01:18:10,418 --> 01:18:11,853 THING AND WE SHOULD HIGHLIGHT 1948 01:18:11,853 --> 01:18:14,355 THOSE SO IN ADDITION TO AGE, 1949 01:18:14,355 --> 01:18:15,356 COUNTRY OF ORIGIN, THERE'S SO 1950 01:18:15,356 --> 01:18:17,325 MANY OTHER THINGS THAT WE NEED 1951 01:18:17,325 --> 01:18:20,695 INFORMATION, RIGHT? 1952 01:18:20,695 --> 01:18:25,299 IS THAT AN ISSUE ACCESS TO 1953 01:18:25,299 --> 01:18:29,470 HEALTH INSURANCE, PrEP, 1954 01:18:29,470 --> 01:18:32,940 PRIMARY CARE AND CONTINUING CARE 1955 01:18:32,940 --> 01:18:33,207 PROVIDERS. 1956 01:18:33,207 --> 01:18:36,577 THIS MAY BE AGAIN POLITICAL 1957 01:18:36,577 --> 01:18:40,448 ISSUE, AND POLITICAL ECONOMY 1958 01:18:40,448 --> 01:18:40,848 ISSUE. 1959 01:18:40,848 --> 01:18:42,250 THERE'S ISSUES OF TABOO AND 1960 01:18:42,250 --> 01:18:45,153 THERE'S ISSUES OF WHAT YOU 1961 01:18:45,153 --> 01:18:49,691 DISCUSS IN CERTAIN COMMUNITIES. 1962 01:18:49,691 --> 01:18:50,124 AND DISCRIMINATION. 1963 01:18:50,124 --> 01:18:58,166 I WAS DOING THE SIMPLE PATH IN 1964 01:18:58,166 --> 01:18:59,033 MY HEAD. 1965 01:18:59,033 --> 01:19:01,202 >> THE PRIORITIES UNDER THE LAST 1966 01:19:01,202 --> 01:19:02,837 SECTION WORKING WITH FOLKS, 1967 01:19:02,837 --> 01:19:04,372 NON-TRADITIONAL PARTNERS, IF YOU 1968 01:19:04,372 --> 01:19:06,441 WILL, I THINK OFTENTIMES IN HIV 1969 01:19:06,441 --> 01:19:08,843 WE KIND OF GUY IN THE SAME 1970 01:19:08,843 --> 01:19:11,612 CIRCUIT, TALK TO SAME PARTNERS, 1971 01:19:11,612 --> 01:19:12,747 SAME CONFERENCES AT MEETINGS. 1972 01:19:12,747 --> 01:19:15,550 ONE THING I WANT TO PRIORITIZE 1973 01:19:15,550 --> 01:19:16,718 IS GOING TO ORGANIZATIONS THAT 1974 01:19:16,718 --> 01:19:26,461 MAYBE DON'T HAVE HIV AS A FUNDED 1975 01:19:26,461 --> 01:19:26,894 CENTER TOPIC. 1976 01:19:26,894 --> 01:19:28,496 WE NEED TO FIGURE OUT WHY THE 1977 01:19:28,496 --> 01:19:30,732 FOLKS NOT GOING TO THE HIV 1978 01:19:30,732 --> 01:19:33,034 MEETINGS AND CONFERENCES ARE 1979 01:19:33,034 --> 01:19:43,311 ATTENDING INSTAGRAM LIVES, HOW 1980 01:19:43,311 --> 01:19:48,783 DO WE REACH PEOPLE, NATIONAL 1981 01:19:48,783 --> 01:19:49,884 URBAN LEAGUE, HBCUS, NAACP. 1982 01:19:49,884 --> 01:19:52,820 ONE OF MY GOAL IS TO ENGAGE 1983 01:19:52,820 --> 01:19:55,923 CONTINUING TO LEAN INTO HISTORY 1984 01:19:55,923 --> 01:19:59,627 OF A LOT OF THESE SPACES AND 1985 01:19:59,627 --> 01:20:02,029 ORGANIZATIONS, ALSO BRINGING 1986 01:20:02,029 --> 01:20:03,865 CONVERSATION ABOUT HIV EDUCATION 1987 01:20:03,865 --> 01:20:06,400 TO PLACES THAT ARE HAPPENING. 1988 01:20:06,400 --> 01:20:08,603 THAT'S GOING -- HOPEFULLY WE'LL 1989 01:20:08,603 --> 01:20:09,771 SEE RESULTS THERE. 1990 01:20:09,771 --> 01:20:12,440 A LOT OF PARTNERS THAT CDC FOR 1991 01:20:12,440 --> 01:20:14,175 EXAMPLE AND DR. MERMIN'S SHOP IS 1992 01:20:14,175 --> 01:20:16,244 DOING THAT AS WELL, A LOT OF 1993 01:20:16,244 --> 01:20:17,779 PARTNER ENGAGEMENT HAPPENING 1994 01:20:17,779 --> 01:20:23,417 OVER THERE. 1995 01:20:23,417 --> 01:20:23,918 >> THANK YOU. 1996 01:20:23,918 --> 01:20:26,220 >> ARE THERE ANY OTHER 1997 01:20:26,220 --> 01:20:26,888 QUESTIONS? 1998 01:20:26,888 --> 01:20:29,490 I WOULD LIKE TO ADD A COMMENT. 1999 01:20:29,490 --> 01:20:30,691 FRANCISCO, ONE OF THE THINGS I 2000 01:20:30,691 --> 01:20:35,062 HAVE TO SAY OVER MY WORK WITH 2001 01:20:35,062 --> 01:20:37,932 THIS FIELD FOR SEVERAL YEARS, 2002 01:20:37,932 --> 01:20:44,505 THE OFFICE OF AIDS POLICY. 2003 01:20:44,505 --> 01:20:46,808 STRATEGIES ARE HUGE, THEY 2004 01:20:46,808 --> 01:20:47,675 SOMETIMES FEEL UNWIELDY, RIGHT? 2005 01:20:47,675 --> 01:20:49,177 WHAT HAPPENS WITH THE COMMUNITY 2006 01:20:49,177 --> 01:20:50,845 IS THAT THEY GET LOST IN THE 2007 01:20:50,845 --> 01:20:52,914 SENSE THEY NEVER REALLY KNOW 2008 01:20:52,914 --> 01:20:55,817 WHAT GOES ON, WHAT THE RESULTS 2009 01:20:55,817 --> 01:20:56,050 ARE. 2010 01:20:56,050 --> 01:20:58,519 SO, I GUESS MY COMMENT OR MY 2011 01:20:58,519 --> 01:21:00,688 QUESTION TO YOU IS HAVE YOU 2012 01:21:00,688 --> 01:21:02,223 THOUGHT ABOUT OR ARE THERE 2013 01:21:02,223 --> 01:21:04,959 THOUGHTS ABOUT HOW TO ACTUALLY 2014 01:21:04,959 --> 01:21:15,436 BEGIN, MAYBE IT'S THROUGH A 2015 01:21:17,405 --> 01:21:18,606 PROGRESS REPORT, THAT INFORMS US 2016 01:21:18,606 --> 01:21:21,409 OF THE STRATEGY WITH THE 2017 01:21:21,409 --> 01:21:23,678 UNWIELDY STRATEGY TO IMPLEMENT 2018 01:21:23,678 --> 01:21:24,679 ACROSS THE COUNTRY. 2019 01:21:24,679 --> 01:21:25,313 >> A HUNDRED PERCENT. 2020 01:21:25,313 --> 01:21:27,081 I THINK A STRATEGY IS ONLY AS 2021 01:21:27,081 --> 01:21:31,319 GOOD AS PEOPLE ACTUALLY USING 2022 01:21:31,319 --> 01:21:31,652 IT. 2023 01:21:31,652 --> 01:21:32,987 ALSO MEASURING SUCCESS. 2024 01:21:32,987 --> 01:21:35,923 THAT'S ONE OF THE THINGS, THE 2025 01:21:35,923 --> 01:21:38,092 CURRENT STRATEGY GOES TO 2025, 2026 01:21:38,092 --> 01:21:40,628 WHICH MEANS THIS IS THE TIME TO 2027 01:21:40,628 --> 01:21:42,363 START THINK ABOUT THE NEXT 2028 01:21:42,363 --> 01:21:43,798 ITERATION, ALSO THE TIME TO 2029 01:21:43,798 --> 01:21:45,099 THINK ABOUT THE IMPACT STORIES, 2030 01:21:45,099 --> 01:21:48,703 WHAT HAVE WE DONE SINCE 2021, 2031 01:21:48,703 --> 01:21:49,570 RELEASED THE LAST STRATEGY, 2032 01:21:49,570 --> 01:21:50,805 THAT'S SOMETHING THAT I'M 2033 01:21:50,805 --> 01:21:57,111 COMMITTED TO DO WITH OUR FEDERL 2034 01:21:57,111 --> 01:21:59,013 PARTNERS, TO TELL A STORY TO 2035 01:21:59,013 --> 01:22:00,882 LEARN FROM EACH OTHER TO BUILD 2036 01:22:00,882 --> 01:22:03,317 MOMENTUM AT THE HIGHEST LEVELS 2037 01:22:03,317 --> 01:22:05,353 OF GOVERNMENT, SO THAT WE HAVE 2038 01:22:05,353 --> 01:22:06,287 THAT SUPPORT. 2039 01:22:06,287 --> 01:22:11,792 BUT ALSO TO BRING VISIBILITY AND 2040 01:22:11,792 --> 01:22:14,729 AWARENESS IN OUR COMMUNITIES. 2041 01:22:14,729 --> 01:22:16,163 WE CAN HAVE STRATEGY BUT IT'S 2042 01:22:16,163 --> 01:22:18,032 MORE THAN JUST SORT OF A 2043 01:22:18,032 --> 01:22:22,904 PUBLICATION THAT WE SEND OUT VIA 2044 01:22:22,904 --> 01:22:23,938 E-MAIL AND WEBSITE. 2045 01:22:23,938 --> 01:22:26,140 I'M ALL FOR PRINTING THINGS, 2046 01:22:26,140 --> 01:22:27,341 HAVING THAT DOCUMENT ON THE 2047 01:22:27,341 --> 01:22:29,577 DESK, WHAT AM I DOING TODAY TO 2048 01:22:29,577 --> 01:22:33,848 HELP ADVANCE SOME OF THIS, AND 2049 01:22:33,848 --> 01:22:35,917 SO I'M HOPEFUL TO HAVE 2050 01:22:35,917 --> 01:22:37,718 DISCUSSIONS IN THE COMING MONTHS 2051 01:22:37,718 --> 01:22:39,020 WITH FEDERAL PARTNERS. 2052 01:22:39,020 --> 01:22:45,793 >> THANK YOU. 2053 01:22:45,793 --> 01:22:49,297 DR. NEILAN? 2054 01:22:49,297 --> 01:22:54,001 >> THANKS FOR THE ENERGY YOU 2055 01:22:54,001 --> 01:22:54,802 BRING. 2056 01:22:54,802 --> 01:22:57,471 I HOPE THAT LIST INCLUDES 2057 01:22:57,471 --> 01:22:58,806 ORGANIZATIONS THAT ENGAGE YOUTH 2058 01:22:58,806 --> 01:23:01,642 AND YOUNGEST INDIVIDUALS, I'M 2059 01:23:01,642 --> 01:23:04,278 THINKING OF NEW DIAGNOSES IN 2060 01:23:04,278 --> 01:23:05,346 CLINIC, INDIVIDUAL WHO NEVER 2061 01:23:05,346 --> 01:23:08,316 HEARD OF PrEP WHO IS 22, THE 2062 01:23:08,316 --> 01:23:09,483 OLDER BUCKET, OR 26, BUT STILL 2063 01:23:09,483 --> 01:23:15,856 UNDER THE CARE OF OF A PEDIATRN 2064 01:23:15,856 --> 01:23:17,992 WHO MAY NOT BE PRESCRIBING 2065 01:23:17,992 --> 01:23:20,561 PrEP, I ENCOURAGE YOU TO THINK 2066 01:23:20,561 --> 01:23:24,632 ABOUT MINORS WHO ARE -- THERE'S 2067 01:23:24,632 --> 01:23:25,933 SO MUCH HETEROGENEITY IN ACCESS 2068 01:23:25,933 --> 01:23:27,668 BECAUSE OF DIFFERENCES IN STATE 2069 01:23:27,668 --> 01:23:29,303 LAWS AS YOU ARE DEVELOPING YOUR 2070 01:23:29,303 --> 01:23:29,770 PLANS. 2071 01:23:29,770 --> 01:23:33,174 THANK YOU. 2072 01:23:33,174 --> 01:23:33,607 >> ABSOLUTELY. 2073 01:23:33,607 --> 01:23:37,044 ALSO ENGAGING INTERDISCIPLINARY 2074 01:23:37,044 --> 01:23:41,382 FOLKS, LOOKING AT SOCIAL 2075 01:23:41,382 --> 01:23:42,917 WORKERS, NURSES, PHARMACISTS, 2076 01:23:42,917 --> 01:23:43,851 OUTLIED TRADITIONAL ROLE. 2077 01:23:43,851 --> 01:23:45,219 BRINGING YOUNG FOLKS TO THE 2078 01:23:45,219 --> 01:23:47,188 TABLE, RIGHT? 2079 01:23:47,188 --> 01:23:48,189 OFTENTIMES WE SPEAK ON THEIR 2080 01:23:48,189 --> 01:23:49,156 BEHALF BUT I THINK IT'S 2081 01:23:49,156 --> 01:23:50,925 IMPORTANT TO BRING THEM TO THE 2082 01:23:50,925 --> 01:23:52,860 TABLE AND SEE, HEY, WHAT DO YOU 2083 01:23:52,860 --> 01:23:54,695 THINK IS INNOVATIVE, WHAT DO YOU 2084 01:23:54,695 --> 01:23:56,197 THINK YOU WANT TO SEE AND GIVE 2085 01:23:56,197 --> 01:23:59,433 THEM THE MIC, FOR SURE. 2086 01:23:59,433 --> 01:24:03,437 THANK YOU. 2087 01:24:03,437 --> 01:24:04,271 >> ONE MORE THING. 2088 01:24:04,271 --> 01:24:08,209 ON THE HEELS OF DR. NEILAN'S 2089 01:24:08,209 --> 01:24:09,443 QUESTION OR COMMENT, IN TERMS OF 2090 01:24:09,443 --> 01:24:11,178 LIKE THE YOUTH AND YOUNG PEOPLE, 2091 01:24:11,178 --> 01:24:13,214 MAKING SURE THEY HAVE A VOICE AT 2092 01:24:13,214 --> 01:24:16,350 THE AVAILABLE, WE'VE GOT TO BE 2093 01:24:16,350 --> 01:24:17,952 TALKING ABOUT VERY SPECIFIC 2094 01:24:17,952 --> 01:24:20,688 COHORT OF THE POPULATION LATER 2095 01:24:20,688 --> 01:24:28,596 ON THIS AFTERNOON, AND THOSE ARE 2096 01:24:28,596 --> 01:24:33,300 ALL OF THE INDIVIDUALS WITH 2097 01:24:33,300 --> 01:24:33,934 PERINATALLY ACQUIRED HIV, THOSE 2098 01:24:33,934 --> 01:24:37,238 YOUNG PEOPLE ARE NOW IN THEIR 2099 01:24:37,238 --> 01:24:39,206 30s, SOME OF THEM TO BE 40. 2100 01:24:39,206 --> 01:24:47,014 SO WHAT IS THE STRATEGIES, IS 2101 01:24:47,014 --> 01:24:48,749 THERE A MECHANISM INCLUSIVE OF 2102 01:24:48,749 --> 01:24:51,852 THAT COHORT OF THE POPULATION 2103 01:24:51,852 --> 01:24:53,254 INTO THIS STRATEGY? 2104 01:24:53,254 --> 01:24:53,621 >> ABSOLUTELY. 2105 01:24:53,621 --> 01:24:56,323 WHEN WE TALK ABOUT HIV AND 2106 01:24:56,323 --> 01:24:59,160 AGING, IT'S NOT JUST WHO ARE 2107 01:24:59,160 --> 01:25:01,395 50+, 60+, IT'S ABOUT THOSE WHO 2108 01:25:01,395 --> 01:25:02,797 ARE AGING WITH HIV, ALL THEIR 2109 01:25:02,797 --> 01:25:06,500 LIVES, MOST OF THEIR LIVES LIVED 2110 01:25:06,500 --> 01:25:07,935 WITH HIV. 2111 01:25:07,935 --> 01:25:08,769 THAT'S THE CONVERSATION WE NEED 2112 01:25:08,769 --> 01:25:09,570 TO HAVE. 2113 01:25:09,570 --> 01:25:11,338 I HEARD EARLIER TODAY 2114 01:25:11,338 --> 01:25:12,640 CONVERSATIONS AROUND THAT, AND I 2115 01:25:12,640 --> 01:25:22,817 THINK MORE WORK NEEDS TO BE DONE 2116 01:25:22,817 --> 01:25:25,453 TO LOOK AT POTENTIAL GAPS AND 2117 01:25:25,453 --> 01:25:26,754 BRINGING IN THE PRINCIPLES 2118 01:25:26,754 --> 01:25:27,621 MAKING SURE THEY SPEAK AND THEY 2119 01:25:27,621 --> 01:25:29,423 ARE PART OF THE DECISION IN 2120 01:25:29,423 --> 01:25:39,967 TERMS OF POLICIES BEING FORMED. 2121 01:25:40,634 --> 01:25:43,537 ONE OF MY COMMITMENTS IS MAKING 2122 01:25:43,537 --> 01:25:48,042 SURE IN ANY CONVENINGS WE HAVE 2123 01:25:48,042 --> 01:25:50,744 THOSE LIVING WITH HIV AND THOSE 2124 01:25:50,744 --> 01:25:52,146 IMPACTED, THAT'S MY COMMITMENT 2125 01:25:52,146 --> 01:25:58,185 TO THE WORK. 2126 01:25:58,185 --> 01:25:59,587 >> THANK YOU. 2127 01:25:59,587 --> 01:26:05,292 ANY OTHER QUESTIONS OR COMMENTS 2128 01:26:05,292 --> 01:26:07,595 FOR MR. RUIZ? 2129 01:26:07,595 --> 01:26:11,098 SEEING NONE, WE WILL NOW TAKE A 2130 01:26:11,098 --> 01:26:12,633 BREAK. 2131 01:26:12,633 --> 01:26:14,136 WE WILL RESTART PROMPTLY AT 2132 01:26:14,136 --> 01:26:15,637 1:45. 2133 01:26:15,637 --> 01:26:17,707 WELCOME BACK FROM BREAK, 2134 01:26:17,707 --> 01:26:18,641 EVERYONE. 2135 01:26:18,641 --> 01:26:25,281 WE WILL NOW BEGIN THE SEGMENT ON 2136 01:26:25,281 --> 01:26:26,416 ISSUES IN PERINATAL HIV RESEARCH 2137 01:26:26,416 --> 01:26:28,485 AND RESPONSE. 2138 01:26:28,485 --> 01:26:33,490 FIRST PRESENTER IS DR. MAURICIO 2139 01:26:33,490 --> 01:26:34,824 MARTINS, ASSOCIATE PROFESSOR AT 2140 01:26:34,824 --> 01:26:37,660 SCRIPPS INSTITUTE FOR BIOMEDICAL 2141 01:26:37,660 --> 01:26:38,895 INTERVENTION AND TECHNOLOGY, A 2142 01:26:38,895 --> 01:26:41,498 BRANCH OF THE UNIVERSITY OF 2143 01:26:41,498 --> 01:26:44,567 FLORIDA LOCATED IN UPPER, 2144 01:26:44,567 --> 01:26:46,769 FLORIDA. 2145 01:26:46,769 --> 01:26:48,505 IN HIS LAB HIS WORK ON 2146 01:26:48,505 --> 01:26:51,674 DEVELOPMENT OF INTERVENTION WITH 2147 01:26:51,674 --> 01:26:57,447 FOCUS ON GENE THERAPIES FOR 2148 01:26:57,447 --> 01:27:01,951 PROMOTING IN VIVO EXPRESSION OF 2149 01:27:01,951 --> 01:27:03,386 HIV BIOLOGICS IN DIFFERENT 2150 01:27:03,386 --> 01:27:03,686 POPULATIONS. 2151 01:27:03,686 --> 01:27:06,122 I WILL TURN IT OVER TO YOU. 2152 01:27:06,122 --> 01:27:07,524 >> THANK YOU FOR THE 2153 01:27:07,524 --> 01:27:07,857 INTRODUCTION. 2154 01:27:07,857 --> 01:27:09,192 IT'S A GREAT HONOR TO BE HERE. 2155 01:27:09,192 --> 01:27:14,998 THANK YOU FOR THE INVITATION AS 2156 01:27:14,998 --> 01:27:15,999 WELL. 2157 01:27:15,999 --> 01:27:19,602 SO MY GROUP WORK HAS BEEN 2158 01:27:19,602 --> 01:27:21,337 WORKING WITH DELIVERY, I'M GOING 2159 01:27:21,337 --> 01:27:23,640 TO BEGIN WITH A BRIEF OVERVIEW 2160 01:27:23,640 --> 01:27:27,577 OF STATISTICS THAT EMPHASIZE THE 2161 01:27:27,577 --> 01:27:30,880 SEVERITY OF THE EPIDEMIC. 2162 01:27:30,880 --> 01:27:32,048 2022, 39 MILLION PEOPLE LIVING 2163 01:27:32,048 --> 01:27:34,784 IN THE VIRUS. 2164 01:27:34,784 --> 01:27:37,086 SAME YEAR, 1.3 MILLION PEOPLE 2165 01:27:37,086 --> 01:27:39,756 GAME NEWLY INFECTED, TWO NEW 2166 01:27:39,756 --> 01:27:43,226 INFECTIONS PER MINUTE. 2167 01:27:43,226 --> 01:27:46,296 SAME YEAR, ABOUT 6 MILLION AND 2168 01:27:46,296 --> 01:27:48,765 30,000 PERSONS UNFORTUNATELY 2169 01:27:48,765 --> 01:27:50,533 SUCCUMBED TO HIV-RELATED CAUSES 2170 01:27:50,533 --> 01:27:53,169 LEADING TO ABOUT A DEATH PER 2171 01:27:53,169 --> 01:27:53,403 MINUTE. 2172 01:27:53,403 --> 01:27:55,672 SO, WE TAKE THESE MATTERS 2173 01:27:55,672 --> 01:27:58,074 SERIOUSLY IN THE LAB, WORKING TO 2174 01:27:58,074 --> 01:27:59,509 REDUCE THESE NUMBERS, HOPEFULLY 2175 01:27:59,509 --> 01:28:05,248 BRING THEM DOWN TO ZERO. 2176 01:28:05,248 --> 01:28:06,316 WE'RE EXPLORING VARIOUS 2177 01:28:06,316 --> 01:28:07,951 TECHNOLOGIES INCLUDING LARGE 2178 01:28:07,951 --> 01:28:11,421 LANGUAGE MODELS THAT HAVE BEEN 2179 01:28:11,421 --> 01:28:12,221 DESIGNED RECENTLY. 2180 01:28:12,221 --> 01:28:21,364 AND ONE OF THEM IS ChatGPT, 2181 01:28:21,364 --> 01:28:24,367 QUITE USEFUL AND INACCURATE AT 2182 01:28:24,367 --> 01:28:26,235 TIMES, WE'RE STILL EXPLORING 2183 01:28:26,235 --> 01:28:28,104 POTENTIALS THAT THIS TECHNOLOGY 2184 01:28:28,104 --> 01:28:29,539 OFFERED. 2185 01:28:29,539 --> 01:28:31,474 IN PREPARING FOR THIS 2186 01:28:31,474 --> 01:28:32,475 PRESENTATION I ASKED ChatGPT 2187 01:28:32,475 --> 01:28:35,378 THE FOLLOWING QUESTION. 2188 01:28:35,378 --> 01:28:37,714 HOW WOULD YOU DESCRIBE THE 2189 01:28:37,714 --> 01:28:39,048 DISTRIBUTION OF PEOPLE LIVING 2190 01:28:39,048 --> 01:28:42,652 WITH HIV ACROSS THE GLOBE. 2191 01:28:42,652 --> 01:28:43,252 GEOGRAPHICALLY UNEVEN, HIGHLY 2192 01:28:43,252 --> 01:28:44,621 CONCENTRATED IN SPECIFIC 2193 01:28:44,621 --> 01:28:45,188 REGIONS, QUITE ACCURATE. 2194 01:28:45,188 --> 01:28:47,223 LET ME SHOW YOU WHY. 2195 01:28:47,223 --> 01:28:53,730 THIS IS A WORLD MAP WITH EVERY 2196 01:28:53,730 --> 01:28:55,598 COUNTRY DISPLAYED BY DIFFERENT 2197 01:28:55,598 --> 01:28:57,033 SHADES, CORRESPONDENTING TO 2198 01:28:57,033 --> 01:28:57,400 CONTINENT. 2199 01:28:57,400 --> 01:29:00,203 IF WE CHANGE THE SIZE OF EACH 2200 01:29:00,203 --> 01:29:02,038 COUNTRY TO REFLECT ITS HIV 2201 01:29:02,038 --> 01:29:03,373 PREFERENCE WE SEE SOMETHING 2202 01:29:03,373 --> 01:29:05,241 QUITE DIFFERENT. 2203 01:29:05,241 --> 01:29:07,744 SOMETHING THAT IS GEOGRAPHICALLY 2204 01:29:07,744 --> 01:29:09,278 UNEVEN, HIGHLY CONCENTRATED IN 2205 01:29:09,278 --> 01:29:11,781 SPECIFIC REGIONS AS DESCRIBED BY 2206 01:29:11,781 --> 01:29:12,281 ChatGPT. 2207 01:29:12,281 --> 01:29:14,651 OF COURSE, UNFORTUNATELY, MOST 2208 01:29:14,651 --> 01:29:17,687 OF THE INFECTIONS ARE IN REGIONS 2209 01:29:17,687 --> 01:29:20,890 OF THE WORLD WITH NOT READY 2210 01:29:20,890 --> 01:29:23,960 ACCESS TO SOME PREVENTIONS FOR 2211 01:29:23,960 --> 01:29:25,628 COMBATING THE EPIDEMIC. 2212 01:29:25,628 --> 01:29:27,997 GLOBAL PREFERENCE OF PEDIATRIC 2213 01:29:27,997 --> 01:29:32,769 HIV INFECTIONS REFLECT THIS IS 2214 01:29:32,769 --> 01:29:33,636 DISTRIBUTION AS WELL, WITH 2215 01:29:33,636 --> 01:29:38,041 1.5 MILLION CHILDREN LIVING WITH 2216 01:29:38,041 --> 01:29:48,618 HIV IN 2022, 90% IN 21 COUNTRIS 2217 01:29:50,987 --> 01:29:55,792 IN AFRICA. 2218 01:29:55,792 --> 01:29:59,162 WHEN ART IS AVAILABLE, AND 2219 01:29:59,162 --> 01:30:00,563 IMPLEMENTED, ART CAN PREVENT 2220 01:30:00,563 --> 01:30:02,298 VERTICAL HIV TRANSMISSION WITH 2221 01:30:02,298 --> 01:30:02,799 CAVEATS. 2222 01:30:02,799 --> 01:30:06,469 THE FIRST ONE BEING UNDIAGNOSED 2223 01:30:06,469 --> 01:30:08,471 WITH CURRENT INFECTION, WOMEN 2224 01:30:08,471 --> 01:30:12,408 BECAME MORE SUSCEPTIBLE IN LATE 2225 01:30:12,408 --> 01:30:16,079 PREGNANCY AND POSTPARTUM PERIOD, 2226 01:30:16,079 --> 01:30:19,148 AND THERAPY CAN BE TOXIC TO 2227 01:30:19,148 --> 01:30:20,049 CHILDREN, ESPECIALLY INFANTS, 2228 01:30:20,049 --> 01:30:22,351 POTENTIAL FOR ACQUISITION OF 2229 01:30:22,351 --> 01:30:23,619 DRUG RESISTANCE. 2230 01:30:23,619 --> 01:30:25,722 POOR ADHERENCE IS A MAJOR 2231 01:30:25,722 --> 01:30:26,322 PROBLEM. 2232 01:30:26,322 --> 01:30:27,356 IF YOU DON'T TAKE MEDICATIONS, 2233 01:30:27,356 --> 01:30:29,025 YOU DON'T SUPPRESS THE VIRUS, 2234 01:30:29,025 --> 01:30:31,294 MORE LIKELY TO TRANSMIT TO YOUR 2235 01:30:31,294 --> 01:30:31,728 CHILD. 2236 01:30:31,728 --> 01:30:33,930 OF COURSE, STIGMA WHICH DESERVES 2237 01:30:33,930 --> 01:30:36,466 A TOPIC OF ITS OWN. 2238 01:30:36,466 --> 01:30:38,968 OUR INCREASED UNDERSTANDING OF 2239 01:30:38,968 --> 01:30:42,672 HIV TRANSMISSION HOW TO BLOCK IT 2240 01:30:42,672 --> 01:30:44,240 WITH THE SCALEUP OF THERAPY 2241 01:30:44,240 --> 01:30:46,442 PREVENTED THOUSANDS OF PEDIATRIC 2242 01:30:46,442 --> 01:30:47,477 INFECTIONS AND DEATHS. 2243 01:30:47,477 --> 01:30:51,948 WE'VE SEEN GAINS BY REDUCTIONS 2244 01:30:51,948 --> 01:30:52,749 OF INFECTION AND DEATH BUT THE 2245 01:30:52,749 --> 01:30:55,184 STATE OF THE CARE IS UNLIKELY TO 2246 01:30:55,184 --> 01:30:57,120 END PEDIATRIC HIV INFECTION IN 2247 01:30:57,120 --> 01:30:59,288 MY VIEW, WE NEED SOMETHING ELSE. 2248 01:30:59,288 --> 01:31:03,826 AND MY GROUP AND MANY OTHERS 2249 01:31:03,826 --> 01:31:07,263 HAVE BEEN VERY -- HAVE BEEN 2250 01:31:07,263 --> 01:31:08,598 WORKING WITH BROADLY 2251 01:31:08,598 --> 01:31:10,566 NEUTRALIZING ANTIBODIES, THOSE 2252 01:31:10,566 --> 01:31:11,667 THESE ARE MONOCLONAL ANTIBODIES 2253 01:31:11,667 --> 01:31:16,806 THAT CAR -- TARGET COULD BE 2254 01:31:16,806 --> 01:31:18,641 SERVED REGIONS MAKING THEM 2255 01:31:18,641 --> 01:31:21,177 EFFECTIVE AGAINST A LARGE SWATH 2256 01:31:21,177 --> 01:31:22,044 OF CIRCULATING HIV ISOLATES, 2257 01:31:22,044 --> 01:31:23,913 MANY ADVANTAGES FOR USING THIS 2258 01:31:23,913 --> 01:31:27,650 APPROACH ESPECIALLY IN CHILDREN. 2259 01:31:27,650 --> 01:31:30,853 MOLECULES ARE SAFE, INCLUDING 2260 01:31:30,853 --> 01:31:34,090 INFANTS, EVIDENCE FROM ANIMAL 2261 01:31:34,090 --> 01:31:42,398 MODELS SHOW PRE AND POST 2262 01:31:42,398 --> 01:31:45,468 EXPOSURE CAN PREVENT IN INFANT 2263 01:31:45,468 --> 01:31:48,437 MACAQUES AND NOW EVIDENCE IN 2264 01:31:48,437 --> 01:31:50,206 CHILDREN WITH HIV. 2265 01:31:50,206 --> 01:31:52,608 IT REQUIRES REPEATED INFUSIONS 2266 01:31:52,608 --> 01:31:55,778 AND IN THE CASE OF PROPHYLAXIS 2267 01:31:55,778 --> 01:32:01,217 THE VISION HERE IS THAT YOU 2268 01:32:01,217 --> 01:32:07,190 RECEIVE REGULAR INFUSION WITH 2269 01:32:07,190 --> 01:32:08,991 THESE MOLECULES. 2270 01:32:08,991 --> 01:32:11,961 WHICH CAN PREVENT -- PROTECT 2271 01:32:11,961 --> 01:32:15,031 RECIPIENT FROM INFECTION UPON 2272 01:32:15,031 --> 01:32:17,400 HIV EXPOSURES BUT ONCE YOU -- 2273 01:32:17,400 --> 01:32:19,535 ONCE LEVELS OF ANTIBODIES 2274 01:32:19,535 --> 01:32:21,470 DECREASE TO A CERTAIN LEVEL, OR 2275 01:32:21,470 --> 01:32:24,106 IF YOU STOP RECEIVING THESE 2276 01:32:24,106 --> 01:32:29,712 INFUSIONS YOU THEN BECOME 2277 01:32:29,712 --> 01:32:33,216 SUSCEPTIBLE AGAIN, BECOME 2278 01:32:33,216 --> 01:32:33,583 INFECTED. 2279 01:32:33,583 --> 01:32:38,120 bNAbS HAVE BEEN USED IN 2280 01:32:38,120 --> 01:32:41,290 PEOPLE LIVING WITH HIV, WHERE 2281 01:32:41,290 --> 01:32:46,696 PEOPLE HARBOR VIRUSES SENSITIVE 2282 01:32:46,696 --> 01:32:51,467 TO bNAbS WE SEE CONTROL OF 2283 01:32:51,467 --> 01:32:55,171 VIREMIA AFTER STOPPING BUT ONCE 2284 01:32:55,171 --> 01:32:55,705 THE ANTIBODIES FELL BELOW 2285 01:32:55,705 --> 01:32:58,207 THERAPEUTIC LEVELS THE VIRUS 2286 01:32:58,207 --> 01:33:04,814 CAME BACK AND THE JARGON HERE IS 2287 01:33:04,814 --> 01:33:05,448 VIRUS REBOUND. 2288 01:33:05,448 --> 01:33:06,916 THIS IS VERY ENCOURAGING BUT 2289 01:33:06,916 --> 01:33:10,953 THERE'S A MAIN CAVEAT, SINCE 2290 01:33:10,953 --> 01:33:15,224 REPEATED DOSING FACES CHALLENGES 2291 01:33:15,224 --> 01:33:17,560 TO BROAD SCALE IMPLEMENTATION. 2292 01:33:17,560 --> 01:33:19,695 BUT THEN WHAT IF bNAbS COULD 2293 01:33:19,695 --> 01:33:23,766 BE PRODUCED BY HOST CELLS, 2294 01:33:23,766 --> 01:33:25,301 OBVIATING THE NEED FOR REPEAT 2295 01:33:25,301 --> 01:33:26,602 ADMINISTRATIONS, AND THIS IS 2296 01:33:26,602 --> 01:33:29,772 WHAT WE HOPE TO ACHIEVE WITH AAV 2297 01:33:29,772 --> 01:33:30,940 VECTOR DELIVERY OF MOLECULES. 2298 01:33:30,940 --> 01:33:40,816 THE VISION IS THAT A SINGLE DOE 2299 01:33:40,816 --> 01:33:41,817 WOULD PRE-CIVIL IN REDUCTION IN 2300 01:33:41,817 --> 01:33:43,886 VIVO, IN THE CASE OF 2301 01:33:43,886 --> 01:33:46,689 PROPHYLAXIS, IN THE CASE OF 2302 01:33:46,689 --> 01:33:49,125 THERAPY A SINGLE DOSE OF THESE 2303 01:33:49,125 --> 01:33:53,195 PERHAPS DURING THE TIME OF ART 2304 01:33:53,195 --> 01:33:54,630 INITIATION COULD RESULT IN 2305 01:33:54,630 --> 01:33:55,798 PRODUCTION OF MOLECULES ALLOWING 2306 01:33:55,798 --> 01:33:57,867 RECIPIENT TO STOP TAKING THERAPY 2307 01:33:57,867 --> 01:34:04,106 AND REMAIN AVIREMIC FOLLOWING 2308 01:34:04,106 --> 01:34:05,107 TREATMENT INTERRUPTION. 2309 01:34:05,107 --> 01:34:07,643 SEEMS PERTINENT TO TALK ABOUT 2310 01:34:07,643 --> 01:34:11,781 WHAT AAV IS, STANDS FOR 2311 01:34:11,781 --> 01:34:12,348 ADENOASSOCIATED VIRUS, 2312 01:34:12,348 --> 01:34:16,252 DISCOVERED IN 1967, A CELL 2313 01:34:16,252 --> 01:34:22,158 CULTURE CONTAMINANT, HENCE THE 2314 01:34:22,158 --> 01:34:26,629 NAME, ADENO-ASSOCIATED, BUT IT'S 2315 01:34:26,629 --> 01:34:28,597 DIFFERENT. 2316 01:34:28,597 --> 01:34:36,839 IT'S PARVO VIRUS, A MEMBER OF 2317 01:34:36,839 --> 01:34:37,406 DEPENDOPARVOWVIRUS, CANNOT 2318 01:34:37,406 --> 01:34:39,442 REPLICATE ON ITS OWN. 2319 01:34:39,442 --> 01:34:42,278 THE AAV GENOME WAS CLONED IN THE 2320 01:34:42,278 --> 01:34:47,049 1980s, LEADING TO DEVELOP OF 2321 01:34:47,049 --> 01:34:49,318 GENETIC SYSTEMS. 2322 01:34:49,318 --> 01:34:54,256 IT'S SIMPLE, THE WILDTYPE AAV 2323 01:34:54,256 --> 01:34:57,193 HAS TWO GENES, IN VECTORS BOTH 2324 01:34:57,193 --> 01:35:00,963 AAV GENES ARE REMOVED AND PLACED 2325 01:35:00,963 --> 01:35:01,897 BY TRANSGENE EXPRESSION 2326 01:35:01,897 --> 01:35:02,465 CASSETTE. 2327 01:35:02,465 --> 01:35:04,767 IN THE END, THE ONLY PROTEIN 2328 01:35:04,767 --> 01:35:09,038 EXPRESSED FROM AN AAV VECTOR IS 2329 01:35:09,038 --> 01:35:11,073 TRANSGENE PRODUCT. 2330 01:35:11,073 --> 01:35:12,775 WHICH SIMPLICITY CONTRIBUTES TO 2331 01:35:12,775 --> 01:35:17,380 SAFETY OF THIS APPROACH, LOW 2332 01:35:17,380 --> 01:35:19,515 IMMUNOGENICITY, LOW CYTOTOXICITY 2333 01:35:19,515 --> 01:35:22,918 COMPARED TO OTHER VIRAL VECTORS 2334 01:35:22,918 --> 01:35:23,119 USED. 2335 01:35:23,119 --> 01:35:28,057 THERE ARE MANY ADVANTAGES BUT I 2336 01:35:28,057 --> 01:35:34,530 ONLY WISH TO EMPHASIZE FOLLOWING 2337 01:35:34,530 --> 01:35:40,202 AAV TRANSDUCTION IT'S 2338 01:35:40,202 --> 01:35:41,537 NON-INTEGRATING, PERSISTING AS 2339 01:35:41,537 --> 01:35:43,205 LONG AS THE TRANSDUCED CELL 2340 01:35:43,205 --> 01:35:47,543 LIVES, HOPING TO ACHIEVE DURABLE 2341 01:35:47,543 --> 01:35:48,978 EXPRESSION OF bNAbS, 2342 01:35:48,978 --> 01:35:50,279 TARGETING SKELETAL MUSCLE 2343 01:35:50,279 --> 01:35:57,987 BECAUSE MYOCYTES ARE ABUNDANT 2344 01:35:57,987 --> 01:35:59,522 AND DISPLAY LITTLE TURNOVER. 2345 01:35:59,522 --> 01:36:01,457 GENE EXPRESSION CAN PERSIST IN 2346 01:36:01,457 --> 01:36:03,759 SKELETAL MUSCLE FOR YEARS, 2347 01:36:03,759 --> 01:36:05,227 POSSIBLY EVEN DECADES. 2348 01:36:05,227 --> 01:36:09,799 SO, HOW DO WE APPLY THIS IN THE 2349 01:36:09,799 --> 01:36:11,734 CONTEXT OF PERINATAL HIV 2350 01:36:11,734 --> 01:36:14,370 RESEARCH ESPECIALLY IN CASES FOR 2351 01:36:14,370 --> 01:36:21,277 PREVENTING INFECTION IN INFANTS? 2352 01:36:21,277 --> 01:36:23,079 OUR HYPOTHESIS AAV bNAb 2353 01:36:23,079 --> 01:36:25,881 INOCULATION AT BIRTH RESULTS IN 2354 01:36:25,881 --> 01:36:28,417 EXPRESSION THROUGHOUT INFANCY, 2355 01:36:28,417 --> 01:36:29,952 PREVENTING VERTICAL TRANSMISSION 2356 01:36:29,952 --> 01:36:30,619 THROUGH BREASTFEEDING. 2357 01:36:30,619 --> 01:36:33,422 CHILD BIRTH IS ONE OF THE MOST 2358 01:36:33,422 --> 01:36:34,190 CONSISTENT TIMES OF INTERACTION 2359 01:36:34,190 --> 01:36:36,959 IN THE DYAD SO TREATING BREAKS 2360 01:36:36,959 --> 01:36:39,762 WITH AAV VECTORS AT THIS TIME 2361 01:36:39,762 --> 01:36:41,230 COULD GRANT DURABLE IMMUNITY 2362 01:36:41,230 --> 01:36:42,731 EVEN IF LOST TO FOLLOW-UP. 2363 01:36:42,731 --> 01:36:45,334 THE WAY WE ADDRESS THIS IN MY 2364 01:36:45,334 --> 01:36:47,303 GROUP IS THROUGH USE OF 2365 01:36:47,303 --> 01:36:48,737 NON-HUMAN PRIMATE MODEL, A 2366 01:36:48,737 --> 01:36:50,840 PEDIATRIC NON-HUMAN PRIMATE, OF 2367 01:36:50,840 --> 01:36:51,707 HIV/AIDS. 2368 01:36:51,707 --> 01:36:53,776 WE SELECTED NEWBORN RHESUS 2369 01:36:53,776 --> 01:36:56,645 MACAQUES FROM CALIFORNIA CENTER 2370 01:36:56,645 --> 01:36:59,381 AND TREATED WITH AAV VECTORS, 2371 01:36:59,381 --> 01:37:08,824 SELECTED TWO bNAbS OR 2372 01:37:08,824 --> 01:37:11,127 MOLECULES, ONE OF THE MOST 2373 01:37:11,127 --> 01:37:15,931 CONSERVED REGIONS OF THE 2374 01:37:15,931 --> 01:37:17,433 ENVELOPE. 2375 01:37:17,433 --> 01:37:24,106 MOLECULES WERE THE bNAbS IN 2376 01:37:24,106 --> 01:37:27,743 MULTIPLE CLINICAL TRIALS, AND 2377 01:37:27,743 --> 01:37:30,246 ECD 4-IG WHICH MIMICS GRANTING 2378 01:37:30,246 --> 01:37:31,580 EXCEPTIONAL BREAD THAT. 2379 01:37:31,580 --> 01:37:36,919 WE TREATED A TOTAL OF THREE 2380 01:37:36,919 --> 01:37:40,089 GROUPS WITH, ONE RECEIVED AN 2381 01:37:40,089 --> 01:37:43,392 INJECTION, WITHIN 24 HOURS OF 2382 01:37:43,392 --> 01:37:44,360 BIRTH. 2383 01:37:44,360 --> 01:37:46,795 GROUP 2 RECEIVED INTRAVENOUS 2384 01:37:46,795 --> 01:37:52,535 DOSE OF AAV8, AND FOUR WEEKS 2385 01:37:52,535 --> 01:37:56,906 LATER ANIMALS RECEIVED THE SAME 2386 01:37:56,906 --> 01:38:00,776 DOSE DELIVERED INTRAMUSCULARLY. 2387 01:38:00,776 --> 01:38:02,945 GROUP 3 A DOSE AGAIN WITHIN 24 2388 01:38:02,945 --> 01:38:06,482 HOURS OF BIRTH. 2389 01:38:06,482 --> 01:38:13,155 WE ALSO SELECTED SIX CONTROL 2390 01:38:13,155 --> 01:38:15,057 MACAQUES WHICH SERVED AS 2391 01:38:15,057 --> 01:38:16,425 CONTROLS FOR SUBSEQUENT ORAL 2392 01:38:16,425 --> 01:38:18,627 SHIFT CHALLENGES WE SUBJECT 2393 01:38:18,627 --> 01:38:21,030 THESE ANIMALS TO. 2394 01:38:21,030 --> 01:38:23,566 I MUST EMPHASIZE THE 2395 01:38:23,566 --> 01:38:27,069 INOCULATIONS WITH SAFE, WELL 2396 01:38:27,069 --> 01:38:27,803 TOLERATED, ANIMALS GAINED 2397 01:38:27,803 --> 01:38:33,809 WEIGHT, WHICH WAS WITHIN 2398 01:38:33,809 --> 01:38:34,443 EXPECTED. 2399 01:38:34,443 --> 01:38:35,244 WE TRACKED EXPRESSION OF 2400 01:38:35,244 --> 01:38:36,445 MOLECULES IN ALL GROUPS OVER 2401 01:38:36,445 --> 01:38:37,112 TIME. 2402 01:38:37,112 --> 01:38:41,517 SHOWN IS THE SERUM 2403 01:38:41,517 --> 01:38:45,221 CONCENTRATIONS IN GROUP 1, 2, 2404 01:38:45,221 --> 01:38:46,622 SERUM CONCENTRATION IN GROUP 3, 2405 01:38:46,622 --> 01:38:49,358 ALL ANIMALS EXCEPT FOR ONE IN 2406 01:38:49,358 --> 01:38:51,860 GROUP 3 DEVELOPED PERSISTENT 2407 01:38:51,860 --> 01:38:53,329 EXPRESSION OF RESPECTIVE 2408 01:38:53,329 --> 01:38:54,163 bNAbS OR bNAb MOLECULES 2409 01:38:54,163 --> 01:38:55,397 OVER TIME. 2410 01:38:55,397 --> 01:38:56,932 ONE OF THE ANIMALS IN GROUP 3, 2411 01:38:56,932 --> 01:39:00,769 THE ONE THAT FAILED TO DEVELOP 2412 01:39:00,769 --> 01:39:02,137 PERSISTENT EXPRESSION, HAD TO BE 2413 01:39:02,137 --> 01:39:06,609 EXCLUDED FROM THE STUDY DUE TO 2414 01:39:06,609 --> 01:39:08,010 REASONS UNRELATED TO 2415 01:39:08,010 --> 01:39:08,410 INOCULATION. 2416 01:39:08,410 --> 01:39:10,412 WE ALSO CONFIRMED THAT THE 2417 01:39:10,412 --> 01:39:13,148 MOLECULES PRODUCED IN VIVO IN 2418 01:39:13,148 --> 01:39:14,350 THESE ANIMALS DISPLAYED 2419 01:39:14,350 --> 01:39:18,053 ANTI-VIRAL ACTIVITY SHOWN HERE 2420 01:39:18,053 --> 01:39:27,696 ARE THE ID 80 NEUTRALIZATION 2421 01:39:27,696 --> 01:39:29,164 TITERS, MOLECULES WERE PRODUCED, 2422 01:39:29,164 --> 01:39:30,532 FUNCTIONALLY ACTIVE. 2423 01:39:30,532 --> 01:39:33,836 AND THE RESULTS OF THE ORAL SHIV 2424 01:39:33,836 --> 01:39:35,671 CHALLENGE PHASE, EXPOSING 2425 01:39:35,671 --> 01:39:37,439 ANIMALS ORALLY TO ESCALATING 2426 01:39:37,439 --> 01:39:42,044 DOSES OF A SIMEON HIV CLONE, 2427 01:39:42,044 --> 01:39:44,647 SHIV 88 TO MIMIC CHILDHOOD 2428 01:39:44,647 --> 01:39:46,215 TRANSMISSION IN BREASTFEEDING. 2429 01:39:46,215 --> 01:39:48,851 SHOWN IS THE RATE IN THE CONTROL 2430 01:39:48,851 --> 01:39:50,352 GROUPS, ALL ANIMALS BECAME 2431 01:39:50,352 --> 01:39:52,554 INFECTED BY THE 12th ORAL 2432 01:39:52,554 --> 01:39:52,855 EXPOSURE. 2433 01:39:52,855 --> 01:39:56,325 AND THEN ON TOP OF THIS CURVE WE 2434 01:39:56,325 --> 01:39:58,560 HAVE THE GROUP 1 RATE OF 2435 01:39:58,560 --> 01:40:01,397 ACQUISITION, WITH ONLY ONE 2436 01:40:01,397 --> 01:40:03,265 ANIMAL BECOMING INFECTED, ONLY 2437 01:40:03,265 --> 01:40:05,768 AFTER THEY WERE EXPOSED TO 2438 01:40:05,768 --> 01:40:11,006 UNDILUTED VIERS WHICH -- VIRUSY 2439 01:40:11,006 --> 01:40:16,078 HIGH DOSE OF VIRUS. 2440 01:40:16,078 --> 01:40:19,281 OTHER THAN THAT, THE ANIMALS 2441 01:40:19,281 --> 01:40:20,349 WERE COMPLETELY PROTECTED. 2442 01:40:20,349 --> 01:40:23,185 WE KEPT THESE ANIMALS ALIVE 2443 01:40:23,185 --> 01:40:26,188 AFTER THE ORAL SHIV CHALLENGE 2444 01:40:26,188 --> 01:40:29,358 PHASE AND MONITORED 2445 01:40:29,358 --> 01:40:30,659 CONCENTRATIONS OVER TIME. 2446 01:40:30,659 --> 01:40:34,930 TWO GROUP 3 ANIMALS CONTINUED TO 2447 01:40:34,930 --> 01:40:35,731 SEE CONTINUOUS UNINTERRUPTED 2448 01:40:35,731 --> 01:40:37,266 EXPRESSION OVER TIME FOR UP TO 2449 01:40:37,266 --> 01:40:38,967 THREE YEARS. 2450 01:40:38,967 --> 01:40:40,936 AFTER RECEIVING SINGLE DOSE OF 2451 01:40:40,936 --> 01:40:43,272 THE VECTOR AT BIRTH. 2452 01:40:43,272 --> 01:40:44,707 WE CONTINUED TO MONITOR FOR 2453 01:40:44,707 --> 01:40:46,542 EXPRESSION IN THE TWO ANIMALS 2454 01:40:46,542 --> 01:40:51,547 FROM ONE AND TWO OVER TIME AND 2455 01:40:51,547 --> 01:40:53,082 SAW UNINTERRUPTED EXPRESSION FOR 2456 01:40:53,082 --> 01:40:54,450 UP TO FOUR YEARS. 2457 01:40:54,450 --> 01:40:57,986 JUST TO SUMMARIZE THE FIRST 2458 01:40:57,986 --> 01:41:00,155 PART, NEONATAL DELIVERY ENCODING 2459 01:41:00,155 --> 01:41:02,725 HIV BIOLOGICS IS SAFE AND 2460 01:41:02,725 --> 01:41:05,994 CONFERS DURABLE HIV IMMUNITY IN 2461 01:41:05,994 --> 01:41:07,296 INFANT MACAQUES. 2462 01:41:07,296 --> 01:41:09,164 IN VIVO PRODUCTION LASTED FOR 2463 01:41:09,164 --> 01:41:11,300 THREE TO FOUR YEARS WITHOUT 2464 01:41:11,300 --> 01:41:13,702 REDOSING, MORE THAN ENOUGH TO 2465 01:41:13,702 --> 01:41:14,336 COVER THE BREASTFEEDING PERIOD 2466 01:41:14,336 --> 01:41:16,939 IN MOST REGIONS OF THE WORLD. 2467 01:41:16,939 --> 01:41:19,208 IN ADDITION TO PROPHYLAXIS, 2468 01:41:19,208 --> 01:41:22,311 WE'RE ALSO USING, TESTING THIS 2469 01:41:22,311 --> 01:41:23,545 APPROACH FOR TREATING PERINATAL 2470 01:41:23,545 --> 01:41:26,815 HIV INFECTION AND USING A 2471 01:41:26,815 --> 01:41:28,884 SIMILAR NON-HUMAN PRIMATE MODEL 2472 01:41:28,884 --> 01:41:32,821 VERTICAL TRANSMISSION. 2473 01:41:32,821 --> 01:41:36,158 SO HERE WE ENROLLED TEN INFANT 2474 01:41:36,158 --> 01:41:37,426 RHESUS MACAQUES, ORALLY INFECTED 2475 01:41:37,426 --> 01:41:40,496 WITH DIFFERENT TYPE OF SHIV. 2476 01:41:40,496 --> 01:41:43,665 ONE WEEK LATER, THESE ANIMALS 2477 01:41:43,665 --> 01:41:50,906 STARTED ANTIRETROVIRAL THERAPY 2478 01:41:50,906 --> 01:41:55,210 AND RECEIVED TWO AAA FACTORS, 2479 01:41:55,210 --> 01:42:01,817 AND A NEW bNAb WHICH TARGETS 2480 01:42:01,817 --> 01:42:03,919 A DIFFERENT REGION. 2481 01:42:03,919 --> 01:42:06,488 WE INFECTED SIX CONTROL ANIMALS 2482 01:42:06,488 --> 01:42:07,790 IN PARALLEL, PLACED ON 2483 01:42:07,790 --> 01:42:09,958 ANTIRETROVIRAL, THEY DID NOT 2484 01:42:09,958 --> 01:42:11,059 RECEIVE ANY AAV VECTORS. 2485 01:42:11,059 --> 01:42:14,263 LET'S LOOK AT THE RESULTS FROM 2486 01:42:14,263 --> 01:42:15,564 THE ANTIRETROVIRAL PHASE. 2487 01:42:15,564 --> 01:42:18,967 SHOWING THE DATA AS INDIVIDUAL 2488 01:42:18,967 --> 01:42:20,569 GRAPHS FOR EACH ANIMAL, 2489 01:42:20,569 --> 01:42:22,104 INDICATING IN THE CONTROL GROUP, 2490 01:42:22,104 --> 01:42:25,707 IN THE CASE OF THE CONTROL 2491 01:42:25,707 --> 01:42:26,842 MONKEY, WE'RE LOOKING AT PLASMA 2492 01:42:26,842 --> 01:42:29,945 VIRAL LOADS AS RED CIRCUMSTANCE 2493 01:42:29,945 --> 01:42:31,747 ALSO, PLOTTED AGAINST LEFT 2494 01:42:31,747 --> 01:42:33,715 Y-AXIS, SHADED AREA CORRESPONDS 2495 01:42:33,715 --> 01:42:35,451 TO PERIOD OF ANTIRETROVIRAL IN 2496 01:42:35,451 --> 01:42:36,251 ALL ANIMALS. 2497 01:42:36,251 --> 01:42:42,157 AND THE POINT HERE IS THAT THE 2498 01:42:42,157 --> 01:42:43,325 ANTIRETROVIRAL THERAPY PHASE 2499 01:42:43,325 --> 01:42:45,093 SUPPRESSED VIREMIA IN ALL SIX 2500 01:42:45,093 --> 01:42:47,529 CONTROL ANIMALS AND DID SO TOO 2501 01:42:47,529 --> 01:42:55,170 IN ALL TEN EXPERIMENTAL ANIMALS. 2502 01:42:55,170 --> 01:42:57,706 THE GRAPH, A RIGHT Y-AXIS THAT 2503 01:42:57,706 --> 01:42:58,807 INDICATES SERUM CONCENTRATIONS 2504 01:42:58,807 --> 01:43:04,480 OF EACH MOLECULE DELIVERED BY 2505 01:43:04,480 --> 01:43:07,082 AAV VECTORS, THE CD4 IG HAD 2506 01:43:07,082 --> 01:43:09,952 GREEN CIRCLES, THE POINT IS THAT 2507 01:43:09,952 --> 01:43:13,121 ALL EXPERIMENTAL ANIMALS 2508 01:43:13,121 --> 01:43:13,889 DEVELOPED PERSISTENT EXPRESSION, 2509 01:43:13,889 --> 01:43:20,162 FOR REASONS I DON'T HAVE TIME TO 2510 01:43:20,162 --> 01:43:22,764 TALK ABOUT, EXPRESSION WAS MORE 2511 01:43:22,764 --> 01:43:23,298 VARIABLE. 2512 01:43:23,298 --> 01:43:26,835 WHAT HAPPENS TO THE VIRUS WHEN 2513 01:43:26,835 --> 01:43:28,136 WE INTERRUPTED ART? 2514 01:43:28,136 --> 01:43:29,972 WELL, THE VIRUS COMES BACK 2515 01:43:29,972 --> 01:43:34,576 QUICKLY IN ALL SIX CONTROL 2516 01:43:34,576 --> 01:43:35,244 ANIMALS. 2517 01:43:35,244 --> 01:43:38,180 AND EXPRESSION OF AT LEAST ONE 2518 01:43:38,180 --> 01:43:40,582 MOLECULE IS MAINTAINED BY ALL 2519 01:43:40,582 --> 01:43:42,117 TEN EXPERIMENTAL MACAQUES. 2520 01:43:42,117 --> 01:43:44,753 AND WE WERE VERY ENCOURAGED TO 2521 01:43:44,753 --> 01:43:47,389 SEE NO REBOUND, NO VIRUS, NO 2522 01:43:47,389 --> 01:43:51,026 VIREMIA, IN A TOTAL OF SEVEN 2523 01:43:51,026 --> 01:43:53,395 AAV-TREATED MACAQUES. 2524 01:43:53,395 --> 01:43:59,268 WE ANALYZED MORE THAN 225 PLASMA 2525 01:43:59,268 --> 01:44:01,570 SAMPLES, FROM SEVEN AAV TREATED 2526 01:44:01,570 --> 01:44:04,306 INFANTS, NO EVIDENCE OF VIRUS. 2527 01:44:04,306 --> 01:44:07,709 THERE WAS ONE CASE IN LATE VERY 2528 01:44:07,709 --> 01:44:12,080 SMALL BREAKTHROUGH IN ONE 2529 01:44:12,080 --> 01:44:14,483 EXPERIMENTAL ANIMAL, BUT VIRAL 2530 01:44:14,483 --> 01:44:16,351 LOADS WERE CONTROLLED 2531 01:44:16,351 --> 01:44:16,952 EVENTUALLY. 2532 01:44:16,952 --> 01:44:20,989 AND THE TWO LAST EXPERIMENTAL 2533 01:44:20,989 --> 01:44:25,561 ANIMALS BECAME VIREMIC SHORTLY 2534 01:44:25,561 --> 01:44:27,062 AFTER THE ANTIRETROVIRAL 2535 01:44:27,062 --> 01:44:29,164 THERAPY, THE END OF THE PHASE, 2536 01:44:29,164 --> 01:44:32,334 BUT THESE WERE CAPABLE OF 2537 01:44:32,334 --> 01:44:36,171 REGAINING CONTROL WHICH 2538 01:44:36,171 --> 01:44:39,808 COINCIDED WITH A DECREASE IN 2539 01:44:39,808 --> 01:44:40,142 CONCENTRATION. 2540 01:44:40,142 --> 01:44:43,145 WHEN WE ANALYZED RATE OF REBOUND 2541 01:44:43,145 --> 01:44:46,815 BETWEEN THE TWO GROUPS WE SEE 2542 01:44:46,815 --> 01:44:47,716 STATISTICALLY SIGNIFICANT 2543 01:44:47,716 --> 01:44:53,455 DIFFERENCE BETWEEN CONTROL GROUP 2544 01:44:53,455 --> 01:44:55,190 AND EXPERIMENTAL GROUP. 2545 01:44:55,190 --> 01:44:58,260 WE SEE THAT EARLY ART INITIATION 2546 01:44:58,260 --> 01:45:00,729 AND AAV bNAb THERAPY CAN 2547 01:45:00,729 --> 01:45:03,231 PREVENT VIRUS REBOUND IN 2548 01:45:03,231 --> 01:45:04,666 SHIV-INFECTED INFANT MACAQUES 2549 01:45:04,666 --> 01:45:07,502 TREATED ONE WEEK POST INFECTION, 2550 01:45:07,502 --> 01:45:09,705 ENCOURAGING BUT MADE US WONDER 2551 01:45:09,705 --> 01:45:13,976 THAT THE LENGTH OF TIME THAT THE 2552 01:45:13,976 --> 01:45:16,144 VIRUS HAD TO REPLICATE, TOO 2553 01:45:16,144 --> 01:45:18,180 SHORT, ONLY SEVEN DAYS, WHICH 2554 01:45:18,180 --> 01:45:20,349 MAY HAVE CREATED ANT 2555 01:45:20,349 --> 01:45:22,184 ARTIFICIALLY SMALL RESERVOIR 2556 01:45:22,184 --> 01:45:23,485 THAT COULD MADE IT EASIER 2557 01:45:23,485 --> 01:45:25,354 PERHAPS FOR THE INTERVENTION WE 2558 01:45:25,354 --> 01:45:27,656 USED TO BE EFFECTIVE SO WITH 2559 01:45:27,656 --> 01:45:29,625 THIS IN MIND WE ASKED WHETHER 2560 01:45:29,625 --> 01:45:33,228 THE SAME APPROACH WOULD WORK IN 2561 01:45:33,228 --> 01:45:35,464 ANIMALS HARBORING LARGER 2562 01:45:35,464 --> 01:45:35,764 RESERVOIRS. 2563 01:45:35,764 --> 01:45:38,033 AND WE DID -- TO CREATE A LARGER 2564 01:45:38,033 --> 01:45:40,902 RESERVOIR IN THE SYSTEM WE 2565 01:45:40,902 --> 01:45:42,804 CONDUCTED A VERY SIMILAR 2566 01:45:42,804 --> 01:45:44,640 EXPERIMENT BUT INSTEAD OF 2567 01:45:44,640 --> 01:45:46,942 INITIATING ANTIRETROVIRAL 2568 01:45:46,942 --> 01:45:49,778 THERAPY SEVEN DAYS AFTER 2569 01:45:49,778 --> 01:45:50,746 INFECTION, AND DELIVERING THE 2570 01:45:50,746 --> 01:45:53,582 VECTORS AT THE SAME TIME WE 2571 01:45:53,582 --> 01:45:55,117 WAITED LONGER. 2572 01:45:55,117 --> 01:45:59,287 WE DID SO AT WEEK THREE POST 2573 01:45:59,287 --> 01:45:59,988 INFECTION. 2574 01:45:59,988 --> 01:46:01,590 THERE WAS ADDITIONAL TWO WEEKS 2575 01:46:01,590 --> 01:46:04,760 OF TIME FOR THE VIRUS TO 2576 01:46:04,760 --> 01:46:06,628 REPLICATE UNCHECKED IN BOTH 2577 01:46:06,628 --> 01:46:10,565 EXPERIMENTAL AND CONTROL 2578 01:46:10,565 --> 01:46:11,566 ANIMALS. 2579 01:46:11,566 --> 01:46:13,902 AND WE WERE ABLE TO SUPPRESS 2580 01:46:13,902 --> 01:46:17,339 VIREMIA DURING THE 30 WEEKS OF 2581 01:46:17,339 --> 01:46:18,507 ANTIRETROVIRAL THERAPY, AND SAW 2582 01:46:18,507 --> 01:46:20,542 REBOUND IN ALL CONTROL ANIMALS 2583 01:46:20,542 --> 01:46:27,449 AGAIN LIKE THE FIRST EXPERIMENT. 2584 01:46:27,449 --> 01:46:28,550 WE ALSO SO PERSISTENT 2585 01:46:28,550 --> 01:46:31,053 COMPRESSION OF BIOLOGICS AND 2586 01:46:31,053 --> 01:46:32,821 DURABLE CONTROL OF VIREMIA IN 2587 01:46:32,821 --> 01:46:35,123 FIVE OF THE SIX EXPERIMENTAL 2588 01:46:35,123 --> 01:46:39,594 ANIMALS EVEN WHEN THESE MACAQUES 2589 01:46:39,594 --> 01:46:41,763 HAD LARGER RESERVOIRS CREATED BY 2590 01:46:41,763 --> 01:46:43,765 STARTING THE THERAPY AT WEEK 3 2591 01:46:43,765 --> 01:46:49,337 INSTEAD OF WEEK 7. 2592 01:46:49,337 --> 01:46:52,207 AND ONCE AGAIN STATISTICALLY 2593 01:46:52,207 --> 01:46:52,941 SIGNIFICANT. 2594 01:46:52,941 --> 01:46:59,081 TO SUMMARIZE THE SECOND PARTY 2595 01:46:59,081 --> 01:47:01,783 EARLY ANTIRETROVIRAL THERAPY CAN 2596 01:47:01,783 --> 01:47:03,585 SUBSTANTIALLY DELAY REQUIRES WE 2597 01:47:03,585 --> 01:47:03,919 BOUND. 2598 01:47:03,919 --> 01:47:05,721 THIS APPROACH WORKS WHEN 2599 01:47:05,721 --> 01:47:07,756 INTERVENTIONS ARE GIVEN ONE OR 2600 01:47:07,756 --> 01:47:15,864 THREE WEEKS POST SHIV INFECTION 2601 01:47:15,864 --> 01:47:17,332 AND REQUIRES CONTROLS EXPRESSION 2602 01:47:17,332 --> 01:47:18,333 OF bNAbS. 2603 01:47:18,333 --> 01:47:28,176 I WANT TO HIGHLIGHT UNIQUE 2604 01:47:28,176 --> 01:47:29,478 FEATURES OF AAA VECTORED 2605 01:47:29,478 --> 01:47:30,579 DELIVERY OF bNAbS. 2606 01:47:30,579 --> 01:47:32,447 IT DOES NOT REQUIRE PATIENT 2607 01:47:32,447 --> 01:47:34,516 ADHERENCE BECAUSE OF LONGER-TERM 2608 01:47:34,516 --> 01:47:40,856 EXPRESSION OF MOLECULES, WE CAN 2609 01:47:40,856 --> 01:47:43,291 POTENTIALLY TREAT AND TREAT 2610 01:47:43,291 --> 01:47:46,128 INFANT OR CHILD LIVING WITH HIV 2611 01:47:46,128 --> 01:47:49,731 ONCE AND NOT WORRY HOPEFULLY 2612 01:47:49,731 --> 01:47:54,169 ABOUT COMPLIANCE TO MEDICATIONS. 2613 01:47:54,169 --> 01:48:02,577 AAV EXPRESSED bNAbS ARE LESS 2614 01:48:02,577 --> 01:48:03,678 IMMUNOGENIC, WE SEE THE 2615 01:48:03,678 --> 01:48:07,649 TOLERANCE IMMUNE SIS FEMME IN 2616 01:48:07,649 --> 01:48:09,651 EARLY LIFE MAKES INFANTS IDEAL 2617 01:48:09,651 --> 01:48:11,887 SUBJECTS TO RECEIVE THESE 2618 01:48:11,887 --> 01:48:12,521 MOLECULES, THIS INTERVENTION, 2619 01:48:12,521 --> 01:48:15,757 BECAUSE THEY ARE LESS LIKELY TO 2620 01:48:15,757 --> 01:48:19,194 DEVELOP POST-IMMUNE RESPONSES 2621 01:48:19,194 --> 01:48:20,095 TARGETING AAV-ENCODED bNAbS 2622 01:48:20,095 --> 01:48:23,598 THAT CURB THEIR EXPRESSION. 2623 01:48:23,598 --> 01:48:25,000 ALSO EAST OF ADMINISTRATION, IT 2624 01:48:25,000 --> 01:48:27,369 ONLY TOOK TWO OR FOUR 2625 01:48:27,369 --> 01:48:28,303 INTRAMUSCULAR INJECTIONS GIVEN 2626 01:48:28,303 --> 01:48:30,505 AT THE SAME TIME TO ACHIEVE 2627 01:48:30,505 --> 01:48:33,408 PERSISTENT EXPRESSION OF 2628 01:48:33,408 --> 01:48:33,675 MOLECULES. 2629 01:48:33,675 --> 01:48:34,776 AGAIN, INTRAMUSCULAR INJECTIONS 2630 01:48:34,776 --> 01:48:36,845 DO NOT REQUIRE ADVANCED MEDICAL 2631 01:48:36,845 --> 01:48:37,813 TRAINING TO DELIVER, SO THIS 2632 01:48:37,813 --> 01:48:41,016 MAKES IT EASY TO DEPLOY THESE 2633 01:48:41,016 --> 01:48:43,185 INTERVENTIONS IN REMOTE AREAS OF 2634 01:48:43,185 --> 01:48:46,822 THE GLOBE WHERE THE HIV EPIDEMIC 2635 01:48:46,822 --> 01:48:50,058 IS CONCENTRATED. 2636 01:48:50,058 --> 01:48:54,563 THE VECTORS ARE STABLE ACROSS 2637 01:48:54,563 --> 01:48:55,230 TEMPERATURES, ACROSS pHs, 2638 01:48:55,230 --> 01:48:57,199 REGARDLESS OF EXPOSURE TO HUMAN 2639 01:48:57,199 --> 01:49:00,368 SERUM OR NOT AGAIN MAKING IT 2640 01:49:00,368 --> 01:49:01,636 CRITICAL FOR IMPLEMENTING THESE 2641 01:49:01,636 --> 01:49:04,306 TYPES OF THERAPIES IN REGIONS 2642 01:49:04,306 --> 01:49:06,575 WHERE A COLD CHAIN CANNOT BE 2643 01:49:06,575 --> 01:49:09,978 RELIABLY MAINTAINED. 2644 01:49:09,978 --> 01:49:12,113 COST EFFECTIVENESS, YES, AAV 2645 01:49:12,113 --> 01:49:13,582 GENE THERAPIES ARE EXPENSED BUT 2646 01:49:13,582 --> 01:49:15,817 DOSED BY BODY MASS, TARGETING 2647 01:49:15,817 --> 01:49:20,088 INFANTS WHICH WEIGH LESS WE CAN 2648 01:49:20,088 --> 01:49:23,158 GET GAINS IN COST HERE. 2649 01:49:23,158 --> 01:49:24,159 FINALLY, AGAIN, I DIDN'T HAVE 2650 01:49:24,159 --> 01:49:26,661 TIME TO TALK ABOUT THIS, 2651 01:49:26,661 --> 01:49:28,964 bNAb EXPRESSION LASTS FOR 2652 01:49:28,964 --> 01:49:32,567 YEARS AND IN OUR TIME MODEL 2653 01:49:32,567 --> 01:49:34,369 LASTS UNTIL ANIMALS BECOME 2654 01:49:34,369 --> 01:49:36,605 SEXUALLY MATURE, ADOLESCENCE, 2655 01:49:36,605 --> 01:49:40,442 WITH A SINGLE NEONATAL DOSE OF 2656 01:49:40,442 --> 01:49:41,343 THERAPY THEY ARE PROTECTED 2657 01:49:41,343 --> 01:49:43,745 AGAINST CHALLENGE WITH SHIV IN 2658 01:49:43,745 --> 01:49:45,947 MODELS DESIGNED TO MIMIC SEXUAL 2659 01:49:45,947 --> 01:49:48,583 TRANSMISSION OF HIV. 2660 01:49:48,583 --> 01:49:51,953 SO, WITH ONE FELL SWOOP IF WE 2661 01:49:51,953 --> 01:49:53,054 CAN TARGET THESE POPULATIONS AT 2662 01:49:53,054 --> 01:49:54,990 RISK AT BIRTH, ONE OF THE MOST 2663 01:49:54,990 --> 01:49:56,558 CONSISTENT TIMES OF INTERACTION 2664 01:49:56,558 --> 01:50:03,231 WITH HEALTH CARE PROVIDERS, WE 2665 01:50:03,231 --> 01:50:04,232 COULD POTENTIALLY PREVENT 2666 01:50:04,232 --> 01:50:06,835 INFECTION IN INFANCY AND LATER 2667 01:50:06,835 --> 01:50:07,135 ADOLESCENCE. 2668 01:50:07,135 --> 01:50:08,937 THERE ARE LIMITATIONS, TO BE 2669 01:50:08,937 --> 01:50:12,540 OPEN ABOUT THEM, DIVERSITY OF 2670 01:50:12,540 --> 01:50:14,509 HIV ISOLATES SIMPLY IS DIFFICULT 2671 01:50:14,509 --> 01:50:18,013 TO DESCRIBE, IT'S OVERWHELMING. 2672 01:50:18,013 --> 01:50:18,680 IT'S MUCH MORE, MUCH GREATER 2673 01:50:18,680 --> 01:50:20,115 THAN DIVERSITY OR LACK OF 2674 01:50:20,115 --> 01:50:21,883 DIVERSITY USED IN THE SHIV 2675 01:50:21,883 --> 01:50:24,920 CHALLENGE MODELS IN THE STUDY. 2676 01:50:24,920 --> 01:50:30,058 THIS LEADS TO BE CONSIDERED 2677 01:50:30,058 --> 01:50:31,927 CAREFULLY SO PROPER MODEL FOR 2678 01:50:31,927 --> 01:50:33,528 CLINICAL TRIALS. 2679 01:50:33,528 --> 01:50:37,432 COST, EQUITABLE ACCESS, GENE 2680 01:50:37,432 --> 01:50:38,700 THERAPIES ARE COST PROHIBITIVELY 2681 01:50:38,700 --> 01:50:41,670 NOW, MAYBE BECAUSE THEY ARE 2682 01:50:41,670 --> 01:50:44,005 NOVEL INTERVENTIONS, BUT WE 2683 01:50:44,005 --> 01:50:46,141 WOULD REQUIRE PUBLIC/PRIVATE 2684 01:50:46,141 --> 01:50:47,342 PARTNERSHIPS TO DEPLOY 2685 01:50:47,342 --> 01:50:49,244 INTERVENTIONS TO REGIONS WHERE 2686 01:50:49,244 --> 01:50:52,314 MOST NEEDED AND FINALLY AAV IS 2687 01:50:52,314 --> 01:50:55,250 ENDEMIC IN THE HUMAN POPULATION 2688 01:50:55,250 --> 01:50:56,785 SO MANY INDIVIDUALS CARRY 2689 01:50:56,785 --> 01:50:58,787 ALREADY ANTIBODIES THAT CAN 2690 01:50:58,787 --> 01:51:02,958 NEUTRALIZE THE AAV THERAPY 2691 01:51:02,958 --> 01:51:03,658 VECTORS. 2692 01:51:03,658 --> 01:51:07,395 THE MESSAGE IS THAT WITH PROPER 2693 01:51:07,395 --> 01:51:09,297 INVESTMENT AAV DELIVERY OF 2694 01:51:09,297 --> 01:51:14,903 BIOLOGICS MAY HOLD KEY TO 2695 01:51:14,903 --> 01:51:15,603 ACHIEVING SUSTAINED IN CHILDREN 2696 01:51:15,603 --> 01:51:18,106 IN A PRACTICAL AND SCALABLE WAY. 2697 01:51:18,106 --> 01:51:19,941 I THANK MY GROUP AND OTHERS 2698 01:51:19,941 --> 01:51:21,876 INVOLVED IN THIS STUDY, SPECIAL 2699 01:51:21,876 --> 01:51:24,546 THANKS TO THE NIH FOR GRANT 2700 01:51:24,546 --> 01:51:33,922 SUPPORT AND ALSO MY COLLEAGUES 2701 01:51:33,922 --> 01:51:34,956 FROM PAVE LABORATORY, AND I 2702 01:51:34,956 --> 01:51:36,424 WOULD BE HAPPY TO TAKE QUESTIONS 2703 01:51:36,424 --> 01:51:36,591 NOW. 2704 01:51:36,591 --> 01:51:41,496 THANK YOU VERY MUCH FOR YOUR 2705 01:51:41,496 --> 01:51:45,033 ATTENTION. 2706 01:51:45,033 --> 01:51:47,135 >> THANK YOU, DR. MARTINS, FOR 2707 01:51:47,135 --> 01:51:48,269 YOUR PRESENTATION. 2708 01:51:48,269 --> 01:51:50,238 OARAC MEMBERS, PLEASE HOLD YOUR 2709 01:51:50,238 --> 01:51:52,273 QUESTIONS UNTIL AFTER OUR NEXT 2710 01:51:52,273 --> 01:51:54,509 PRESENTER. 2711 01:51:54,509 --> 01:52:00,515 2712 01:52:00,515 --> 01:52:05,920 IT'S A PRIVILEGE TO INTRODUCE 2713 01:52:05,920 --> 01:52:06,521 KIMBERLY CANADY-GRIFFITH, A 2714 01:52:06,521 --> 01:52:09,090 TESTAMENT TO THE WORK IN THIS 2715 01:52:09,090 --> 01:52:14,262 COUNTRY REGARDING PERINATAL HIV 2716 01:52:14,262 --> 01:52:14,529 INFECTION. 2717 01:52:14,529 --> 01:52:17,132 HOWEVER, THERE IS MUCH TO LEARN 2718 01:52:17,132 --> 01:52:20,301 AND MUCH TO BE LEARNED FROM THE 2719 01:52:20,301 --> 01:52:26,141 LIVED EXPERIENCE OF PERSONS WHO 2720 01:52:26,141 --> 01:52:27,609 ACQUIRED HIV DURING INFANCY. 2721 01:52:27,609 --> 01:52:30,245 KIM BRINGS A LIFETIME OF 2722 01:52:30,245 --> 01:52:32,781 EXPERIENCE AS AN ADVOCATE, AND 2723 01:52:32,781 --> 01:52:34,749 EDUCATOR, IN ADDRESSING THE 2724 01:52:34,749 --> 01:52:38,353 UNIQUE NEEDS OF THIS PARTICULAR 2725 01:52:38,353 --> 01:52:40,221 COHORT OF POPULATION. 2726 01:52:40,221 --> 01:52:42,857 KIM, OVER TO YOU. 2727 01:52:42,857 --> 01:52:44,859 2728 01:52:44,859 --> 01:52:47,729 >> THANK YOU, IVY. 2729 01:52:47,729 --> 01:52:52,067 I APPRECIATE IT SO MUCH. 2730 01:52:52,067 --> 01:52:55,003 WHEW, THE FORGOTTEN PIECES OF 2731 01:52:55,003 --> 01:52:55,703 THE EPIDEMIC. 2732 01:52:55,703 --> 01:52:57,639 SO, FIRST I WANT TO SAY THANK 2733 01:52:57,639 --> 01:52:59,207 YOU FOR HAVING ME. 2734 01:52:59,207 --> 01:53:02,644 I ALSO WANTED TO TAKE A MOMENT 2735 01:53:02,644 --> 01:53:04,879 ON THE SIDE, YOU SEE THE PICTURE 2736 01:53:04,879 --> 01:53:13,488 OF ME AND THREE OTHER PEOPLE, I 2737 01:53:13,488 --> 01:53:17,192 AM ONE OF FOUR WHO ARE HIV 2738 01:53:17,192 --> 01:53:17,459 POSITIVE. 2739 01:53:17,459 --> 01:53:21,563 EVERY TIME I HAVE AN 2740 01:53:21,563 --> 01:53:22,931 ACCOMPLISHMENT, GRADUATED FROM 2741 01:53:22,931 --> 01:53:27,268 SCHOOL, YOU CAN JUST WAKE UP AND 2742 01:53:27,268 --> 01:53:28,703 CHOOSE TO LIVE. 2743 01:53:28,703 --> 01:53:32,507 MY OLDEST SISTER NEXT TO ME, I 2744 01:53:32,507 --> 01:53:34,375 WAS NUMBER TWO, SHE ALWAYS TELLS 2745 01:53:34,375 --> 01:53:35,910 ME THE DOCTORS SAID YOU WASN'T 2746 01:53:35,910 --> 01:53:37,779 GOING TO LIVE PAST AGE OF ONE, 2747 01:53:37,779 --> 01:53:39,781 NOW LOOK AT YOU. 2748 01:53:39,781 --> 01:53:42,050 FOR ME, IT'S A REALLY LONG TIME, 2749 01:53:42,050 --> 01:53:44,119 I HAD THAT FEELING THAT I WASN'T 2750 01:53:44,119 --> 01:53:45,987 GOING MAKE IT, AND SHE WAS ONE 2751 01:53:45,987 --> 01:53:47,388 OF MY BIGGEST SUPPORTERS, IS ONE 2752 01:53:47,388 --> 01:53:48,823 OF MY BIGGEST SUPPORTERS TO 2753 01:53:48,823 --> 01:53:54,629 REMIND ME EVERY DAY. 2754 01:53:54,629 --> 01:53:56,364 NEXT SLIDE. 2755 01:53:56,364 --> 01:54:00,635 CHILDHOOD, THE TIMELINE OF MY 2756 01:54:00,635 --> 01:54:02,704 LIFE, ALSO BRIEF HISTORY, 2757 01:54:02,704 --> 01:54:06,441 EVERYBODY HAS EXPERIENCE OR HAS 2758 01:54:06,441 --> 01:54:08,176 LIVED THROUGH, I WANTED TO PUT 2759 01:54:08,176 --> 01:54:11,913 THIS UP HERE SO THAT WAY YOU CAN 2760 01:54:11,913 --> 01:54:13,448 SEE HOW THE HIV EPIDEMIC 2761 01:54:13,448 --> 01:54:16,084 PROGRESSED AS MUCH AS I 2762 01:54:16,084 --> 01:54:18,419 PROGRESSED, BEING THE AGE OF 36. 2763 01:54:18,419 --> 01:54:20,522 ACTUALLY I'M 37. 2764 01:54:20,522 --> 01:54:27,061 I DON'T EVEN KNOW HOW OLD I AM. 2765 01:54:27,061 --> 01:54:27,362 1986. 2766 01:54:27,362 --> 01:54:32,667 RIGHT BEFORE IT, BEGINNING OF 2767 01:54:32,667 --> 01:54:40,175 THIS EPIDEMIC, HIV/AIDS 2768 01:54:40,175 --> 01:54:41,309 PROGRAMS, AIDS SERVICE, I'M FROM 2769 01:54:41,309 --> 01:54:44,546 NEW YORK, ONE OF THE CITIES THAT 2770 01:54:44,546 --> 01:54:46,848 ACTUALLY HAD SOME FUNDING. 2771 01:54:46,848 --> 01:54:51,686 ALSO I WAS BORN DECEMBER 7, 2772 01:54:51,686 --> 01:54:54,189 1986, TO A MOM WHO DIDN'T KNOW 2773 01:54:54,189 --> 01:54:55,590 SHE WAS HIV POSITIVE AT THE 2774 01:54:55,590 --> 01:54:56,791 TIME. 2775 01:54:56,791 --> 01:54:59,594 SHE FOUND OUT SHE WAS POSITIVE 2776 01:54:59,594 --> 01:55:03,398 AFTER SHE GAVE BIRTH TO ME. 2777 01:55:03,398 --> 01:55:05,033 WHICH WAS A SAD THING, THAT AT 2778 01:55:05,033 --> 01:55:06,434 THAT TIME THAT'S HOW MANY 2779 01:55:06,434 --> 01:55:11,839 MOTHERS FOUND OUT OF THEIR HIV 2780 01:55:11,839 --> 01:55:12,707 STATUS. 2781 01:55:12,707 --> 01:55:14,576 MY MOM DIDN'T UNDERSTAND HOW SHE 2782 01:55:14,576 --> 01:55:18,179 COULD GIVE BIRTH TO BABY WHO HAS 2783 01:55:18,179 --> 01:55:19,614 A VIRUS, SHE DIDN'T UNDERSTAND 2784 01:55:19,614 --> 01:55:20,481 HOW SHE GOT IT. 2785 01:55:20,481 --> 01:55:23,651 AT THAT TIME THERE WASN'T THAT 2786 01:55:23,651 --> 01:55:28,890 MUCH INFORMATION, THAT WAS 1986 2787 01:55:28,890 --> 01:55:32,393 COMPARED TO 2024. 2788 01:55:32,393 --> 01:55:34,128 SAD REALITY SHE COULDN'T GRASP 2789 01:55:34,128 --> 01:55:35,797 WITH HER DIAGNOSIS AND MINE AS 2790 01:55:35,797 --> 01:55:37,098 WELL, ESPECIALLY WITH DOCTORS 2791 01:55:37,098 --> 01:55:39,000 LETTING HER NO, I WASN'T GOING 2792 01:55:39,000 --> 01:55:41,035 TO MAKE IT PAST ONE, AND TO MAKE 2793 01:55:41,035 --> 01:55:44,105 ARRANGEMENTS FOR ME TO PASS ON. 2794 01:55:44,105 --> 01:55:45,840 GROWING UP I WASN'T LIVING WITH 2795 01:55:45,840 --> 01:55:46,608 MY MOM. 2796 01:55:46,608 --> 01:55:48,042 SHE GAVE ME STRAIGHT TO MY 2797 01:55:48,042 --> 01:55:51,346 GRANDMOTHER AT THE HOSPITAL. 2798 01:55:51,346 --> 01:55:53,948 AND JUST LIKE A LOT OF PEERS WE 2799 01:55:53,948 --> 01:55:56,384 WERE BABIES WHO DIDN'T LIVE WITH 2800 01:55:56,384 --> 01:56:00,622 PARENTS, LIVED IN FOSTER CARE, 2801 01:56:00,622 --> 01:56:03,091 MY GRAND HAD KINSHIP WITH ME, 2802 01:56:03,091 --> 01:56:05,360 1989, IT WAS SOMETHING I CAN SAY 2803 01:56:05,360 --> 01:56:09,497 THAT CHANGED MY LIFE, LIVING 2804 01:56:09,497 --> 01:56:11,466 WITH MY SISTERS, TYPICAL 2805 01:56:11,466 --> 01:56:15,069 HOUSEHOLD WITH EVERYBODY IN THE 2806 01:56:15,069 --> 01:56:15,436 HOME. 2807 01:56:15,436 --> 01:56:17,272 AND THAT REALLY WAS THE SUPPORT 2808 01:56:17,272 --> 01:56:19,240 I DIDN'T KNOW I NEEDED AND 2809 01:56:19,240 --> 01:56:20,775 DIDN'T REALIZE A LOT OF MY 2810 01:56:20,775 --> 01:56:24,912 FRIENDS DIDN'T HAVE AT THAT 2811 01:56:24,912 --> 01:56:27,315 TIME. 2812 01:56:27,315 --> 01:56:30,518 NEXT SLIDE. 2813 01:56:30,518 --> 01:56:31,719 MY ADOLESCENT YEARS WAS 2814 01:56:31,719 --> 01:56:34,555 SOMETHING THAT CHANGED MY LIFE 2815 01:56:34,555 --> 01:56:38,726 IN A DIFFERENT WAY. 2816 01:56:38,726 --> 01:56:42,463 GROWING UP, FOR ME 10 WAS A BIG 2817 01:56:42,463 --> 01:56:42,830 DEAL. 2818 01:56:42,830 --> 01:56:44,532 WAY BEFORE I WOULD GO TO THE 2819 01:56:44,532 --> 01:56:46,100 DOCTOR I WANT TO SAY EVERY SIX 2820 01:56:46,100 --> 01:56:47,035 WEEKS. 2821 01:56:47,035 --> 01:56:49,537 THEN I WENT TO THE DOCTOR BY 2822 01:56:49,537 --> 01:56:53,508 1996, GOING ABOUT EVERY TWO 2823 01:56:53,508 --> 01:56:53,975 MONTHS. 2824 01:56:53,975 --> 01:57:04,485 BY THE TIME AGE 12 I WAS GOING 2825 01:57:07,388 --> 01:57:09,390 EVERY THREE MONTHS. 2826 01:57:09,390 --> 01:57:11,125 WE DON'T TALK ABOUT THE PAST, 2827 01:57:11,125 --> 01:57:14,962 HOW OFT WEAN GO TO THE DOCTOR, 2828 01:57:14,962 --> 01:57:16,497 HOW WE WERE HAVING 30 TO 40 2829 01:57:16,497 --> 01:57:17,131 DIFFERENT VIALS OF BLOOD TAKEN 2830 01:57:17,131 --> 01:57:17,799 FROM US. 2831 01:57:17,799 --> 01:57:20,068 I REMEMBER ALL OF IT. 2832 01:57:20,068 --> 01:57:23,705 I REMEMBER HAVING TO TALK TO 2833 01:57:23,705 --> 01:57:28,076 EVERYBODY AT THE DOCTOR, BUT NOT 2834 01:57:28,076 --> 01:57:29,944 UNDERSTANDING WHY I WAS WITH SO 2835 01:57:29,944 --> 01:57:31,179 MANY PEOPLE. 2836 01:57:31,179 --> 01:57:33,481 MY GRANDMOTHER DIDN'T TELL ME I 2837 01:57:33,481 --> 01:57:35,249 WAS LIVING WITH HIV UNTIL AFTER 2838 01:57:35,249 --> 01:57:37,352 BOTH MY PARENTS PASSED AWAY. 2839 01:57:37,352 --> 01:57:39,721 SO 1996, THE LAST DAY OF SCHOOL, 2840 01:57:39,721 --> 01:57:44,392 FOURTH GRADE, MY FATHER PASSED 2841 01:57:44,392 --> 01:57:44,726 AWAY. 2842 01:57:44,726 --> 01:57:46,494 THREE MONTHS LATER, LABOR DAY, 2843 01:57:46,494 --> 01:57:50,531 MY MOM PASSED AWAY, GOING TO HER 2844 01:57:50,531 --> 01:57:51,766 FUNERAL FIRST DAY OF FIFTH 2845 01:57:51,766 --> 01:57:52,066 GRADE. 2846 01:57:52,066 --> 01:57:53,935 TWO WEEKS BEFORE MY FRIEND'S 2847 01:57:53,935 --> 01:57:55,269 BIRTHDAY, TWO WEEKS LATER, I WAS 2848 01:57:55,269 --> 01:57:57,572 TOLD I WAS LIVING WITH HIV. 2849 01:57:57,572 --> 01:58:00,274 AS A 9-YEAR-OLD ABOUT TO BE 10 I 2850 01:58:00,274 --> 01:58:08,049 WAS SOMEBODY WHO I WANTED -- 2851 01:58:08,049 --> 01:58:09,717 WARRANTED A BIRTHDAY PARTY, 2852 01:58:09,717 --> 01:58:11,052 DIDN'T UNDERSTAND THE 2853 01:58:11,052 --> 01:58:11,619 COMPLICATIONS, STILL DIDN'T 2854 01:58:11,619 --> 01:58:12,620 UNDERSTAND AT THAT TIME WHY MY 2855 01:58:12,620 --> 01:58:14,989 PARENTS WASN'T ABLE TO TAKE CARE 2856 01:58:14,989 --> 01:58:16,090 OF ME. 2857 01:58:16,090 --> 01:58:20,528 TRYING TO EXPLAIN WHAT HIV WAS 2858 01:58:20,528 --> 01:58:21,662 AT THAT TIME, AND UNDERSTANDING 2859 01:58:21,662 --> 01:58:23,498 WHAT THAT WAS LIKE IN YOUR BODY 2860 01:58:23,498 --> 01:58:25,500 AS A 9-YEAR-OLD WHEN ALL YOU 2861 01:58:25,500 --> 01:58:27,735 WANTED WAS A 10-YEAR-OLD 2862 01:58:27,735 --> 01:58:29,504 BIRTHDAY PARTY WAS SOMETHING 2863 01:58:29,504 --> 01:58:30,705 THAT WAS HARD TO FOLLOW 2864 01:58:30,705 --> 01:58:34,942 ESPECIALLY AT THAT TIME, MY MOM, 2865 01:58:34,942 --> 01:58:37,879 SHE WASN'T ABLE TO GET BURIED, 2866 01:58:37,879 --> 01:58:39,147 WAS CREMATED, DIDN'T EVEN GET TO 2867 01:58:39,147 --> 01:58:41,549 SEE HER ONE LAST TIME. 2868 01:58:41,549 --> 01:58:42,550 THAT WAS SOMETHING THAT REALLY 2869 01:58:42,550 --> 01:58:45,086 TOOK A TOLL ON ME AS A CHILD, 2870 01:58:45,086 --> 01:58:46,821 TRYING TO UNDERSTAND MY STATUS, 2871 01:58:46,821 --> 01:58:48,456 UNDERSTAND WHAT WAS HAPPENING, 2872 01:58:48,456 --> 01:58:50,858 AND THEN ALSO TRYING TO LIVE, 2873 01:58:50,858 --> 01:58:52,393 HOW COULD YOU GIVE AT THAT TIME, 2874 01:58:52,393 --> 01:58:54,996 LIKE HOW COULD YOU KEEP GOING 2875 01:58:54,996 --> 01:58:57,098 WHEN EVERYTHING AROUND YOU FELT 2876 01:58:57,098 --> 01:58:57,799 LIKE DESPAIR. 2877 01:58:57,799 --> 01:59:00,067 EVEN THOUGH I WAS MADE AWARE OF 2878 01:59:00,067 --> 01:59:01,569 MY STATUS I DIDN'T, AGAIN, LIKE 2879 01:59:01,569 --> 01:59:02,503 I SAID I DIDN'T UNDERSTAND, 2880 01:59:02,503 --> 01:59:05,740 DIDN'T KNOW WHAT WAS GOING ON. 2881 01:59:05,740 --> 01:59:07,842 AND IT TOOK ME A COUPLE YEARS 2882 01:59:07,842 --> 01:59:09,710 BEFORE I FULLY GRASPED I WAS 2883 01:59:09,710 --> 01:59:13,114 LIVING WITH HIV. 2884 01:59:13,114 --> 01:59:17,585 AT THAT TIME EVEN GOING TO THE 2885 01:59:17,585 --> 01:59:18,653 CLINIC AND SEEING OTHER KIDS 2886 01:59:18,653 --> 01:59:19,654 DIDN'T KNOW UNTIL AFTER I WAS 2887 01:59:19,654 --> 01:59:21,722 TOLD I WAS LIVING WITH HIV THAT 2888 01:59:21,722 --> 01:59:26,227 OTHER KIDS WERE HIV POSITIVE AS 2889 01:59:26,227 --> 01:59:26,427 WELL. 2890 01:59:26,427 --> 01:59:28,529 AND THOSE WHO KNOW WASN'T 2891 01:59:28,529 --> 01:59:33,034 ALLOWED TO TELL WHAT YOUR STATUS 2892 01:59:33,034 --> 01:59:34,135 WAS BECAUSE THEIR PARENTS DIDN'T 2893 01:59:34,135 --> 01:59:35,136 TELL THEM. 2894 01:59:35,136 --> 01:59:38,072 BY THAT TIME WE LOOKED 2895 01:59:38,072 --> 01:59:39,040 DIFFERENT, NOW YOU'RE THE KID 2896 01:59:39,040 --> 01:59:41,776 GOING TO THE DOCTOR ALL THE 2897 01:59:41,776 --> 01:59:43,010 TIME, MISSING SCHOOL, NOW YOU 2898 01:59:43,010 --> 01:59:45,746 SEE ALL THE OTHER CHILDREN AND 2899 01:59:45,746 --> 01:59:48,449 IT BECAME A LITTLE CLIQUE, TO 2900 01:59:48,449 --> 01:59:50,551 THE POINT WHERE I WANTED TO FIND 2901 01:59:50,551 --> 01:59:53,221 MY PEOPLE, WANTED TO FIND THOSE 2902 01:59:53,221 --> 02:00:00,428 WHO WERE LIVING WITH HIV, BECAME 2903 02:00:00,428 --> 02:00:03,865 VERY EMOTIONAL, VERY DEPRESSED 2904 02:00:03,865 --> 02:00:06,167 JUST WANTED TO FIND SOMETHING 2905 02:00:06,167 --> 02:00:07,368 WHO LOOKED LIKE MY. 2906 02:00:07,368 --> 02:00:08,202 MY SISTERS WERE NEGATIVE. 2907 02:00:08,202 --> 02:00:12,240 I GREW UP IN A RELIGIOUS 2908 02:00:12,240 --> 02:00:13,241 HOUSEHOLD, MY GRANDMOTHER WAS -- 2909 02:00:13,241 --> 02:00:17,044 SHE JUST WANTED ME TO BE HAPPY, 2910 02:00:17,044 --> 02:00:21,549 SO I STARTED GOING TO HIV CAMPS, 2911 02:00:21,549 --> 02:00:23,084 THAT'S WHAT CHANGED MY LIFE TO 2912 02:00:23,084 --> 02:00:25,620 ACTUALLY ACCEPT WHO I AM AS A 2913 02:00:25,620 --> 02:00:27,021 PERSON, LIVING WITH HIV, AND TO 2914 02:00:27,021 --> 02:00:29,757 WANT TO CHANGE AND DO MORE. 2915 02:00:29,757 --> 02:00:32,093 EVEN THOUGH I WENT TO CAMP 2916 02:00:32,093 --> 02:00:35,263 THINGS, I WENT TO GROUP, I STILL 2917 02:00:35,263 --> 02:00:38,099 FELT ALONE BECAUSE EVEN THOUGH 2918 02:00:38,099 --> 02:00:40,968 I'M MAKING THESE FRIENDS, THEY 2919 02:00:40,968 --> 02:00:44,205 KEEP PASSING AWAY. 2920 02:00:44,205 --> 02:00:46,841 AND THAT WAS SOMETHING THAT I 2921 02:00:46,841 --> 02:00:49,277 DIDN'T KNOW HOW TO COPE WITH. 2922 02:00:49,277 --> 02:00:54,048 BECAUSE IN ONE PART, I WAS TOLD 2923 02:00:54,048 --> 02:00:56,584 I AM NON-PROGRESSIVE, HIV WAS 2924 02:00:56,584 --> 02:00:58,386 DIFFERENT, HOW THEY EXPLAINED TO 2925 02:00:58,386 --> 02:00:58,886 ME. 2926 02:00:58,886 --> 02:01:02,290 HIV IS LIKE A TURTLE, SLOW 2927 02:01:02,290 --> 02:01:05,159 MOVING, AND IT DOESN'T CHANGE AS 2928 02:01:05,159 --> 02:01:07,728 RAPIDLY AS EVERYBODY ELSE IS. 2929 02:01:07,728 --> 02:01:08,763 YOU'RE OKAY NOW, YOU KNOW, THE 2930 02:01:08,763 --> 02:01:12,066 COAST IS KIND OF CLEAR. 2931 02:01:12,066 --> 02:01:16,470 THAT'S WHAT I HAD IN MY HEAD 2932 02:01:16,470 --> 02:01:19,540 LIKE 15 AND 16 2933 02:01:19,540 --> 02:01:22,910 BOTTOM DATES, BUT I KEPT GOING 2934 02:01:22,910 --> 02:01:23,644 TO FUNERALS, DIDN'T UNDERSTAND 2935 02:01:23,644 --> 02:01:26,514 WHY THIS WAS MY LIFE, WHY DO WE 2936 02:01:26,514 --> 02:01:29,383 HAVE TO KEEP DYING, WHAT AM I 2937 02:01:29,383 --> 02:01:30,451 MISSING, HOW IS HIV PROGRESSING 2938 02:01:30,451 --> 02:01:32,186 IN THE WORLD WITH ALL THESE 2939 02:01:32,186 --> 02:01:34,622 MEDICAL ADVANCES, MEDICATION IS 2940 02:01:34,622 --> 02:01:39,760 OUT, BUT WE STILL KEEP PASSING 2941 02:01:39,760 --> 02:01:40,194 AWAY? 2942 02:01:40,194 --> 02:01:41,395 SO, NEXT SLIDE. 2943 02:01:41,395 --> 02:01:44,265 I HAVE TO KEEP TRYING TO FIGURE 2944 02:01:44,265 --> 02:01:48,436 IT OUT, WHICH SOME DAYS IT'S SO 2945 02:01:48,436 --> 02:01:48,769 HARD. 2946 02:01:48,769 --> 02:01:52,607 EVEN RIGHT NOW. 2947 02:01:52,607 --> 02:01:56,143 AS A YOUNG ADULT, 2006, THAT WAS 2948 02:01:56,143 --> 02:01:58,546 ONE OF THE HARDEST TIMES FOR ME. 2949 02:01:58,546 --> 02:02:01,616 IT SHOULD HAVE BEEN ONE OF THE 2950 02:02:01,616 --> 02:02:05,519 GREATEST TIMES BECAUSE I CHOSE 2951 02:02:05,519 --> 02:02:06,954 MYSELF, I CHOSE TO DISCLOSE MY 2952 02:02:06,954 --> 02:02:09,590 STATUS HONESTLY TO THE WORLD. 2953 02:02:09,590 --> 02:02:13,861 I WAS SECRETLY DOING HIV WORK IN 2954 02:02:13,861 --> 02:02:16,631 SCHOOL, IN HIGH SCHOOL, AND IT 2955 02:02:16,631 --> 02:02:19,000 WAS SOMETHING THAT I WANTED 2956 02:02:19,000 --> 02:02:22,503 TO -- I WAS LIVING A DOUBLE 2957 02:02:22,503 --> 02:02:23,204 LIFE. 2958 02:02:23,204 --> 02:02:26,207 I HAD HIV POSITIVE KIM WAS WHO 2959 02:02:26,207 --> 02:02:29,610 WAS AN ACTIVIST, ADVOCATE. 2960 02:02:29,610 --> 02:02:31,045 AND THE OTHER HAND, I WAS A 2961 02:02:31,045 --> 02:02:33,547 REGULAR PERSON WHO WANTED TO BE 2962 02:02:33,547 --> 02:02:34,548 THE CHICK THAT LIVES IN THE 2963 02:02:34,548 --> 02:02:37,051 PROJECT THAT JUST WANTED TO KEEP 2964 02:02:37,051 --> 02:02:41,455 GOING, WANTED TO HAVE A NORMAL 2965 02:02:41,455 --> 02:02:42,089 LIFE. 2966 02:02:42,089 --> 02:02:43,591 I WAS STRUGGLING WITH THESE TWO 2967 02:02:43,591 --> 02:02:46,260 WORDS AND IN 2006 DECIDED TO 2968 02:02:46,260 --> 02:02:47,728 COMBINE INTO ONE. 2969 02:02:47,728 --> 02:02:51,065 AND WHEN MY GRANDMOTHER WAS 2970 02:02:51,065 --> 02:02:56,070 SOMEBODY WHO SAW HOW RYAN WHITE 2971 02:02:56,070 --> 02:02:58,739 WAS, HOW THINGS PLAYED OUT, SHE 2972 02:02:58,739 --> 02:02:59,640 WAS SCARED THAT THAT WOULD HAVE 2973 02:02:59,640 --> 02:03:04,145 BEEN MY LIFE IF I CHOSE TO BE 2974 02:03:04,145 --> 02:03:08,649 OPEN WITH IT. 2975 02:03:08,649 --> 02:03:10,184 AND I BEGGED PLEASE LET ME BE 2976 02:03:10,184 --> 02:03:14,155 OPEN, I HAVE NOTHING TO BE 2977 02:03:14,155 --> 02:03:16,257 ASHAMED OF, I WANT TO EDUCATE 2978 02:03:16,257 --> 02:03:18,059 AND DO MORE THAN WHAT I'M DOING. 2979 02:03:18,059 --> 02:03:19,360 SHE GAVE ME HER BLESSING. 2980 02:03:19,360 --> 02:03:22,129 TWO WEEKS LATER SHE GAVE ME HER 2981 02:03:22,129 --> 02:03:24,298 BLESSING, SHE PASSED AWAY. 2982 02:03:24,298 --> 02:03:26,600 AND IT CRIPPLED ME BECAUSE I 2983 02:03:26,600 --> 02:03:28,536 WANTED TO HONOR HER AND THE 2984 02:03:28,536 --> 02:03:30,738 OTHER PART I WANTED TO HONOR 2985 02:03:30,738 --> 02:03:32,707 MYSELF, BUT I CHOSE TO HONOR 2986 02:03:32,707 --> 02:03:35,142 HER, I CHOSE TO TAKE THAT 2987 02:03:35,142 --> 02:03:37,878 BLESSING AND KEEP GOING AND GOT 2988 02:03:37,878 --> 02:03:39,413 DIFFERENT OPPORTUNITIES, 2989 02:03:39,413 --> 02:03:42,717 SOMETHING SHE BEGGED ME TO DO, 2990 02:03:42,717 --> 02:03:46,754 TO CONTINUE. 2991 02:03:46,754 --> 02:03:49,557 , CONTINUE WITH SCHOOL. 2992 02:03:49,557 --> 02:03:51,292 I HAD TO DROP OUT TO TAKE CARE 2993 02:03:51,292 --> 02:03:52,493 OF HER. 2994 02:03:52,493 --> 02:03:57,031 THE SECOND TIME I CAME OUT 2995 02:03:57,031 --> 02:03:58,532 OPENLY AS POSITIVE. 2996 02:03:58,532 --> 02:03:59,734 THE SCHOOL WASN'T RECEPTIVE. 2997 02:03:59,734 --> 02:04:02,703 THIS IS IN 2006. 2998 02:04:02,703 --> 02:04:05,106 MY NEIGHBORHOOD, SOME PEOPLE 2999 02:04:05,106 --> 02:04:07,074 WERE RECEPTIVE, OTHERS WERE 3000 02:04:07,074 --> 02:04:08,809 TRYING TO UNDERSTAND, I KNOW, I 3001 02:04:08,809 --> 02:04:10,578 HAVE MY SISTERS BUT I'M A 3002 02:04:10,578 --> 02:04:12,213 19-YEAR-OLD WHO HAS TO LEARN HOW 3003 02:04:12,213 --> 02:04:14,849 TO PAY BILLS, WHO IS TRYING TO 3004 02:04:14,849 --> 02:04:16,817 UNDERSTAND WHY IS ALL MY FRIENDS 3005 02:04:16,817 --> 02:04:18,586 PASSING AWAY, AND NOW I HAVE TO 3006 02:04:18,586 --> 02:04:20,888 FIGURE OUT HOW DO YOU EVEN PAY 3007 02:04:20,888 --> 02:04:21,355 RENT? 3008 02:04:21,355 --> 02:04:22,189 WHAT IS THIS? 3009 02:04:22,189 --> 02:04:25,392 THIS IS SOMETHING THAT I DIDN'T 3010 02:04:25,392 --> 02:04:26,560 THINK THAT WOULD EVEN HAPPEN. 3011 02:04:26,560 --> 02:04:31,699 LIKE EVERY YEAR I HAD TO -- I 3012 02:04:31,699 --> 02:04:33,501 WAS IN DISBELIEF, THIS IS A NEW 3013 02:04:33,501 --> 02:04:35,436 PART OF ADULTHOOD THAT I NEVER 3014 02:04:35,436 --> 02:04:39,273 THOUGHT THAT I WOULD BE ABLE TO 3015 02:04:39,273 --> 02:04:39,473 REACH. 3016 02:04:39,473 --> 02:04:41,776 AND THAT WAS LIVING A LONG TIME, 3017 02:04:41,776 --> 02:04:43,010 FOR TRYING TO UNDERSTAND HOW DID 3018 02:04:43,010 --> 02:04:44,111 I EVEN GET HERE. 3019 02:04:44,111 --> 02:04:45,479 THE WORLD IS TELLING ME I SHOULD 3020 02:04:45,479 --> 02:04:46,480 HAVE PASSED AWAY. 3021 02:04:46,480 --> 02:04:48,315 NOT ONLY BECAUSE I'M LIVING WITH 3022 02:04:48,315 --> 02:04:49,717 HIV BUT BECAUSE I'M A BLACK 3023 02:04:49,717 --> 02:04:55,222 WOMAN THAT LIVES IN THE HOOD. 3024 02:04:55,222 --> 02:04:56,423 THAT LIVES IN BROOKLYN, 3025 02:04:56,423 --> 02:04:57,858 RESOURCES ARE SCARCE, I'M 3026 02:04:57,858 --> 02:04:59,960 SUPPOSED TO BE UNEDUCATED, 3027 02:04:59,960 --> 02:05:02,396 SUPPOSED TO NOT HAVE ANY KIND OF 3028 02:05:02,396 --> 02:05:04,331 HOPE COMING FROM A DRUNK 3029 02:05:04,331 --> 02:05:09,937 ADDICTED MOM AND MAJORITY OF MY 3030 02:05:09,937 --> 02:05:11,639 FAMILY WHO DABBLE IN DRUGS, MY 3031 02:05:11,639 --> 02:05:12,439 ENVIRONMENT ALONE SHOULD HAVE 3032 02:05:12,439 --> 02:05:13,507 HAD ME CRIPPLED. 3033 02:05:13,507 --> 02:05:15,743 ALSO WITH MY HIV STATUS, I 3034 02:05:15,743 --> 02:05:16,811 SHOULDN'T BE ABLE TO BE THIS 3035 02:05:16,811 --> 02:05:19,446 PERSON THAT I AM RIGHT NOW. 3036 02:05:19,446 --> 02:05:21,882 SO I HAD TO FIND THAT INNER 3037 02:05:21,882 --> 02:05:22,449 STRENGTH. 3038 02:05:22,449 --> 02:05:25,052 A LOT WAS I WAS IN THE RIGHT 3039 02:05:25,052 --> 02:05:27,688 PLACE AT THE RIGHT TIME. 3040 02:05:27,688 --> 02:05:28,989 I ALWAYS HAD PEOPLE WHO BELIEVED 3041 02:05:28,989 --> 02:05:32,927 IN ME, SAW SOMETHING I DIDN'T 3042 02:05:32,927 --> 02:05:35,663 SEE IN MYSELF, SOMETIMES STILL 3043 02:05:35,663 --> 02:05:36,430 STRUGGLE TO SEE. 3044 02:05:36,430 --> 02:05:40,701 I GOT OFFERED TO BE PART OF 3045 02:05:40,701 --> 02:05:43,337 UNICEF, TRAVELED TO AFRICA, THAT 3046 02:05:43,337 --> 02:05:44,872 WAS SOMETHING THAT I NEVER 3047 02:05:44,872 --> 02:05:46,941 THOUGHT, ONE, JUST TO GO TO 3048 02:05:46,941 --> 02:05:49,109 AFRICA, I LIVE IN THE HOOD, 3049 02:05:49,109 --> 02:05:50,778 GOING TO AFRICA WAS LIFE 3050 02:05:50,778 --> 02:05:51,045 CHANGING. 3051 02:05:51,045 --> 02:05:52,413 AND THEN ALSO TO SEE WHAT HIV 3052 02:05:52,413 --> 02:05:54,381 LOOKS LIKE OUT THERE COMPARED TO 3053 02:05:54,381 --> 02:05:56,684 WHAT IT LOOKS LIKE HERE, TO GIVE 3054 02:05:56,684 --> 02:05:58,886 THEM HOPE THAT IT CAN BE BETTER, 3055 02:05:58,886 --> 02:06:02,156 CHANGED MY VIEW OF WHAT HIV 3056 02:06:02,156 --> 02:06:02,489 LOOKS LIKE. 3057 02:06:02,489 --> 02:06:04,558 I WAS SOMEBODY WHO DROPPED OUT 3058 02:06:04,558 --> 02:06:07,528 OF HIGH SCHOOL, NEEDED TO GET A 3059 02:06:07,528 --> 02:06:09,163 GED, OBTAINED IT, AND STARTED 3060 02:06:09,163 --> 02:06:10,598 WORKING HEAD ON WITH IT. 3061 02:06:10,598 --> 02:06:15,202 AS I WAS DOING THIS, I GOT TIRED 3062 02:06:15,202 --> 02:06:18,172 OF MORE FRIENDS PASSED AWAY. 3063 02:06:18,172 --> 02:06:20,608 I WENT TO OVER 50 FUNERALS BY 3064 02:06:20,608 --> 02:06:22,710 THIS TIME. 3065 02:06:22,710 --> 02:06:25,613 I HAD REPORTED -- I HAD A BOX 3066 02:06:25,613 --> 02:06:28,115 THAT RECORDED WHAT MY FUNERAL 3067 02:06:28,115 --> 02:06:29,316 WOULD LOOK LIKE. 3068 02:06:29,316 --> 02:06:31,619 I JUST TOLD THIS TO MY HUSBAND. 3069 02:06:31,619 --> 02:06:40,060 I HAD PICKED OUT THE PERFECT 3070 02:06:40,060 --> 02:06:42,029 FONT OF MY OBITUARY, PICTURES OF 3071 02:06:42,029 --> 02:06:45,766 WHAT I WANTED, PLANNED OUT MY 3072 02:06:45,766 --> 02:06:47,268 FUNERAL SINCE THE AGE OF 14, 3073 02:06:47,268 --> 02:06:50,337 I'VE BEEN HOLDING ON TO THAT 3074 02:06:50,337 --> 02:06:54,909 UNTIL MAYBE FOUR OR FIVE -- NO, 3075 02:06:54,909 --> 02:06:55,709 SIX YEARS AGO. 3076 02:06:55,709 --> 02:06:57,344 AND ONE THING THAT I NEVER 3077 02:06:57,344 --> 02:07:01,148 THOUGHT THAT I WOULD BE ABLE TO 3078 02:07:01,148 --> 02:07:04,385 SEE IS EVEN THE FACT OF HAVING A 3079 02:07:04,385 --> 02:07:05,786 BABY, GETTING MARRIED, I WAS 3080 02:07:05,786 --> 02:07:08,856 TOLD FOR SO LONG NOBODY WOULD 3081 02:07:08,856 --> 02:07:09,523 LOVE US. 3082 02:07:09,523 --> 02:07:12,693 I HEARD STORIES OF PEOPLE NOT 3083 02:07:12,693 --> 02:07:14,194 ONLY GETTING ABUSED BECAUSE OF 3084 02:07:14,194 --> 02:07:15,629 THE STATUS, PEOPLE TAKING 3085 02:07:15,629 --> 02:07:17,564 ADVANTAGE OF THEM, BUT ALSO OF 3086 02:07:17,564 --> 02:07:23,170 THE FACT OF A LOT OF US LOOK AT 3087 02:07:23,170 --> 02:07:25,239 US AS THE STIGMA OF LIVING WITH 3088 02:07:25,239 --> 02:07:27,641 HIV, FEELING YOU'RE NOT WORTHY, 3089 02:07:27,641 --> 02:07:28,742 UNDERSTANDING -- TRYING TO 3090 02:07:28,742 --> 02:07:29,877 UNDERSTAND FOR YOURSELF THAT YOU 3091 02:07:29,877 --> 02:07:32,713 ARE THAT PERSON THAT DESERVES 3092 02:07:32,713 --> 02:07:32,947 LIFE. 3093 02:07:32,947 --> 02:07:39,586 MOVE TO THE NEXT SLIDE. 3094 02:07:39,586 --> 02:07:41,355 OVERCOMING VERSUS GIVING UP, I 3095 02:07:41,355 --> 02:07:43,857 WAS STRUGGLING WHAT TO SAY ON 3096 02:07:43,857 --> 02:07:45,426 THIS SLIDE. 3097 02:07:45,426 --> 02:07:47,728 I FELT THIS IS IMPORTANT BUT 3098 02:07:47,728 --> 02:07:52,866 BEFORE THEN I WAS SOMEBODY WHO 3099 02:07:52,866 --> 02:07:53,968 STRUGGLED WITH MY CONFIDENCE 3100 02:07:53,968 --> 02:07:55,502 BECAUSE -- AND STRUGGLES TO EVEN 3101 02:07:55,502 --> 02:07:57,338 WANT TO CONTINUE TO DO THIS 3102 02:07:57,338 --> 02:07:57,538 WORK. 3103 02:07:57,538 --> 02:08:02,776 THIS WORK IS TIRING, STRESSFUL. 3104 02:08:02,776 --> 02:08:04,178 I'VE BEEN ADVOCATING SINCE AGE 3105 02:08:04,178 --> 02:08:07,381 OF 13, TALKING TO DOCTORS, 3106 02:08:07,381 --> 02:08:10,818 TALKING TO PEOPLE, AND I NEVER 3107 02:08:10,818 --> 02:08:13,821 GOT TO SEE US, THOSE LIVING WITH 3108 02:08:13,821 --> 02:08:17,524 HIV SINCE BIRTH, IN THE FRONT. 3109 02:08:17,524 --> 02:08:20,260 AND IT SEEMS LIKE AFTER FUNDING 3110 02:08:20,260 --> 02:08:21,562 DISAPPEARED PEOPLE STOPPED 3111 02:08:21,562 --> 02:08:22,863 TALKING ABOUT US. 3112 02:08:22,863 --> 02:08:25,766 WE WASN'T IMPORTANT. 3113 02:08:25,766 --> 02:08:27,868 WHEN WE WERE -- WE WERE THE 3114 02:08:27,868 --> 02:08:30,437 EXAMPLE OF WHAT IT WAS AT THAT 3115 02:08:30,437 --> 02:08:31,972 TIME, EARLIER IN THE EPIDEMIC, 3116 02:08:31,972 --> 02:08:33,974 OF WHAT HIV WAS. 3117 02:08:33,974 --> 02:08:36,877 YOU KNOW, WE GOT TO A POINT 3118 02:08:36,877 --> 02:08:38,312 WHERE WE STARTED LIVING AND 3119 02:08:38,312 --> 02:08:40,914 PEOPLE JUST KIND OF IGNORED US. 3120 02:08:40,914 --> 02:08:43,917 AND I WANTED MY LIFE BACK, TO BE 3121 02:08:43,917 --> 02:08:46,120 THE PERSON WHO COULD NOT ONLY BE 3122 02:08:46,120 --> 02:08:47,621 PROUD OF WHO I AM AND DO THIS 3123 02:08:47,621 --> 02:08:49,256 WORK FOR THOSE WHO COULDN'T DO 3124 02:08:49,256 --> 02:08:51,091 THE WORK, I WANTED TO DO IT FOR 3125 02:08:51,091 --> 02:08:52,559 MYSELF, NOT JUST FOR MY FRIENDS 3126 02:08:52,559 --> 02:08:54,595 THAT PASSED AWAY. 3127 02:08:54,595 --> 02:08:56,363 AND I HAD CHOSEN TO DO THAT. 3128 02:08:56,363 --> 02:08:57,331 NEXT SLIDE. 3129 02:08:57,331 --> 02:09:00,701 THAT'S WHAT A LOT OF US HAVE, 3130 02:09:00,701 --> 02:09:02,836 NOT TO GIVE UP. 3131 02:09:02,836 --> 02:09:04,671 THIS IS ME NOW. 3132 02:09:04,671 --> 02:09:07,441 I HAVE A 13-YEAR-OLD TODAY, 3133 02:09:07,441 --> 02:09:09,309 PROBABLY WHY I'M TIRED AND 3134 02:09:09,309 --> 02:09:11,745 DISHEVELED, I CAME BACK FROM MY 3135 02:09:11,745 --> 02:09:14,114 SON'S GRADUATION, AGAIN I WANTED 3136 02:09:14,114 --> 02:09:17,918 TO EMPHASIZE MY SON IS 14, HIV 3137 02:09:17,918 --> 02:09:18,352 NEGATIVE. 3138 02:09:18,352 --> 02:09:19,386 THAT'S SOMETHING I NEVER THOUGHT 3139 02:09:19,386 --> 02:09:20,554 I WOULD BE ABLE TO SEE. 3140 02:09:20,554 --> 02:09:23,524 I NEVER THOUGHT THAT I WOULD BE 3141 02:09:23,524 --> 02:09:26,827 MARRIED TO SOMEBODY WHO ACCEPTS 3142 02:09:26,827 --> 02:09:28,295 ME, NOT BECAUSE OF FEELING BAD 3143 02:09:28,295 --> 02:09:32,966 FOR ME, BECAUSE I HAVE HIV, BUT 3144 02:09:32,966 --> 02:09:34,701 BECAUSE HE SEES ME, FOR A CHILD 3145 02:09:34,701 --> 02:09:37,871 TO BE HEALTHY, FOR US TO -- 3146 02:09:37,871 --> 02:09:44,545 13,000 OF US RIGHT NOW, LIFETIME 3147 02:09:44,545 --> 02:09:47,714 SURVIVORS, A HUGE NUMBER FOR US. 3148 02:09:47,714 --> 02:09:50,484 WE'RE STILL HERE. 3149 02:09:50,484 --> 02:09:54,321 BUT I HAVE OUR OWN BUSINESS, 3150 02:09:54,321 --> 02:09:55,989 EVERY DAY IT'S EASIER TO KNOW 3151 02:09:55,989 --> 02:09:58,258 THAT I HAVE A PURPOSE, BUT IT'S 3152 02:09:58,258 --> 02:10:01,862 STILL HARD BECAUSE PEOPLE ARE 3153 02:10:01,862 --> 02:10:02,963 STILL DYING, AND NOBODY IS 3154 02:10:02,963 --> 02:10:03,630 TALKING ABOUT THAT. 3155 02:10:03,630 --> 02:10:06,700 WE TALK ABOUT IT FOR FIVE 3156 02:10:06,700 --> 02:10:08,001 MINUTES AND IT DISAPPEARS. 3157 02:10:08,001 --> 02:10:11,071 NOTHING ELSE HAPPENS. 3158 02:10:11,071 --> 02:10:11,605 NEXT SLIDE. 3159 02:10:11,605 --> 02:10:14,441 THIS IS ME AGAIN WITH ME, MY 3160 02:10:14,441 --> 02:10:19,847 FAMILY, THIS IS ME WITH THE HIV 3161 02:10:19,847 --> 02:10:22,382 CAMPAIGN WHERE I'VE BEEN A 3162 02:10:22,382 --> 02:10:25,452 SPOKESPERSON FOR ABOUT 12 YEARS. 3163 02:10:25,452 --> 02:10:27,821 WE ARE EDUCATING THOSE THAT LIVE 3164 02:10:27,821 --> 02:10:29,790 WITH HIV TO STAY ON TREATMENT, 3165 02:10:29,790 --> 02:10:31,558 WHATEVER TREATMENT LOOKS LIKE 3166 02:10:31,558 --> 02:10:34,928 FOR YOU, EDUCATE OTHERS, MY SON 3167 02:10:34,928 --> 02:10:36,797 HAS A FOOTBALL BANQUET, PART OF 3168 02:10:36,797 --> 02:10:42,936 MY NORMAL LIFE, I'M NOT TALKING 3169 02:10:42,936 --> 02:10:45,105 ABOUT ME LIVING WITH HIV, AND 3170 02:10:45,105 --> 02:10:48,275 THE WELL PROJECT, THAT HELPS 3171 02:10:48,275 --> 02:10:52,646 WOMEN LIVING WITH HIV, THE 3172 02:10:52,646 --> 02:10:56,183 WEBSITE THE WELLPROJECT.ORG. 3173 02:10:56,183 --> 02:11:01,555 NEXT SLIDE. 3174 02:11:01,555 --> 02:11:05,125 SO DANDELION MOVEMENT, TAKING 3175 02:11:05,125 --> 02:11:06,226 OWNERSHIP, NOT WANTING TO GIVE 3176 02:11:06,226 --> 02:11:10,964 UP, I WASN'T THE ONLY ONE. 3177 02:11:10,964 --> 02:11:12,900 VALENCIA WILLIAMS AND ANTOINETTE 3178 02:11:12,900 --> 02:11:14,101 JONES WERE CO-FOUNDERS. 3179 02:11:14,101 --> 02:11:20,674 LAST YEAR EVERYBODY HAS BEEN 3180 02:11:20,674 --> 02:11:24,878 HEARING, WE WANTED A NAME THAT 3181 02:11:24,878 --> 02:11:29,349 WE CAN OPENED BY US, WE CREATED. 3182 02:11:29,349 --> 02:11:35,155 BASED OFF OF A POEM, WE CAME UP 3183 02:11:35,155 --> 02:11:36,790 WITH THIS NAME DANDELIONS FOR 3184 02:11:36,790 --> 02:11:37,824 ALL OF US. 3185 02:11:37,824 --> 02:11:40,294 TWO YEARS AGO, MAYBE THREE YEARS 3186 02:11:40,294 --> 02:11:42,796 AGO, CAME ONE THE NAME LIFETIME 3187 02:11:42,796 --> 02:11:43,564 SURVIVORS, WE'VE BEEN TELLING 3188 02:11:43,564 --> 02:11:45,866 EVERYBODY THIS IS WHO WE ARE. 3189 02:11:45,866 --> 02:11:52,105 CALL US BY THAT NAME. 3190 02:11:52,105 --> 02:11:54,374 AND TIFFANY PASSED AWAY LAST 3191 02:11:54,374 --> 02:11:58,979 YEAR, INTEGRAL AT THE INCEPTION 3192 02:11:58,979 --> 02:12:00,881 OF THE MOVEMENT, PEOPLE BORN 3193 02:12:00,881 --> 02:12:02,482 POSITIVE, NOT JUST A NAME FOR 3194 02:12:02,482 --> 02:12:04,117 EVERYBODY TO USE AS A RESEARCHER 3195 02:12:04,117 --> 02:12:05,686 BUT FOR A MOVEMENT THAT YOU CAN 3196 02:12:05,686 --> 02:12:06,553 SUPPORT AS WELL. 3197 02:12:06,553 --> 02:12:10,691 THAT'S FOR US, BY US. 3198 02:12:10,691 --> 02:12:12,025 NEXT SLIDE. 3199 02:12:12,025 --> 02:12:15,963 WHAT IS CURRENTLY IMPLEMENTED 3200 02:12:15,963 --> 02:12:17,164 AND REQUIRES IMPROVEMENT? 3201 02:12:17,164 --> 02:12:24,171 TIME RIGHT NOW I WANTED TO 3202 02:12:24,171 --> 02:12:24,671 HIGHLIGHT BREASTFEEDING 3203 02:12:24,671 --> 02:12:28,442 ADVANCES, GUIDELINES FOR CHANGE. 3204 02:12:28,442 --> 02:12:29,543 THE PROJECT, A LOT OF PEOPLE 3205 02:12:29,543 --> 02:12:32,012 HAVE BEEN PART OF THE 3206 02:12:32,012 --> 02:12:32,579 BREASTFEEDING ADVANCES, AND 3207 02:12:32,579 --> 02:12:43,123 ESPECIALLY I WANTED TO SHOUT OUT 3208 02:12:44,958 --> 02:12:48,629 WHO WAS A BIG PART OF THIS. 3209 02:12:48,629 --> 02:12:54,768 NEXT SLIDE, WHAT NEEDS TO 3210 02:12:54,768 --> 02:12:55,435 HAPPEN. 3211 02:12:55,435 --> 02:12:57,170 THERE'S NOTHING SPECIFIC TO LIFE 3212 02:12:57,170 --> 02:12:58,939 STIME SURVIVORS AND OUR 3213 02:12:58,939 --> 02:13:00,707 CHILDREN, ALSO THERE NEEDS TO BE 3214 02:13:00,707 --> 02:13:07,914 FUNDING -- I WOULD LOVE FUNDING 3215 02:13:07,914 --> 02:13:12,352 NAMED AFTER HYDEIA BROADBENT WHO 3216 02:13:12,352 --> 02:13:13,854 RECENTLY PASSED AWAY THIS YEAR, 3217 02:13:13,854 --> 02:13:16,823 A HIT IN OUR COMMUNITY. 3218 02:13:16,823 --> 02:13:18,892 AND WE KEEP TAKING THESE HITS, 3219 02:13:18,892 --> 02:13:21,328 OVER AND OVER AND OVER AGAIN. 3220 02:13:21,328 --> 02:13:25,465 AND I HOPE THAT WE CAN START 3221 02:13:25,465 --> 02:13:29,603 LISTENING TO WHAT'S HAPPENING. 3222 02:13:29,603 --> 02:13:36,176 AND WHAT ELSE NEEDS TO BE DONE? 3223 02:13:36,176 --> 02:13:36,843 ACKNOWLEDGMENT. 3224 02:13:36,843 --> 02:13:38,045 RIGHT NOW, JUST BY HAVING ME 3225 02:13:38,045 --> 02:13:43,550 HERE IS A HUGE STEP. 3226 02:13:43,550 --> 02:13:46,486 AND EVERYTHING IS A HUGE STEP. 3227 02:13:46,486 --> 02:13:47,321 BEFORE THIS YEAR, BEFORE ALL OF 3228 02:13:47,321 --> 02:13:51,558 US WENT ON THAT STAGE AT USC 3229 02:13:51,558 --> 02:13:54,828 LAST YEAR YOU HEARD ANYBODY 3230 02:13:54,828 --> 02:13:58,665 TALKING ABOUT LIFETIME 3231 02:13:58,665 --> 02:13:59,733 SURVIVORS, THERE WAS WHISPERS, 3232 02:13:59,733 --> 02:14:02,703 WHAT CAN I DO, AND IT 3233 02:14:02,703 --> 02:14:03,670 DISAPPEARED. 3234 02:14:03,670 --> 02:14:06,973 RIGHT NOW THIS IS WHERE WE 3235 02:14:06,973 --> 02:14:07,741 STARTED. 3236 02:14:07,741 --> 02:14:11,078 EVEN TO SOMETHING AS RECOGNIZING 3237 02:14:11,078 --> 02:14:12,546 LONG-TERM SURVIVORS, YES, WE'RE 3238 02:14:12,546 --> 02:14:13,180 LIFETIME SURVIVORS. 3239 02:14:13,180 --> 02:14:14,981 WE'VE HAD IT FOR A LIFETIME. 3240 02:14:14,981 --> 02:14:17,517 BUT THERE'S MANY CASES WHERE WE 3241 02:14:17,517 --> 02:14:19,252 ARE IN SPACES, WHERE PEOPLE ARE 3242 02:14:19,252 --> 02:14:22,622 SAYING BECAUSE OF OUR AGE, 3243 02:14:22,622 --> 02:14:24,691 BECAUSE WE'RE YOUNG, THEY DO NOT 3244 02:14:24,691 --> 02:14:28,428 LOOK AT US AS A LONGTIME EVEN 3245 02:14:28,428 --> 02:14:29,363 THOUGH WE'RE LIVING WITH THE 3246 02:14:29,363 --> 02:14:31,231 VIRUS OUR WHOLE LIFE. 3247 02:14:31,231 --> 02:14:39,272 FUNDING FOR PROGRAMS FOR 3248 02:14:39,272 --> 02:14:41,441 LIFETIME SURVIVORS FOR 3249 02:14:41,441 --> 02:14:45,178 PROTECTION, WE DON'T FEEL 3250 02:14:45,178 --> 02:14:45,912 PROTECTED. 3251 02:14:45,912 --> 02:14:48,782 WHEN IT COMES TO GROUP THERAPY, 3252 02:14:48,782 --> 02:14:50,217 A LOT IS GONE. 3253 02:14:50,217 --> 02:14:53,286 WE DON'T HAVE THE RESEARCH, AND 3254 02:14:53,286 --> 02:14:55,689 I DON'T EVEN KNOW -- NEXT SLIDE, 3255 02:14:55,689 --> 02:15:02,996 WE CAN GO OVER THE RESEARCH FOR 3256 02:15:02,996 --> 02:15:04,398 LIFETIME SURVIVORS, WHAT'S 3257 02:15:04,398 --> 02:15:04,631 MISSING. 3258 02:15:04,631 --> 02:15:07,768 THERE IS A FEW PIECES OF 3259 02:15:07,768 --> 02:15:10,370 RESEARCH THAT'S AROUND US, BUT 3260 02:15:10,370 --> 02:15:11,471 NOT A LOT. 3261 02:15:11,471 --> 02:15:16,610 MAYBE TWO, THESE TWO RIGHT HERE. 3262 02:15:16,610 --> 02:15:19,246 SOME ARE UP COMING BUT HIV OUT 3263 02:15:19,246 --> 02:15:22,382 FOR OVER 40 YEARS, I'M ABOUT TO 3264 02:15:22,382 --> 02:15:24,684 BE 38 IN DECEMBER, THIS IS ALL 3265 02:15:24,684 --> 02:15:26,853 THE RESEARCH OUT RIGHT NOW, AND 3266 02:15:26,853 --> 02:15:28,422 RIGHT NOW AS FAR AS THE FACT 3267 02:15:28,422 --> 02:15:31,725 THAT WE'RE GRIEVING EVERY DAY OF 3268 02:15:31,725 --> 02:15:34,728 THE LOSSES, I'M HOLDING MY 3269 02:15:34,728 --> 02:15:34,961 BREATH. 3270 02:15:34,961 --> 02:15:36,396 EVERY TIME WE HAVE A LOSS OF 3271 02:15:36,396 --> 02:15:41,201 SOMEBODY IN OUR COMMUNITY, IT'S 3272 02:15:41,201 --> 02:15:42,636 A HIT. 3273 02:15:42,636 --> 02:15:45,605 SOMETHING WHERE I FEEL THE 3274 02:15:45,605 --> 02:15:46,740 RESPONSIBILITY WAS DROPPED. 3275 02:15:46,740 --> 02:15:50,110 LIKE THE PRIORITY OF WHO WE WERE 3276 02:15:50,110 --> 02:15:52,312 DROPPED THE BALL A LONG TIME 3277 02:15:52,312 --> 02:15:53,046 AGO. 3278 02:15:53,046 --> 02:15:54,481 AND WHY SHOULD YOU CARE ABOUT 3279 02:15:54,481 --> 02:15:54,781 US? 3280 02:15:54,781 --> 02:15:56,450 IT'S THE PUBLIC'S 3281 02:15:56,450 --> 02:15:56,817 RESPONSIBILITY. 3282 02:15:56,817 --> 02:15:58,618 AGAIN, WE WERE THE BABIES. 3283 02:15:58,618 --> 02:16:01,755 NOW WE'RE GOING TO BE IN ANOTHER 3284 02:16:01,755 --> 02:16:02,556 TEN YEARS THE NEXT GENERATION 3285 02:16:02,556 --> 02:16:08,094 THAT'S GOING TO BE AGING WITH 3286 02:16:08,094 --> 02:16:09,296 HIV, WE'VE BEEN AGING WITH HIV 3287 02:16:09,296 --> 02:16:11,298 BUT PAST THE STANDARD OF WHAT 3288 02:16:11,298 --> 02:16:13,133 PEOPLE WOULD LIKE TO ACTUALLY 3289 02:16:13,133 --> 02:16:16,369 ACKNOWLEDGE OF AGING WITH HIV, 3290 02:16:16,369 --> 02:16:19,806 THOSE OVER 50, THAT WILL BE US 3291 02:16:19,806 --> 02:16:21,541 IN THE NEXT TEN YEARS. 3292 02:16:21,541 --> 02:16:27,347 WILL THERE BE RESEARCH, WILL 3293 02:16:27,347 --> 02:16:30,417 ANYBODY CARE FOR US. 3294 02:16:30,417 --> 02:16:30,917 WE'RE NEVER PRIORITIZED. 3295 02:16:30,917 --> 02:16:31,618 WE HAVEN'T BEEN PRIORITIZED IN 3296 02:16:31,618 --> 02:16:35,222 THE WAY WE SHOULD HAVE BEEN 3297 02:16:35,222 --> 02:16:35,655 PRIORITIZED. 3298 02:16:35,655 --> 02:16:39,059 THAT'S SOMETHING THAT NEEDS TO 3299 02:16:39,059 --> 02:16:41,561 CHANGE MOVING FORWARD. 3300 02:16:41,561 --> 02:16:42,362 NEXT SLIDE. 3301 02:16:42,362 --> 02:16:43,663 THANK YOU. 3302 02:16:43,663 --> 02:16:47,167 I DIDN'T WANT TO -- I KNOW THE 3303 02:16:47,167 --> 02:16:48,502 TIME IS GEARING UP, I DIDN'T 3304 02:16:48,502 --> 02:16:52,539 WANT TO FOCUS ON CERTAIN THINGS 3305 02:16:52,539 --> 02:16:58,044 BUT I DID WANT TO SAY I 3306 02:16:58,044 --> 02:17:00,447 SHOULDN'T HAVE BEEN 50 PEOPLE IN 3307 02:17:00,447 --> 02:17:04,518 MY LIFE, THOSE WHO ARE BORN 3308 02:17:04,518 --> 02:17:06,653 POSITIVE, IT'S A SAD NUMBER. 3309 02:17:06,653 --> 02:17:07,787 MY EXPERIENCE OF CHANGE, WHO I 3310 02:17:07,787 --> 02:17:09,422 AM, HOW I DO THIS WORK, HOW I 3311 02:17:09,422 --> 02:17:13,059 SHOW UP FOR MY PEOPLE, IT'S VERY 3312 02:17:13,059 --> 02:17:15,028 HARD TO TELL MY STORY BECAUSE 3313 02:17:15,028 --> 02:17:17,397 I'M PAST THAT IN MY LIFE, AND TO 3314 02:17:17,397 --> 02:17:20,267 OPEN UP THE SPACE FOR A PART OF 3315 02:17:20,267 --> 02:17:22,269 ME WHERE IT'S VULNERABLE, 3316 02:17:22,269 --> 02:17:24,070 BECAUSE I FEEL THAT I'M A 3317 02:17:24,070 --> 02:17:26,706 STRONGER PERSON NOW THAN WHEN I 3318 02:17:26,706 --> 02:17:28,008 WAS 19, 20, REALLY IN THE HEAT 3319 02:17:28,008 --> 02:17:30,343 OF IT. 3320 02:17:30,343 --> 02:17:33,046 EVEN AT THAT TIME I FELT LIKE 3321 02:17:33,046 --> 02:17:33,980 NOBODY HEARD ME. 3322 02:17:33,980 --> 02:17:37,851 I HOPE THAT AFTER THIS 3323 02:17:37,851 --> 02:17:40,053 PRESENTATION SOMEBODY IN THIS 3324 02:17:40,053 --> 02:17:42,122 ROOM, ON THIS CALL, HEARD THIS, 3325 02:17:42,122 --> 02:17:44,658 THIS IS A MATTER THAT SHOULDN'T 3326 02:17:44,658 --> 02:17:45,659 BE FORGOTTEN. 3327 02:17:45,659 --> 02:17:51,531 WE SHOULDN'T BE FORGOTTEN IN THE 3328 02:17:51,531 --> 02:17:51,798 EPIDEMIC. 3329 02:17:51,798 --> 02:17:52,532 THANK YOU FOR LISTENING. 3330 02:17:52,532 --> 02:18:01,608 I THINK IT'S TIME FOR QUESTIONS 3331 02:18:01,608 --> 02:18:04,878 >> I THANK YOU BOTH. 3332 02:18:04,878 --> 02:18:09,182 THANK YOU BOTH FOR YOUR 3333 02:18:09,182 --> 02:18:10,283 INSIGHTFUL AND POWERFUL 3334 02:18:10,283 --> 02:18:10,850 PRESENTATIONS. 3335 02:18:10,850 --> 02:18:13,887 WE NOW HAVE TIME FOR OPEN 3336 02:18:13,887 --> 02:18:15,288 DISCUSSION REGARDING THIS ISSUE. 3337 02:18:15,288 --> 02:18:18,625 DR. GLENSHAW AND I ARE GOING TO 3338 02:18:18,625 --> 02:18:20,594 MODERATE THIS DISCUSSION. 3339 02:18:20,594 --> 02:18:23,063 STARTING WITH THE MEMBERS ON THE 3340 02:18:23,063 --> 02:18:24,097 ZOOM CALL. 3341 02:18:24,097 --> 02:18:25,899 SO PLEASE RAISE YOUR HAND WHEN 3342 02:18:25,899 --> 02:18:36,343 YOU WANT TO PARTICIPATE. 3343 02:18:37,611 --> 02:18:38,078 DR. MONTANER? 3344 02:18:38,078 --> 02:18:41,715 >> I THANK DR. MARTINS AND 3345 02:18:41,715 --> 02:18:44,084 MS. CANADY FOR IMPRESSIVE AND 3346 02:18:44,084 --> 02:18:44,818 INSIGHTFUL PRESENTATIONS THAT 3347 02:18:44,818 --> 02:18:47,854 LEAVES A LOT FOR US TO THINK 3348 02:18:47,854 --> 02:18:48,221 ABOUT. 3349 02:18:48,221 --> 02:18:52,859 DR. MARTINS, THE DATA YOU SHOWED 3350 02:18:52,859 --> 02:18:54,861 IS REALLY INCREDIBLE, INCREDIBLY 3351 02:18:54,861 --> 02:18:58,164 ENCOURAGING FOR THE STRATEGY 3352 02:18:58,164 --> 02:18:59,766 OVERALL AND THE IMPRESSIVE 3353 02:18:59,766 --> 02:19:01,635 CONTROL THAT YOU HAVE 3354 02:19:01,635 --> 02:19:02,002 DOCUMENTED. 3355 02:19:02,002 --> 02:19:05,538 I WANTED TO LEARN MORE ABOUT HOW 3356 02:19:05,538 --> 02:19:07,140 YOU ANTICIPATE THIS MOVING 3357 02:19:07,140 --> 02:19:07,540 FORWARD. 3358 02:19:07,540 --> 02:19:10,677 FIRST QUESTION IS, YOU MENTIONED 3359 02:19:10,677 --> 02:19:12,946 THERE WAS HIGH LEVEL OF IMMUNITY 3360 02:19:12,946 --> 02:19:16,516 IN THE ADULTS, SO DO YOU 3361 02:19:16,516 --> 02:19:20,920 ANTICIPATE THIS STRATEGY WOULD 3362 02:19:20,920 --> 02:19:30,630 SORT OF HOLD CLAUSTRUM UNTIL 3363 02:19:30,630 --> 02:19:32,499 UNTIL BREAST FEEDING AND RESUME, 3364 02:19:32,499 --> 02:19:36,870 HAVE SUME, 3365 02:19:36,870 --> 02:19:41,274 HAVE TO MANAGE THE BREASTFEEDING 3366 02:19:41,274 --> 02:19:43,043 IN RELATION TO IMMUNITY? 3367 02:19:43,043 --> 02:19:44,744 >> REGARDING BREASTFEEDING AND 3368 02:19:44,744 --> 02:19:45,578 PREEXISTING IMMUNITY, THERE ARE 3369 02:19:45,578 --> 02:19:48,281 TWO COMPONENTS THAT MUST BE 3370 02:19:48,281 --> 02:19:51,017 DIFFERENTIATED, YES, AND WE TALK 3371 02:19:51,017 --> 02:19:55,255 ABOUT PREEXISTING IMMUNITY INTO 3372 02:19:55,255 --> 02:19:59,359 AAV, AND BABIES, THEY CAN BE 3373 02:19:59,359 --> 02:20:05,699 BORN WITH MATERNAL ANTIBODIES 3374 02:20:05,699 --> 02:20:07,467 THAT TARGET THE AAV VECTOR WHICH 3375 02:20:07,467 --> 02:20:09,502 CAN INTERFERE WITH THIS APPROACH 3376 02:20:09,502 --> 02:20:10,503 BUT AS MATERNAL ANTIBODIES WANE 3377 02:20:10,503 --> 02:20:11,871 OVER TIME WE BELIEVE THIS IS 3378 02:20:11,871 --> 02:20:15,008 STILL TO BE IDENTIFIED, THERE 3379 02:20:15,008 --> 02:20:18,511 MAY BE A SWEET SPOT, WINDOW OF 3380 02:20:18,511 --> 02:20:19,512 OPPORTUNITY, WHERE WHEN THE 3381 02:20:19,512 --> 02:20:23,483 MATERNAL ANTIBODIES HAVE CLEARED 3382 02:20:23,483 --> 02:20:26,086 FROM THE BABY'S CIRCULATION 3383 02:20:26,086 --> 02:20:29,389 ALLOWING THEN THIS CHILD TO 3384 02:20:29,389 --> 02:20:32,592 RECEIVE THE VECTORS WITHOUT 3385 02:20:32,592 --> 02:20:34,761 INTERFERENCE, AN ONGOING AREA OF 3386 02:20:34,761 --> 02:20:36,062 EXPLORATION IN MY LAB, WE HOPE 3387 02:20:36,062 --> 02:20:40,066 TO HAVE DATA SOON. 3388 02:20:40,066 --> 02:20:43,303 THE OTHER ASPECT, WHEN HOSTS 3389 02:20:43,303 --> 02:20:47,240 REACT TO THE AAV ENCODED 3390 02:20:47,240 --> 02:20:49,209 bNAb, YES, THESE RESPONSES 3391 02:20:49,209 --> 02:20:51,111 WITH SIGNIFICANTLY LESS COMMON 3392 02:20:51,111 --> 02:20:52,746 IN INFANTS THAN ADULTS WHICH I 3393 02:20:52,746 --> 02:20:55,715 BELIEVE COULD MAKE THIS 3394 02:20:55,715 --> 02:20:59,953 PARTICULARLY USEFUL FOR TREATING 3395 02:20:59,953 --> 02:21:01,087 PEDIATRIC HIV INFECTIONS. 3396 02:21:01,087 --> 02:21:03,389 >> WITH REGARDS TO CONTROL IN 3397 02:21:03,389 --> 02:21:07,293 THOSE CASES WHERE YOU TREATED 3398 02:21:07,293 --> 02:21:09,562 AFTER INFECTION, DID YOU -- HAVE 3399 02:21:09,562 --> 02:21:11,998 YOU HAD OPPORTUNITY TO DEPLETE 3400 02:21:11,998 --> 02:21:14,901 CD8 OR CONFIRM THIS IS ANTIBODY 3401 02:21:14,901 --> 02:21:16,236 MEDIATED CONTROL AND WHEN IT 3402 02:21:16,236 --> 02:21:17,670 COMMENTS TO THE WORD CONTROL ARE 3403 02:21:17,670 --> 02:21:20,006 YOU ALSO ABLE TO REDUCE 3404 02:21:20,006 --> 02:21:21,474 PERSISTENT VIRUS OR DO YOU 3405 02:21:21,474 --> 02:21:25,745 INTERPRET THIS TO BE A LONG-TERM 3406 02:21:25,745 --> 02:21:26,846 CONTROL SCENARIO? 3407 02:21:26,846 --> 02:21:30,717 >> YES, WE HAVE PERFORMED CD8 3408 02:21:30,717 --> 02:21:32,418 DEPLETIONS, WE HAVE SEEN NO 3409 02:21:32,418 --> 02:21:36,623 REBOUND IN CONTEXT OF CD 8 3410 02:21:36,623 --> 02:21:40,093 DEPLETIONS, PERFORMED IgG 3411 02:21:40,093 --> 02:21:44,197 DEPLETIONS USING ANTIBODY, AND 3412 02:21:44,197 --> 02:21:45,698 THEREFORE ACCELERATES 3413 02:21:45,698 --> 02:21:46,299 CATABOLISM. 3414 02:21:46,299 --> 02:21:50,637 AS ANTIBODIES GO DOWN WE SEE 3415 02:21:50,637 --> 02:21:51,971 VIRUS RECORD ESSENCE, ACCURACY 3416 02:21:51,971 --> 02:21:53,940 DEPENDS ON PERSISTENT EXPRESSION 3417 02:21:53,940 --> 02:21:56,109 OF MOLECULES WHICH ADDRESSED 3418 02:21:56,109 --> 02:21:58,611 YOUR SECOND QUESTION, THAT THIS 3419 02:21:58,611 --> 02:22:01,214 IS PROBABLY SOMETHING -- THIS IS 3420 02:22:01,214 --> 02:22:03,583 ONGOING CONTROL OF THE VIRUS. 3421 02:22:03,583 --> 02:22:11,024 HOWEVER, WE MUST REMEMBER THAT 3422 02:22:11,024 --> 02:22:14,761 ANTIBODIES DIFFER FROM 3423 02:22:14,761 --> 02:22:16,629 ANTIRETROVIRAL DRUGS, FUNCTION 3424 02:22:16,629 --> 02:22:20,500 IN FC COMPONENTS THAT ENABLE 3425 02:22:20,500 --> 02:22:22,969 THEM TO KILL HIV CELLS, WE'RE 3426 02:22:22,969 --> 02:22:24,704 EXPLAINING TO EXPLORE OVER TIME 3427 02:22:24,704 --> 02:22:29,742 TO SEE IF WE CAN EFFECT 3428 02:22:29,742 --> 02:22:32,145 SIGNIFICANT REDUCTION IN 3429 02:22:32,145 --> 02:22:39,953 RESERVOIRS THROUGH FCF FUNCTIONS 3430 02:22:39,953 --> 02:22:40,353 DESCRIBED. 3431 02:22:40,353 --> 02:22:41,020 >> TO MISS CANADAY. 3432 02:22:41,020 --> 02:22:43,089 THANK YOU FOR SHARING YOUR LIFE 3433 02:22:43,089 --> 02:22:43,456 EXPERIENCE. 3434 02:22:43,456 --> 02:22:44,424 WE HEAR YOU WELL. 3435 02:22:44,424 --> 02:22:46,593 THE REASON YOU'RE HERE, IT IS AN 3436 02:22:46,593 --> 02:22:49,562 IMPORTANT GROUP OF PEOPLE THAT 3437 02:22:49,562 --> 02:22:53,099 NEED TO BE INCLUDED IN THE 3438 02:22:53,099 --> 02:22:56,135 PLANNING AND IN THE FUTURE 3439 02:22:56,135 --> 02:22:57,170 INTERVENTIONS THAT HOPEFULLY 3440 02:22:57,170 --> 02:22:58,438 WOULD COME OUT OF THE STRATEGIC 3441 02:22:58,438 --> 02:23:01,608 PLAN THAT WE JUST DISCUSSED IS 3442 02:23:01,608 --> 02:23:06,079 GOING TO BE CRAFTED AS WELL AS 3443 02:23:06,079 --> 02:23:08,081 INCREASING AMOUNT OF ATTENTION 3444 02:23:08,081 --> 02:23:10,350 IN RESEARCH AROUND PERINATAL 3445 02:23:10,350 --> 02:23:14,854 INFECTION, JUST AS YOU HEARD 3446 02:23:14,854 --> 02:23:19,192 FROM ONE OF THE LABORATORIES 3447 02:23:19,192 --> 02:23:20,260 FOCUSED ON PERINATAL, AND SO 3448 02:23:20,260 --> 02:23:22,929 LASTLY I WANT TO SAY THAT YOU'RE 3449 02:23:22,929 --> 02:23:24,063 INCREDIBLY, YOU KNOW, COURAGEOUS 3450 02:23:24,063 --> 02:23:27,000 AND BRAVE TO SHARE YOUR STORY 3451 02:23:27,000 --> 02:23:29,969 AND YOU REALLY SPEAK VOLUMES OF 3452 02:23:29,969 --> 02:23:32,038 TAKING DOWN THE STIGMA AND BEING 3453 02:23:32,038 --> 02:23:33,740 AN EXAMPLE FOR OTHERS TO LOOK AT 3454 02:23:33,740 --> 02:23:35,708 YOUR LIFE EXPERIENCE AND FEEL 3455 02:23:35,708 --> 02:23:36,876 EMPOWERED BY YOUR STORY SO THANK 3456 02:23:36,876 --> 02:23:38,878 YOU FOR SHARING IT AND I HOPE 3457 02:23:38,878 --> 02:23:41,047 MANY MORE PEOPLE GET TO HEAR 3458 02:23:41,047 --> 02:23:41,381 YOU. 3459 02:23:41,381 --> 02:23:44,651 >> THANK YOU. 3460 02:23:44,651 --> 02:23:46,552 3461 02:23:46,552 --> 02:23:46,953 >> DR. ABRAMS. 3462 02:23:46,953 --> 02:23:52,625 >> YES, THANKS SO MUCH. 3463 02:23:52,625 --> 02:23:54,394 AND KIMBERLY, I WANT TO ALSO 3464 02:23:54,394 --> 02:23:57,764 EXPRESS MY APPRECIATION FOR YOUR 3465 02:23:57,764 --> 02:24:00,533 STORY, FOR YOUR WILLINGNESS TO 3466 02:24:00,533 --> 02:24:01,801 GET OUT THERE AFTER ALL THESE 3467 02:24:01,801 --> 02:24:03,202 YEARS AND SHARE WITH US. 3468 02:24:03,202 --> 02:24:06,306 I KNOW THAT THERE ARE LOTS OF -- 3469 02:24:06,306 --> 02:24:10,443 SIMILAR CONVERSATIONS ARE TAKING 3470 02:24:10,443 --> 02:24:12,278 PLACE IN DIFFERENT SPACES, 3471 02:24:12,278 --> 02:24:16,049 THERE'S A LAB AT HOWARD 3472 02:24:16,049 --> 02:24:17,817 UNIVERSITY, WHERE YOUNG PEOPLE 3473 02:24:17,817 --> 02:24:19,252 WITH PERINATAL INFECTION ARE 3474 02:24:19,252 --> 02:24:20,687 TALKING ABOUT THESE THINGS, THE 3475 02:24:20,687 --> 02:24:22,722 AIDS INSTITUTE IN NEW YORK. 3476 02:24:22,722 --> 02:24:25,458 I WAS WANTED TO BOTH ENCOURAGE 3477 02:24:25,458 --> 02:24:28,428 YOU AND ASK YOUR OPINION ABOUT 3478 02:24:28,428 --> 02:24:32,598 HOW DO WE HARNESS THESE 3479 02:24:32,598 --> 02:24:34,367 CONVERSATIONS TO BEGIN TO INFORM 3480 02:24:34,367 --> 02:24:35,234 A RESEARCH AGENDA PARTICULARLY 3481 02:24:35,234 --> 02:24:39,505 IN THE CONTEXT OF WHERE WE ARE 3482 02:24:39,505 --> 02:24:41,808 TODAY IN THIS MEETING, BECAUSE 3483 02:24:41,808 --> 02:24:42,942 THERE ARE DEFINITELY CARE 3484 02:24:42,942 --> 02:24:45,411 OBJECTIVES BUT I THINK THERE'S A 3485 02:24:45,411 --> 02:24:46,679 CLEAR SET OF RESEARCH QUESTIONS 3486 02:24:46,679 --> 02:24:52,719 THAT NEED TO BE ADDRESSED, AND 3487 02:24:52,719 --> 02:24:55,355 UNDERSTAND TO KNOW THOSE 3488 02:24:55,355 --> 02:24:57,857 QUESTIONS FROM THE COMMUNITY 3489 02:24:57,857 --> 02:24:58,858 POINT OF VIEW. 3490 02:24:58,858 --> 02:25:00,293 >> THANK YOU AGAIN FOR HAVING 3491 02:25:00,293 --> 02:25:00,593 ME. 3492 02:25:00,593 --> 02:25:03,029 THANK YOU FOR ASKING THAT 3493 02:25:03,029 --> 02:25:03,296 QUESTION. 3494 02:25:03,296 --> 02:25:05,098 I THINK ONE OF THE THINGS THAT 3495 02:25:05,098 --> 02:25:10,370 CAN BE DONE IS ME BEING THE 3496 02:25:10,370 --> 02:25:12,005 CONNECTION, THE NETWORK YOU'RE 3497 02:25:12,005 --> 02:25:15,274 AFFILIATED WITH, REACHING OUT TO 3498 02:25:15,274 --> 02:25:16,909 THOSE HOSPITALS REACHING OUT TO 3499 02:25:16,909 --> 02:25:18,478 THESE PEOPLE, IF THOSE WHO ARE 3500 02:25:18,478 --> 02:25:21,848 BORN POSITIVE IF THEY COULD BE 3501 02:25:21,848 --> 02:25:24,050 WILLING TO COME TOGETHER AND BE 3502 02:25:24,050 --> 02:25:27,020 OPEN TO HAVING THESE 3503 02:25:27,020 --> 02:25:29,022 CONVERSATIONS, I THINK PART IS 3504 02:25:29,022 --> 02:25:30,490 PEOPLE ASK THE QUESTION, ANSWER 3505 02:25:30,490 --> 02:25:31,724 THE QUESTIONS FOR US, VERSUS 3506 02:25:31,724 --> 02:25:34,660 HAVING US AT THE TABLE. 3507 02:25:34,660 --> 02:25:38,197 SO IF Y'ALL CAN COME TOGETHER 3508 02:25:38,197 --> 02:25:39,365 AND GET THOSE DIFFERENT GROUPS 3509 02:25:39,365 --> 02:25:40,833 THAT ARE ALREADY DOING THE WORK 3510 02:25:40,833 --> 02:25:41,901 TO ACTUALLY COME TOGETHER AND 3511 02:25:41,901 --> 02:25:44,270 THEN YOU WOULD HAVE DIFFERENT 3512 02:25:44,270 --> 02:25:46,706 PEOPLE WHO ARE LIVING WITH HIV, 3513 02:25:46,706 --> 02:25:49,876 BORN WITH IT, TO ACTUALLY TRY TO 3514 02:25:49,876 --> 02:25:53,413 ASK RESEARCH QUESTIONS OF WHAT'S 3515 02:25:53,413 --> 02:25:53,813 NEEDED. 3516 02:25:53,813 --> 02:25:59,585 I KNOW A STUDY THAT'S COMING OUT 3517 02:25:59,585 --> 02:26:01,254 SOON, USING NETWORKS AND 3518 02:26:01,254 --> 02:26:02,922 REACHING OUT, HEY, WE WANT TO 3519 02:26:02,922 --> 02:26:04,424 REACH OUT TO THIS POPULATION, WE 3520 02:26:04,424 --> 02:26:06,859 WANT TO DO THIS FOCUS GROUP, DO 3521 02:26:06,859 --> 02:26:08,694 THIS RESEARCH, AND THEY ARE NOT 3522 02:26:08,694 --> 02:26:09,962 JUST TALKING TO THEMSELVES. 3523 02:26:09,962 --> 02:26:12,465 THEY ARE TALKING TO PEOPLE IN 3524 02:26:12,465 --> 02:26:12,865 DIFFERENT STATES. 3525 02:26:12,865 --> 02:26:17,003 MAYBE THAT COULD BE A GOOD START 3526 02:26:17,003 --> 02:26:19,205 MOVING FORWARD. 3527 02:26:19,205 --> 02:26:21,674 >> ONE QUESTION FOR DR. MARTINS. 3528 02:26:21,674 --> 02:26:24,277 THERE'S A LOT OF ONGOING 3529 02:26:24,277 --> 02:26:29,248 DISCUSSION IN THE PERINATAL 3530 02:26:29,248 --> 02:26:31,884 PREVENTION ARENA AROUND USING 3531 02:26:31,884 --> 02:26:33,719 bNAbS FOR PERINATAL 3532 02:26:33,719 --> 02:26:34,187 PREVENTION. 3533 02:26:34,187 --> 02:26:36,556 AND I'M JUST WONDERING FROM YOUR 3534 02:26:36,556 --> 02:26:44,530 POINT OF VIEW WHAT EVIDENCE OF 3535 02:26:44,530 --> 02:26:48,167 EFFICACY DO WE NEED, EITHER 3536 02:26:48,167 --> 02:26:50,403 ADULTS OR IN CHILDREN, BEFORE WE 3537 02:26:50,403 --> 02:26:56,209 CAN MOVE FORWARD WITH SOME OF 3538 02:26:56,209 --> 02:26:59,779 THESE TECHNOLOGIES OR GENE 3539 02:26:59,779 --> 02:27:00,646 THERAPY? 3540 02:27:00,646 --> 02:27:03,850 WE DON'T HAVE PK STUDIES, WE 3541 02:27:03,850 --> 02:27:07,753 KNOW THESE ARE -- bNAbS PER 3542 02:27:07,753 --> 02:27:11,390 SE ARE SAFE. BUT IN HUMANS, 3543 02:27:11,390 --> 02:27:15,561 CHILDREN, WE HAVE NO EFFICACY. 3544 02:27:15,561 --> 02:27:18,397 >> YES, AND YOU'RE SPEAKING 3545 02:27:18,397 --> 02:27:21,567 SPECIFICALLY ABOUT PROPHYLAXIS, 3546 02:27:21,567 --> 02:27:21,767 RIGHT? 3547 02:27:21,767 --> 02:27:23,769 >> YES, PREVENTION. 3548 02:27:23,769 --> 02:27:31,010 NOT FOR TREATMENT AT ALL OR 3549 02:27:31,010 --> 02:27:31,277 REMISSION. 3550 02:27:31,277 --> 02:27:31,644 >> RIGHT. 3551 02:27:31,644 --> 02:27:34,547 YOU KNOW, I MUST SAY, I HOPED 3552 02:27:34,547 --> 02:27:39,418 THAT SOME OF THE COMPANIES THAT 3553 02:27:39,418 --> 02:27:41,187 HAVE LICENSED THESE BROADLY 3554 02:27:41,187 --> 02:27:43,022 NEUTRALIZING ANTIBODIES WOULD BE 3555 02:27:43,022 --> 02:27:44,991 MORE OPEN AND EXCITED ABOUT 3556 02:27:44,991 --> 02:27:50,796 USING THESE MOLECULES FOR 3557 02:27:50,796 --> 02:27:51,931 TESTING IN PEDIATRIC 3558 02:27:51,931 --> 02:27:54,200 POPULATIONS. 3559 02:27:54,200 --> 02:27:59,772 AND AS OF YET, I -- WE ARE 3560 02:27:59,772 --> 02:28:03,075 ACTUALLY IN COLLABORATION TO USE 3561 02:28:03,075 --> 02:28:05,811 N 6 FOR ONGOING HP STUDIES, IN 3562 02:28:05,811 --> 02:28:07,146 THE CONTEXT OF THERAPY. 3563 02:28:07,146 --> 02:28:10,816 AND I GUESS WHAT I'M TRYING TO 3564 02:28:10,816 --> 02:28:14,954 SAY IS IF ONLY THERE WERE MORE 3565 02:28:14,954 --> 02:28:18,491 INTEREST FROM THE PRIVATE SECTOR 3566 02:28:18,491 --> 02:28:18,991 ABOUT THESE LONG-ACTING 3567 02:28:18,991 --> 02:28:20,826 STRATEGIES FOR, YOU KNOW, 3568 02:28:20,826 --> 02:28:23,362 CHILDREN, I SUSPECT, I MIGHT BE 3569 02:28:23,362 --> 02:28:25,398 WRONG, THAT THEY ARE WAITING FOR 3570 02:28:25,398 --> 02:28:28,367 MORE DATA TO BE PERFORMED IN 3571 02:28:28,367 --> 02:28:30,136 OLDER AGE GROUPS, PERHAPS GOING 3572 02:28:30,136 --> 02:28:33,406 DOWN THE -- MAYBE FROM ADULTS, 3573 02:28:33,406 --> 02:28:34,340 ADOLESCENTS, THEN OLDER CHILDREN 3574 02:28:34,340 --> 02:28:35,808 BEFORE IT CAN BE TESTED IN 3575 02:28:35,808 --> 02:28:36,175 INFANTS. 3576 02:28:36,175 --> 02:28:40,947 AND IF THIS IS THE CASE, WELL, I 3577 02:28:40,947 --> 02:28:43,583 GUESS, YOU KNOW, WE'RE -- IN MY 3578 02:28:43,583 --> 02:28:44,684 VIEW, THESE THERAPIES ARE READY 3579 02:28:44,684 --> 02:28:46,752 TO BE TESTED. 3580 02:28:46,752 --> 02:28:50,256 WE WOULD HAVE LARGE AMOUNT OF 3581 02:28:50,256 --> 02:28:54,293 SAFETY DATA, LARGE AMOUNT OF 3582 02:28:54,293 --> 02:28:57,263 CLINICAL EFFICACY DATA, AND I 3583 02:28:57,263 --> 02:28:58,197 SHARE YOUR CONFUSION SOMETIMES 3584 02:28:58,197 --> 02:29:03,069 ON WHY THIS IS NOT MOVING 3585 02:29:03,069 --> 02:29:03,769 FASTER. 3586 02:29:03,769 --> 02:29:09,175 I WISH IT WERE. 3587 02:29:09,175 --> 02:29:17,283 >> THANKS. 3588 02:29:17,283 --> 02:29:18,251 >> DR. NAGHAVI. 3589 02:29:18,251 --> 02:29:19,919 >> THANK YOU FOR SHARING YOUR 3590 02:29:19,919 --> 02:29:20,920 STORY, KIMBERLY. 3591 02:29:20,920 --> 02:29:22,521 COMING FROM MYSELF AS A 3592 02:29:22,521 --> 02:29:23,723 SCIENTIST, THIS IS NOT SOMETHING 3593 02:29:23,723 --> 02:29:26,959 WE HEAR ON A DAY-TO-DAY BASIS. 3594 02:29:26,959 --> 02:29:28,194 IT REALLY GIVES US SOMETHING TO 3595 02:29:28,194 --> 02:29:29,028 THINK ABOUT. 3596 02:29:29,028 --> 02:29:33,799 THANK YOU FOR BEING YOU. 3597 02:29:33,799 --> 02:29:34,567 AND DR. MARTINS, JUST WONDERING 3598 02:29:34,567 --> 02:29:39,405 IF YOU COULD GIVE US SOME 3599 02:29:39,405 --> 02:29:44,510 INSIGHTS ON WHAT THE RESERVOIRS 3600 02:29:44,510 --> 02:29:47,413 MIGHT BE IN THIS PEDIATRIC 3601 02:29:47,413 --> 02:29:51,250 INFECTIONS, IF THERE ARE UNIQUE 3602 02:29:51,250 --> 02:29:57,256 COMPOSITIONS OF ITS RESES AS 3603 02:29:57,256 --> 02:30:02,795 OPPOSED LIKE THEY ARE NAIVE 3604 02:30:02,795 --> 02:30:08,734 CDCELLS, WHETHER THAT SHOULD BE 3605 02:30:08,734 --> 02:30:10,403 CONSIDERED IN THIS ERADICATION 3606 02:30:10,403 --> 02:30:10,670 STRATEGY? 3607 02:30:10,670 --> 02:30:14,774 >> THANK YOU FOR THE QUESTION. 3608 02:30:14,774 --> 02:30:16,409 WE'RE MONITORING RESERVOIR 3609 02:30:16,409 --> 02:30:20,680 LEVELS IN OUR NHP STUDIES 3610 02:30:20,680 --> 02:30:24,784 THROUGH THIS ASSET DEVELOPED AT 3611 02:30:24,784 --> 02:30:27,353 JOHNS HOPKINS UNIVERSITY, IPDA 3612 02:30:27,353 --> 02:30:27,553 ASSAY. 3613 02:30:27,553 --> 02:30:32,325 AND WE SEE A DECLINE IN LEVELS 3614 02:30:32,325 --> 02:30:35,828 OF VIRUSES THAT AT LEAST DURING 3615 02:30:35,828 --> 02:30:37,797 THE PERIOD OF ANTIRETROVIRAL 3616 02:30:37,797 --> 02:30:39,065 THERAPY RESEMBLES DECLINE OF THE 3617 02:30:39,065 --> 02:30:41,067 CONTROL GROUP, SO DURING THE 30 3618 02:30:41,067 --> 02:30:42,568 WEEKS OF ANTIRETROVIRAL THERAPY 3619 02:30:42,568 --> 02:30:45,905 WE STUDY, WHICH IS VERY SHORT, 3620 02:30:45,905 --> 02:30:48,941 WE DID NOT OBSERVE AN 3621 02:30:48,941 --> 02:30:55,081 ACCELERATION IN DECAY RATE OF 3622 02:30:55,081 --> 02:30:55,614 MOLECULES. 3623 02:30:55,614 --> 02:30:57,049 LONGER STUDIES, HOPEFULLY LAST 3624 02:30:57,049 --> 02:31:00,986 MORE THAN A YEAR, ALSO USING 3625 02:31:00,986 --> 02:31:03,756 ANTIBODIES THAT ARE MORE 3626 02:31:03,756 --> 02:31:04,490 EFFECTIVE AT ELIMINATING 3627 02:31:04,490 --> 02:31:05,524 INFECTED CELLS. 3628 02:31:05,524 --> 02:31:07,793 THERE WAS ONE DETAIL I DID NOT 3629 02:31:07,793 --> 02:31:09,995 EXPLORE AS MUCH PERHAPS AS I 3630 02:31:09,995 --> 02:31:10,963 SHOULD HAVE THAT THE ANTIBODIES 3631 02:31:10,963 --> 02:31:14,266 I USED IN OUR ONGOING STUDIES 3632 02:31:14,266 --> 02:31:17,103 WERE OF THE IgG 2 SUBCLASS, 3633 02:31:17,103 --> 02:31:20,172 WHICH ARE NOT SO RAPID, SO FAST 3634 02:31:20,172 --> 02:31:24,777 AT KILLING AFFECTED CELLS IN 3635 02:31:24,777 --> 02:31:27,313 MACAQUES COMPARED TO IGG1 3636 02:31:27,313 --> 02:31:31,784 SUBCLASS, IN THE NEXT STUDIES 3637 02:31:31,784 --> 02:31:35,621 WE'LL USE IGG1 SUBCLASS TO AC 3638 02:31:35,621 --> 02:31:37,990 SET RATE DECLINED KINETICS, WITH 3639 02:31:37,990 --> 02:31:39,191 HOPES OF REDUCING OR ELIMINATE 3640 02:31:39,191 --> 02:31:39,692 IT. 3641 02:31:39,692 --> 02:31:40,659 >> THANK YOU. 3642 02:31:40,659 --> 02:31:43,796 IT'S A VERY POWERFUL TECHNIQUE. 3643 02:31:43,796 --> 02:31:49,468 >> THANK YOU VERY MUCH. 3644 02:31:49,468 --> 02:31:49,602 3645 02:31:49,602 --> 02:31:50,469 >> DR. FINZI? 3646 02:31:50,469 --> 02:31:51,270 >> THANK YOU. 3647 02:31:51,270 --> 02:31:54,874 I WANTED TO THANK YOU BOTH. 3648 02:31:54,874 --> 02:31:59,445 I HAVE A QUESTION FOR DR. 3649 02:31:59,445 --> 02:32:02,281 MARTINS. 3650 02:32:02,281 --> 02:32:06,685 WHEN YOU THINK OF YOUR METHOD 3651 02:32:06,685 --> 02:32:09,188 AND SUSTAINING THE LEVELS THAT 3652 02:32:09,188 --> 02:32:13,559 WOULD BE NEEDED AND THE TYPES OF 3653 02:32:13,559 --> 02:32:17,596 ANTIBODIES, DO YOU ENVISION 3654 02:32:17,596 --> 02:32:19,165 USING VARIOUS DIFFERENT 3655 02:32:19,165 --> 02:32:21,567 ANTIBODIES OVER TIME OR HOW 3656 02:32:21,567 --> 02:32:24,870 WOULD YOU SUSTAIN THE LEVEL 3657 02:32:24,870 --> 02:32:27,039 NEEDED TO KEEP CONTROL OVER 3658 02:32:27,039 --> 02:32:29,809 LONGER TIMES? 3659 02:32:29,809 --> 02:32:34,013 AND ALSO, MONITORING FOR 3660 02:32:34,013 --> 02:32:34,814 DEVELOPMENT OF RESISTANCE? 3661 02:32:34,814 --> 02:32:37,216 >> YES, SO IN MY VIEW WE SHOULD 3662 02:32:37,216 --> 02:32:41,587 BE USING COMBINATIONS OF 3663 02:32:41,587 --> 02:32:43,689 MOLECULES TO REALLY EXPAND THE 3664 02:32:43,689 --> 02:32:44,657 BREADTH OF NEUTRALIZATION AND 3665 02:32:44,657 --> 02:32:46,058 FUNCTION IN THESE ANIMALS. 3666 02:32:46,058 --> 02:32:50,329 I THINK WE ONLY USED TWO 3667 02:32:50,329 --> 02:32:52,298 MOLECULES IN OUR STUDIES BECAUSE 3668 02:32:52,298 --> 02:32:54,400 THOSE WERE THE REAGENTS 3669 02:32:54,400 --> 02:32:57,470 AVAILABLE. 3670 02:32:57,470 --> 02:33:00,105 ONE MOLECULE ACTUALLY DISPLACED 3671 02:33:00,105 --> 02:33:01,273 VERY IMPRESSIVE BREADTH, CDIG 4 3672 02:33:01,273 --> 02:33:03,843 MOLECULE, WE HOPE TO MAKE IT 3673 02:33:03,843 --> 02:33:05,478 MORE EFFECTIVE MOVING FORWARD 3674 02:33:05,478 --> 02:33:06,779 BUT FROM THE STANDPOINT OF A 3675 02:33:06,779 --> 02:33:08,514 CLINICAL TRIAL I WOULD CERTAINLY 3676 02:33:08,514 --> 02:33:10,716 ADVOCATE FOR USING AT LEAST 3677 02:33:10,716 --> 02:33:11,417 THREE MOLECULES TARGETING 3678 02:33:11,417 --> 02:33:13,752 DIFFERENT SITES OF THE ENVELOPE 3679 02:33:13,752 --> 02:33:14,186 PROTEIN. 3680 02:33:14,186 --> 02:33:17,156 AND IN TERMS OF SUSTAINING THE 3681 02:33:17,156 --> 02:33:20,192 LEVELS, THIS IS A VERY GOOD 3682 02:33:20,192 --> 02:33:21,327 QUESTION ACTUALLY BECAUSE THESE 3683 02:33:21,327 --> 02:33:24,363 AAV GENOMES THAT WE DELIVER TO 3684 02:33:24,363 --> 02:33:26,899 THE MUSCLE CELLS OF BABIES THEY 3685 02:33:26,899 --> 02:33:30,102 ARE NOT SUPPOSED TO DIVIDE OVER 3686 02:33:30,102 --> 02:33:30,503 TIME. 3687 02:33:30,503 --> 02:33:36,008 SO EVENTUALLY AS CHILDREN GROW 3688 02:33:36,008 --> 02:33:37,176 OVER YEARS WE EXPECT, WE HAVEN'T 3689 02:33:37,176 --> 02:33:40,880 SEEN THIS YET BECAUSE IT TAKE 3690 02:33:40,880 --> 02:33:44,283 YEARS, BUT WE PREDICT AS BLOOD 3691 02:33:44,283 --> 02:33:48,354 VOLUMES INCREASE, LEVELS MAY GET 3692 02:33:48,354 --> 02:33:51,056 DILUTED REQUIRES PERHAPS A BOOST 3693 02:33:51,056 --> 02:33:52,291 AND UNKNOWN AMOUNT OF TIME. 3694 02:33:52,291 --> 02:33:56,028 WHEN THAT TIME COMES WE HAVE THE 3695 02:33:56,028 --> 02:34:00,833 TECHNIQUES AT LEAST TO REMOVE 3696 02:34:00,833 --> 02:34:03,669 ANTIBODIES WHICH WOULD HOPEFULLY 3697 02:34:03,669 --> 02:34:06,572 ALLOW FOR READMINISTRATION TO 3698 02:34:06,572 --> 02:34:08,240 BOOST CONCENTRATION OF VIRUS 3699 02:34:08,240 --> 02:34:12,311 REBOUND LATER IN LIFE. 3700 02:34:12,311 --> 02:34:12,778 >> RIGHT. 3701 02:34:12,778 --> 02:34:13,279 THANK YOU. 3702 02:34:13,279 --> 02:34:16,081 THANK YOU VERY MUCH. 3703 02:34:16,081 --> 02:34:17,883 AND MS. CANADY, I WANTED TO ECHO 3704 02:34:17,883 --> 02:34:19,618 WHAT OTHER PEOPLE HAVE SAID. 3705 02:34:19,618 --> 02:34:21,954 I MEAN, WHAT AN AMAZING STORY. 3706 02:34:21,954 --> 02:34:26,025 AND I ALSO HAVE BEEN WORKING ON 3707 02:34:26,025 --> 02:34:29,061 HIV, AT LEAST WORKING ON HIV FOR 3708 02:34:29,061 --> 02:34:31,163 OVER 30 YEARS, AND THINKING 3709 02:34:31,163 --> 02:34:34,733 ABOUT IT SINCE BEFORE YOU WERE 3710 02:34:34,733 --> 02:34:34,934 BORN. 3711 02:34:34,934 --> 02:34:39,371 AND TO HEAR YOUR STORY REALLY IS 3712 02:34:39,371 --> 02:34:42,641 AMAZING AS A RESEARCHER AND 3713 02:34:42,641 --> 02:34:46,245 HEARTWARMING AS JUST A PERSON 3714 02:34:46,245 --> 02:34:49,982 WHO HAS KNOWN ABOUT HIV FROM THE 3715 02:34:49,982 --> 02:34:51,584 SCIENTIFIC SIDE FOR SO MANY 3716 02:34:51,584 --> 02:34:55,421 YEARS AND ALSO AS A MOM. 3717 02:34:55,421 --> 02:34:56,088 JUST AMAZING. 3718 02:34:56,088 --> 02:34:57,323 KEEP IT UP. 3719 02:34:57,323 --> 02:35:02,094 IF WE CAN ENCOURAGE YOU IN ANY 3720 02:35:02,094 --> 02:35:03,562 WAY, LET US KNOW. 3721 02:35:03,562 --> 02:35:11,670 AND WE DID HEAR YOUR STORY. 3722 02:35:11,670 --> 02:35:14,707 >> DR. GALARRAGA? 3723 02:35:14,707 --> 02:35:16,709 >> THANK YOU. 3724 02:35:16,709 --> 02:35:17,176 EXCUSE ME. 3725 02:35:17,176 --> 02:35:19,345 KIM, THANK YOU SO MUCH FOR 3726 02:35:19,345 --> 02:35:20,412 SHARING YOUR PERSONAL STORY. 3727 02:35:20,412 --> 02:35:25,484 IT IS AGAIN VERY UNUSUAL FOR US 3728 02:35:25,484 --> 02:35:26,418 TO HEAR THAT. 3729 02:35:26,418 --> 02:35:28,754 I DO A LOT OF NUMBERS AND A LOT 3730 02:35:28,754 --> 02:35:31,223 OF STATISTICS, I LOOK AT 3731 02:35:31,223 --> 02:35:34,660 PROGRAMS, LIKE IN KENYA, WE HAVE 3732 02:35:34,660 --> 02:35:35,761 200,000 PEOPLE IN TREATMENT, 3733 02:35:35,761 --> 02:35:37,930 15,000 NEW CASES OF HIV PER 3734 02:35:37,930 --> 02:35:40,332 YEAR, THOSE DON'T MEAN ANYTHING, 3735 02:35:40,332 --> 02:35:40,899 RIGHT? 3736 02:35:40,899 --> 02:35:42,434 ONCE YOU SEE NUMBERS, NUMBERS, 3737 02:35:42,434 --> 02:35:42,768 NUMBERS. 3738 02:35:42,768 --> 02:35:45,504 THEN I SEE YOUR FACE, WOW, 3739 02:35:45,504 --> 02:35:48,774 THERE'S HOPE, THERE'S A 3740 02:35:48,774 --> 02:35:49,041 STRENGTH. 3741 02:35:49,041 --> 02:35:51,610 AND THERE'S RESILIENCE OF HUMANS 3742 02:35:51,610 --> 02:35:52,645 AND IT'S JUST AMAZING. 3743 02:35:52,645 --> 02:35:53,612 THANK YOU. 3744 02:35:53,612 --> 02:35:56,148 IF I MAY, I MEAN, AGAIN, JUST IN 3745 02:35:56,148 --> 02:35:58,150 THE SPIRIT OF ENCOURAGING YOU, I 3746 02:35:58,150 --> 02:35:59,418 HOPE YOU CAN, YOU KNOW, WRITE 3747 02:35:59,418 --> 02:36:01,854 YOUR STORY IN A BOOK OR I MEAN I 3748 02:36:01,854 --> 02:36:05,057 HOPE THAT YOUR STORY BECOMES A 3749 02:36:05,057 --> 02:36:05,257 MOVIE. 3750 02:36:05,257 --> 02:36:07,860 I HOPE THAT -- I'M SURE YOU KNOW 3751 02:36:07,860 --> 02:36:10,596 YOU'RE YOUNGER SO I HOPE YOU 3752 02:36:10,596 --> 02:36:12,464 HAVE A VERY ACTIVE INSTAGRAM 3753 02:36:12,464 --> 02:36:13,966 YOUNGER PAGE, SO THE YOUNGER 3754 02:36:13,966 --> 02:36:15,100 GENERATIONS HEAR YOUR MESSAGE 3755 02:36:15,100 --> 02:36:18,237 AND ARE INSPIRED BY YOUR 3756 02:36:18,237 --> 02:36:20,439 RESILIENCE AND YOUR TOUGHNESS. 3757 02:36:20,439 --> 02:36:26,178 I THINK THAT'S VERY MOVING. 3758 02:36:26,178 --> 02:36:30,449 I HAVE A SUGGESTION ALSO. 3759 02:36:30,449 --> 02:36:33,419 YOUR WORK SEEMS AMAZING, 3760 02:36:33,419 --> 02:36:35,354 MAURICIO, A GAME CHANGER. 3761 02:36:35,354 --> 02:36:40,859 SOME OF THE PRICES OF THE DRUGS, 3762 02:36:40,859 --> 02:36:43,062 YOU KNOW, AAV DRUGS, AS MANY 3763 02:36:43,062 --> 02:36:45,898 PEOPLE KNOW ARE STAGGERING, HALF 3764 02:36:45,898 --> 02:36:50,969 A MILLION FOR SOME OF THE 3765 02:36:50,969 --> 02:36:51,203 SHOTS, 3766 02:36:51,203 --> 02:36:51,937 HOW CAN THIS BE? 3767 02:36:51,937 --> 02:36:54,640 WE LIVE IN A MARKET WHERE IT'S 3768 02:36:54,640 --> 02:36:55,874 SUPPLY AND DEMAND. 3769 02:36:55,874 --> 02:36:58,944 REALLY THE U.S. IS WHATEVER THE 3770 02:36:58,944 --> 02:37:00,012 MARKET WILL BEAR. 3771 02:37:00,012 --> 02:37:03,115 AND THAT'S REALLY UNFORTUNATE. 3772 02:37:03,115 --> 02:37:05,851 AND SO YOU ALREADY SPOKE THAT 3773 02:37:05,851 --> 02:37:07,152 YOU'RE IN CONVERSATIONS WITH 3774 02:37:07,152 --> 02:37:11,290 SOME OF THE DRUG MANUFACTURERS, 3775 02:37:11,290 --> 02:37:12,758 BUT I ASSUME THAT AGAIN HAVING 3776 02:37:12,758 --> 02:37:14,259 BEEN WORKING IN THIS AREA FOR 3777 02:37:14,259 --> 02:37:16,128 OVER 20 YEARS AT THIS POINT, 3778 02:37:16,128 --> 02:37:20,432 OVER 25 YEARS, I'VE SEEN A LOT 3779 02:37:20,432 --> 02:37:21,834 OF CHANGES. 3780 02:37:21,834 --> 02:37:23,335 AND SO I JUST DON'T THINK 3781 02:37:23,335 --> 02:37:24,369 REGULAR CHANNELS ARE GOING TO BE 3782 02:37:24,369 --> 02:37:28,540 WHAT GETS THIS TO THE MARKET, 3783 02:37:28,540 --> 02:37:28,941 RIGHT? 3784 02:37:28,941 --> 02:37:29,942 IT ALMOST SEEMS SOMETHING LIKE 3785 02:37:29,942 --> 02:37:34,546 ADVANCED PURCHASE COMMITMENT IS 3786 02:37:34,546 --> 02:37:36,348 NEEDED, SAYING PEPFAR OR W.H.O. 3787 02:37:36,348 --> 02:37:37,182 IS COMMITTED TO BUYING, I DON'T 3788 02:37:37,182 --> 02:37:42,054 KNOW, HALF A MILLION OF THESE OR 3789 02:37:42,054 --> 02:37:43,756 100,000 EVERY YEAR, WILLING TO 3790 02:37:43,756 --> 02:37:45,457 PUT A BUNCH OF MONEY TO MAKE IT 3791 02:37:45,457 --> 02:37:46,992 INTERESTING FOR THE COMPANIES TO 3792 02:37:46,992 --> 02:37:47,659 REALLY DEVELOP THIS. 3793 02:37:47,659 --> 02:37:51,163 OTHERWISE THERE'S NOT GOING TO 3794 02:37:51,163 --> 02:37:52,264 BE THE MARKET BECAUSE 3795 02:37:52,264 --> 02:37:53,766 UNFORTUNATELY AS YOU SHOWED THE 3796 02:37:53,766 --> 02:37:55,534 MAP, WHERE THE MOST NEED IS IS 3797 02:37:55,534 --> 02:37:58,170 NOT WHERE THE MONEY IS. 3798 02:37:58,170 --> 02:37:59,204 THE BUSINESS OPPORTUNITY. 3799 02:37:59,204 --> 02:38:02,474 AND SO I THINK THAT SORT OF 3800 02:38:02,474 --> 02:38:03,408 MULTI-TRADITIONAL CHANNELS IS 3801 02:38:03,408 --> 02:38:07,079 WHAT'S GOING TO WORK HERE. 3802 02:38:07,079 --> 02:38:10,082 AND YOU HAVE YOUR OWN VIEWS OF 3803 02:38:10,082 --> 02:38:11,583 COURSE BUT THAT'S MY OPINION 3804 02:38:11,583 --> 02:38:13,318 BASED ON WHAT I'VE SEEN IN THE 3805 02:38:13,318 --> 02:38:16,121 MARKET, HOW THE MARKET WORKS THE 3806 02:38:16,121 --> 02:38:17,489 LAST 20, 30 YEARS. 3807 02:38:17,489 --> 02:38:21,093 >> YOU MAKE VERY GOOD POINTS. 3808 02:38:21,093 --> 02:38:23,195 I THINK MY NUMBER ONE PRIORITY, 3809 02:38:23,195 --> 02:38:26,999 WE NEED TO ADDRESS THIS IN A 3810 02:38:26,999 --> 02:38:28,033 STEP-WISE FASHION. 3811 02:38:28,033 --> 02:38:30,068 MY PRIORITY NOW, THOSE OF MY 3812 02:38:30,068 --> 02:38:31,403 COLLEAGUES, TO CONDUCT FIRST 3813 02:38:31,403 --> 02:38:34,907 CLINICAL TRIAL TO DEMONSTRATE 3814 02:38:34,907 --> 02:38:35,741 SAFETY. 3815 02:38:35,741 --> 02:38:46,285 AND WE'RE WORKING WITH ACTUALLY 3816 02:38:46,819 --> 02:38:54,359 BILL AND MELINDA GATES NETWORK, 3817 02:38:54,359 --> 02:38:56,562 BUT, YES, I HEAR YOU. 3818 02:38:56,562 --> 02:38:57,896 I ALSO SHARE THESE CONCERNS. 3819 02:38:57,896 --> 02:39:02,501 BUT I ALSO WANT TO MAKE SURE 3820 02:39:02,501 --> 02:39:04,970 THAT WE ARE NOT -- THAT THE 3821 02:39:04,970 --> 02:39:07,406 EXCITEMENT AND THE PRIORITY FOR 3822 02:39:07,406 --> 02:39:14,513 THIS INFORMATION IS NOT DAMPEND 3823 02:39:14,513 --> 02:39:18,250 BY THE CURRENT PRICE TAG. 3824 02:39:18,250 --> 02:39:24,790 EARLIER IN THE EPIDEMIC PEOPLE 3825 02:39:24,790 --> 02:39:26,558 WERE HAVING CONVERSATIONS ABOUT 3826 02:39:26,558 --> 02:39:27,860 COST, DEPLOYING THIS TO REGIONS 3827 02:39:27,860 --> 02:39:31,496 WITH THE HIGHEST NUMBERS OF 3828 02:39:31,496 --> 02:39:31,930 INFECTIONS. 3829 02:39:31,930 --> 02:39:34,867 NOWADAYS THROUGH GENERICS AND 3830 02:39:34,867 --> 02:39:36,635 AGREEMENTS, A PERSON CAN HAVE 3831 02:39:36,635 --> 02:39:46,345 ACCESS TO A FULL YEAR OF 3832 02:39:46,345 --> 02:39:49,314 ANTI-RETRO VIRALS FOR LESS THAN 3833 02:39:49,314 --> 02:39:50,616 $100, THERE'S A PART FORWARD BUT 3834 02:39:50,616 --> 02:39:53,652 DOESN'T MEAN THE PATH NOW TO 3835 02:39:53,652 --> 02:39:56,188 THEN IS GOING TO BE EASY AND I 3836 02:39:56,188 --> 02:39:57,556 HOPE WE CAN HAVE THIS IN PLACE 3837 02:39:57,556 --> 02:40:02,327 WITH THE W.H.O. AS YOU DESCRIBED 3838 02:40:02,327 --> 02:40:04,963 AND DRUG COMPANIES, I'M A BENCH 3839 02:40:04,963 --> 02:40:06,598 SCIENTIST BY TRAINING. 3840 02:40:06,598 --> 02:40:09,668 >> YEAH, NO, I FULLY HEAR YOU. 3841 02:40:09,668 --> 02:40:12,437 IT'S SUPPLY AND DEMAND, 3842 02:40:12,437 --> 02:40:13,972 PHARMACEUTICAL COMPANY CAN MAKE 3843 02:40:13,972 --> 02:40:16,575 HALF A MILLION DOLLARS SELLING 3844 02:40:16,575 --> 02:40:18,010 ONE SHOT, HALF MILLION, OR HALF 3845 02:40:18,010 --> 02:40:19,845 MILLION SHOTS AT ONE DOLLAR, 3846 02:40:19,845 --> 02:40:20,445 RIGHT? 3847 02:40:20,445 --> 02:40:27,085 HOW DO YOU TRANSFER THAT TO GO 3848 02:40:27,085 --> 02:40:29,488 LOW- AND MIDDLE-INCOME 3849 02:40:29,488 --> 02:40:32,758 COUNTRIES, SUB-SAHARAN AFRICA, 3850 02:40:32,758 --> 02:40:36,795 TO BE HONEST, UNICEF, W.H.O., 3851 02:40:36,795 --> 02:40:38,997 PEPFAR, COMMITTED TO USING X TO 3852 02:40:38,997 --> 02:40:40,999 THE FIRST PHARMACEUTICAL THAT 3853 02:40:40,999 --> 02:40:43,168 DOES IT. 3854 02:40:43,168 --> 02:40:44,603 I'M PROBABLY -- YOU SHOULD 3855 02:40:44,603 --> 02:40:46,238 PARTNER WITH SOMETHING THAT HAS 3856 02:40:46,238 --> 02:40:48,240 MORE EXPERIENCE, OBVIOUSLY 3857 02:40:48,240 --> 02:40:50,575 YOU'RE AN EXPERT IN THE BENCH 3858 02:40:50,575 --> 02:40:52,277 SCIENCE, OTHERS HAVE TO DEAL 3859 02:40:52,277 --> 02:40:55,714 WITH MARKETING ISSUES THAT ARE 3860 02:40:55,714 --> 02:40:56,448 COMPLEX. 3861 02:40:56,448 --> 02:40:58,083 BUT IT'S VERY IMPRESSIVE. 3862 02:40:58,083 --> 02:41:00,052 >> GREAT POINTS. 3863 02:41:00,052 --> 02:41:01,720 I HEAR YOU. 3864 02:41:01,720 --> 02:41:06,792 >> FINAL QUESTION FROM DR. 3865 02:41:06,792 --> 02:41:07,059 MONTANER. 3866 02:41:07,059 --> 02:41:10,128 >> THANK YOU. 3867 02:41:10,128 --> 02:41:12,631 MISS CANADY, IN YOUR STORY YOU 3868 02:41:12,631 --> 02:41:15,400 REFERRING TO THE CONTINUITY OF 3869 02:41:15,400 --> 02:41:16,935 DEATH IN YOUR COMMUNITY PEOPLE 3870 02:41:16,935 --> 02:41:17,669 LIVING WITH HIV. 3871 02:41:17,669 --> 02:41:20,305 I WANTED TO EXPAND A LITTLE BIT. 3872 02:41:20,305 --> 02:41:22,307 WE TALKED ABOUT IMPLEMENTATION 3873 02:41:22,307 --> 02:41:24,009 SCIENCE, HOW BEST TO ADDRESS 3874 02:41:24,009 --> 02:41:25,110 HEALTH DISPARITIES WITH PEOPLE 3875 02:41:25,110 --> 02:41:27,312 THAT DON'T HAVE ADEQUATE SUPPORT 3876 02:41:27,312 --> 02:41:29,548 FOR HEALTH INFRASTRUCTURE OR 3877 02:41:29,548 --> 02:41:30,248 FOLLOW-UPS. 3878 02:41:30,248 --> 02:41:34,052 SO IS THIS THE MAIN REASON THAT 3879 02:41:34,052 --> 02:41:35,654 YOU WOULD ASSIGN TO THIS 3880 02:41:35,654 --> 02:41:38,023 CONTINUAL DEATHS, IN AN ERA 3881 02:41:38,023 --> 02:41:38,790 WHERE THERE IS ANTIRETROVIRAL 3882 02:41:38,790 --> 02:41:41,326 THERAPY OR IS THERE MORE TO 3883 02:41:41,326 --> 02:41:41,526 THIS? 3884 02:41:41,526 --> 02:41:44,062 IF YOU CAN DIRECT YOUR COMMENTS 3885 02:41:44,062 --> 02:41:46,131 AROUND IMPLEMENTATION GAPS OR 3886 02:41:46,131 --> 02:41:47,132 AREAS THAT YOU THINK THAT 3887 02:41:47,132 --> 02:41:49,968 STRATEGIC PLAN SHOULD FOCUS ON 3888 02:41:49,968 --> 02:41:55,907 AS TRYING TO TRY TO BETTER 3889 02:41:55,907 --> 02:41:56,742 ADDRESS HEALTH DISPARITIES, 3890 02:41:56,742 --> 02:41:58,076 IMPLEMENTING PROGRAMS THAT CAN 3891 02:41:58,076 --> 02:42:03,415 MAKE ANTIRETROVIRAL THERAPY MORE 3892 02:42:03,415 --> 02:42:03,715 ACCESSIBLE. 3893 02:42:03,715 --> 02:42:07,586 >> WITH A LOT OF MY FRIENDS, A 3894 02:42:07,586 --> 02:42:11,056 LOT WAS IMPLEMENTATION WOULD 3895 02:42:11,056 --> 02:42:12,290 REALLY BE HELPFUL FOR BETTER 3896 02:42:12,290 --> 02:42:13,925 STRATEGIC PLANNING WHEN IT COMES 3897 02:42:13,925 --> 02:42:15,360 TO TRANSITIONING FROM PEDIATRIC 3898 02:42:15,360 --> 02:42:16,661 CARE TO ADULT CARE. 3899 02:42:16,661 --> 02:42:22,167 THAT'S WHY A LOT OF US GET LOST. 3900 02:42:22,167 --> 02:42:24,569 WHEN -- EARLIER ON A LOT OF BULK 3901 02:42:24,569 --> 02:42:27,606 OF PASSING OF MY FRIENDS WERE 3902 02:42:27,606 --> 02:42:34,613 EARLY TEENAGERS, SO THIS IS THE 3903 02:42:34,613 --> 02:42:37,849 TIMELINE, 1996 TO MAYBE 2006 TO 3904 02:42:37,849 --> 02:42:39,217 2010. 3905 02:42:39,217 --> 02:42:42,421 MEDICATION WAS THERE. 3906 02:42:42,421 --> 02:42:43,188 WE WERE YOUNG. 3907 02:42:43,188 --> 02:42:47,325 I WAS ONE OF THE LUCKY OR 3908 02:42:47,325 --> 02:42:49,261 BLESSED ONES, I WASN'T ON 3909 02:42:49,261 --> 02:42:51,696 MEDICATION UNTIL 30, THAT WAS MY 3910 02:42:51,696 --> 02:42:52,130 CHOICE. 3911 02:42:52,130 --> 02:42:55,267 THAT'S GOING WITH STIGMA AND ME 3912 02:42:55,267 --> 02:42:57,135 FEELING I'M 30, WHY AM I STILL 3913 02:42:57,135 --> 02:42:57,702 HERE? 3914 02:42:57,702 --> 02:43:02,040 I SHOULD BE ON MEDICATION, EVEN 3915 02:43:02,040 --> 02:43:03,341 THOUGH MY NUMBERS SAY I'M GOOD. 3916 02:43:03,341 --> 02:43:04,142 LET'S SEE WHAT HAPPENS. 3917 02:43:04,142 --> 02:43:06,211 A LOT OF FRIENDS WERE ON 3918 02:43:06,211 --> 02:43:09,014 MEDICATION OFF AND ON SINCE AGE 3919 02:43:09,014 --> 02:43:13,085 7, AGE 8, NOT BEING TOLD ABOUT 3920 02:43:13,085 --> 02:43:15,353 THE MEDICATION BECAUSE WE DIDN'T 3921 02:43:15,353 --> 02:43:17,122 KNOW WE WERE POSITIVE. 3922 02:43:17,122 --> 02:43:18,090 SO NOT TAKING MEDICATION 3923 02:43:18,090 --> 02:43:18,423 PRESCRIBED. 3924 02:43:18,423 --> 02:43:22,928 BY THE TIME THEY WERE TAKING THE 3925 02:43:22,928 --> 02:43:25,764 MEDICATION, THEY WERE ON 3926 02:43:25,764 --> 02:43:31,536 EXPERIMENTAL DRUGS, THEIR BODIES 3927 02:43:31,536 --> 02:43:36,475 SUFFERED FROM DYSTROPHY OR ORGAN 3928 02:43:36,475 --> 02:43:37,275 FAILURE. 3929 02:43:37,275 --> 02:43:40,112 BECAUSE THE MEDICATION WAS HUGE, 3930 02:43:40,112 --> 02:43:42,380 DISGUSTING, THEY DIDN'T KNOW HOW 3931 02:43:42,380 --> 02:43:43,748 TO SWALLOW, NOBODY WOULD ASSIST 3932 02:43:43,748 --> 02:43:45,584 THEM ON HOW TO TAKE THE 3933 02:43:45,584 --> 02:43:47,752 MEDICATION, WHAT THAT LOOKED 3934 02:43:47,752 --> 02:43:47,953 LIKE. 3935 02:43:47,953 --> 02:43:48,954 THE IMPORTANCE BECAUSE WE WERE 3936 02:43:48,954 --> 02:43:49,721 CHILDREN. 3937 02:43:49,721 --> 02:43:51,690 BY THE TIME WE BECAME 3938 02:43:51,690 --> 02:43:53,792 ADOLESCENT, OUR BODIES GAVE OUT. 3939 02:43:53,792 --> 02:43:56,661 FOR A LOT OF THEM, MEDICATION 3940 02:43:56,661 --> 02:43:57,429 WASN'T WORKING. 3941 02:43:57,429 --> 02:43:59,164 BY THE TIME THAT A LOT OF US 3942 02:43:59,164 --> 02:44:01,099 WANTED TOKING BACK ON IT, TRY TO 3943 02:44:01,099 --> 02:44:03,135 GET ON THOSE, THEY WERE 3944 02:44:03,135 --> 02:44:04,769 RESISTANT AND MEDICATION WASN'T 3945 02:44:04,769 --> 02:44:05,504 WORKING. 3946 02:44:05,504 --> 02:44:07,839 THE BODY ALREADY TOOK THE TOLL. 3947 02:44:07,839 --> 02:44:10,876 FOR A LOT, THE BULK WAS BECAUSE 3948 02:44:10,876 --> 02:44:11,610 OF THAT. 3949 02:44:11,610 --> 02:44:13,945 FOR THOSE WHO PASSED AWAY ON A 3950 02:44:13,945 --> 02:44:14,880 LOT IS MENTAL HEALTH SERVICES 3951 02:44:14,880 --> 02:44:16,481 WASN'T THERE TO TALK ABOUT WHAT 3952 02:44:16,481 --> 02:44:19,985 IT LOOKS LIKE TO CONTINUE TO BE 3953 02:44:19,985 --> 02:44:21,620 HIV POSITIVE GROWING UP. 3954 02:44:21,620 --> 02:44:24,222 THEY PREPARED US FOR DEATH SO 3955 02:44:24,222 --> 02:44:26,024 MUCH, WE WEREN'T PREPARED FOR 3956 02:44:26,024 --> 02:44:26,525 LIFE. 3957 02:44:26,525 --> 02:44:28,426 THAT SOUNDS INSANE. 3958 02:44:28,426 --> 02:44:33,632 WHY WOULD YOU DIG THIS UP, YEA, 3959 02:44:33,632 --> 02:44:34,966 YOU'RE RESILIENT, YOU SHOULD BE 3960 02:44:34,966 --> 02:44:37,736 HAPPY YOU'RE ALIVE BUT THERE'S 3961 02:44:37,736 --> 02:44:38,837 THE PROGRAMS DISAPPEARED FOR US 3962 02:44:38,837 --> 02:44:41,106 TO WANT TO BE ALIVE. 3963 02:44:41,106 --> 02:44:44,176 AND WE FELT ALONE. 3964 02:44:44,176 --> 02:44:46,244 AND THEN ACCESS -- BEING ADULT 3965 02:44:46,244 --> 02:44:48,647 AND ACCESSING CARE TRYING TO 3966 02:44:48,647 --> 02:44:50,215 LIVE A NORMAL LIFE DOESN'T 3967 02:44:50,215 --> 02:44:52,951 EQUATE BECAUSE I'M TRYING TO BE 3968 02:44:52,951 --> 02:44:55,253 IN A RELATIONSHIP, NOT SPEAKING 3969 02:44:55,253 --> 02:44:56,755 FOR MYSELF BUT BEING IN A 3970 02:44:56,755 --> 02:44:57,789 RELATIONSHIP AND LIVING WITH 3971 02:44:57,789 --> 02:44:59,891 SOMEBODY BECAUSE A LOT OF US 3972 02:44:59,891 --> 02:45:01,793 HAVE LIVED WITH OUR GRANDPARENTS 3973 02:45:01,793 --> 02:45:02,827 WHO PASSED AWAY. 3974 02:45:02,827 --> 02:45:09,501 WE'VE SEEN THEM PASS AWAY 3975 02:45:09,501 --> 02:45:10,502 BEFORE -- WE OUTLIVED THE 3976 02:45:10,502 --> 02:45:16,841 PARENTS, THE FOSTER CARE SYSTEM, 3977 02:45:16,841 --> 02:45:18,176 NOW NAVIGATING WITH THAT 3978 02:45:18,176 --> 02:45:19,244 MEDICAL, THE CO-PAYMENT FOR 3979 02:45:19,244 --> 02:45:21,246 MEDICATION, WANT TO LIVE LIFE, 3980 02:45:21,246 --> 02:45:24,950 BUT BECAUSE WE CAN'T AFFORD $300 3981 02:45:24,950 --> 02:45:29,354 FOR A CO-PAYMENT, I'D RATHER NOT 3982 02:45:29,354 --> 02:45:30,455 BE ON MEDICATION. 3983 02:45:30,455 --> 02:45:33,058 AND NOBODY IS TALKING ABOUT THE 3984 02:45:33,058 --> 02:45:34,359 RESOURCES TO EVEN COMPENSATE 3985 02:45:34,359 --> 02:45:35,160 THAT. 3986 02:45:35,160 --> 02:45:37,195 OKAY, YOU DON'T HAVE TO -- 3987 02:45:37,195 --> 02:45:38,296 THERE'S DIFFERENT PROGRAMS OUT 3988 02:45:38,296 --> 02:45:41,700 THERE TO ASSIST YOU WHERE WE CAN 3989 02:45:41,700 --> 02:45:45,403 PAY FOR THE CO-PAYS, BUT NOBODY 3990 02:45:45,403 --> 02:45:51,643 IS TALKING ABOUT. 3991 02:45:51,643 --> 02:45:53,211 TRANSITIONING OUT OF PEDIATRIC 3992 02:45:53,211 --> 02:45:56,648 CARE, THEY ARE RUSHING YOU OUT, 3993 02:45:56,648 --> 02:45:58,316 TALKING AT YOU AND NOT WITH YOU. 3994 02:45:58,316 --> 02:46:02,120 TRYING TO COME UP WITH ACTUAL 3995 02:46:02,120 --> 02:46:02,654 GAME PLAN. 3996 02:46:02,654 --> 02:46:05,557 IF YOU EXPERIENCED PEDIATRIC 3997 02:46:05,557 --> 02:46:06,925 CARE IT'S A WHOLESOME LOVING 3998 02:46:06,925 --> 02:46:09,160 ENVIRONMENT, FOR A LOT OF US, I 3999 02:46:09,160 --> 02:46:13,198 DON'T WANT TO GO TO CARE BECAUSE 4000 02:46:13,198 --> 02:46:14,499 NOW I'M NOBODY, I'M A NUMBER. 4001 02:46:14,499 --> 02:46:17,335 IT'S THE WAY PEOPLE ARE TRAINED. 4002 02:46:17,335 --> 02:46:18,570 THEY ARE NOT TRAINED PROPERLY 4003 02:46:18,570 --> 02:46:21,072 HOW TO TALK TO PEOPLE LIVING 4004 02:46:21,072 --> 02:46:24,709 WITH HIV, AND ESPECIALLY THIS 4005 02:46:24,709 --> 02:46:25,777 POPULATION ON THE AMOUNT OF 4006 02:46:25,777 --> 02:46:26,878 STUFF THAT'S HAPPENING. 4007 02:46:26,878 --> 02:46:28,413 THE HISTORY PART WHAT WE'VE BEEN 4008 02:46:28,413 --> 02:46:30,482 THROUGH AS CHILDREN, GOING TO 4009 02:46:30,482 --> 02:46:33,118 DOCTOR CONTINUOUSLY AS CHILDREN, 4010 02:46:33,118 --> 02:46:34,753 TRYING TO DIFFERENT MEDICATIONS, 4011 02:46:34,753 --> 02:46:38,423 IN AND OUT OF THE SYSTEM, LOSING 4012 02:46:38,423 --> 02:46:40,025 PARENTS, BEING AN ADULT, TRYING 4013 02:46:40,025 --> 02:46:41,026 TO NAVIGATE WHAT THAT LOOKS 4014 02:46:41,026 --> 02:46:44,629 LIKE, A LOT OF PEOPLE THAT THIS 4015 02:46:44,629 --> 02:46:46,131 IS NOT BEING TAUGHT HOW TO 4016 02:46:46,131 --> 02:46:47,399 ACTUALLY CARE FOR US. 4017 02:46:47,399 --> 02:46:50,902 I WOULD SAY THE CARE PART, 4018 02:46:50,902 --> 02:46:53,672 TRANSITION PART PEDIATRIC TO 4019 02:46:53,672 --> 02:46:55,807 ADULT CARE, MORE PROGRAMS 4020 02:46:55,807 --> 02:46:57,008 INITIATED FOR ART, WHEN 4021 02:46:57,008 --> 02:46:58,743 EMOTIONAL ASPECTS ARE NOW STILL 4022 02:46:58,743 --> 02:47:00,378 BEING ALIVE, WHAT THAT LOOKS 4023 02:47:00,378 --> 02:47:00,578 LIKE. 4024 02:47:00,578 --> 02:47:05,216 >> THANK YOU. 4025 02:47:05,216 --> 02:47:06,184 >> WE COULD HAVE THIS 4026 02:47:06,184 --> 02:47:06,918 CONVERSATION FOREVER. 4027 02:47:06,918 --> 02:47:09,587 I WANT TO ADD SOMETHING TOO WHAT 4028 02:47:09,587 --> 02:47:15,694 KIM SAID AS WELL AS TO RESPOND 4029 02:47:15,694 --> 02:47:18,363 TO YOU, ALSO TO DR. MONTANER, 4030 02:47:18,363 --> 02:47:19,764 ONE THING WE HAVEN'T LOOKED AT 4031 02:47:19,764 --> 02:47:21,866 OVER THE COURSE OF THE 4032 02:47:21,866 --> 02:47:23,034 TRANSITION FROM PEDIATRIC CARE 4033 02:47:23,034 --> 02:47:24,803 TO ADOLESCENT TO ADULT CARE, 4034 02:47:24,803 --> 02:47:26,504 MANY PATIENTS WHO HAVE BEEN ON 4035 02:47:26,504 --> 02:47:29,808 DRUGS FOR A LONG TIME, NOT 4036 02:47:29,808 --> 02:47:33,978 DRUGS, THEY HAVE LOTS OF 4037 02:47:33,978 --> 02:47:34,346 CO-MORBIDITIES. 4038 02:47:34,346 --> 02:47:35,814 COMORBIDITIES ARE FRIGHTENING, 4039 02:47:35,814 --> 02:47:41,319 YOUNG WOMEN AND MEN HAVE HEART 4040 02:47:41,319 --> 02:47:42,821 DISEASE, HYPERTENSIVE. 4041 02:47:42,821 --> 02:47:50,395 AND IT'S THOSE KINDS OF THINGS 4042 02:47:50,395 --> 02:47:51,196 VERY OFTEN NECESSARILY HIV, 4043 02:47:51,196 --> 02:47:53,865 SOMETHING ELSE THAT KILLS THEM. 4044 02:47:53,865 --> 02:47:55,300 WE HAVEN'T FOCUSED ON WHAT 4045 02:47:55,300 --> 02:47:58,670 SPECIFIC AREAS ARE BUT WITH KIM 4046 02:47:58,670 --> 02:47:59,904 HERE AND WITH DR. MARTINS' 4047 02:47:59,904 --> 02:48:01,139 RESEARCH WE DO HAVE THE 4048 02:48:01,139 --> 02:48:05,577 OPPORTUNITY TO DO THAT. 4049 02:48:05,577 --> 02:48:10,181 THANK YOU ALL FOR SUCH AN 4050 02:48:10,181 --> 02:48:10,782 INSIGHTFUL CONVERSATION. 4051 02:48:10,782 --> 02:48:13,251 NOW I WANT TO MOVE FORWARD WITH 4052 02:48:13,251 --> 02:48:18,089 THE AGENDA SO WE CAN NOW HEAR A 4053 02:48:18,089 --> 02:48:20,592 BRIEF UPDATE FROM NIAID AIDS 4054 02:48:20,592 --> 02:48:24,229 RESEARCH ADVISORY COMMITTEE, DR. 4055 02:48:24,229 --> 02:48:27,499 ELAINE ABRAMS. 4056 02:48:27,499 --> 02:48:29,167 THE FLOOR IS YOURS. 4057 02:48:29,167 --> 02:48:32,203 >> JUST NEED MY SLIDES. 4058 02:48:32,203 --> 02:48:32,570 GREAT. 4059 02:48:32,570 --> 02:48:34,906 AND I WILL SAY THIS IS A LITTLE 4060 02:48:34,906 --> 02:48:38,309 BIT LIKE A GOLDILOCKS MOMENT, AS 4061 02:48:38,309 --> 02:48:42,847 I HOPE I'M NOT TOO LONG OR TOO 4062 02:48:42,847 --> 02:48:43,314 SHORT. 4063 02:48:43,314 --> 02:48:46,551 THIS IS MY FIRST OPPORTUNITY TO 4064 02:48:46,551 --> 02:48:48,520 JOIN THIS MEETING. 4065 02:48:48,520 --> 02:48:49,954 BEAR WITH ME. 4066 02:48:49,954 --> 02:48:54,025 SO I'M GOING TO REPORT BACK ON 4067 02:48:54,025 --> 02:48:56,628 THE NIAID COUNCIL ARAC MEETING 4068 02:48:56,628 --> 02:48:59,164 OF JUNE 3. 4069 02:48:59,164 --> 02:49:01,766 NEXT SLIDE PLEASE. 4070 02:49:01,766 --> 02:49:03,301 THE MEETING STARTED WITH THE 4071 02:49:03,301 --> 02:49:07,372 DIRECTOR DR. CARL DIEFFENBACH'S 4072 02:49:07,372 --> 02:49:07,705 REPORT. 4073 02:49:07,705 --> 02:49:10,275 I'LL GO THROUGH THE HIGHLIGHTS 4074 02:49:10,275 --> 02:49:15,513 OF WHAT HE SHARED WITH US. 4075 02:49:15,513 --> 02:49:19,651 NEXT PLEASE. 4076 02:49:19,651 --> 02:49:24,823 HE INTRODUCED NEW ARAC MEMBERS 4077 02:49:24,823 --> 02:49:28,626 INCLUDING DR. GRACE ALDROVANDI, 4078 02:49:28,626 --> 02:49:34,532 DR. SHAH, DR. GEBO, TIMOTHY 4079 02:49:34,532 --> 02:49:36,401 HENRICH, DR. LANDOVIT DIS 4080 02:49:36,401 --> 02:49:39,437 DR. LUVU. 4081 02:49:39,437 --> 02:49:41,506 NEXT PLEASE. 4082 02:49:41,506 --> 02:49:46,444 HE ALSO INTRODUCED THE NEW OR 4083 02:49:46,444 --> 02:49:48,546 UPDATED NIAID HIV LANGUAGE GUIDE 4084 02:49:48,546 --> 02:49:50,215 AND RELATED MATERIALS WHICH 4085 02:49:50,215 --> 02:49:55,753 COULD ALL BE FOUND AT THIS 4086 02:49:55,753 --> 02:49:56,287 WEBSITE. 4087 02:49:56,287 --> 02:49:59,724 NIAID IS MAKING EVERY EFFORT TO 4088 02:49:59,724 --> 02:50:00,992 ELIMINATE USE OF STIGMATIZING 4089 02:50:00,992 --> 02:50:04,195 TERMINOLOGY AND ADVANCE THE USE 4090 02:50:04,195 --> 02:50:06,498 OF PERSON FIRST INCLUSIVE AND 4091 02:50:06,498 --> 02:50:07,365 RESPECTFUL LANGUAGE. 4092 02:50:07,365 --> 02:50:09,234 AND I'M SURE EVERYBODY IS 4093 02:50:09,234 --> 02:50:10,969 FAMILIAR WITH THIS GUIDE. 4094 02:50:10,969 --> 02:50:15,039 IT'S BEEN ESSENTIAL TO 4095 02:50:15,039 --> 02:50:16,808 RESEARCHERS AS WELL AS TO THE 4096 02:50:16,808 --> 02:50:21,045 COMMUNITY TO GET US ALL ON BOARD 4097 02:50:21,045 --> 02:50:26,751 TO USING THIS PERSON-FIRST 4098 02:50:26,751 --> 02:50:29,454 RESPECTFUL LANGUAGE. 4099 02:50:29,454 --> 02:50:32,323 HE SPENT SOME TIME REVIEWING 4100 02:50:32,323 --> 02:50:37,795 BUDGETARY ISSUES. 4101 02:50:37,795 --> 02:50:40,532 POINTING OUT THAT THE 2024, FY 4102 02:50:40,532 --> 02:50:45,803 24 ENACTED BUDGET, WAS FLAT 4103 02:50:45,803 --> 02:50:48,773 LINED, UNCHANGED, COMPARED WITH 4104 02:50:48,773 --> 02:50:51,409 FY 2023 AUTHOR NIAID IN 4105 02:50:51,409 --> 02:50:51,809 PARTICULAR. 4106 02:50:51,809 --> 02:51:01,686 IT'S HIGHLIGHTED IN YELLOW HERE. 4107 02:51:01,686 --> 02:51:02,987 R01 PAYLINE ESTABLISHED 4108 02:51:02,987 --> 02:51:05,323 INVESTIGATORS AT THE 10th 4109 02:51:05,323 --> 02:51:06,824 PERCENTILE. 4110 02:51:06,824 --> 02:51:12,497 NEW P.I.s AT 14th 4111 02:51:12,497 --> 02:51:13,364 PERCENTILE. 4112 02:51:13,364 --> 02:51:14,265 NON-COMPETING AT 100%, COMPETING 4113 02:51:14,265 --> 02:51:18,469 GRANTS WILL BE FUNDED AT 90% OF 4114 02:51:18,469 --> 02:51:20,505 APPROVED FUNDING. 4115 02:51:20,505 --> 02:51:24,442 NO ADJUSTMENTS TO FELLOWSHIP 4116 02:51:24,442 --> 02:51:25,343 TRAINING, CAREER DEVELOPMENT, 4117 02:51:25,343 --> 02:51:26,878 SMALL BUSINESS AWARDS. 4118 02:51:26,878 --> 02:51:29,581 COMPETING RESEARCH INITIATIVES 4119 02:51:29,581 --> 02:51:33,117 MAY HAVE UP TO 20% CUT, OVERALL 4120 02:51:33,117 --> 02:51:38,256 ESTIMATED SUCCESS RATE IS 4121 02:51:38,256 --> 02:51:38,556 16-20%. 4122 02:51:38,556 --> 02:51:41,225 NEXT PLEASE. 4123 02:51:41,225 --> 02:51:42,860 FINALLY HE REVIEWED THE HEARING 4124 02:51:42,860 --> 02:51:46,998 AIDS CLINICAL TRIALS NETWORK 4125 02:51:46,998 --> 02:51:47,565 RECOMPETITION TIMELINE, THE 4126 02:51:47,565 --> 02:51:49,634 PROCESS HAS ALREADY BEEN 4127 02:51:49,634 --> 02:51:52,003 LAUNCHED THIS SPRING WITH 4128 02:51:52,003 --> 02:51:54,005 NETWORK PRESENTATIONS TO 4129 02:51:54,005 --> 02:51:55,607 STRATEGIC WORKING GROUP, WE'LL 4130 02:51:55,607 --> 02:51:57,442 HAVE PRELIMINARY DISCUSSIONS 4131 02:51:57,442 --> 02:52:00,178 WITH ARAC AND OTHER ADVISORY 4132 02:52:00,178 --> 02:52:03,681 COMMITTEES IN THE FALL, CAN 4133 02:52:03,681 --> 02:52:06,851 EXPECT THE RFAs TO BE 4134 02:52:06,851 --> 02:52:09,287 PUBLISHED IN JANUARY 2026. 4135 02:52:09,287 --> 02:52:13,191 AND GRANTS WILL BE DUE IN THE 4136 02:52:13,191 --> 02:52:14,726 FALL OF 2026. 4137 02:52:14,726 --> 02:52:18,663 ALL OF THE NETWORKS ARE ALREADY 4138 02:52:18,663 --> 02:52:25,103 DEEP INTO INTERNAL CONVERSATIONS 4139 02:52:25,103 --> 02:52:26,671 ABOUT THEIR PROCESSES. 4140 02:52:26,671 --> 02:52:29,607 IN ADDITION TO DIRECTOR'S 4141 02:52:29,607 --> 02:52:31,042 REPORT, PRIMARY ACTIVITIES 4142 02:52:31,042 --> 02:52:34,846 DURING MEETING WERE TO APPROVE 4143 02:52:34,846 --> 02:52:40,118 THE REVIEW AND APPROVE THE NEW 4144 02:52:40,118 --> 02:52:40,852 CONCEPTS. 4145 02:52:40,852 --> 02:52:42,220 THERE WERE SEVEN CONCEPTS 4146 02:52:42,220 --> 02:52:46,457 PRESENTED AND APPROVED AT THIS 4147 02:52:46,457 --> 02:52:46,858 MEETING. 4148 02:52:46,858 --> 02:52:53,431 LISTED HERE. 4149 02:52:53,431 --> 02:52:54,632 NEXT SLIDE PLEASE. 4150 02:52:54,632 --> 02:52:55,900 THERE WERE A LOT OF DISCUSSIONS 4151 02:52:55,900 --> 02:52:59,237 DURING THIS MEETING ABOUT THE 4152 02:52:59,237 --> 02:53:02,373 MARTIN DELANEY COLLABORATORIES, 4153 02:53:02,373 --> 02:53:06,844 THIS IS THE FIRST OF THREE 4154 02:53:06,844 --> 02:53:10,148 COLLABORATORY CONCEPTS, THIS ONE 4155 02:53:10,148 --> 02:53:14,185 IS A REISSUE FOR FIVE-YEAR AWARD 4156 02:53:14,185 --> 02:53:17,221 FROM NIAID WITH MULTIPLE 4157 02:53:17,221 --> 02:53:17,922 INSTITUTES OF POTENTIAL 4158 02:53:17,922 --> 02:53:21,526 PARTNERS, THE INTENT IS TO 4159 02:53:21,526 --> 02:53:22,493 ACCELERATE INNOVATIVE DYNAMIC 4160 02:53:22,493 --> 02:53:27,765 AND COLLABORATIVE BASIC AND 4161 02:53:27,765 --> 02:53:28,733 TRANSLATIONAL AND CLINICAL 4162 02:53:28,733 --> 02:53:37,742 RESEARCH, BROAD PARTNERSHIP 4163 02:53:37,742 --> 02:53:39,777 ACROSS ACADEMIA, TO ACHIEVE 4164 02:53:39,777 --> 02:53:42,180 ERADICATION OF HIV. 4165 02:53:42,180 --> 02:53:44,282 NEXT SLIDE PLEASE. 4166 02:53:44,282 --> 02:53:46,484 THE INITIATIVE SEEKS AND HAS 4167 02:53:46,484 --> 02:53:49,687 BEEN SEEKING OVER TIME TO 4168 02:53:49,687 --> 02:53:51,756 ADDRESS MAJOR OBSTACLES TO CURE 4169 02:53:51,756 --> 02:53:53,491 AND REMISSION IN PEOPLE LIVING 4170 02:53:53,491 --> 02:53:56,461 WITH HIV, WITH THE GOAL TO 4171 02:53:56,461 --> 02:53:59,163 EXTEND UNDERSTANDING OF BASIC 4172 02:53:59,163 --> 02:54:02,266 BIOLOGY AND DYNAMICS OF 4173 02:54:02,266 --> 02:54:05,303 PERSISTENT RESERVOIRS, DEVELOP 4174 02:54:05,303 --> 02:54:06,738 IMPROVED ASSAYS, METHODOLOGY, 4175 02:54:06,738 --> 02:54:08,740 EXPEDITE RESEARCH AND PROGRESS, 4176 02:54:08,740 --> 02:54:12,009 TO DESIGN, DEVELOP, TEST 4177 02:54:12,009 --> 02:54:14,278 THERAPEUTIC STRATEGIES ACHIEVING 4178 02:54:14,278 --> 02:54:15,379 LONG-TERM REMISSION OR 4179 02:54:15,379 --> 02:54:18,816 ERADICATION, WHEN YOU CAN SEE 4180 02:54:18,816 --> 02:54:22,420 THE SETUP OF THE COLLABORATORIES 4181 02:54:22,420 --> 02:54:25,223 IN THIS FIGURE. 4182 02:54:25,223 --> 02:54:27,725 NEXT PLEASE. 4183 02:54:27,725 --> 02:54:29,494 THE SECOND CONCEPT PARALLELS THE 4184 02:54:29,494 --> 02:54:32,764 FIRST FOR ANOTHER MARTIN DELANEY 4185 02:54:32,764 --> 02:54:33,731 COLLABORATORY. 4186 02:54:33,731 --> 02:54:38,469 THIS ONE IS SPECIFICALLY FOCUSED 4187 02:54:38,469 --> 02:54:40,538 ON PEDIATRIC HIV RESEARCH, ON 4188 02:54:40,538 --> 02:54:42,740 THE CURRENT COLLABORATORY WAS 4189 02:54:42,740 --> 02:54:45,810 JUST DISCUSSED, LAST SESSION. 4190 02:54:45,810 --> 02:54:48,312 THERE WOULD BE ONE AWARD ALSO A 4191 02:54:48,312 --> 02:54:51,749 REISSUE, AND THE PURPOSE IS ALSO 4192 02:54:51,749 --> 02:54:53,351 TO ACCELERATE RESEARCH TO 4193 02:54:53,351 --> 02:54:57,989 ADDRESS MAJOR OBSTACLES IN HIV 4194 02:54:57,989 --> 02:55:01,325 ERADICATION, LONG-TERM ART-FREE 4195 02:55:01,325 --> 02:55:01,859 CONTROL. 4196 02:55:01,859 --> 02:55:06,297 BUT FOR PEDIATRIC HIV CURE 4197 02:55:06,297 --> 02:55:09,133 RESEARCHERS FOCUSING ON 4198 02:55:09,133 --> 02:55:09,534 CHILDREN. 4199 02:55:09,534 --> 02:55:10,802 NEXT SLIDE PLEASE. 4200 02:55:10,802 --> 02:55:15,139 YOU CAN SEE THE STRUCTURE OF 4201 02:55:15,139 --> 02:55:16,073 THIS COLLABORATORY, IN THIS 4202 02:55:16,073 --> 02:55:17,241 FIGURE. 4203 02:55:17,241 --> 02:55:23,181 THIS IS THE FIRST PEDIATRIC MDC. 4204 02:55:23,181 --> 02:55:25,850 AND RESEARCH FOCI ON BASIC 4205 02:55:25,850 --> 02:55:30,988 SCIENCE, CONTROL OF REBOUND, 4206 02:55:30,988 --> 02:55:33,090 ERADICATION, ASSAY DEVELOPMENT. 4207 02:55:33,090 --> 02:55:35,459 THIS PROGRAM IS SPECIFICALLY 4208 02:55:35,459 --> 02:55:39,330 FOCUSED ON PEOPLE LIVING WITH 4209 02:55:39,330 --> 02:55:44,535 HIV, UNDER 18 YEARS OF AGE. 4210 02:55:44,535 --> 02:55:49,707 THE GOALS PARALLEL NON-PEDIATRIC 4211 02:55:49,707 --> 02:55:51,542 OR ADULT COLLABORATORIES. 4212 02:55:51,542 --> 02:55:55,079 THE FINAL MARTIN DELANEY 4213 02:55:55,079 --> 02:55:58,649 COLLABORATORY CONCEPT WAS FOR A 4214 02:55:58,649 --> 02:56:02,420 NEW AWARD TO ESTABLISH A 4215 02:56:02,420 --> 02:56:05,089 COORDINATION CENTER. 4216 02:56:05,089 --> 02:56:07,425 FACILITATE COMMUNICATION, 4217 02:56:07,425 --> 02:56:09,493 COLLABORATION, COORDINATION, 4218 02:56:09,493 --> 02:56:13,564 AMONG THE INDIVIDUAL MDCS AND 4219 02:56:13,564 --> 02:56:15,766 KEY STAKEHOLDERS, SUPPORTING A 4220 02:56:15,766 --> 02:56:19,136 COORDINATION CENTER THAT WOULD 4221 02:56:19,136 --> 02:56:20,004 PROVIDE ADMINISTRATIVE, 4222 02:56:20,004 --> 02:56:22,273 SCIENTIFIC, TECHNICAL AND 4223 02:56:22,273 --> 02:56:25,276 MANAGEMENT SUPPORT TO ENHANCE 4224 02:56:25,276 --> 02:56:35,653 THE COLLABORATIVE AND 4225 02:56:36,954 --> 02:56:37,655 COOPERATIVE INTERDISCIPLINARY 4226 02:56:37,655 --> 02:56:38,189 ENVIRONMENT. 4227 02:56:38,189 --> 02:56:42,660 AND THIS IS REALLY THE VISION 4228 02:56:42,660 --> 02:56:44,095 FOR THE COORDINATION CENTER 4229 02:56:44,095 --> 02:56:44,762 SUPPORT. 4230 02:56:44,762 --> 02:56:48,566 YOU CAN SEE THE COLLABORATORIES, 4231 02:56:48,566 --> 02:56:52,737 THE JEWELS, AND THE COORDINATION 4232 02:56:52,737 --> 02:56:54,705 CENTER WOULD PROVIDE 4233 02:56:54,705 --> 02:56:57,375 COORDINATION BETWEEN THE 4234 02:56:57,375 --> 02:57:00,311 COLLABORATORIES, WITH THE NIH 4235 02:57:00,311 --> 02:57:04,982 PROGRAM TEAM, AND ALL OF THE 4236 02:57:04,982 --> 02:57:06,417 COMMUNITY AND SCIENTIFIC 4237 02:57:06,417 --> 02:57:07,285 CONSULTANTS. 4238 02:57:07,285 --> 02:57:11,689 ALSO LIKELY SUPPORT SOME EARLY 4239 02:57:11,689 --> 02:57:19,230 CROSS-CUTTING EARLY INVESTIGATOR 4240 02:57:19,230 --> 02:57:20,932 FELLOWSHIPS OR SCHOLARSHIPS. 4241 02:57:20,932 --> 02:57:25,636 WE WENT FROM COLLABORATORIES TO 4242 02:57:25,636 --> 02:57:28,739 TALK ABOUT ANOTHER FLAGSHIP 4243 02:57:28,739 --> 02:57:33,244 PROGRAM, THE IEDEA NETWORK OR 4244 02:57:33,244 --> 02:57:33,711 PROGRAM, INTERNATIONAL 4245 02:57:33,711 --> 02:57:34,912 EPIDEMIOLOGY DATABASES TO 4246 02:57:34,912 --> 02:57:36,314 EVALUATE AIDS. 4247 02:57:36,314 --> 02:57:40,885 THIS IS A U01 MECHANISM, LIMITED 4248 02:57:40,885 --> 02:57:43,821 COMPETITION AND REISSUE, 4249 02:57:43,821 --> 02:57:45,589 OBJECTIVE TO CONTINUE 4250 02:57:45,589 --> 02:57:46,590 INTERNATIONAL EPIDEMIOLOGY 4251 02:57:46,590 --> 02:57:53,164 PROGRAM FOCUSED ON CLINICAL 4252 02:57:53,164 --> 02:57:54,365 EFFECTIVENESS ACROSS NIH'S 4253 02:57:54,365 --> 02:57:58,502 CURRENT PROGRAMS TO UNDERSTAND 4254 02:57:58,502 --> 02:58:00,871 THE CHANGING HIV EPIDEMIC 4255 02:58:00,871 --> 02:58:01,472 GLOBALLY. 4256 02:58:01,472 --> 02:58:04,141 AND THIS IS -- HAS MULTIPLE 4257 02:58:04,141 --> 02:58:07,511 INSTITUTES THAT OVER TIME HAVE 4258 02:58:07,511 --> 02:58:10,114 PARTICIPATED AND CONTINUE TO 4259 02:58:10,114 --> 02:58:12,883 PARTICIPATE IN THIS PROGRAM. 4260 02:58:12,883 --> 02:58:16,587 NEXT SLIDE PLEASE. 4261 02:58:16,587 --> 02:58:19,790 SO, THERE ARE CURRENTLY SEVEN 4262 02:58:19,790 --> 02:58:23,260 REGIONAL DATA CENTER AWARDS THAT 4263 02:58:23,260 --> 02:58:28,332 COVER 7 REGIONS, 44 COUNTRIES, 4264 02:58:28,332 --> 02:58:29,533 388 SITES, OVER 2 MILLION 4265 02:58:29,533 --> 02:58:33,137 PEOPLE, CLOSE TO A QUARTER OF A 4266 02:58:33,137 --> 02:58:36,974 MILLION CHILDREN. 4267 02:58:36,974 --> 02:58:41,278 AND OVERALL, SUPPORT DATA 4268 02:58:41,278 --> 02:58:42,646 COLLECTION, AGGREGATION, 4269 02:58:42,646 --> 02:58:44,815 QUALITY, DEVELOP NOVEL DATA 4270 02:58:44,815 --> 02:58:45,850 CORRECTION, CONDUCT RESEARCH IN 4271 02:58:45,850 --> 02:58:49,653 COLLABORATION WITH CLINICS, WITH 4272 02:58:49,653 --> 02:58:51,622 EACH OTHER, IN-COUNTRY PARTNERS, 4273 02:58:51,622 --> 02:58:53,491 HUGE INVESTMENT IN TRAINING 4274 02:58:53,491 --> 02:59:00,064 INVESTIGATORS AND SERVES AS 4275 02:59:00,064 --> 02:59:01,265 PLATFORM FOR OTHER RESEARCH. 4276 02:59:01,265 --> 02:59:03,467 IT WILL BRING TOGETHER CLINICAL 4277 02:59:03,467 --> 02:59:09,707 AND RESEARCH DATA WITHIN THE 4278 02:59:09,707 --> 02:59:11,008 REGIONS AND COLLABORATION 4279 02:59:11,008 --> 02:59:12,443 GLOBALLY, TO MONITOR AND GUIDE 4280 02:59:12,443 --> 02:59:15,746 RESPONSE WITH KEY QUESTIONS 4281 02:59:15,746 --> 02:59:18,015 AROUND LONG-TERM IMPACT OF HIV 4282 02:59:18,015 --> 02:59:19,683 AND TREATMENT, EPIDEMIOLOGY OF 4283 02:59:19,683 --> 02:59:24,889 COMMON INFECTION, HEALTH CARE 4284 02:59:24,889 --> 02:59:31,729 UTILIZATION, ULTIMATELY COMPARE 4285 02:59:31,729 --> 02:59:33,864 BETWEEN REGIONS. 4286 02:59:33,864 --> 02:59:35,699 AND IMPRESSIVE NUMBER OF PAPERS 4287 02:59:35,699 --> 02:59:37,201 AND YOUNG INVESTIGATORS 4288 02:59:37,201 --> 02:59:38,702 PARTICULARLY FROM LOW- AND 4289 02:59:38,702 --> 02:59:47,478 MIDDLE-INCOME COUNTRIES THAT 4290 02:59:47,478 --> 02:59:49,547 HAVE LAUNCHED THEIR CAREERS. 4291 02:59:49,547 --> 02:59:52,416 WE THEN LOOKED AT CONSORTIA FOR 4292 02:59:52,416 --> 02:59:58,089 HIV/AIDS VACCINE DEVELOPMENT AND 4293 02:59:58,089 --> 03:00:03,794 IMMUNOLOGY, CHAVDI, THE UM 1 4294 03:00:03,794 --> 03:00:06,897 MECHANISM, TO ESTABLISH A 4295 03:00:06,897 --> 03:00:13,104 COORDINATED MULTI-DISCIPLINARY 4296 03:00:13,104 --> 03:00:17,808 EFFORT FOCUSED ON PRE-CLINICAL 4297 03:00:17,808 --> 03:00:20,544 VACCINE DISCOVERY, CLINICAL 4298 03:00:20,544 --> 03:00:21,846 VACCINE MANUFACTURE, AND 4299 03:00:21,846 --> 03:00:22,613 ULTIMATELY ACHIEVE PROOF OF 4300 03:00:22,613 --> 03:00:25,149 CONCEPT OF VACCINE INDUCTION OF 4301 03:00:25,149 --> 03:00:26,784 bNAbS TO THREE DIFFERENT 4302 03:00:26,784 --> 03:00:35,326 bNAb TARGETS AND INCLUSION OF 4303 03:00:35,326 --> 03:00:43,467 OTHER COOPERATIVE IMMUNE 4304 03:00:43,467 --> 03:00:43,868 RESPONSES. 4305 03:00:43,868 --> 03:00:46,203 YOU CAN SEE IT FITS INTO THE 4306 03:00:46,203 --> 03:00:47,605 VACCINE RESEARCH PROGRAM, 4307 03:00:47,605 --> 03:00:51,208 HIGHLIGHTED ABOVE THE RED LINE, 4308 03:00:51,208 --> 03:00:53,944 YOU'LL SEE THE PROGRAM EXTENDS 4309 03:00:53,944 --> 03:00:57,014 FROM DISCOVERY PRE-CLINICAL TO 4310 03:00:57,014 --> 03:00:58,649 TRANSLATIONAL, MANUFACTURING, 4311 03:00:58,649 --> 03:01:07,224 ALL THE WAY TO CLINICAL RESEARCH 4312 03:01:07,224 --> 03:01:09,627 NEXT PLEASE. 4313 03:01:09,627 --> 03:01:11,962 NEXT CONCEPT WAS THE LAST 4314 03:01:11,962 --> 03:01:13,464 PROGRAM, ADVANCING TRANSLATION 4315 03:01:13,464 --> 03:01:17,668 OF LONG ACTING STRATEGIES FOR 4316 03:01:17,668 --> 03:01:21,138 HIV AND HIV-ASSOCIATED 4317 03:01:21,138 --> 03:01:21,572 CO-INFECTION. 4318 03:01:21,572 --> 03:01:26,510 AND THIS IS A NEW GRANT, R61, 4319 03:01:26,510 --> 03:01:28,979 R33, OBJECTIVE IS TO SUPPORT 4320 03:01:28,979 --> 03:01:30,414 PRE-CLINICAL ACTIVITIES FOR THE 4321 03:01:30,414 --> 03:01:34,018 DEVELOPMENT OF SAFE AND 4322 03:01:34,018 --> 03:01:36,754 EFFECTIVE LONG ACTING SUSTAINED 4323 03:01:36,754 --> 03:01:38,155 RELEASED TECHNOLOGIES FOR 4324 03:01:38,155 --> 03:01:41,358 PREVENTION, TREATMENT OF HIV AND 4325 03:01:41,358 --> 03:01:44,195 ASSOCIATED TB AND HEPATITIS AND 4326 03:01:44,195 --> 03:01:46,664 TO ULTIMATELY ENABLE SUBMISSION 4327 03:01:46,664 --> 03:01:49,567 OF IND APPLICATIONS TO THE FDA, 4328 03:01:49,567 --> 03:01:51,669 REALLY TO FACILITATE THE 4329 03:01:51,669 --> 03:01:55,005 TRANSITION OF THE INNOVATIVE 4330 03:01:55,005 --> 03:01:57,174 LONG ACTING LOW-RELEASE 4331 03:01:57,174 --> 03:02:03,214 TECHNOLOGIES, FROM R&D TO IND. 4332 03:02:03,214 --> 03:02:03,781 NEXT PLEASE. 4333 03:02:03,781 --> 03:02:07,518 IN THIS FIGURE YOU SEE THE 4334 03:02:07,518 --> 03:02:11,755 OVERALL PROGRAM FROM LONG ACTING 4335 03:02:11,755 --> 03:02:13,958 RELEASE DEVELOPMENT TO CLINICAL 4336 03:02:13,958 --> 03:02:17,027 TRIALS, AND IN YELLOW THE AT 4337 03:02:17,027 --> 03:02:19,430 LAST PROGRAM INTENDED TO FIT, IN 4338 03:02:19,430 --> 03:02:23,901 THE MIDDLE IT'S A TRANSITION 4339 03:02:23,901 --> 03:02:26,337 FROM THOSE DEVELOPMENT TO TRIAL. 4340 03:02:26,337 --> 03:02:28,505 THE PROGRAM INITIATIVES AND 4341 03:02:28,505 --> 03:02:32,042 RESOURCES ARE BEING PROVIDED TO 4342 03:02:32,042 --> 03:02:34,078 OVERCOME THIS TRANSLATIONAL GAP, 4343 03:02:34,078 --> 03:02:37,414 AND FACILITATE ADVANCEMENT OF 4344 03:02:37,414 --> 03:02:38,582 THESE INNOVATIVE TECHNOLOGIES. 4345 03:02:38,582 --> 03:02:41,185 THE PURPOSE IS TO SUPPORT AND 4346 03:02:41,185 --> 03:02:43,754 ULTIMATELY ENABLE SUBMISSION OF 4347 03:02:43,754 --> 03:02:46,490 A NEW INVESTIGATIONAL DRUG TO 4348 03:02:46,490 --> 03:02:50,928 THE FDA, THE FIRST PHASE WOULD 4349 03:02:50,928 --> 03:02:51,729 SUPPORT RESEARCH THAT 4350 03:02:51,729 --> 03:02:52,296 DEMONSTRATED SIGNIFICANT 4351 03:02:52,296 --> 03:02:53,797 PRELIMINARY DATA THAT HASN'T 4352 03:02:53,797 --> 03:02:55,766 ADVANCED TO THE LEVEL OF 4353 03:02:55,766 --> 03:02:57,334 CLINICAL TRANSLATION. 4354 03:02:57,334 --> 03:02:59,603 AND THE SECOND PHASE WOULD 4355 03:02:59,603 --> 03:03:01,705 SUPPORT RESEARCH THAT'S IN THE 4356 03:03:01,705 --> 03:03:04,541 FINAL STAGE OF PRE-CLINICAL 4357 03:03:04,541 --> 03:03:12,182 DEVELOPMENT WITH POTENTIAL FOR 4358 03:03:12,182 --> 03:03:13,851 IND SUBMISSION. 4359 03:03:13,851 --> 03:03:20,057 LAST, THE VQ ARKS VIRAL QUALITY 4360 03:03:20,057 --> 03:03:23,360 ASSURANCE PROGRAM, VQA, TO 4361 03:03:23,360 --> 03:03:26,530 PROVIDE A COMPREHENSIVE QUALITY 4362 03:03:26,530 --> 03:03:30,367 ASSESSMENT PROGRAM FOR DAIDS 4363 03:03:30,367 --> 03:03:33,304 LABS PERFORMING VIROLOGYOLOGIC 4364 03:03:33,304 --> 03:03:36,807 ASSAYS IN SUPPORT OF 4365 03:03:36,807 --> 03:03:37,341 NIAID-SPONSORED MULTI-SITE 4366 03:03:37,341 --> 03:03:42,046 CLINICAL STUDIES. 4367 03:03:42,046 --> 03:03:42,346 NEXT PLEASE. 4368 03:03:42,346 --> 03:03:45,716 THE VQA PROGRAM WAS ESTABLISHED 4369 03:03:45,716 --> 03:03:48,319 IN 1988, PROVIDES QUALITY 4370 03:03:48,319 --> 03:03:50,754 ASSURANCE AND PROFICIENCY 4371 03:03:50,754 --> 03:03:51,422 TESTING FOR VIROLOGIC-BASED 4372 03:03:51,422 --> 03:03:57,194 ASSAYS FOR HIV AND OTHER 4373 03:03:57,194 --> 03:03:57,928 PATHOGENS, CONDUCTED AT 4374 03:03:57,928 --> 03:03:59,930 NIAID-SUPPORTED LABS. 4375 03:03:59,930 --> 03:04:02,399 AND IT'S REALLY CONSIDERED 4376 03:04:02,399 --> 03:04:04,601 CRITICAL TO THE SCIENTIFIC 4377 03:04:04,601 --> 03:04:10,407 INTEGRITY OF ONGOING AND FUTURE 4378 03:04:10,407 --> 03:04:10,974 NIAID-FUNDED STUDIES. 4379 03:04:10,974 --> 03:04:14,712 THOSE ARE THE SEVEN CONCEPTS 4380 03:04:14,712 --> 03:04:18,248 APPROVED AND REVIEWED. 4381 03:04:18,248 --> 03:04:21,485 THE NEXT COUNCIL ARAC MEETING IS 4382 03:04:21,485 --> 03:04:22,353 SEPTEMBER 9. 4383 03:04:22,353 --> 03:04:26,557 I WANT TO REMIND EVERYBODY THAT 4384 03:04:26,557 --> 03:04:28,359 OUR MEETINGS ARE RECORDED, 4385 03:04:28,359 --> 03:04:33,263 PUBLICLY POSTED ON THE NIH 4386 03:04:33,263 --> 03:04:34,498 VIDEOCAST WEBSITE. 4387 03:04:34,498 --> 03:04:39,837 THANK YOU VERY MUCH FOR ALLOWING 4388 03:04:39,837 --> 03:04:43,707 ME TO REPORT BACK. 4389 03:04:43,707 --> 03:04:51,048 4390 03:04:51,048 --> 03:04:52,383 4391 03:04:52,383 --> 03:04:54,685 >> THANK YOU, DR. ABRAMS. 4392 03:04:54,685 --> 03:04:57,721 NEXT UPDATE WILL BE FROM MISS 4393 03:04:57,721 --> 03:05:00,023 CORETTÉ BYRD WITH INFORMATION 4394 03:05:00,023 --> 03:05:02,760 FROM THE NIH AIDS EXECUTIVE 4395 03:05:02,760 --> 03:05:03,894 COMMITTEE. 4396 03:05:03,894 --> 03:05:08,232 YOU HAVE THE FLOOR, MISS BYRD. 4397 03:05:08,232 --> 03:05:09,266 >> GOOD AFTERNOON. 4398 03:05:09,266 --> 03:05:11,635 HAPPY FIRST DAY OF SUMMER. 4399 03:05:11,635 --> 03:05:13,470 TODAY I WILL PROVIDE A BRIEF 4400 03:05:13,470 --> 03:05:17,141 OVERVIEW OF A FEW OTHER RECENTLY 4401 03:05:17,141 --> 03:05:18,609 CLEARED HIV CONCEPTS, AND 4402 03:05:18,609 --> 03:05:21,945 REISSUED CONCEPTS AS WELL AS 4403 03:05:21,945 --> 03:05:24,014 SCIENTIFIC ADVANCES FROM OUR 4404 03:05:24,014 --> 03:05:24,882 PARTNER INSTITUTES, CENTERS, 4405 03:05:24,882 --> 03:05:29,353 OFFICES AT NIH SINCE OUR LAST 4406 03:05:29,353 --> 03:05:30,254 MEETING IN FEBRUARY. 4407 03:05:30,254 --> 03:05:33,891 THIS IS A SUMMARY OF ALL NEW AND 4408 03:05:33,891 --> 03:05:34,858 REISSUED CLEARED CONCEPTS FOR 4409 03:05:34,858 --> 03:05:36,493 MARCH THROUGH END OF THIS MONTH. 4410 03:05:36,493 --> 03:05:38,996 AS YOU CAN SEE THERE ARE SEVEN 4411 03:05:38,996 --> 03:05:41,198 NEW AND TWO REISSUED CONCEPTS. 4412 03:05:41,198 --> 03:05:47,337 TOTAL OF NINE FOR THIS PERIOD. 4413 03:05:47,337 --> 03:05:50,474 NATIONAL CANCER INSTITUTE HAS 4414 03:05:50,474 --> 03:05:51,275 TWO NEW CONCEPTS, NATIONAL 4415 03:05:51,275 --> 03:05:53,010 INSTITUTE OF ALCOHOL ABUSE AND 4416 03:05:53,010 --> 03:05:56,513 ALCOHOLISM HAS ONE NEW CLEARED 4417 03:05:56,513 --> 03:05:56,847 CONCEPT. 4418 03:05:56,847 --> 03:05:58,315 NCI THE FIRST CONCEPT SOCIAL 4419 03:05:58,315 --> 03:05:59,616 DETERMINANTS OF HEALTH AND 4420 03:05:59,616 --> 03:06:01,819 QUALITY OF CARE CONTRIBUTORS TO 4421 03:06:01,819 --> 03:06:04,455 CANCER DISPARITIES IN PEOPLE 4422 03:06:04,455 --> 03:06:09,560 WITH HIV, AIMS TO INCREASE NCI 4423 03:06:09,560 --> 03:06:10,194 RESEARCH PORTFOLIO, 4424 03:06:10,194 --> 03:06:11,528 INVESTIGATING CANCER DISPARITIES 4425 03:06:11,528 --> 03:06:14,398 IN PEOPLE WITH HIV. 4426 03:06:14,398 --> 03:06:16,033 AND ADVANCE UNDERSTANDING OF 4427 03:06:16,033 --> 03:06:16,767 WHICH SOCIAL DETERMINANTS OF 4428 03:06:16,767 --> 03:06:19,203 HEALTH ARE IMPORTANT AND HOW 4429 03:06:19,203 --> 03:06:21,805 THEY INTERSECT WITH CANCER CARE, 4430 03:06:21,805 --> 03:06:28,045 INEQUALITY, TO CONTRIBUTE TO 4431 03:06:28,045 --> 03:06:30,681 DISPARITIES IN PEOPLE WITH HIV 4432 03:06:30,681 --> 03:06:31,882 AND CANCER. 4433 03:06:31,882 --> 03:06:36,153 EXPECTATION THE RESEARCH MAY 4434 03:06:36,153 --> 03:06:39,323 INFORM FUTURE INTERVENTIONS. 4435 03:06:39,323 --> 03:06:42,392 THE CONFLUENCE OF CANCER AND HIV 4436 03:06:42,392 --> 03:06:43,360 STIGMA IN HIV-POSITIVE 4437 03:06:43,360 --> 03:06:50,834 INDIVIDUALS DIAGNOSED WITH 4438 03:06:50,834 --> 03:06:52,402 CANCER AIMS TO INFLUENCE AMONG 4439 03:06:52,402 --> 03:06:55,105 PEOPLE WITH HIV DIAGNOSED WITH 4440 03:06:55,105 --> 03:06:55,539 CANCER. 4441 03:06:55,539 --> 03:06:57,841 ASSESS IMPACT OF THESE TWO 4442 03:06:57,841 --> 03:07:00,244 CONVERGING STIGMAS ON CANCER 4443 03:07:00,244 --> 03:07:04,214 OUTCOMES AMONG PEOPLE WITH HIV, 4444 03:07:04,214 --> 03:07:05,849 WITH CANCER, SUPPORT 4445 03:07:05,849 --> 03:07:08,418 EXPERIMENTAL MEDICINE APPROACHES 4446 03:07:08,418 --> 03:07:15,158 THAT LEVERAGE STIGMA REDUCTION, 4447 03:07:15,158 --> 03:07:17,361 TO ELUCIDATE MECHANISMS OF 4448 03:07:17,361 --> 03:07:22,566 STIGMA CONTRIBUTING TO NEGATIVE 4449 03:07:22,566 --> 03:07:23,667 OUTCOMES AND PROMOTE RESEARCH, 4450 03:07:23,667 --> 03:07:29,373 FOCUS ON REGIONS IN WHICH HIV 4451 03:07:29,373 --> 03:07:32,876 CANCER BURDEN IS ELEVATED. 4452 03:07:32,876 --> 03:07:36,880 THE ALCOHOL-HIV/AIDS PROGRAM 4453 03:07:36,880 --> 03:07:37,814 PROJECT COMORBIDITIES, 4454 03:07:37,814 --> 03:07:38,916 CO-INFECTIONS, COMPLICATIONS 4455 03:07:38,916 --> 03:07:41,251 RESEARCH, INTERVENTION AND 4456 03:07:41,251 --> 03:07:42,553 CROSS-CUTTING FOUNDATIONAL 4457 03:07:42,553 --> 03:07:43,320 RESEARCH WILL SOLICIT 4458 03:07:43,320 --> 03:07:45,255 APPLICATIONS FOR HUMAN STUDIES 4459 03:07:45,255 --> 03:07:48,158 THAT WILL ADVANCE OPERATIONS OR 4460 03:07:48,158 --> 03:07:51,194 IMPLEMENTATION RESEARCH IN THE 4461 03:07:51,194 --> 03:07:54,498 CONTEXT OF ALCOHOL AND HIV/AIDS 4462 03:07:54,498 --> 03:07:56,633 BY FACILITATING DEVELOPMENT OF A 4463 03:07:56,633 --> 03:07:59,069 BROADER SYSTEMS APPROACH FOR 4464 03:07:59,069 --> 03:08:02,673 MONITORING COMPLEX HIV AND 4465 03:08:02,673 --> 03:08:03,640 ALCOHOL-RELATED MORBIDITY AND 4466 03:08:03,640 --> 03:08:03,907 MORTALITY. 4467 03:08:03,907 --> 03:08:05,943 AS WELL AS INTERVENTION TO 4468 03:08:05,943 --> 03:08:09,479 REDUCE IMPACT OF ALCOHOL ON HIV 4469 03:08:09,479 --> 03:08:11,214 DISEASE PROGRESSION AND 4470 03:08:11,214 --> 03:08:12,082 TRANSMISSION. 4471 03:08:12,082 --> 03:08:13,383 RESEARCH FUNDED UNDER THIS 4472 03:08:13,383 --> 03:08:14,952 ANNOUNCEMENT WILL SERVE AS 4473 03:08:14,952 --> 03:08:17,688 FOUNDATION FOR NEXT GENERATION 4474 03:08:17,688 --> 03:08:19,356 OF INTERVENTION STUDIES, TO 4475 03:08:19,356 --> 03:08:20,624 ADDRESS ALCOHOL USE FROM 4476 03:08:20,624 --> 03:08:26,430 TRANSMISSION TO TREATMENT OF 4477 03:08:26,430 --> 03:08:26,997 HIV. 4478 03:08:26,997 --> 03:08:30,667 LISTED ARE THE FOUR NEWLY 4479 03:08:30,667 --> 03:08:31,802 CLEARED CONCEPTS FROM NATIONAL 4480 03:08:31,802 --> 03:08:34,404 INSTITUTE ON DRUG ABUSE. 4481 03:08:34,404 --> 03:08:36,273 THE FIRST FUNDAMENTAL RESEARCH 4482 03:08:36,273 --> 03:08:38,108 INTO MECHANISMS THAT CONTRIBUTE 4483 03:08:38,108 --> 03:08:39,776 TO HIV-ASSOCIATED PAIN IN THE 4484 03:08:39,776 --> 03:08:43,046 CONTEXT OF SUBSTANCE USE 4485 03:08:43,046 --> 03:08:46,016 DISORDER IS NOTICE OF FUNDING 4486 03:08:46,016 --> 03:08:47,884 OPPORTUNITY THAT SUPPORTS BASIC 4487 03:08:47,884 --> 03:08:50,487 RESEARCH INTO MECHANISMS OF 4488 03:08:50,487 --> 03:08:52,889 PAIN, MODIFICATION OF PAIN AS A 4489 03:08:52,889 --> 03:08:55,025 CHRONIC CONDITION IN THE CONTEXT 4490 03:08:55,025 --> 03:08:56,994 OF HIV INFECTION. 4491 03:08:56,994 --> 03:08:59,730 WITH SPECIAL EMPHASIS ON 4492 03:08:59,730 --> 03:09:02,499 IDENTIFICATION OF TARGETS FOR 4493 03:09:02,499 --> 03:09:05,135 THERAPEUTIC INTERVENTION TO 4494 03:09:05,135 --> 03:09:06,703 REDUCE RISK OF ANALGESIC 4495 03:09:06,703 --> 03:09:08,105 MEDICATION ESCALATION AND 4496 03:09:08,105 --> 03:09:10,507 TOLERANCE UNDER LONG-TERM USE. 4497 03:09:10,507 --> 03:09:12,042 THE SECOND CONCEPT IN VIVO 4498 03:09:12,042 --> 03:09:14,077 RESEARCH ON EFFECTS OF 4499 03:09:14,077 --> 03:09:17,814 METHAMPHETAMINE USE ON HIV 4500 03:09:17,814 --> 03:09:19,549 INFECTION, EXPRESSION, AND 4501 03:09:19,549 --> 03:09:21,184 PERSISTENCE, PROMOTES RESEARCH 4502 03:09:21,184 --> 03:09:23,487 INTO THE COMPLEX INTERACTIONS 4503 03:09:23,487 --> 03:09:26,023 BETWEEN METH USE AND HIV DISEASE 4504 03:09:26,023 --> 03:09:28,625 BIOLOGY IN VIVO. 4505 03:09:28,625 --> 03:09:31,061 THIS INITIATIVE SUPPORTS METH 4506 03:09:31,061 --> 03:09:35,532 RELEVANT MECHANISTIC STUDIES 4507 03:09:35,532 --> 03:09:36,233 CONNECTING RESEARCH OUTCOMES 4508 03:09:36,233 --> 03:09:39,403 WITH IN VIVO MODELS OF HIV IN 4509 03:09:39,403 --> 03:09:42,339 CLINICAL STUDIES, IN PEOPLE WITH 4510 03:09:42,339 --> 03:09:45,175 HIV ACROSS THE HUMAN LIFESPAN. 4511 03:09:45,175 --> 03:09:46,076 CLINICAL RESEARCH ON 4512 03:09:46,076 --> 03:09:48,145 HIV-ASSOCIATED PAIN IN THE 4513 03:09:48,145 --> 03:09:51,181 CONTEXT OF SUBSTANCE USE 4514 03:09:51,181 --> 03:09:53,183 DISORDERS SEEKS TO UNDERSTAND 4515 03:09:53,183 --> 03:09:54,484 MECHANISM AND FACTORS ASSOCIATED 4516 03:09:54,484 --> 03:09:57,421 WITH PAIN IN PEOPLE WITH HIV AND 4517 03:09:57,421 --> 03:09:59,122 SUBSTANCE USE DISORDER. 4518 03:09:59,122 --> 03:10:00,057 EVEN FURTHER, THIS OPPORTUNITY 4519 03:10:00,057 --> 03:10:01,925 SEEKS TO LEARN MORE ABOUT SAFE 4520 03:10:01,925 --> 03:10:03,727 AND EFFECTIVE TREATMENTS WITH 4521 03:10:03,727 --> 03:10:05,729 THIS POPULATION. 4522 03:10:05,729 --> 03:10:14,071 AND LASTLY, EFFECTS OF HIV ON 4523 03:10:14,071 --> 03:10:18,008 DRUG-SEEKING AND IMPULSIVE 4524 03:10:18,008 --> 03:10:22,612 BEHAVIOR, EFFECTS ON 4525 03:10:22,612 --> 03:10:27,484 DRUG-SEEKING BEHAVIOR AND 4526 03:10:27,484 --> 03:10:30,721 IMPULSIVITY ON INFECTION. 4527 03:10:30,721 --> 03:10:31,722 REISSUANCE BOTH NATIONAL HEART, 4528 03:10:31,722 --> 03:10:37,394 LUNG AND BLOOD INSTITUTE AND 4529 03:10:37,394 --> 03:10:39,062 NATIONAL INSTITUTE OF CHILD 4530 03:10:39,062 --> 03:10:41,798 HEALTH DEVELOPMENT HAVE ONE, 4531 03:10:41,798 --> 03:10:46,937 RENEWAL OF MACS/WIHS COHORT 4532 03:10:46,937 --> 03:10:49,506 STUDY FOR SEVEN YEARS VIA 4533 03:10:49,506 --> 03:10:50,941 COOPERATIVE AGREEMENT MECHANISM, 4534 03:10:50,941 --> 03:10:52,609 KEY AREAS OF SCIENCE WILL BE 4535 03:10:52,609 --> 03:10:55,312 EXPANDED IN RESPONSE TO BOTH 4536 03:10:55,312 --> 03:10:58,215 EVOLVING HIV KNOWLEDGE BASE AND 4537 03:10:58,215 --> 03:11:00,684 AGING OF THE COHORT. 4538 03:11:00,684 --> 03:11:04,521 NICHD EARLY IMMUNE SYSTEM 4539 03:11:04,521 --> 03:11:06,890 DEVELOPMENT AND ONTOGENY WILL 4540 03:11:06,890 --> 03:11:09,126 FOCUS ON UNDERSTANDING THE 4541 03:11:09,126 --> 03:11:10,460 DEVELOPMENT OF ADAPTIVE IMMUNE 4542 03:11:10,460 --> 03:11:13,830 SYSTEM AND HOW IMMUNE FACTORS 4543 03:11:13,830 --> 03:11:16,800 ARE MODULATED BY HIV AND 4544 03:11:16,800 --> 03:11:26,109 EXPOSURE TO HIV AND 4545 03:11:26,109 --> 03:11:27,377 ANTIRETROVIRALS. 4546 03:11:27,377 --> 03:11:28,879 WE'VE RECEIVED NOTIFICATION OF 4547 03:11:28,879 --> 03:11:30,614 23 ADVANCES PUBLICATIONS, I'M 4548 03:11:30,614 --> 03:11:32,282 NOT GOING OVER EACH BUT I WANT 4549 03:11:32,282 --> 03:11:35,418 TO JUST PROVIDE A SNAPSHOT OF A 4550 03:11:35,418 --> 03:11:36,486 FEW OF THOSE PUBLICATIONS ON 4551 03:11:36,486 --> 03:11:39,723 THIS SLIDE AND ON THE NEXT 4552 03:11:39,723 --> 03:11:39,923 SLIDE. 4553 03:11:39,923 --> 03:11:42,492 YOU ALL WERE PROVIDED MORE 4554 03:11:42,492 --> 03:11:44,661 INFORMATION ABOUT THESE 4555 03:11:44,661 --> 03:11:45,562 PUBLICATIONS IN YOUR BRIEFING 4556 03:11:45,562 --> 03:11:50,267 MATERIALS FOR YOU TO READ AT 4557 03:11:50,267 --> 03:11:51,568 YOUR LEISURE. 4558 03:11:51,568 --> 03:11:52,803 AND WITH THAT I THANK YOU FOR 4559 03:11:52,803 --> 03:11:55,071 YOUR TIME AND I WILL TURN IT 4560 03:11:55,071 --> 03:12:03,413 BACK OVER TO DR. TURNBULL. 4561 03:12:03,413 --> 03:12:03,980 4562 03:12:03,980 --> 03:12:05,148 >> THANK YOU. 4563 03:12:05,148 --> 03:12:07,751 FINAL UPDATE FOR TODAY WILL COME 4564 03:12:07,751 --> 03:12:11,521 FROM THE HIV CLINICAL GUIDELINES 4565 03:12:11,521 --> 03:12:13,623 WORKING GROUP OF OARAC. 4566 03:12:13,623 --> 03:12:20,497 INCLUDING GUIDELINES AND PANEL 4567 03:12:20,497 --> 03:12:21,364 UPDATES. 4568 03:12:21,364 --> 03:12:24,534 DR. NAHIDA CHVMENTRAKHTOURA WILL 4569 03:12:24,534 --> 03:12:26,536 PROVIDE AN UPDATE ON THE 4570 03:12:26,536 --> 03:12:27,404 GUIDELINES. 4571 03:12:27,404 --> 03:12:28,238 OVER TO YOU. 4572 03:12:28,238 --> 03:12:30,207 >> THANK YOU. 4573 03:12:30,207 --> 03:12:35,912 I'M PRESENTING ON BEHALF OF DR. 4574 03:12:35,912 --> 03:12:38,448 HASRA, THE EXECUTIVE SECRETARY 4575 03:12:38,448 --> 03:12:39,783 FOR PEDIATRIC GUIDELINES. 4576 03:12:39,783 --> 03:12:40,784 THANK YOU. 4577 03:12:40,784 --> 03:12:43,386 NEXT SLIDE PLEASE. 4578 03:12:43,386 --> 03:12:46,790 THESE GUIDELINES WILL BE UPDATED 4579 03:12:46,790 --> 03:12:49,659 THIS MONTH, SECTION UPDATES ARE 4580 03:12:49,659 --> 03:12:50,794 BEING FINALIZED AND SHOULD BE 4581 03:12:50,794 --> 03:12:56,032 LIVE IN A COUPLE OF WEEKS. 4582 03:12:56,032 --> 03:13:02,706 NEXT SLIDE PLEASE. 4583 03:13:02,706 --> 03:13:05,208 SO, WE PRESENTED PERINATAL 4584 03:13:05,208 --> 03:13:07,277 GUIDELINES AT LAST OARAC, THERE 4585 03:13:07,277 --> 03:13:09,579 WERE THREE SECTIONS DEVELOPED IN 4586 03:13:09,579 --> 03:13:11,548 COLLABORATION WITH THE PEDIATRIC 4587 03:13:11,548 --> 03:13:14,150 PANEL, AND THOSE WILL BE PLANNED 4588 03:13:14,150 --> 03:13:18,088 TO BE PUBLISHED IN THIS CYCLE SO 4589 03:13:18,088 --> 03:13:19,422 INFANT FEEDING FOR INDIVIDUALS 4590 03:13:19,422 --> 03:13:21,858 WITH HIV DIAGNOSIS OF HIV 4591 03:13:21,858 --> 03:13:23,026 INFECTION AND INFANTS AND 4592 03:13:23,026 --> 03:13:26,630 CHILDREN AND THEN THE 4593 03:13:26,630 --> 03:13:27,964 ANTIRETROVIRAL MANAGEMENT WITH 4594 03:13:27,964 --> 03:13:30,267 PERINATAL HIV EXPOSURE WILL BE 4595 03:13:30,267 --> 03:13:34,537 UPDATED IN THIS UPCOMING CYCLE. 4596 03:13:34,537 --> 03:13:35,939 NEXT SLIDE. 4597 03:13:35,939 --> 03:13:38,608 AND THEY WELCOMED SEVERAL NEW 4598 03:13:38,608 --> 03:13:44,514 MEMBERS IN THIS CYCLE, DR. AZIZ 4599 03:13:44,514 --> 03:13:54,958 FROM RUSH UNIVERSITY, DR. 4600 03:13:58,161 --> 03:14:00,864 DIRAJILAL-FARGO FROM LURIE AND 4601 03:14:00,864 --> 03:14:05,902 DR. GRIFFITH FROM JOHNS HOPKINS 4602 03:14:05,902 --> 03:14:11,241 UNIVERSITY, DR. ANDERSON FROM 4603 03:14:11,241 --> 03:14:17,881 UNIVERSITY OF COLORADO, DR. 4604 03:14:17,881 --> 03:14:22,185 ETHEL WELD, FROM JOHNS HOPKINS. 4605 03:14:22,185 --> 03:14:24,587 AND DR. BYRD FROM CDC 4606 03:14:24,587 --> 03:14:27,657 REPRESENTING THE ADULT AND 4607 03:14:27,657 --> 03:14:28,892 PEDIATRIC INFECTIOUS DISEASE. 4608 03:14:28,892 --> 03:14:34,130 AND THEY HAVE SEVERAL RETIRING 4609 03:14:34,130 --> 03:14:35,865 OR MEMBERS WHO RESIGNED, 4610 03:14:35,865 --> 03:14:38,935 INDIVIDUALS THAT WERE SELECTED 4611 03:14:38,935 --> 03:14:41,671 WERE REPLACING SPECIALISTS THAT 4612 03:14:41,671 --> 03:14:43,740 HAD EITHER RESIGNED OR AGAIN 4613 03:14:43,740 --> 03:14:49,379 RETIRED FOR THE 2023 CYCLE. 4614 03:14:49,379 --> 03:14:52,182 SPECIFIC GUIDELINES, SECTIONS 4615 03:14:52,182 --> 03:14:55,585 THAT WILL BE REVISED THROUGHOUT 4616 03:14:55,585 --> 03:14:57,454 GUIDELINES TO INCORPORATE 4617 03:14:57,454 --> 03:14:58,888 UPDATED TEXT AND REFERENCES FOR 4618 03:14:58,888 --> 03:15:02,025 CLINICAL LABORATORY MONITORING 4619 03:15:02,025 --> 03:15:03,827 OF PEDIATRIC INFECTIONS UPDATED 4620 03:15:03,827 --> 03:15:05,562 UPDATES TO ADDRESS RECOMMENDED 4621 03:15:05,562 --> 03:15:14,237 BASELINE SCREENING TESTS FOR 4622 03:15:14,237 --> 03:15:18,575 CO-INFECTION AND OPPORTUNISTIC 4623 03:15:18,575 --> 03:15:19,776 INFECTIONS. 4624 03:15:19,776 --> 03:15:22,612 AND NEW DATA REAFFIRMED 4625 03:15:22,612 --> 03:15:24,581 ADDITIONAL EVIDENCE TO SUPPORT 4626 03:15:24,581 --> 03:15:25,682 NEURODEVELOPMENTAL AND IMMUNE 4627 03:15:25,682 --> 03:15:28,518 BENEFITS ASSOCIATED WITH EARLY 4628 03:15:28,518 --> 03:15:29,986 INITIATION OF ART. 4629 03:15:29,986 --> 03:15:34,224 THAT WILL BE HIGHLIGHTED. 4630 03:15:34,224 --> 03:15:36,426 NEXT SLIDE. 4631 03:15:36,426 --> 03:15:41,131 WHAT TO START SECTION WAS 4632 03:15:41,131 --> 03:15:42,665 RECOMMENDATIONS FOR INITIAL ART 4633 03:15:42,665 --> 03:15:43,533 PRESENTED, NOW DISCUSSED BY AGE 4634 03:15:43,533 --> 03:15:46,636 GROUP SO BIRTH TO LESS THAN 30 4635 03:15:46,636 --> 03:15:53,276 DAYS, 30 DAYS UP TO 2 YEARS, 2 4636 03:15:53,276 --> 03:15:56,012 YEARS AND ABOVE TO 12 YEARS, AND 4637 03:15:56,012 --> 03:15:58,548 12 YEARS AND ABOVE RATHER THAN 4638 03:15:58,548 --> 03:16:01,918 BY ARV DRUG CLASS SO THEY ADDED 4639 03:16:01,918 --> 03:16:03,720 A CONTENT ADDRESSING PRACTICAL 4640 03:16:03,720 --> 03:16:06,923 CONSIDERATIONS IN THE DRUG 4641 03:16:06,923 --> 03:16:09,559 REGIMEN SELECTION AND 4642 03:16:09,559 --> 03:16:10,894 IMPLEMENTATION FOR INITIAL ART, 4643 03:16:10,894 --> 03:16:13,096 NEW TABLES TO SUMMARIZE FACTORS 4644 03:16:13,096 --> 03:16:15,231 TO CONSIDER IN REGIMEN 4645 03:16:15,231 --> 03:16:18,101 SELECTION, AND ADVANTAGES AND 4646 03:16:18,101 --> 03:16:18,935 DISADVANTAGES OF REGIMENS 4647 03:16:18,935 --> 03:16:20,170 RECOMMENDED FOR INFANTS FROM 4648 03:16:20,170 --> 03:16:23,673 BIRTH TO LESS THAN 30 DAYS OF 4649 03:16:23,673 --> 03:16:24,040 AGE. 4650 03:16:24,040 --> 03:16:27,310 ALSO UPDATES TO REFERRED AND 4651 03:16:27,310 --> 03:16:29,179 ALTERNATIVE ART REGIMENS AND 4652 03:16:29,179 --> 03:16:30,713 ARVs THAT WERE SUMMARIZED AND 4653 03:16:30,713 --> 03:16:39,222 UPDATED IN THE VARIOUS TABLES, 4654 03:16:39,222 --> 03:16:43,860 TABLE 8, TABLE B. 4655 03:16:43,860 --> 03:16:51,601 NEXT WERE PANEL RECOMMENDED 4656 03:16:51,601 --> 03:16:52,802 RECOMMENDATION AROUND 4657 03:16:52,802 --> 03:16:54,104 BICTEGRAVIR IN INFANTS AND 4658 03:16:54,104 --> 03:16:59,342 CHILDREN AGED 30 DAYS AND ABOVE 4659 03:16:59,342 --> 03:17:03,413 AND WEIGHING ABOVE 3 KILOGRAMS 4660 03:17:03,413 --> 03:17:10,220 OR ABOVE WHENEVER POSSIBLE. 4661 03:17:10,220 --> 03:17:14,457 CHANGES TO ABACAVIR FOR INFANTS 4662 03:17:14,457 --> 03:17:17,660 LESS THAN 30 DAYS TO AVOID 4663 03:17:17,660 --> 03:17:21,030 DELAYS WITH HLA TESTING PRIOR TO 4664 03:17:21,030 --> 03:17:21,598 USE. 4665 03:17:21,598 --> 03:17:23,032 NEXT SLIDE. 4666 03:17:23,032 --> 03:17:27,036 UPDATES WERE INCLUDED FOR 4667 03:17:27,036 --> 03:17:28,238 ADHERENCE TO ANTIRETROVIRAL 4668 03:17:28,238 --> 03:17:29,706 THERAPY, PANEL RECOMMENDS 4669 03:17:29,706 --> 03:17:36,045 DISCUSSING OPTION OF LONG ACTING 4670 03:17:36,045 --> 03:17:37,614 INJECTABLE THERAPY TO SUPPORT 4671 03:17:37,614 --> 03:17:39,115 ADHERENCE WITH ELIGIBLE PATIENTS 4672 03:17:39,115 --> 03:17:47,423 AND CAREGIVERS. 4673 03:17:47,423 --> 03:17:51,361 MANAGEMENT OF CHILDREN RECEIVING 4674 03:17:51,361 --> 03:17:54,931 ART TO INCORPORATE IN LINE WITH 4675 03:17:54,931 --> 03:17:55,965 APPROVAL AND RECOMMENDATION, AND 4676 03:17:55,965 --> 03:17:58,902 PANEL RECOMMENDATIONS HAVE BEEN 4677 03:17:58,902 --> 03:18:00,270 UPDATED TO UNDERSCORE THAT 4678 03:18:00,270 --> 03:18:03,506 TREATMENT INTERRUPTION IS NOT 4679 03:18:03,506 --> 03:18:05,441 RECOMMENDED AS STRATEGY TO 4680 03:18:05,441 --> 03:18:08,778 CONFIRM DIAGNOSIS AND/OR ASSESS 4681 03:18:08,778 --> 03:18:11,648 REEMISSION OR CURE IN CLINICAL 4682 03:18:11,648 --> 03:18:13,483 SETTINGS AND CONTENT ABOUT 4683 03:18:13,483 --> 03:18:14,250 MITIGATING UNPLANNED 4684 03:18:14,250 --> 03:18:18,321 INTERRUPTION TO TREATMENT, 4685 03:18:18,321 --> 03:18:21,157 THAT'S BEEN EXPANDED. 4686 03:18:21,157 --> 03:18:28,464 AND PEDIATRIC DRUG SESSION FIXED 4687 03:18:28,464 --> 03:18:31,467 DOSE SECTION HAS NOW FDA 4688 03:18:31,467 --> 03:18:33,102 APPROVAL DOSING FOR INFANTS, AND 4689 03:18:33,102 --> 03:18:37,707 CHILDREN AGE 3 MONTHS AND ABOVE, 4690 03:18:37,707 --> 03:18:40,777 AND WEIGHING 6 KILOGRAMS OR 4691 03:18:40,777 --> 03:18:50,119 ABOVE TO LESS THAN 25 KILOGRAMS, 4692 03:18:50,119 --> 03:18:54,924 FDC D TY/LAMIVUDINE IS NOW 4693 03:18:54,924 --> 03:18:58,661 APPROVED, 25 KILOGRAMS OR ABOVE. 4694 03:18:58,661 --> 03:19:01,164 AND THEN THE ORAL SOLUTION NO 4695 03:19:01,164 --> 03:19:06,436 LONGER AVAILABLE SO 4696 03:19:06,436 --> 03:19:07,103 100-MILLIGRAM PACKETS ARE 4697 03:19:07,103 --> 03:19:08,871 AVAILABLE FOR CHILDREN NOT ABLE 4698 03:19:08,871 --> 03:19:13,142 TO SWALLOW PILLS AND VARIOUS 4699 03:19:13,142 --> 03:19:13,810 DOSING ADJUSTED. 4700 03:19:13,810 --> 03:19:15,345 THIS MAY BE THE LAST SLIDE. 4701 03:19:15,345 --> 03:19:15,712 YES. 4702 03:19:15,712 --> 03:19:17,280 THANK YOU VERY MUCH. 4703 03:19:17,280 --> 03:19:19,415 I'M HAPPY TO TAKE QUESTIONS BUT 4704 03:19:19,415 --> 03:19:22,952 ALSO HAPPY THAT DR. ELAINE 4705 03:19:22,952 --> 03:19:29,192 ABRAMS WHO IS ON THE PERINATAL 4706 03:19:29,192 --> 03:19:30,059 COMMITTEE CAN ANSWER QUESTIONS 4707 03:19:30,059 --> 03:19:33,129 RELATED TO PEDIATRIC AND NOT 4708 03:19:33,129 --> 03:19:33,396 PERINATAL. 4709 03:19:33,396 --> 03:19:34,464 THANK YOU. 4710 03:19:34,464 --> 03:19:36,432 AND ANYTHING TO ADD, ELAINE, 4711 03:19:36,432 --> 03:19:39,702 THAT I MAY HAVE MISSED? 4712 03:19:39,702 --> 03:19:43,106 4713 03:19:43,106 --> 03:19:44,173 THANK YOU. 4714 03:19:44,173 --> 03:19:47,410 BACK TO YOU IF THERE ARE NO 4715 03:19:47,410 --> 03:19:50,880 QUESTIONS, DR. TURNBULL. 4716 03:19:50,880 --> 03:19:52,315 >> THANK YOU SO MUCH. 4717 03:19:52,315 --> 03:19:56,152 AS WE BEGIN TO CLOSE, REMINDER 4718 03:19:56,152 --> 03:19:58,121 THAT THIS HAS BEEN -- THIS TIME 4719 03:19:58,121 --> 03:20:00,056 HAS BEEN ALLOTTED FOR PUBLIC 4720 03:20:00,056 --> 03:20:00,423 COMMENT. 4721 03:20:00,423 --> 03:20:01,824 DR. GLENSHAW, HAVE YOU RECEIVED 4722 03:20:01,824 --> 03:20:04,994 ANY COMMENTS FOR TODAY'S 4723 03:20:04,994 --> 03:20:05,662 MEETING? 4724 03:20:05,662 --> 03:20:10,400 >> YES, I HAVE TWO. 4725 03:20:10,400 --> 03:20:10,933 >> OKAY. 4726 03:20:10,933 --> 03:20:12,368 >> IF YOU COULD PUT THE FIRST 4727 03:20:12,368 --> 03:20:14,904 ONE ON THE SCREEN. 4728 03:20:14,904 --> 03:20:17,607 THIS WAS RECEIVED FROM THE WELL 4729 03:20:17,607 --> 03:20:18,508 PROJECT, FOR TODAY'S MEETING. 4730 03:20:18,508 --> 03:20:19,942 WE WILL SHOW IT ON THE SCREEN 4731 03:20:19,942 --> 03:20:23,713 BUT ALSO READ IT OUT LOUD. 4732 03:20:23,713 --> 03:20:26,049 FROM THE WELL PROJECT, TODAY, 4733 03:20:26,049 --> 03:20:26,649 JUNE 20, 2024. 4734 03:20:26,649 --> 03:20:29,352 THE WELL PROJECT IS A NON-PROFIT 4735 03:20:29,352 --> 03:20:30,553 ORGANIZATION WHOSE MISSION IS TO 4736 03:20:30,553 --> 03:20:33,089 CHANGE THE COURSE OF THE HEARING 4737 03:20:33,089 --> 03:20:35,024 AIDS PANDEMIC THROUGH A UNIQUE 4738 03:20:35,024 --> 03:20:36,993 AND COMPREHENSIVE FOCUS ON WOMEN 4739 03:20:36,993 --> 03:20:39,395 AND GIRLS ACROSS THE GENDER 4740 03:20:39,395 --> 03:20:39,962 SPECTRUM. 4741 03:20:39,962 --> 03:20:41,030 THE WELL PROJECT ENVISIONS A 4742 03:20:41,030 --> 03:20:43,700 WORLD IN WHICH WOMEN HAVE THE 4743 03:20:43,700 --> 03:20:44,767 INFORMATION, SUPPORT, TOOLS THEY 4744 03:20:44,767 --> 03:20:46,302 NEED TO ADVOCATE FOR THEIR 4745 03:20:46,302 --> 03:20:48,404 HEALTH AND WELL-BEING AND TO 4746 03:20:48,404 --> 03:20:50,139 LIVE FREE FROM STIGMA. 4747 03:20:50,139 --> 03:20:52,208 WE UNAPOLL JET REALLY FOCUS ON 4748 03:20:52,208 --> 03:20:53,576 THE UNIQUE INTERSECTIONAL NEEDS 4749 03:20:53,576 --> 03:20:55,178 OF WOMEN ACROSS THE GENDER 4750 03:20:55,178 --> 03:20:58,047 SPECTRUM LIVING WITH AND 4751 03:20:58,047 --> 03:20:58,815 VULNERABLE TO HIV, CENTERING 4752 03:20:58,815 --> 03:21:01,317 BLACK WOMEN AND OTHER WOMEN OF 4753 03:21:01,317 --> 03:21:02,885 COLOR. 4754 03:21:02,885 --> 03:21:04,087 OUR HIGHLY RESPONSIVE 4755 03:21:04,087 --> 03:21:06,389 PROGRAMMING AIMS TO IMPROVE 4756 03:21:06,389 --> 03:21:09,192 AGENCY, HEALTH, AND WELLNESS 4757 03:21:09,192 --> 03:21:10,293 AMONG WOMEN LIVING WITH AND 4758 03:21:10,293 --> 03:21:13,696 VULNERABLE TO HIV BY ADVANCING 4759 03:21:13,696 --> 03:21:15,998 WOMEN-SPECIFIC HIV EDUCATION, 4760 03:21:15,998 --> 03:21:17,333 SUPPORT, RESEARCH, AND POLICY; 4761 03:21:17,333 --> 03:21:20,169 AND ADDRESS THE MOST URGENT GAPS 4762 03:21:20,169 --> 03:21:22,472 IDENTIFIED BY OUR DIVERTS 4763 03:21:22,472 --> 03:21:26,976 COMMUNITY OF STAKEHOLDERS. 4764 03:21:26,976 --> 03:21:30,580 WHILE WE ADDRESS ISSUES WITH 4765 03:21:30,580 --> 03:21:31,681 HIV, WE'VE HIGHLIGHTED SEVERAL 4766 03:21:31,681 --> 03:21:31,981 PRIORITIES. 4767 03:21:31,981 --> 03:21:34,183 FIRST ENSURE THAT WOMEN AND 4768 03:21:34,183 --> 03:21:35,585 OTHER BIRTHING PARENTS LIVING 4769 03:21:35,585 --> 03:21:37,253 WITH HIV CAN EXPERIENCE THEIR 4770 03:21:37,253 --> 03:21:40,757 FUNDAMENTAL RIGHTS TO MAKE 4771 03:21:40,757 --> 03:21:42,925 INFORMED, SUPPORTED, UNCOERCED 4772 03:21:42,925 --> 03:21:43,893 INFANT-FEEDING DECISIONS. 4773 03:21:43,893 --> 03:21:45,561 DOING SO WILL REQUIRE RESEARCH 4774 03:21:45,561 --> 03:21:48,664 TO ADDRESS KNOWLEDGE GAPS AND 4775 03:21:48,664 --> 03:21:49,298 DISSEMINATION OF EVIDENCE-BASED 4776 03:21:49,298 --> 03:21:50,700 INFORMATION TO BOTH PARENTS 4777 03:21:50,700 --> 03:21:53,336 LIVING WITH HIV AND HEALTHCARE 4778 03:21:53,336 --> 03:21:56,739 PROVIDERS THAT AFFIRMS SHARED 4779 03:21:56,739 --> 03:21:57,707 DECISION-MAKING AND BODILY 4780 03:21:57,707 --> 03:22:01,210 AUTONOMY AND ADDRESSES RECENT 4781 03:22:01,210 --> 03:22:03,079 GUIDELINE UPDATES. 4782 03:22:03,079 --> 03:22:03,846 SECOND, INTEGRATE SEXUAL AND 4783 03:22:03,846 --> 03:22:05,815 REPRODUCTIVE HEALTH INCLUDING 4784 03:22:05,815 --> 03:22:07,884 SEX POSITIVITY AND PLEASURE, 4785 03:22:07,884 --> 03:22:10,486 INTO WOMEN-FOLKED HIV CARE, 4786 03:22:10,486 --> 03:22:11,587 PREVENTION, EDUCATION EFFORTS. 4787 03:22:11,587 --> 03:22:13,656 THIS APPROACH TO WOMEN'S OVERALL 4788 03:22:13,656 --> 03:22:16,726 WELLNESS SHOULD BE HOLISTIC, 4789 03:22:16,726 --> 03:22:17,393 ADDRESSING BIOMEDICAL, 4790 03:22:17,393 --> 03:22:18,728 BEHAVIORAL, SOCIAL AS 4791 03:22:18,728 --> 03:22:22,865 SECRETARIES OF HEALTH, AND SHIFT 4792 03:22:22,865 --> 03:22:23,766 THE LANGUAGE OF RISK AROUND 4793 03:22:23,766 --> 03:22:27,370 VULNERABLE TO HIV TO A FRAMEWORK 4794 03:22:27,370 --> 03:22:29,439 THAT PRIORITIZES AGENCY. 4795 03:22:29,439 --> 03:22:31,607 THIRD, ADDRESS GAPS IN RESEARCH, 4796 03:22:31,607 --> 03:22:33,810 PROGRAMMING, AND CARE FOR WOMEN 4797 03:22:33,810 --> 03:22:37,346 AGING WITH HIV ACROSS THE 4798 03:22:37,346 --> 03:22:38,414 LIFESPAN, INCLUDING LIFETIME 4799 03:22:38,414 --> 03:22:39,682 SURVIVORS, WOMEN WHO ACQUIRED 4800 03:22:39,682 --> 03:22:44,253 HIV AT BIRTH OR IN INFANCY. 4801 03:22:44,253 --> 03:22:45,154 THIS AGENDA SHOULD INCLUDE 4802 03:22:45,154 --> 03:22:46,989 RESEARCH ON EFFECT IT'S OF 4803 03:22:46,989 --> 03:22:48,758 LONG-TERM HIV TREATMENT ON 4804 03:22:48,758 --> 03:22:50,593 ACCELERATED AGING AMONG WOMEN 4805 03:22:50,593 --> 03:22:51,561 AND PRIOR TIDES UNIQUE MENTAL 4806 03:22:51,561 --> 03:22:56,199 HEALTH NEEDS OF OLDER WOMEN AND 4807 03:22:56,199 --> 03:22:57,066 LIFETIME SURVIVORS. 4808 03:22:57,066 --> 03:22:58,801 FOURTH, ATTEND TO THE 4809 03:22:58,801 --> 03:23:00,102 BIOMEDICAL, BEHAVIORAL, AND 4810 03:23:00,102 --> 03:23:04,674 SOCIAL ASPECTS OF HIV IN WOMEN'S 4811 03:23:04,674 --> 03:23:06,042 LIVES THROUGH RESEARCH. 4812 03:23:06,042 --> 03:23:08,110 PARTNER WITH COMMUNITY TO ENSURE 4813 03:23:08,110 --> 03:23:09,779 TRULY MEANINGFUL AND EQUITABLE 4814 03:23:09,779 --> 03:23:10,746 ENGAGEMENT OF ALL RELEVANT 4815 03:23:10,746 --> 03:23:12,281 POPULATIONS OF WOMEN IN HIV 4816 03:23:12,281 --> 03:23:13,483 RESEARCH INCLUDING BLACK WOMEN 4817 03:23:13,483 --> 03:23:15,885 AND OTHER WOMEN OF COLOR, WOMEN 4818 03:23:15,885 --> 03:23:17,887 AND OTHER BIRTHING PARENTS WHO 4819 03:23:17,887 --> 03:23:21,157 ARE PREGNANT OR LACTATING, WOMEN 4820 03:23:21,157 --> 03:23:22,358 OF TRANS EXPERIENCE, LIFE 4821 03:23:22,358 --> 03:23:23,559 SOMETIME TIME SURVIVORS, WOMEN 4822 03:23:23,559 --> 03:23:27,497 WHO USE DRUGS, AND SEX WORKERS. 4823 03:23:27,497 --> 03:23:29,765 IN CLOSING THEY STATE ENSURING 4824 03:23:29,765 --> 03:23:31,234 THAT HIV AGENDA ADDRESSES NEEDS 4825 03:23:31,234 --> 03:23:33,402 OF WOMEN LIVING WITH AND 4826 03:23:33,402 --> 03:23:35,171 VULNERABLE TO HIV REQUIRES 4827 03:23:35,171 --> 03:23:36,539 CONCERTED PARTNERSHIPS THAT 4828 03:23:36,539 --> 03:23:37,974 CENTER THE LIVES AND EXPERIENCES 4829 03:23:37,974 --> 03:23:43,579 OF DIVERSE POPULATIONS OF WOMEN 4830 03:23:43,579 --> 03:23:46,115 ACROSS ALL HIV STAKEHOLDERS. 4831 03:23:46,115 --> 03:23:52,722 THE SECOND PUBLIC COMMENT IS 4832 03:23:52,722 --> 03:23:54,824 FROM A PROFESSOR AT THE STATE 4833 03:23:54,824 --> 03:23:59,395 UNIVERSITY COLLEGE OF NEW YORK 4834 03:23:59,395 --> 03:24:00,830 AT BUFFALO. 4835 03:24:00,830 --> 03:24:05,968 AND SHE STATES, TODAY'S OARAC 4836 03:24:05,968 --> 03:24:07,069 MEETING HAD INSITES THAT ARE 4837 03:24:07,069 --> 03:24:09,472 AVAILABLE ESPECIALLY PRIORITIES 4838 03:24:09,472 --> 03:24:14,076 OF OAR. 4839 03:24:14,076 --> 03:24:16,312 OUR COMMITMENT IS COMMENDABLE. 4840 03:24:16,312 --> 03:24:19,015 SHE REFERENCES WHERE SHE AND I 4841 03:24:19,015 --> 03:24:23,052 MET, AT THE HIV PREVENTION -- 4842 03:24:23,052 --> 03:24:25,021 MEDICAL PREVENTION SUMMIT 4843 03:24:25,021 --> 03:24:27,757 RECENTLY IN SEATTLE, AND SHE 4844 03:24:27,757 --> 03:24:29,258 STATES AFRICAN AMERICAN 4845 03:24:29,258 --> 03:24:30,192 IMMIGRANTS OFTEN FACE UNIQUE 4846 03:24:30,192 --> 03:24:31,861 CHALLENGES AND BARRIERS IN 4847 03:24:31,861 --> 03:24:35,131 ACCESSING HIV PREVENTION AND 4848 03:24:35,131 --> 03:24:37,633 CARE SERVICES, THESE CAN INCLUDE 4849 03:24:37,633 --> 03:24:38,968 CULTURAL STIGMA, LANGUAGE 4850 03:24:38,968 --> 03:24:40,269 DIFFERENCE, LIMITED ACCESS TO 4851 03:24:40,269 --> 03:24:44,206 HEALTH CARE RESOURCES. 4852 03:24:44,206 --> 03:24:45,641 AS WE CONTINUE DISCUSSIONS IT IS 4853 03:24:45,641 --> 03:24:47,410 CRUCIAL TO INCLUDE AFRICAN 4854 03:24:47,410 --> 03:24:49,745 AMERICAN IMMIGRANTS IN THE 4855 03:24:49,745 --> 03:24:52,315 CONVERSATION TO ENSURE -- 4856 03:24:52,315 --> 03:24:53,583 AFRICAN IMMIGRANTS IN THE 4857 03:24:53,583 --> 03:24:53,916 CONVERSATION. 4858 03:24:53,916 --> 03:24:55,818 THEY ARE DEVELOPING STRATEGIES 4859 03:24:55,818 --> 03:24:59,655 TO INCREASE HIV TESTING AND 4860 03:24:59,655 --> 03:25:02,525 PrEP AMONG UNDERREPRESENTED 4861 03:25:02,525 --> 03:25:04,694 POPULATIONS, PARTICULARLY 4862 03:25:04,694 --> 03:25:07,063 AFRICAN IMMIGRANTS, PRELIMINARY 4863 03:25:07,063 --> 03:25:08,464 FINDINGS INDICATE WILLINGNESS TO 4864 03:25:08,464 --> 03:25:10,299 ADOPT PrEP FOR HIV PREVENTION. 4865 03:25:10,299 --> 03:25:13,035 AND I BELIEVE THAT CONCLUDES ALL 4866 03:25:13,035 --> 03:25:19,041 OF THE PUBLIC COMMENTS. 4867 03:25:19,041 --> 03:25:19,642 THANK YOU. 4868 03:25:19,642 --> 03:25:25,982 >> I THANK YOU, DR. GLENSHAW. 4869 03:25:25,982 --> 03:25:27,817 I THINK WE'RE NOW TO THE PORTION 4870 03:25:27,817 --> 03:25:31,220 TO TALK ABOUT THE OARAC MEMBERS 4871 03:25:31,220 --> 03:25:32,288 TO RETURN THEIR CONFLICT OF 4872 03:25:32,288 --> 03:25:33,723 INTEREST FORMS. 4873 03:25:33,723 --> 03:25:35,691 DO YOU WANT TO TAKE THAT? 4874 03:25:35,691 --> 03:25:36,826 >> SURE, YES. 4875 03:25:36,826 --> 03:25:38,127 THANK YOU. 4876 03:25:38,127 --> 03:25:39,562 FOR VOTING MEMBERS KINDLY CHECK 4877 03:25:39,562 --> 03:25:42,064 YOUR E-MAIL AND PLEASE SIGN AND 4878 03:25:42,064 --> 03:25:43,265 RETURN THE FORMS THAT WE SENT 4879 03:25:43,265 --> 03:25:51,440 YOU TODAY. 4880 03:25:51,440 --> 03:25:53,576 >> OUR NEXT OARAC MEETING PLEASE 4881 03:25:53,576 --> 03:25:57,013 NOTE IS SCHEDULED FOR OCTOBER 4882 03:25:57,013 --> 03:25:57,279 24, 2024. 4883 03:25:57,279 --> 03:25:59,382 >> IT WILL BE A VIRTUAL MEETING 4884 03:25:59,382 --> 03:26:02,118 AT THIS POINT. 4885 03:26:02,118 --> 03:26:04,820 4886 03:26:04,820 --> 03:26:06,589 >> IF YOU COULD GIVE US A 4887 03:26:06,589 --> 03:26:08,791 CLOSING STATEMENT WE CAN 4888 03:26:08,791 --> 03:26:10,226 CONCLUDE TODAY'S MEETING. 4889 03:26:10,226 --> 03:26:12,561 >> SO, I WANTED TO END BY 4890 03:26:12,561 --> 03:26:15,564 THANKING ALL OF THE SPEAKERS SO 4891 03:26:15,564 --> 03:26:15,765 MUCH. 4892 03:26:15,765 --> 03:26:18,968 REALLY, WHAT A WONDERFUL SET OF 4893 03:26:18,968 --> 03:26:19,769 PRESENTATIONS. 4894 03:26:19,769 --> 03:26:23,205 AND ON ALL TOPICS. 4895 03:26:23,205 --> 03:26:25,041 SO VERY HEARTFELT THANK YOU TO 4896 03:26:25,041 --> 03:26:28,911 ALL OF THE SPEAKERS AND ALSO TO 4897 03:26:28,911 --> 03:26:34,483 DR. IVY TURNBULL. 4898 03:26:34,483 --> 03:26:36,585 THANK YOU FOR YOUR WORK AS CHAIR 4899 03:26:36,585 --> 03:26:38,187 PERSON ON THIS COMMITTEE. 4900 03:26:38,187 --> 03:26:41,590 WE LOOK FORWARD TO -- THANK YOU 4901 03:26:41,590 --> 03:26:45,127 ALSO TO MARY FOR YOUR WORK ON 4902 03:26:45,127 --> 03:26:45,761 THIS. 4903 03:26:45,761 --> 03:26:47,063 SO, TAKE CARE, EVERYONE. 4904 03:26:47,063 --> 03:26:49,065 AGAIN, THANK YOU ALL SO MUCH. 4905 03:26:49,065 --> 03:26:51,500 WE LOOK FORWARD TO SEEING YOU 4906 03:26:51,500 --> 03:26:56,172 AGAIN AT THE NEXT MEETING IN 4907 03:26:56,172 --> 03:26:56,772 OCTOBER. 4908 03:26:56,772 --> 03:26:57,807 >> THANK YOU, EVERYONE. 4909 03:26:57,807 --> 03:27:04,280 THANK YOU ALSO FOR THE KIND 4910 03:27:04,280 --> 03:27:05,915 WORDS, DR. FINZI'S. 4911 03:27:05,915 --> 03:27:06,716 TODAY'S MEETING IS NOW 4912 03:27:06,716 --> 03:27:07,049 ADJOURNED. 4913 03:27:07,049 --> 03:27:17,049 THANK YOU ALL FOR ATTENDING.